DrugA,DrugB,Interaction,Mechanism,risk_level
Interferon alfa-n1,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gemcitabine.,increase,risk
Interferon alfa-n1,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Gemtuzumab ozogamicin.,increase,risk
Interferon alfa-n1,Glatiramer,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Glatiramer.,increase,risk
Interferon alfa-n1,Golimumab,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Golimumab.,increase,risk
Interferon alfa-n1,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Guselkumab,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Guselkumab.,increase,risk
Interferon alfa-n1,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone acetate.,increase,risk
Interferon alfa-n1,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone butyrate.,increase,risk
Interferon alfa-n1,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydrocortisone succinate.,increase,risk
Interferon alfa-n1,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydroxychloroquine.,increase,risk
Interferon alfa-n1,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Hydroxyurea.,increase,risk
Interferon alfa-n1,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Obinutuzumab.,increase,risk
Interferon alfa-n1,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ocrelizumab.,increase,risk
Interferon alfa-n1,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ofatumumab.,increase,risk
Interferon alfa-n1,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Olaparib,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Olaparib.,increase,risk
Interferon alfa-n1,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Oxaliplatin.,increase,risk
Interferon alfa-n1,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Ozanimod,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Ozanimod.,increase,risk
Interferon alfa-n1,Quinine,The metabolism of Quinine can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Upadacitinib.,increase,risk
Interferon alfa-n1,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vedolizumab.,increase,risk
Interferon alfa-n1,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Vilanterol,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vilanterol.,increase,risk
Interferon alfa-n1,Vinblastine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vinblastine.,increase,risk
Interferon alfa-n1,Vincristine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vincristine.,increase,risk
Interferon alfa-n1,Vindesine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vindesine.,increase,risk
Interferon alfa-n1,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vinorelbine.,increase,risk
Interferon alfa-n1,Voclosporin,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Voclosporin.,increase,risk
Interferon alfa-n1,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Vorinostat,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Vorinostat.,increase,risk
Interferon alfa-n1,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon alfa-n1.,increase,risk
Interferon alfa-n1,Zidovudine,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Zidovudine.,increase,risk
Interferon alfa-n1,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Interferon alfa-n1,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n1.,decrease,no risk
Darbepoetin alfa,Gefitinib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gefitinib.,increase,risk
Darbepoetin alfa,Gemcitabine,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemcitabine.,increase,risk
Darbepoetin alfa,Gemtuzumab ozogamicin,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gemtuzumab ozogamicin.,increase,risk
Darbepoetin alfa,Gilteritinib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Gilteritinib.,increase,risk
Darbepoetin alfa,Glasdegib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Glasdegib.,increase,risk
Darbepoetin alfa,Goserelin,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Goserelin.,increase,risk
Darbepoetin alfa,Hydroxyprogesterone caproate,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hydroxyprogesterone caproate.,increase,risk
Darbepoetin alfa,Hydroxyurea,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Hydroxyurea.,increase,risk
Darbepoetin alfa,Obinutuzumab,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Obinutuzumab.,increase,risk
Darbepoetin alfa,Octreotide,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Octreotide.,increase,risk
Darbepoetin alfa,Ofatumumab,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Ofatumumab.,increase,risk
Darbepoetin alfa,Olaparib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olaparib.,increase,risk
Darbepoetin alfa,Olaratumab,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olaratumab.,increase,risk
Darbepoetin alfa,Olutasidenib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Olutasidenib.,increase,risk
Darbepoetin alfa,Omacetaxine mepesuccinate,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Omacetaxine mepesuccinate.,increase,risk
Darbepoetin alfa,Osimertinib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Osimertinib.,increase,risk
Darbepoetin alfa,Oxaliplatin,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Oxaliplatin.,increase,risk
Darbepoetin alfa,Quizartinib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Quizartinib.,increase,risk
Darbepoetin alfa,Umbralisib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Umbralisib.,increase,risk
Darbepoetin alfa,Uracil mustard,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Uracil mustard.,increase,risk
Darbepoetin alfa,Urethane,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Urethane.,increase,risk
Darbepoetin alfa,Valproic acid,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Valproic acid.,increase,risk
Darbepoetin alfa,Valrubicin,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Valrubicin.,increase,risk
Darbepoetin alfa,Vandetanib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vandetanib.,increase,risk
Darbepoetin alfa,Vemurafenib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vemurafenib.,increase,risk
Darbepoetin alfa,Venetoclax,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Venetoclax.,increase,risk
Darbepoetin alfa,Vinblastine,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vinblastine.,increase,risk
Darbepoetin alfa,Vincristine,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vincristine.,increase,risk
Darbepoetin alfa,Vindesine,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vindesine.,increase,risk
Darbepoetin alfa,Vinflunine,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vinflunine.,increase,risk
Darbepoetin alfa,Vinorelbine,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vinorelbine.,increase,risk
Darbepoetin alfa,Vismodegib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vismodegib.,increase,risk
Darbepoetin alfa,Vorinostat,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Vorinostat.,increase,risk
Darbepoetin alfa,Zanubrutinib,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Zanubrutinib.,increase,risk
Urokinase,Gemcitabine,The risk or severity of bleeding can be increased when Urokinase is combined with Gemcitabine.,increase,risk
Urokinase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Urokinase is combined with Gemtuzumab ozogamicin.,increase,risk
Urokinase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Urokinase.,increase,risk
Urokinase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Urokinase.,increase,no risk
Urokinase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Urokinase.,increase,risk
Urokinase,Hemin,Hemin may increase the anticoagulant activities of Urokinase.,increase,no risk
Urokinase,Heparin,Urokinase may increase the anticoagulant activities of Heparin.,increase,no risk
Urokinase,Hydrochlorothiazide,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Urokinase,Hydroflumethiazide,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Urokinase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Urokinase.,decrease,no risk
Urokinase,Hydroxyprogesterone caproate,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Urokinase,Hydroxyurea,The risk or severity of bleeding can be increased when Urokinase is combined with Hydroxyurea.,increase,risk
Urokinase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Urokinase.,increase,risk
Urokinase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Urokinase.,increase,risk
Urokinase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Obeticholic acid.,increase,risk
Urokinase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Obinutuzumab.,increase,risk
Urokinase,Olaparib,The risk or severity of bleeding can be increased when Urokinase is combined with Olaparib.,increase,risk
Urokinase,Olive oil,The therapeutic efficacy of Urokinase can be decreased when used in combination with Olive oil.,decrease,no risk
Urokinase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Urokinase.,increase,risk
Urokinase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Urokinase is combined with Omacetaxine mepesuccinate.,increase,risk
Urokinase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Urokinase.,increase,no risk
Urokinase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Urokinase.,increase,risk
Urokinase,Omega-3-carboxylic acids,The therapeutic efficacy of Urokinase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Urokinase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Urokinase.,increase,risk
Urokinase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Urokinase.,increase,risk
Urokinase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Urokinase.,increase,risk
Urokinase,Quinapril,The risk or severity of angioedema can be increased when Urokinase is combined with Quinapril.,increase,risk
Urokinase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Urokinase,Quinidine,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinidine.,increase,no risk
Urokinase,Quinine,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinine.,increase,no risk
Goserelin,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Goserelin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Goserelin.,increase,risk
Goserelin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Goserelin.,increase,risk
Goserelin,Budesonide,Goserelin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Goserelin,Bumadizone,Bumadizone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Bumetanide,Bumetanide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Goserelin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Bupivacaine.,increase,risk
Goserelin,Bupropion,Goserelin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Goserelin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Goserelin.,increase,risk
Goserelin,Buspirone,Goserelin may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Goserelin,Butabarbital,Goserelin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Goserelin,Butacaine,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Butacaine.,increase,risk
Goserelin,Butamben,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Butamben.,increase,risk
Goserelin,Butriptyline,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Butriptyline.,increase,risk
Goserelin,Gabapentin enacarbil,Goserelin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Goserelin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gadobenic acid.,increase,risk
Goserelin,Gadodiamide,Goserelin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Goserelin,Gadofosveset trisodium,Goserelin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Goserelin,Gadopentetic acid,Goserelin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Goserelin,Gadoteric acid,Goserelin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Goserelin,Gadoteridol,Goserelin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Goserelin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Goserelin.,increase,risk
Goserelin,Ganciclovir,Goserelin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Goserelin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Goserelin.,increase,risk
Goserelin,Gemcitabine,Goserelin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Goserelin,Gemfibrozil,Goserelin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Goserelin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gemifloxacin.,increase,risk
Goserelin,Gentamicin,Goserelin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Goserelin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Goserelin.,increase,risk
Goserelin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Gilteritinib.,increase,risk
Goserelin,Gimeracil,Goserelin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Goserelin,Givosiran,Givosiran may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Glasdegib,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Glasdegib.,increase,risk
Goserelin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Glycerol phenylbutyrate,Goserelin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Goserelin,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Golodirsen,Goserelin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Goserelin,Granisetron,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Granisetron.,increase,risk
Goserelin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Grepafloxacin.,increase,risk
Goserelin,Guanethidine,Goserelin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Goserelin,Guanfacine,Goserelin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Goserelin,Halofantrine,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Halofantrine.,increase,risk
Goserelin,Haloperidol,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Haloperidol.,increase,risk
Goserelin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Goserelin.,increase,risk
Goserelin,Hydralazine,Goserelin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Goserelin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Goserelin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Goserelin,Hydromorphone,Goserelin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Goserelin,Hydroxocobalamin,Goserelin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Goserelin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Goserelin.,increase,risk
Goserelin,Hydroxyethyl Starch,Goserelin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Goserelin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Hydroxyzine.,increase,risk
Goserelin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Goserelin.,increase,risk
Goserelin,Kanamycin,Goserelin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Goserelin,Ketamine,Goserelin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Goserelin,Ketazolam,Goserelin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Goserelin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Goserelin.,increase,risk
Goserelin,Ketoprofen,Ketoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Ketorolac,Ketorolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Octinoxate,Goserelin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Goserelin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Goserelin.,increase,risk
Goserelin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ofloxacin.,increase,risk
Goserelin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Goserelin.,increase,risk
Goserelin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Goserelin.,increase,risk
Goserelin,Olsalazine,Olsalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Ondansetron,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ondansetron.,increase,risk
Goserelin,Opium,Goserelin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Goserelin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Goserelin.,increase,risk
Goserelin,Oseltamivir,Goserelin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Goserelin,Oxacillin,Goserelin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Goserelin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Goserelin.,increase,risk
Goserelin,Oxaprozin,Oxaprozin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Oxatomide,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Oxatomide.,increase,risk
Goserelin,Oxazepam,Goserelin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Goserelin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Oxetacaine.,increase,risk
Goserelin,Oxybenzone,Goserelin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Goserelin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Oxybuprocaine.,increase,risk
Goserelin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Oxyquinoline,Goserelin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Goserelin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Goserelin.,increase,risk
Goserelin,Quetiapine,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quetiapine.,increase,risk
Goserelin,Quinethazone,Quinethazone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Goserelin,Quinidine,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinidine.,increase,risk
Goserelin,Quinine,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinine.,increase,risk
Goserelin,Quizartinib,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quizartinib.,increase,risk
Goserelin,Vaborbactam,Goserelin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Goserelin,Valaciclovir,Valaciclovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Valbenazine,Goserelin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Goserelin,Valdecoxib,Valdecoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Goserelin,Valganciclovir,Goserelin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Goserelin,Valproic acid,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Valproic acid.,increase,risk
Goserelin,Vancomycin,Goserelin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Goserelin,Vandetanib,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vandetanib.,increase,risk
Goserelin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Goserelin.,increase,risk
Goserelin,Varenicline,Goserelin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Goserelin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vemurafenib.,increase,risk
Goserelin,Venlafaxine,Goserelin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Goserelin,Verapamil,Goserelin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Goserelin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Goserelin.,increase,risk
Goserelin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Goserelin.,increase,risk
Goserelin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Goserelin,Viloxazine,Goserelin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Goserelin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Goserelin.,increase,risk
Goserelin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Goserelin.,increase,risk
Goserelin,Vortioxetine,Goserelin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Goserelin,Warfarin,Goserelin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Goserelin,Zaleplon,Goserelin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Goserelin,Zanamivir,Goserelin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Goserelin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ziprasidone.,increase,risk
Goserelin,Zonisamide,Zonisamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Goserelin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Zuclopenthixol.,increase,risk
Reteplase,Gemcitabine,The risk or severity of bleeding can be increased when Reteplase is combined with Gemcitabine.,increase,risk
Reteplase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Reteplase is combined with Gemtuzumab ozogamicin.,increase,risk
Reteplase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Reteplase.,increase,risk
Reteplase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Reteplase.,increase,no risk
Reteplase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Reteplase.,increase,risk
Reteplase,Hemin,Hemin may increase the anticoagulant activities of Reteplase.,increase,no risk
Reteplase,Heparin,The risk or severity of bleeding can be increased when Reteplase is combined with Heparin.,increase,risk
Reteplase,Hydrochlorothiazide,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Reteplase,Hydroflumethiazide,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Reteplase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Reteplase.,decrease,no risk
Reteplase,Hydroxyprogesterone caproate,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Reteplase,Hydroxyurea,The risk or severity of bleeding can be increased when Reteplase is combined with Hydroxyurea.,increase,risk
Reteplase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Reteplase.,increase,risk
Reteplase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Reteplase.,increase,risk
Reteplase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Obeticholic acid.,increase,risk
Reteplase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Reteplase is combined with Obinutuzumab.,increase,risk
Reteplase,Olaparib,The risk or severity of bleeding can be increased when Reteplase is combined with Olaparib.,increase,risk
Reteplase,Olive oil,The therapeutic efficacy of Reteplase can be decreased when used in combination with Olive oil.,decrease,no risk
Reteplase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Reteplase.,increase,risk
Reteplase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Reteplase is combined with Omacetaxine mepesuccinate.,increase,risk
Reteplase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Reteplase.,increase,no risk
Reteplase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Reteplase.,increase,risk
Reteplase,Omega-3-carboxylic acids,The therapeutic efficacy of Reteplase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Reteplase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Reteplase.,increase,risk
Reteplase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Reteplase.,increase,risk
Reteplase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Reteplase.,increase,risk
Reteplase,Quinapril,The risk or severity of angioedema can be increased when Reteplase is combined with Quinapril.,increase,risk
Reteplase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Reteplase.,decrease,no risk
Reteplase,Quinidine,The therapeutic efficacy of Reteplase can be increased when used in combination with Quinidine.,increase,no risk
Reteplase,Quinine,The therapeutic efficacy of Reteplase can be increased when used in combination with Quinine.,increase,no risk
Reteplase,Ulipristal,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ulipristal.,decrease,no risk
Reteplase,Urokinase,Urokinase may increase the anticoagulant activities of Reteplase.,increase,no risk
Reteplase,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Ursodeoxycholic acid.,increase,risk
Reteplase,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Reteplase.,increase,risk
Reteplase,Valsartan,The risk or severity of angioedema can be increased when Reteplase is combined with Valsartan.,increase,risk
Reteplase,Venlafaxine,The risk or severity of bleeding can be increased when Reteplase is combined with Venlafaxine.,increase,risk
Reteplase,Vildagliptin,The risk or severity of angioedema can be increased when Reteplase is combined with Vildagliptin.,increase,risk
Reteplase,Vinblastine,The risk or severity of bleeding can be increased when Reteplase is combined with Vinblastine.,increase,risk
Reteplase,Vindesine,The risk or severity of bleeding can be increased when Reteplase is combined with Vindesine.,increase,risk
Reteplase,Vinorelbine,The risk or severity of bleeding can be increased when Reteplase is combined with Vinorelbine.,increase,risk
Reteplase,Vitamin E,Vitamin E may increase the anticoagulant activities of Reteplase.,increase,no risk
Reteplase,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Reteplase.,decrease,no risk
Reteplase,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Reteplase.,increase,risk
Reteplase,Vorinostat,The risk or severity of bleeding can be increased when Reteplase is combined with Vorinostat.,increase,risk
Reteplase,Warfarin,The risk or severity of bleeding can be increased when Reteplase is combined with Warfarin.,increase,risk
Reteplase,Ximelagatran,The risk or severity of bleeding can be increased when Reteplase is combined with Ximelagatran.,increase,risk
Reteplase,Zidovudine,The risk or severity of bleeding can be increased when Reteplase is combined with Zidovudine.,increase,risk
Reteplase,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Reteplase.,increase,risk
Reteplase,Zofenopril,The risk or severity of angioedema can be increased when Reteplase is combined with Zofenopril.,increase,risk
Erythropoietin,Gefitinib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gefitinib.,increase,risk
Erythropoietin,Gemcitabine,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemcitabine.,increase,risk
Erythropoietin,Gemtuzumab ozogamicin,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemtuzumab ozogamicin.,increase,risk
Erythropoietin,Gilteritinib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gilteritinib.,increase,risk
Erythropoietin,Glasdegib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glasdegib.,increase,risk
Erythropoietin,Goserelin,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.,increase,risk
Erythropoietin,Hydroxyprogesterone caproate,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyprogesterone caproate.,increase,risk
Erythropoietin,Hydroxyurea,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyurea.,increase,risk
Erythropoietin,Obinutuzumab,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Obinutuzumab.,increase,risk
Erythropoietin,Octreotide,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Octreotide.,increase,risk
Erythropoietin,Ofatumumab,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ofatumumab.,increase,risk
Erythropoietin,Olaparib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaparib.,increase,risk
Erythropoietin,Olaratumab,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaratumab.,increase,risk
Erythropoietin,Olutasidenib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olutasidenib.,increase,risk
Erythropoietin,Omacetaxine mepesuccinate,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Omacetaxine mepesuccinate.,increase,risk
Erythropoietin,Osimertinib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Osimertinib.,increase,risk
Erythropoietin,Oxaliplatin,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxaliplatin.,increase,risk
Erythropoietin,Quinapril,The serum concentration of Erythropoietin can be decreased when it is combined with Quinapril.,decrease,no risk
Erythropoietin,Quizartinib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Quizartinib.,increase,risk
Erythropoietin,Umbralisib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Umbralisib.,increase,risk
Erythropoietin,Uracil mustard,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Uracil mustard.,increase,risk
Erythropoietin,Urethane,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Urethane.,increase,risk
Erythropoietin,Valproic acid,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valproic acid.,increase,risk
Erythropoietin,Valrubicin,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valrubicin.,increase,risk
Erythropoietin,Vandetanib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vandetanib.,increase,risk
Erythropoietin,Vemurafenib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vemurafenib.,increase,risk
Erythropoietin,Venetoclax,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Venetoclax.,increase,risk
Erythropoietin,Vinblastine,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vinblastine.,increase,risk
Erythropoietin,Vincristine,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vincristine.,increase,risk
Erythropoietin,Vindesine,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vindesine.,increase,risk
Erythropoietin,Vinflunine,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vinflunine.,increase,risk
Erythropoietin,Vinorelbine,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vinorelbine.,increase,risk
Erythropoietin,Vismodegib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vismodegib.,increase,risk
Erythropoietin,Vorinostat,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorinostat.,increase,risk
Erythropoietin,Zanubrutinib,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zanubrutinib.,increase,risk
Erythropoietin,Zofenopril,The serum concentration of Erythropoietin can be decreased when it is combined with Zofenopril.,decrease,no risk
Salmon calcitonin,Gabapentin enacarbil,Salmon calcitonin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gadobenic acid,Salmon calcitonin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gadodiamide,Salmon calcitonin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gadofosveset trisodium,Salmon calcitonin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gadopentetic acid,Salmon calcitonin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gadoteric acid,Salmon calcitonin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gadoteridol,Salmon calcitonin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Ganciclovir,Salmon calcitonin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gefitinib,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gefitinib.,decrease,no risk
Salmon calcitonin,Gemcitabine,Salmon calcitonin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gemfibrozil,Salmon calcitonin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gentamicin,Salmon calcitonin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gilteritinib,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Salmon calcitonin,Gimeracil,Salmon calcitonin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Givosiran,Givosiran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Salmon calcitonin.,decrease,no risk
Salmon calcitonin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Salmon calcitonin.,decrease,no risk
Salmon calcitonin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Salmon calcitonin.,decrease,no risk
Salmon calcitonin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Salmon calcitonin.,decrease,no risk
Salmon calcitonin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Salmon calcitonin.,decrease,no risk
Salmon calcitonin,Glycerol phenylbutyrate,Salmon calcitonin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Golodirsen,Salmon calcitonin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Goserelin,Goserelin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Guanethidine,Salmon calcitonin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Guanfacine,Salmon calcitonin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Haloperidol,Salmon calcitonin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Hydralazine,Salmon calcitonin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Salmon calcitonin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Salmon calcitonin,Hydromorphone,Salmon calcitonin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Hydroxocobalamin,Salmon calcitonin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Hydroxyethyl Starch,Salmon calcitonin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Kanamycin,Salmon calcitonin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Ketamine,Salmon calcitonin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Ketazolam,Salmon calcitonin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Ketoprofen,Ketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Ketorolac,Ketorolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Octinoxate,Salmon calcitonin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Olsalazine,Olsalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Opium,Salmon calcitonin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Salmon calcitonin.,increase,risk
Salmon calcitonin,Oseltamivir,Salmon calcitonin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Osimertinib,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Osimertinib.,decrease,no risk
Salmon calcitonin,Oxacillin,Salmon calcitonin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Oxaprozin,Oxaprozin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Oxazepam,Salmon calcitonin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Oxybenzone,Salmon calcitonin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Salmon calcitonin.,increase,risk
Salmon calcitonin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Oxyquinoline,Salmon calcitonin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Quetiapine,Salmon calcitonin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Quinethazone,Quinethazone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Salmon calcitonin,Quinidine,Salmon calcitonin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Salmon calcitonin,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Quinupramine.,increase,risk
Salmon calcitonin,Quizartinib,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Quizartinib.,decrease,no risk
Interferon alfa-n3,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemcitabine.,increase,risk
Interferon alfa-n3,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemtuzumab ozogamicin.,increase,risk
Interferon alfa-n3,Glatiramer,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Glatiramer.,increase,risk
Interferon alfa-n3,Golimumab,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Golimumab.,increase,risk
Interferon alfa-n3,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Guselkumab,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Guselkumab.,increase,risk
Interferon alfa-n3,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone acetate.,increase,risk
Interferon alfa-n3,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone butyrate.,increase,risk
Interferon alfa-n3,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone succinate.,increase,risk
Interferon alfa-n3,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxychloroquine.,increase,risk
Interferon alfa-n3,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxyurea.,increase,risk
Interferon alfa-n3,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Obinutuzumab.,increase,risk
Interferon alfa-n3,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ocrelizumab.,increase,risk
Interferon alfa-n3,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ofatumumab.,increase,risk
Interferon alfa-n3,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Olaparib,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Olaparib.,increase,risk
Interferon alfa-n3,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Oxaliplatin.,increase,risk
Interferon alfa-n3,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Ozanimod,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ozanimod.,increase,risk
Interferon alfa-n3,Quinine,The metabolism of Quinine can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Upadacitinib.,increase,risk
Interferon alfa-n3,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vedolizumab.,increase,risk
Interferon alfa-n3,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Vilanterol,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vilanterol.,increase,risk
Interferon alfa-n3,Vinblastine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinblastine.,increase,risk
Interferon alfa-n3,Vincristine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vincristine.,increase,risk
Interferon alfa-n3,Vindesine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vindesine.,increase,risk
Interferon alfa-n3,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinorelbine.,increase,risk
Interferon alfa-n3,Voclosporin,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Voclosporin.,increase,risk
Interferon alfa-n3,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Vorinostat,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vorinostat.,increase,risk
Interferon alfa-n3,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon alfa-n3.,increase,risk
Interferon alfa-n3,Zidovudine,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Zidovudine.,increase,risk
Interferon alfa-n3,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Interferon alfa-n3,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n3.,decrease,no risk
Pegfilgrastim,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinblastine.,increase,risk
Pegfilgrastim,Vincristine,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincristine.,increase,risk
Pegfilgrastim,Vindesine,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vindesine.,increase,risk
Pegfilgrastim,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinflunine.,increase,risk
Pegfilgrastim,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine.,increase,risk
Sargramostim,Bleomycin,The risk or severity of adverse effects can be increased when Sargramostim is combined with Bleomycin.,increase,risk
Sargramostim,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinblastine.,increase,risk
Sargramostim,Vincristine,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincristine.,increase,risk
Sargramostim,Vindesine,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vindesine.,increase,risk
Sargramostim,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinflunine.,increase,risk
Sargramostim,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine.,increase,risk
Secretin human,Umeclidinium,The therapeutic efficacy of Secretin human can be decreased when used in combination with Umeclidinium.,decrease,no risk
Secretin human,Vecuronium,The therapeutic efficacy of Secretin human can be decreased when used in combination with Vecuronium.,decrease,no risk
Secretin human,Ziprasidone,The therapeutic efficacy of Secretin human can be decreased when used in combination with Ziprasidone.,decrease,no risk
Peginterferon alfa-2b,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Brodalumab,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brodalumab.,increase,risk
Peginterferon alfa-2b,Bromazepam,The serum concentration of Bromazepam can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Budesonide,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Budesonide.,increase,risk
Peginterferon alfa-2b,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Bupropion,The metabolism of Bupropion can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Buspirone,The metabolism of Buspirone can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Busulfan,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Busulfan.,increase,risk
Peginterferon alfa-2b,Obinutuzumab,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Obinutuzumab.,increase,risk
Peginterferon alfa-2b,Ocrelizumab,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ocrelizumab.,increase,risk
Peginterferon alfa-2b,Ofatumumab,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ofatumumab.,increase,risk
Peginterferon alfa-2b,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Olaparib,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Olaparib.,increase,risk
Peginterferon alfa-2b,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Olodaterol,The metabolism of Olodaterol can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Opium,The metabolism of Opium can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Ospemifene,The metabolism of Ospemifene can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Oxaliplatin,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Oxaliplatin.,increase,risk
Peginterferon alfa-2b,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Ozanimod,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ozanimod.,increase,risk
Peginterferon alfa-2b,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Quinine,The serum concentration of Quinine can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Peginterferon alfa-2b.,increase,risk
Peginterferon alfa-2b,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Upadacitinib,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Upadacitinib.,increase,risk
Peginterferon alfa-2b,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2b.,increase,risk
Peginterferon alfa-2b,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Valproic acid,The metabolism of Valproic acid can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Valsartan,The metabolism of Valsartan can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Vardenafil,The metabolism of Vardenafil can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Peginterferon alfa-2b.,increase,risk
Peginterferon alfa-2b,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Vedolizumab,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vedolizumab.,increase,risk
Peginterferon alfa-2b,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Vilanterol,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vilanterol.,increase,risk
Peginterferon alfa-2b,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Vinblastine,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinblastine.,increase,risk
Peginterferon alfa-2b,Vincristine,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vincristine.,increase,risk
Peginterferon alfa-2b,Vindesine,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vindesine.,increase,risk
Peginterferon alfa-2b,Vinorelbine,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinorelbine.,increase,risk
Peginterferon alfa-2b,Voclosporin,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Voclosporin.,increase,risk
Peginterferon alfa-2b,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2b.,increase,risk
Peginterferon alfa-2b,Voriconazole,The metabolism of Voriconazole can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Vorinostat,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vorinostat.,increase,risk
Peginterferon alfa-2b,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Voxelotor,The metabolism of Voxelotor can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2b.,increase,risk
Peginterferon alfa-2b,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Peginterferon alfa-2b.,increase,risk
Peginterferon alfa-2b,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Zidovudine,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Zidovudine.,increase,risk
Peginterferon alfa-2b,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Peginterferon alfa-2b,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Zopiclone,The metabolism of Zopiclone can be increased when combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Peginterferon alfa-2b.,increase,no risk
Peginterferon alfa-2b,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Peginterferon alfa-2b.,decrease,no risk
Asparaginase Escherichia coli,Benzocaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Benzocaine.,increase,risk
Asparaginase Escherichia coli,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Benzyl alcohol.,increase,risk
Asparaginase Escherichia coli,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Bupivacaine.,increase,risk
Asparaginase Escherichia coli,Butacaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Butacaine.,increase,risk
Asparaginase Escherichia coli,Butamben,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Butamben.,increase,risk
Asparaginase Escherichia coli,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Escherichia coli.,increase,no risk
Asparaginase Escherichia coli,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Oxetacaine.,increase,risk
Asparaginase Escherichia coli,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Oxybuprocaine.,increase,risk
Thyrotropin alfa,Gefitinib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gefitinib.,decrease,no risk
Thyrotropin alfa,Gilteritinib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gilteritinib.,decrease,no risk
Thyrotropin alfa,Gliclazide,Thyrotropin alfa may decrease the hypoglycemic activities of Gliclazide.,decrease,no risk
Thyrotropin alfa,Glimepiride,Thyrotropin alfa may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Thyrotropin alfa,Glipizide,Thyrotropin alfa may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Thyrotropin alfa,Gliquidone,Thyrotropin alfa may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Thyrotropin alfa,Glyburide,Thyrotropin alfa may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Thyrotropin alfa,Glymidine,Thyrotropin alfa may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Thyrotropin alfa,Olsalazine,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Olsalazine.,increase,no risk
Thyrotropin alfa,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Thyrotropin alfa.,increase,risk
Thyrotropin alfa,Osimertinib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Osimertinib.,decrease,no risk
Thyrotropin alfa,Oxprenolol,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Oxprenolol.,decrease,no risk
Thyrotropin alfa,Oxtriphylline,Thyrotropin alfa may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thyrotropin alfa,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Thyrotropin alfa.,increase,risk
Thyrotropin alfa,Quinestrol,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Quinestrol.,decrease,no risk
Thyrotropin alfa,Quinine,Thyrotropin alfa may decrease the hypoglycemic activities of Quinine.,decrease,no risk
Thyrotropin alfa,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Quinupramine.,increase,risk
Thyrotropin alfa,Quizartinib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Quizartinib.,decrease,no risk
Thyrotropin alfa,Vandetanib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vandetanib.,decrease,no risk
Thyrotropin alfa,Vasopressin,Thyrotropin alfa may increase the vasoconstricting activities of Vasopressin.,increase,no risk
Thyrotropin alfa,Vemurafenib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vemurafenib.,decrease,no risk
Thyrotropin alfa,Vildagliptin,Thyrotropin alfa may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Thyrotropin alfa,Warfarin,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Warfarin.,increase,risk
Thyrotropin alfa,Xylometazoline,Thyrotropin alfa may increase the vasoconstricting activities of Xylometazoline.,increase,no risk
Thyrotropin alfa,Zanubrutinib,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Thyrotropin alfa,Zimelidine,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zimelidine.,decrease,no risk
"Antihemophilic factor, human recombinant",Bemiparin,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bemiparin.",decrease,no risk
"Antihemophilic factor, human recombinant",Betrixaban,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Betrixaban.",decrease,no risk
"Antihemophilic factor, human recombinant",Bivalirudin,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin.",decrease,no risk
"Antihemophilic factor, human recombinant",Heparin,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Heparin.",decrease,no risk
"Antihemophilic factor, human recombinant",Hydrogen peroxide,"Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",increase,no risk
"Antihemophilic factor, human recombinant",Urokinase,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Urokinase.",decrease,no risk
"Antihemophilic factor, human recombinant",Vorapaxar,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Vorapaxar.",decrease,no risk
"Antihemophilic factor, human recombinant",Warfarin,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Warfarin.",decrease,no risk
"Antihemophilic factor, human recombinant",Ximelagatran,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ximelagatran.",decrease,no risk
Anakinra,Bosutinib,The metabolism of Bosutinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Anakinra.,increase,no risk
Anakinra,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Anakinra.,increase,no risk
Anakinra,Brigatinib,The metabolism of Brigatinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Anakinra.,increase,no risk
Anakinra,Brodalumab,The risk or severity of adverse effects can be increased when Anakinra is combined with Brodalumab.,increase,risk
Anakinra,Bromazepam,The metabolism of Bromazepam can be increased when combined with Anakinra.,increase,no risk
Anakinra,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Anakinra.,increase,no risk
Anakinra,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Budesonide,The risk or severity of adverse effects can be increased when Anakinra is combined with Budesonide.,increase,risk
Anakinra,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Bupropion,The metabolism of Bupropion can be increased when combined with Anakinra.,increase,no risk
Anakinra,Buspirone,The metabolism of Buspirone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Busulfan,The metabolism of Busulfan can be increased when combined with Anakinra.,increase,no risk
Anakinra,Galantamine,The metabolism of Galantamine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Gefitinib,The metabolism of Gefitinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Gemcitabine,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemcitabine.,increase,risk
Anakinra,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemtuzumab ozogamicin.,increase,risk
Anakinra,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Glasdegib,The metabolism of Glasdegib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Glatiramer,The risk or severity of adverse effects can be increased when Anakinra is combined with Glatiramer.,increase,risk
Anakinra,Gliclazide,The metabolism of Gliclazide can be increased when combined with Anakinra.,increase,no risk
Anakinra,Glimepiride,The metabolism of Glimepiride can be increased when combined with Anakinra.,increase,no risk
Anakinra,Glipizide,The metabolism of Glipizide can be increased when combined with Anakinra.,increase,no risk
Anakinra,Gliquidone,The metabolism of Gliquidone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Glyburide,The metabolism of Glyburide can be increased when combined with Anakinra.,increase,no risk
Anakinra,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Anakinra.,increase,risk
Anakinra,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Anakinra.,increase,no risk
Anakinra,Guanabenz,The metabolism of Guanabenz can be increased when combined with Anakinra.,increase,no risk
Anakinra,Guselkumab,The risk or severity of adverse effects can be increased when Anakinra is combined with Guselkumab.,increase,risk
Anakinra,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Halofantrine,The metabolism of Halofantrine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Haloperidol,The metabolism of Haloperidol can be increased when combined with Anakinra.,increase,no risk
Anakinra,Halothane,The metabolism of Halothane can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Anakinra.,increase,risk
Anakinra,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydrocortisone succinate.,increase,risk
Anakinra,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Anakinra.,increase,no risk
Anakinra,Hydroxyurea,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxyurea.,increase,risk
Anakinra,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Ketamine,The metabolism of Ketamine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ketorolac,The metabolism of Ketorolac can be increased when combined with Anakinra.,increase,no risk
Anakinra,Obinutuzumab,The risk or severity of adverse effects can be increased when Anakinra is combined with Obinutuzumab.,increase,risk
Anakinra,Ocrelizumab,The risk or severity of adverse effects can be increased when Anakinra is combined with Ocrelizumab.,increase,risk
Anakinra,Ofatumumab,The risk or severity of adverse effects can be increased when Anakinra is combined with Ofatumumab.,increase,risk
Anakinra,Olanzapine,The metabolism of Olanzapine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Olaparib,The metabolism of Olaparib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Oliceridine,The metabolism of Oliceridine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Olodaterol,The metabolism of Olodaterol can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Anakinra.,increase,no risk
Anakinra,Omeprazole,The metabolism of Omeprazole can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ondansetron,The metabolism of Ondansetron can be increased when combined with Anakinra.,increase,no risk
Anakinra,Opium,The metabolism of Opium can be increased when combined with Anakinra.,increase,no risk
Anakinra,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Anakinra.,increase,no risk
Anakinra,Osimertinib,The metabolism of Osimertinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ospemifene,The metabolism of Ospemifene can be increased when combined with Anakinra.,increase,no risk
Anakinra,Oxaliplatin,The risk or severity of adverse effects can be increased when Anakinra is combined with Oxaliplatin.,increase,risk
Anakinra,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Anakinra.,increase,no risk
Anakinra,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Anakinra.,increase,no risk
Anakinra,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Anakinra.,increase,no risk
Anakinra,Oxycodone,The metabolism of Oxycodone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ozanimod,The risk or severity of adverse effects can be increased when Anakinra is combined with Ozanimod.,increase,risk
Anakinra,Quetiapine,The metabolism of Quetiapine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Quinidine,The metabolism of Quinidine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Quinine,The metabolism of Quinine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Quizartinib,The metabolism of Quizartinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Anakinra.,increase,risk
Anakinra,Udenafil,The metabolism of Udenafil can be increased when combined with Anakinra.,increase,no risk
Anakinra,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Anakinra.,increase,no risk
Anakinra,Upadacitinib,The risk or severity of adverse effects can be increased when Anakinra is combined with Upadacitinib.,increase,risk
Anakinra,Valbenazine,The metabolism of Valbenazine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Valproic acid,The metabolism of Valproic acid can be increased when combined with Anakinra.,increase,no risk
Anakinra,Valsartan,The metabolism of Valsartan can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vandetanib,The metabolism of Vandetanib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vardenafil,The metabolism of Vardenafil can be increased when combined with Anakinra.,increase,no risk
Anakinra,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Anakinra.,increase,risk
Anakinra,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Vedolizumab,The risk or severity of adverse effects can be increased when Anakinra is combined with Vedolizumab.,increase,risk
Anakinra,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Venetoclax,The metabolism of Venetoclax can be increased when combined with Anakinra.,increase,no risk
Anakinra,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Verapamil,The metabolism of Verapamil can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vernakalant,The metabolism of Vernakalant can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Anakinra.,decrease,no risk
Anakinra,Vilanterol,The risk or severity of adverse effects can be increased when Anakinra is combined with Vilanterol.,increase,risk
Anakinra,Vilazodone,The metabolism of Vilazodone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vinblastine,The metabolism of Vinblastine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vincristine,The metabolism of Vincristine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vindesine,The metabolism of Vindesine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vinflunine,The metabolism of Vinflunine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Voclosporin,The risk or severity of adverse effects can be increased when Anakinra is combined with Voclosporin.,increase,risk
Anakinra,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Anakinra.,increase,no risk
Anakinra,Voriconazole,The metabolism of Voriconazole can be increased when combined with Anakinra.,increase,no risk
Anakinra,Vorinostat,The risk or severity of adverse effects can be increased when Anakinra is combined with Vorinostat.,increase,risk
Anakinra,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Voxelotor,The metabolism of Voxelotor can be increased when combined with Anakinra.,increase,no risk
Anakinra,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Anakinra.,increase,no risk
Anakinra,Warfarin,The metabolism of Warfarin can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Anakinra.,increase,no risk
Anakinra,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Anakinra.,increase,risk
Anakinra,Yohimbine,The metabolism of Yohimbine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zaleplon,The metabolism of Zaleplon can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zidovudine,The metabolism of Zidovudine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zileuton,The metabolism of Zileuton can be increased when combined with Anakinra.,increase,no risk
Anakinra,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zolpidem,The metabolism of Zolpidem can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zonisamide,The metabolism of Zonisamide can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zopiclone,The metabolism of Zopiclone can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zotepine,The metabolism of Zotepine can be increased when combined with Anakinra.,increase,no risk
Anakinra,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Anakinra.,increase,no risk
Gramicidin D,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Gramicidin D.,decrease,no risk
Gramicidin D,Benzocaine,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Benzocaine.,increase,risk
Gramicidin D,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Benzyl alcohol.,increase,risk
Gramicidin D,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Bupivacaine.,increase,risk
Gramicidin D,Butacaine,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Butacaine.,increase,risk
Gramicidin D,Butamben,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Butamben.,increase,risk
Gramicidin D,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Oxetacaine.,increase,risk
Gramicidin D,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Oxybuprocaine.,increase,risk
Gramicidin D,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Gramicidin D.,decrease,no risk
Gramicidin D,Warfarin,The risk or severity of bleeding can be increased when Gramicidin D is combined with Warfarin.,increase,risk
Human immunoglobulin G,Obiltoxaximab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obiltoxaximab.,increase,risk
Human immunoglobulin G,Obinutuzumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obinutuzumab.,increase,risk
Human immunoglobulin G,Ocrelizumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ocrelizumab.,increase,risk
Human immunoglobulin G,Odesivimab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Odesivimab.,increase,risk
Human immunoglobulin G,Ofatumumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ofatumumab.,increase,risk
Human immunoglobulin G,Olaratumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olaratumab.,increase,risk
Human immunoglobulin G,Omalizumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.,increase,risk
Human immunoglobulin G,Quinestrol,Quinestrol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Human immunoglobulin G,Ublituximab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ublituximab.,increase,risk
Human immunoglobulin G,Ustekinumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ustekinumab.,increase,risk
Human immunoglobulin G,Vedolizumab,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vedolizumab.,increase,risk
Anistreplase,Gemcitabine,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemcitabine.,increase,risk
Anistreplase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemtuzumab ozogamicin.,increase,risk
Anistreplase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Anistreplase.,increase,risk
Anistreplase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Anistreplase.,increase,no risk
Anistreplase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Anistreplase.,increase,risk
Anistreplase,Hemin,Hemin may increase the anticoagulant activities of Anistreplase.,increase,no risk
Anistreplase,Heparin,The risk or severity of bleeding can be increased when Anistreplase is combined with Heparin.,increase,risk
Anistreplase,Hydrochlorothiazide,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Anistreplase,Hydroflumethiazide,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Anistreplase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Anistreplase.,decrease,no risk
Anistreplase,Hydroxyprogesterone caproate,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Anistreplase,Hydroxyurea,The risk or severity of bleeding can be increased when Anistreplase is combined with Hydroxyurea.,increase,risk
Anistreplase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Anistreplase.,increase,risk
Anistreplase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Anistreplase.,increase,risk
Anistreplase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Obeticholic acid.,increase,risk
Anistreplase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Obinutuzumab.,increase,risk
Anistreplase,Olaparib,The risk or severity of bleeding can be increased when Anistreplase is combined with Olaparib.,increase,risk
Anistreplase,Olive oil,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Olive oil.,decrease,no risk
Anistreplase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Anistreplase.,increase,risk
Anistreplase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Anistreplase is combined with Omacetaxine mepesuccinate.,increase,risk
Anistreplase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Anistreplase.,increase,no risk
Anistreplase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anistreplase.,increase,risk
Anistreplase,Omega-3-carboxylic acids,The therapeutic efficacy of Anistreplase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Anistreplase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Anistreplase.,increase,risk
Anistreplase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Anistreplase.,increase,risk
Anistreplase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Anistreplase.,increase,risk
Anistreplase,Quinapril,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinapril.,increase,risk
Anistreplase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Anistreplase.,decrease,no risk
Anistreplase,Quinidine,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinidine.,increase,no risk
Anistreplase,Quinine,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinine.,increase,no risk
Anistreplase,Ulipristal,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ulipristal.,decrease,no risk
Anistreplase,Urokinase,Urokinase may increase the anticoagulant activities of Anistreplase.,increase,no risk
Anistreplase,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Ursodeoxycholic acid.,increase,risk
Anistreplase,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Anistreplase.,increase,risk
Anistreplase,Valsartan,The risk or severity of angioedema can be increased when Anistreplase is combined with Valsartan.,increase,risk
Anistreplase,Venlafaxine,The risk or severity of bleeding can be increased when Anistreplase is combined with Venlafaxine.,increase,risk
Anistreplase,Vildagliptin,The risk or severity of angioedema can be increased when Anistreplase is combined with Vildagliptin.,increase,risk
Anistreplase,Vinblastine,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinblastine.,increase,risk
Anistreplase,Vindesine,The risk or severity of bleeding can be increased when Anistreplase is combined with Vindesine.,increase,risk
Anistreplase,Vinorelbine,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinorelbine.,increase,risk
Anistreplase,Vitamin E,Vitamin E may increase the anticoagulant activities of Anistreplase.,increase,no risk
Anistreplase,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Anistreplase.,decrease,no risk
Anistreplase,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Anistreplase.,increase,risk
Anistreplase,Vorinostat,The risk or severity of bleeding can be increased when Anistreplase is combined with Vorinostat.,increase,risk
Anistreplase,Warfarin,The risk or severity of bleeding can be increased when Anistreplase is combined with Warfarin.,increase,risk
Anistreplase,Ximelagatran,The risk or severity of bleeding can be increased when Anistreplase is combined with Ximelagatran.,increase,risk
Anistreplase,Zidovudine,The risk or severity of bleeding can be increased when Anistreplase is combined with Zidovudine.,increase,risk
Anistreplase,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Anistreplase.,increase,risk
Anistreplase,Zofenopril,The risk or severity of angioedema can be increased when Anistreplase is combined with Zofenopril.,increase,risk
Insulin human,Gatifloxacin,The therapeutic efficacy of Insulin human can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin human,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin human.,increase,risk
Insulin human,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin human.,increase,risk
Insulin human,Gemifloxacin,The therapeutic efficacy of Insulin human can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin human,Gestrinone,The therapeutic efficacy of Insulin human can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin human,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin human.,increase,risk
Insulin human,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin human.,increase,risk
Insulin human,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin human.,increase,risk
Insulin human,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin human.,increase,risk
Insulin human,Glucagon,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin human,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin human.,increase,risk
Insulin human,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin human.,increase,risk
Insulin human,Goserelin,The therapeutic efficacy of Insulin human can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin human,Grepafloxacin,The therapeutic efficacy of Insulin human can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin human,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin human.,increase,risk
Insulin human,Haloperidol,The therapeutic efficacy of Insulin human can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin human,Histrelin,The therapeutic efficacy of Insulin human can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin human,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin human.,increase,risk
Insulin human,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin human.,increase,risk
Insulin human,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin human.,increase,risk
Insulin human,Hydroxychloroquine,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin human,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin human,Octreotide,The therapeutic efficacy of Insulin human can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin human,Ofloxacin,The therapeutic efficacy of Insulin human can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin human,Olanzapine,The therapeutic efficacy of Insulin human can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin human,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin human.,increase,risk
Insulin human,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin human.,increase,no risk
Insulin human,Oxprenolol,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin human,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin human.,increase,no risk
Insulin human,Quetiapine,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin human,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin human.,increase,risk
Insulin human,Quinestrol,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin human,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin human.,increase,risk
Insulin human,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin human.,increase,risk
Insulin human,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin human.,decrease,no risk
Insulin human,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin human.,increase,risk
Insulin human,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin human.,increase,risk
Insulin human,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin human.,increase,risk
Insulin human,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin human.,increase,risk
Insulin human,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin human.,increase,risk
Insulin human,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin human.,increase,risk
Insulin human,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin human.,increase,risk
Insulin human,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin human.,increase,risk
Insulin human,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin human.,increase,risk
Insulin human,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Insulin human.,increase,risk
Insulin human,Vorinostat,The therapeutic efficacy of Insulin human can be decreased when used in combination with Vorinostat.,decrease,no risk
Insulin human,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin human.,increase,risk
Insulin human,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin human.,increase,risk
Insulin human,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Insulin human.,increase,risk
Insulin human,Ziprasidone,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ziprasidone.,decrease,no risk
Insulin human,Zofenopril,The risk or severity of hypoglycemia can be increased when Zofenopril is combined with Insulin human.,increase,risk
Insulin human,Zonisamide,The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Insulin human.,increase,risk
Insulin human,Zotepine,The therapeutic efficacy of Insulin human can be decreased when used in combination with Zotepine.,decrease,no risk
Tenecteplase,Gemcitabine,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemcitabine.,increase,risk
Tenecteplase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemtuzumab ozogamicin.,increase,risk
Tenecteplase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Tenecteplase.,increase,risk
Tenecteplase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Tenecteplase.,increase,no risk
Tenecteplase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Tenecteplase.,increase,risk
Tenecteplase,Hemin,Hemin may increase the anticoagulant activities of Tenecteplase.,increase,no risk
Tenecteplase,Heparin,The risk or severity of bleeding can be increased when Tenecteplase is combined with Heparin.,increase,risk
Tenecteplase,Hydrochlorothiazide,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Tenecteplase,Hydroflumethiazide,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Tenecteplase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Tenecteplase.,decrease,no risk
Tenecteplase,Hydroxyprogesterone caproate,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Tenecteplase,Hydroxyurea,The risk or severity of bleeding can be increased when Tenecteplase is combined with Hydroxyurea.,increase,risk
Tenecteplase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Tenecteplase.,increase,risk
Tenecteplase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Tenecteplase.,increase,risk
Tenecteplase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Obeticholic acid.,increase,risk
Tenecteplase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Obinutuzumab.,increase,risk
Tenecteplase,Olaparib,The risk or severity of bleeding can be increased when Tenecteplase is combined with Olaparib.,increase,risk
Tenecteplase,Olive oil,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Olive oil.,decrease,no risk
Tenecteplase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Tenecteplase.,increase,risk
Tenecteplase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Tenecteplase is combined with Omacetaxine mepesuccinate.,increase,risk
Tenecteplase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Tenecteplase.,increase,no risk
Tenecteplase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tenecteplase.,increase,risk
Tenecteplase,Omega-3-carboxylic acids,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Tenecteplase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Tenecteplase.,increase,risk
Tenecteplase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Tenecteplase.,increase,risk
Tenecteplase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Tenecteplase.,increase,risk
Tenecteplase,Quinapril,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinapril.,increase,risk
Tenecteplase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Tenecteplase.,decrease,no risk
Tenecteplase,Quinidine,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinidine.,increase,no risk
Tenecteplase,Quinine,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinine.,increase,no risk
Interferon gamma-1b,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemcitabine.,increase,risk
Interferon gamma-1b,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemtuzumab ozogamicin.,increase,risk
Interferon gamma-1b,Glatiramer,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Glatiramer.,increase,risk
Interferon gamma-1b,Golimumab,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Golimumab.,increase,risk
Interferon gamma-1b,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Guselkumab,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Guselkumab.,increase,risk
Interferon gamma-1b,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone acetate.,increase,risk
Interferon gamma-1b,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone butyrate.,increase,risk
Interferon gamma-1b,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone succinate.,increase,risk
Interferon gamma-1b,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxychloroquine.,increase,risk
Interferon gamma-1b,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxyurea.,increase,risk
Interferon gamma-1b,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Obinutuzumab.,increase,risk
Interferon gamma-1b,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ocrelizumab.,increase,risk
Interferon gamma-1b,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ofatumumab.,increase,risk
Interferon gamma-1b,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Olaparib,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Olaparib.,increase,risk
Interferon gamma-1b,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Oxaliplatin.,increase,risk
Interferon gamma-1b,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Ozanimod,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ozanimod.,increase,risk
Interferon gamma-1b,Quinine,The metabolism of Quinine can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Upadacitinib.,increase,risk
Interferon gamma-1b,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vedolizumab.,increase,risk
Interferon gamma-1b,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Vilanterol,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vilanterol.,increase,risk
Interferon gamma-1b,Vinblastine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinblastine.,increase,risk
Interferon gamma-1b,Vincristine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vincristine.,increase,risk
Interferon gamma-1b,Vindesine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vindesine.,increase,risk
Interferon gamma-1b,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinorelbine.,increase,risk
Interferon gamma-1b,Voclosporin,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Voclosporin.,increase,risk
Interferon gamma-1b,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Vorinostat,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vorinostat.,increase,risk
Interferon gamma-1b,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon gamma-1b.,increase,risk
Interferon gamma-1b,Zidovudine,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Zidovudine.,increase,risk
Interferon gamma-1b,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon gamma-1b,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon gamma-1b.,decrease,no risk
Interferon alfa-2a,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Gemcitabine.,increase,risk
Interferon alfa-2a,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Gemtuzumab ozogamicin.,increase,risk
Interferon alfa-2a,Glatiramer,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Glatiramer.,increase,risk
Interferon alfa-2a,Golimumab,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Golimumab.,increase,risk
Interferon alfa-2a,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Guselkumab,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Guselkumab.,increase,risk
Interferon alfa-2a,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Hydrocortisone acetate.,increase,risk
Interferon alfa-2a,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Hydrocortisone butyrate.,increase,risk
Interferon alfa-2a,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Hydrocortisone succinate.,increase,risk
Interferon alfa-2a,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Hydroxychloroquine.,increase,risk
Interferon alfa-2a,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Hydroxyurea.,increase,risk
Interferon alfa-2a,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Obinutuzumab.,increase,risk
Interferon alfa-2a,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Ocrelizumab.,increase,risk
Interferon alfa-2a,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Ofatumumab.,increase,risk
Interferon alfa-2a,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Olaparib,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Olaparib.,increase,risk
Interferon alfa-2a,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Oxaliplatin.,increase,risk
Interferon alfa-2a,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Interferon alfa-2a is combined with Oxetacaine.,increase,risk
Interferon alfa-2a,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Interferon alfa-2a is combined with Oxybuprocaine.,increase,risk
Interferon alfa-2a,Ozanimod,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Ozanimod.,increase,risk
Interferon alfa-2a,Quinine,The metabolism of Quinine can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Upadacitinib.,increase,risk
Interferon alfa-2a,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vedolizumab.,increase,risk
Interferon alfa-2a,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Vilanterol,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vilanterol.,increase,risk
Interferon alfa-2a,Vinblastine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vinblastine.,increase,risk
Interferon alfa-2a,Vincristine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vincristine.,increase,risk
Interferon alfa-2a,Vindesine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vindesine.,increase,risk
Interferon alfa-2a,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vinorelbine.,increase,risk
Interferon alfa-2a,Voclosporin,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Voclosporin.,increase,risk
Interferon alfa-2a,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Vorinostat,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Vorinostat.,increase,risk
Interferon alfa-2a,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon alfa-2a.,increase,risk
Interferon alfa-2a,Zidovudine,The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Zidovudine.,increase,risk
Interferon alfa-2a,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Interferon alfa-2a,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon alfa-2a.,decrease,no risk
Desmopressin,Gabapentin enacarbil,Desmopressin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Desmopressin,Gadobenic acid,Desmopressin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Desmopressin,Gadodiamide,Desmopressin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Desmopressin,Gadofosveset trisodium,Desmopressin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Desmopressin,Gadopentetic acid,Desmopressin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Desmopressin,Gadoteric acid,Desmopressin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Desmopressin,Gadoteridol,Desmopressin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Desmopressin,Ganciclovir,Desmopressin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Desmopressin,Gemcitabine,Desmopressin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Desmopressin,Gemfibrozil,Desmopressin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Desmopressin,Gentamicin,Desmopressin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Desmopressin,Gimeracil,Desmopressin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Desmopressin,Givosiran,Givosiran may decrease the excretion rate of Desmopressin which could result in a higher serum level.,decrease,no risk
Desmopressin,Glipizide,Desmopressin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Desmopressin,Glycerol phenylbutyrate,Desmopressin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Desmopressin,Glycol salicylate,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Glycol salicylate is combined with Desmopressin.",increase,risk
Desmopressin,Golodirsen,Desmopressin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Desmopressin,Goserelin,Goserelin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,decrease,no risk
Desmopressin,Guanabenz,Desmopressin may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Desmopressin,Guanadrel,Desmopressin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Desmopressin,Guanethidine,Desmopressin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Desmopressin,Guanfacine,Desmopressin may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Desmopressin,Guanoxan,Desmopressin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Desmopressin,Haloperidol,Desmopressin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Desmopressin,Halothane,The risk or severity of hypertension can be increased when Desmopressin is combined with Halothane.,increase,risk
Desmopressin,Hydralazine,Desmopressin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Desmopressin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desmopressin,Hydrocodone,The risk or severity of hyponatremia can be increased when Hydrocodone is combined with Desmopressin.,increase,risk
Desmopressin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desmopressin,Hydromorphone,The risk or severity of hyponatremia can be increased when Hydromorphone is combined with Desmopressin.,increase,risk
Desmopressin,Hydroxocobalamin,Desmopressin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Desmopressin,Hydroxyethyl Starch,Desmopressin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Desmopressin,Kanamycin,Desmopressin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Desmopressin,Ketamine,Desmopressin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Desmopressin,Ketazolam,Desmopressin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Desmopressin,Ketoprofen,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketoprofen is combined with Desmopressin.",increase,risk
Desmopressin,Ketorolac,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketorolac is combined with Desmopressin.",increase,risk
Desmopressin,Octinoxate,Desmopressin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Desmopressin,Oliceridine,The risk or severity of hyponatremia can be increased when Oliceridine is combined with Desmopressin.,increase,risk
Desmopressin,Olmesartan,Desmopressin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Desmopressin,Olodaterol,The risk or severity of hypertension can be increased when Desmopressin is combined with Olodaterol.,increase,risk
Desmopressin,Olsalazine,Olsalazine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,decrease,no risk
Desmopressin,Opium,The risk or severity of hyponatremia can be increased when Opium is combined with Desmopressin.,increase,risk
Desmopressin,Orciprenaline,The risk or severity of hypertension can be increased when Desmopressin is combined with Orciprenaline.,increase,risk
Desmopressin,Oseltamivir,Desmopressin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Desmopressin,Oxacillin,Desmopressin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Desmopressin,Oxaprozin,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxaprozin is combined with Desmopressin.",increase,risk
Desmopressin,Oxazepam,Desmopressin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Desmopressin,Oxprenolol,Desmopressin may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Desmopressin,Oxybenzone,Desmopressin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Desmopressin,Oxycodone,The risk or severity of hyponatremia can be increased when Oxycodone is combined with Desmopressin.,increase,risk
Desmopressin,Oxymetazoline,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxymetazoline.,increase,risk
Desmopressin,Oxymorphone,The risk or severity of hyponatremia can be increased when Oxymorphone is combined with Desmopressin.,increase,risk
Desmopressin,Oxyphenbutazone,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxyphenbutazone is combined with Desmopressin.",increase,risk
Desmopressin,Oxyquinoline,Desmopressin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Desmopressin,Quetiapine,The risk or severity of hypertension can be increased when Desmopressin is combined with Quetiapine.,increase,risk
Desmopressin,Quinapril,Desmopressin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Desmopressin,Quinethazone,Quinethazone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desmopressin,Quinidine,Desmopressin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Desmopressin,Quinupramine,The risk or severity of hyponatremia and water intoxication can be increased when Quinupramine is combined with Desmopressin.,increase,risk
Desmopressin,Vaborbactam,Desmopressin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Desmopressin,Valaciclovir,Valaciclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,decrease,no risk
Desmopressin,Valbenazine,Desmopressin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Desmopressin,Valdecoxib,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Valdecoxib is combined with Desmopressin.",increase,risk
Desmopressin,Valganciclovir,Desmopressin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Desmopressin,Valsartan,Desmopressin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Desmopressin,Vancomycin,Desmopressin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Desmopressin,Varenicline,Desmopressin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Desmopressin,Venlafaxine,Desmopressin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Desmopressin,Verapamil,Desmopressin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Desmopressin,Vilanterol,The risk or severity of hypertension can be increased when Desmopressin is combined with Vilanterol.,increase,risk
Desmopressin,Vilazodone,The risk or severity of hypertension can be increased when Desmopressin is combined with Vilazodone.,increase,risk
Desmopressin,Viloxazine,Desmopressin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Desmopressin,Vortioxetine,The risk or severity of hypertension can be increased when Desmopressin is combined with Vortioxetine.,increase,risk
Desmopressin,Warfarin,Desmopressin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Desmopressin,Xamoterol,The risk or severity of hypertension can be increased when Desmopressin is combined with Xamoterol.,increase,risk
Desmopressin,Xylometazoline,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylometazoline.,increase,risk
Desmopressin,Yohimbine,The risk or severity of hypertension can be increased when Desmopressin is combined with Yohimbine.,increase,risk
Desmopressin,Zaleplon,Desmopressin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Desmopressin,Zanamivir,Desmopressin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Desmopressin,Zimelidine,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Desmopressin.,increase,risk
Desmopressin,Ziprasidone,The risk or severity of hypertension can be increased when Desmopressin is combined with Ziprasidone.,increase,risk
Desmopressin,Zofenopril,Desmopressin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Desmopressin,Zolmitriptan,The risk or severity of hypertension can be increased when Desmopressin is combined with Zolmitriptan.,increase,risk
Desmopressin,Zonisamide,Zonisamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desmopressin,Zuclopenthixol,The risk or severity of hypertension can be increased when Desmopressin is combined with Zuclopenthixol.,increase,risk
Coagulation factor VIIa Recombinant Human,Bemiparin,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bemiparin.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Betrixaban,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Betrixaban.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Bivalirudin,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Heparin,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Heparin.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,increase,no risk
Coagulation factor VIIa Recombinant Human,Urokinase,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Urokinase.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Vorapaxar,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Vorapaxar.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Warfarin,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Warfarin.,decrease,no risk
Coagulation factor VIIa Recombinant Human,Ximelagatran,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ximelagatran.,decrease,no risk
Palifermin,Vinblastine,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinblastine.,decrease,no risk
Palifermin,Vindesine,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vindesine.,decrease,no risk
Palifermin,Vinorelbine,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine.,decrease,no risk
Palifermin,Vorinostat,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vorinostat.,decrease,no risk
Palifermin,Zidovudine,The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine.,decrease,no risk
Glucagon,Quetiapine,Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Glucagon,Quinidine,Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Glucagon,Umeclidinium,Umeclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Glucagon,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Glucagon.,increase,no risk
Glucagon,Ziprasidone,Ziprasidone may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Aldesleukin,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Aldesleukin.,decrease,no risk
Aldesleukin,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Aldesleukin.,increase,risk
Aldesleukin,Bacitracin,Bacitracin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Baclofen,Aldesleukin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Aldesleukin,Balsalazide,Balsalazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Baricitinib,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Baricitinib.,increase,risk
Aldesleukin,Basiliximab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Basiliximab.,increase,risk
Aldesleukin,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Aldesleukin.,increase,risk
Aldesleukin,Beclomethasone dipropionate,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Aldesleukin,Belatacept,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belatacept.,increase,risk
Aldesleukin,Belimumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belimumab.,increase,risk
Aldesleukin,Belinostat,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belinostat.,increase,risk
Aldesleukin,Belumosudil,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belumosudil.,increase,risk
Aldesleukin,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Aldesleukin.,increase,risk
Aldesleukin,Benazepril,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Benazepril.,increase,risk
Aldesleukin,Bendamustine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bendamustine.,increase,risk
Aldesleukin,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aldesleukin,Benorilate,Benorilate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Benserazide,Aldesleukin may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Aldesleukin,Benzatropine,Aldesleukin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Aldesleukin,Benznidazole,Aldesleukin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Aldesleukin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Benzocaine.,increase,risk
Aldesleukin,Benzthiazide,Benzthiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aldesleukin,Benzydamine,Benzydamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Benzyl alcohol.,increase,risk
Aldesleukin,Bepotastine,Aldesleukin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Aldesleukin,Bepridil,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bepridil.,increase,risk
Aldesleukin,Betamethasone,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone.,decrease,no risk
Aldesleukin,Betamethasone phosphate,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Aldesleukin,Betaxolol,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Betaxolol.,increase,risk
Aldesleukin,Bethanidine,Aldesleukin may increase the hypotensive activities of Bethanidine.,increase,no risk
Aldesleukin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Aldesleukin.,increase,risk
Aldesleukin,Bexarotene,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bexarotene.,increase,risk
Aldesleukin,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Bicisate,Aldesleukin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Aldesleukin,Bimekizumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bimekizumab.,increase,risk
Aldesleukin,Bismuth subgallate,Aldesleukin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Aldesleukin,Bisoprolol,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bisoprolol.,increase,risk
Aldesleukin,Bisoxatin,Aldesleukin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.,increase,risk
Aldesleukin,Bleomycin,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleomycin.,increase,risk
Aldesleukin,Blinatumomab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Blinatumomab.,increase,risk
Aldesleukin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Aldesleukin.",decrease,no risk
Aldesleukin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Bosentan,Aldesleukin may increase the hypotensive activities of Bosentan.,increase,no risk
Aldesleukin,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Bretylium,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bretylium.,increase,risk
Aldesleukin,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Brivaracetam,Aldesleukin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Aldesleukin,Brodalumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brodalumab.,increase,risk
Aldesleukin,Bromazepam,Aldesleukin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Aldesleukin,Bromocriptine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bromocriptine.,increase,risk
Aldesleukin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aldesleukin,Budesonide,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Budesonide.,increase,risk
Aldesleukin,Bumadizone,Bumadizone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Bumetanide,Bumetanide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aldesleukin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Bupivacaine.,increase,risk
Aldesleukin,Bupropion,Aldesleukin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Aldesleukin,Buspirone,Aldesleukin may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Aldesleukin,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Butabarbital,Butabarbital may increase the hypotensive activities of Aldesleukin.,increase,no risk
Aldesleukin,Butacaine,The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Butacaine.,increase,risk
Aldesleukin,Butalbital,Butalbital may increase the hypotensive activities of Aldesleukin.,increase,no risk
Aldesleukin,Butamben,The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Butamben.,increase,risk
Aldesleukin,Gabapentin enacarbil,Aldesleukin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gadobenic acid,Aldesleukin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gadodiamide,Aldesleukin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gadofosveset trisodium,Aldesleukin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gadopentetic acid,Aldesleukin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gadoteric acid,Aldesleukin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gadoteridol,Aldesleukin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Aldesleukin,Ganciclovir,Aldesleukin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gemcitabine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemcitabine.,increase,risk
Aldesleukin,Gemfibrozil,Aldesleukin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemtuzumab ozogamicin.,increase,risk
Aldesleukin,Gentamicin,Aldesleukin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Aldesleukin.,decrease,no risk
Aldesleukin,Gimeracil,Aldesleukin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Aldesleukin,Givosiran,Givosiran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Glatiramer,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Glatiramer.,increase,risk
Aldesleukin,Glipizide,Aldesleukin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Aldesleukin,Glycerol phenylbutyrate,Aldesleukin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Aldesleukin,Golimumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Golimumab.,increase,risk
Aldesleukin,Golodirsen,Aldesleukin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Aldesleukin,Goserelin,Goserelin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Guanabenz,Aldesleukin may increase the hypotensive activities of Guanabenz.,increase,no risk
Aldesleukin,Guanadrel,Aldesleukin may increase the hypotensive activities of Guanadrel.,increase,no risk
Aldesleukin,Guanethidine,Aldesleukin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Aldesleukin,Guanfacine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Guanfacine.,increase,risk
Aldesleukin,Guanoxan,Aldesleukin may increase the hypotensive activities of Guanoxan.,increase,no risk
Aldesleukin,Guselkumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Guselkumab.,increase,risk
Aldesleukin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.,decrease,no risk
Aldesleukin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Halothane,The metabolism of Halothane can be decreased when combined with Aldesleukin.,decrease,no risk
Aldesleukin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Aldesleukin.,increase,risk
Aldesleukin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Aldesleukin.,decrease,no risk
Aldesleukin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.,decrease,no risk
Aldesleukin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Aldesleukin.,increase,risk
Aldesleukin,Hydralazine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydralazine.,increase,risk
Aldesleukin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aldesleukin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone acetate.,increase,risk
Aldesleukin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone butyrate.,increase,risk
Aldesleukin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone succinate.,increase,risk
Aldesleukin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aldesleukin,Hydromorphone,Aldesleukin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Aldesleukin,Hydroxocobalamin,Aldesleukin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxychloroquine.,increase,risk
Aldesleukin,Hydroxyethyl Starch,Aldesleukin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Aldesleukin,Hydroxyurea,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxyurea.,increase,risk
Aldesleukin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Aldesleukin.,decrease,no risk
Aldesleukin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,decrease,no risk
Aldesleukin,Kanamycin,Aldesleukin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Ketamine,Aldesleukin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Aldesleukin,Ketazolam,Aldesleukin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Aldesleukin,Ketoprofen,Ketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Ketorolac,Ketorolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Obinutuzumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Obinutuzumab.,increase,risk
Aldesleukin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Aldesleukin.,increase,no risk
Aldesleukin,Octinoxate,Aldesleukin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Aldesleukin,Ofatumumab,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ofatumumab.,increase,risk
Aldesleukin,Olanzapine,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olanzapine.,increase,risk
Aldesleukin,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Olmesartan,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olmesartan.,increase,risk
Aldesleukin,Olsalazine,Olsalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,decrease,no risk
Aldesleukin,Opicapone,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Opicapone.,increase,risk
Aldesleukin,Opium,Aldesleukin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Aldesleukin,Oseltamivir,Aldesleukin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Aldesleukin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Aldesleukin.,increase,no risk
Aldesleukin,Oxacillin,Aldesleukin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Botulinum toxin type B,Gabapentin,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Gabapentin.,increase,risk
Botulinum toxin type B,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Gabapentin enacarbil.,increase,risk
Botulinum toxin type B,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Botulinum toxin type B is combined with Ganaxolone.",increase,risk
Botulinum toxin type B,Gentamicin,The risk or severity of adverse effects can be increased when Gentamicin is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Gepirone,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Gepirone.,increase,risk
Botulinum toxin type B,Glutethimide,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Glutethimide.,increase,risk
Botulinum toxin type B,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Granisetron,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Granisetron.,increase,risk
Botulinum toxin type B,Guanfacine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Guanfacine.,increase,risk
Botulinum toxin type B,Halazepam,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Halazepam.,increase,risk
Botulinum toxin type B,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Halothane,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Halothane.,increase,risk
Botulinum toxin type B,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Hydrocodone,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Botulinum toxin type B,Hydromorphone,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Hydromorphone.,increase,risk
Botulinum toxin type B,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Botulinum toxin type B.,increase,no risk
Botulinum toxin type B,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Kanamycin,The risk or severity of adverse effects can be increased when Kanamycin is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Ketamine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ketamine.,increase,risk
Botulinum toxin type B,Ketazolam,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ketazolam.,increase,risk
Botulinum toxin type B,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Botulinum toxin type B is combined with Oliceridine.",increase,risk
Botulinum toxin type B,Ondansetron,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ondansetron.,increase,risk
Botulinum toxin type B,Opium,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Opium.,increase,risk
Botulinum toxin type B,Orphenadrine,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Botulinum toxin type B,Oxazepam,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxazepam.,increase,risk
Botulinum toxin type B,Oxcarbazepine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxcarbazepine.,increase,risk
Botulinum toxin type B,Oxitriptan,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxitriptan.,increase,risk
Botulinum toxin type B,Oxprenolol,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxprenolol.,increase,risk
Botulinum toxin type B,Oxybuprocaine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxybuprocaine.,increase,risk
Botulinum toxin type B,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Oxycodone,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxycodone.,increase,risk
Botulinum toxin type B,Oxymorphone,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Oxymorphone.,increase,risk
Botulinum toxin type B,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Oxytetracycline,The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Quazepam,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Quazepam.,increase,risk
Botulinum toxin type B,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Quinine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Quinine.,increase,risk
Botulinum toxin type B,Quinupramine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Quinupramine.,increase,risk
Botulinum toxin type B,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Urethane,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Urethane.,increase,risk
Botulinum toxin type B,Valproic acid,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Valproic acid.,increase,risk
Botulinum toxin type B,Vancomycin,The risk or severity of adverse effects can be increased when Vancomycin is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Vasopressin,Botulinum toxin type B may increase the hypertensive activities of Vasopressin.,increase,no risk
Botulinum toxin type B,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Venlafaxine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Venlafaxine.,increase,risk
Botulinum toxin type B,Vigabatrin,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Vigabatrin.,increase,risk
Botulinum toxin type B,Vilazodone,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Vilazodone.,increase,risk
Botulinum toxin type B,Viloxazine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Viloxazine.,increase,risk
Botulinum toxin type B,Viomycin,The risk or severity of adverse effects can be increased when Viomycin is combined with Botulinum toxin type B.,increase,risk
Botulinum toxin type B,Vortioxetine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Vortioxetine.,increase,risk
Botulinum toxin type B,Yohimbine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Yohimbine.,increase,risk
Botulinum toxin type B,Zaleplon,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zaleplon.,increase,risk
Botulinum toxin type B,Ziconotide,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ziconotide.,increase,risk
Botulinum toxin type B,Zimelidine,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Zimelidine.,increase,risk
Botulinum toxin type B,Ziprasidone,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Ziprasidone.,increase,risk
Botulinum toxin type B,Zolmitriptan,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zolmitriptan.,increase,risk
Botulinum toxin type B,Zolpidem,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Botulinum toxin type B,Zonisamide,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zonisamide.,increase,risk
Botulinum toxin type B,Zopiclone,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Zopiclone.,increase,risk
Botulinum toxin type B,Zotepine,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zotepine.,increase,risk
Botulinum toxin type B,Zuclopenthixol,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zuclopenthixol.,increase,risk
Botulinum toxin type B,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Botulinum toxin type B.,increase,risk
Omalizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obiltoxaximab.,increase,risk
Omalizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obinutuzumab.,increase,risk
Omalizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ocrelizumab.,increase,risk
Omalizumab,Odesivimab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Odesivimab.,increase,risk
Omalizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ofatumumab.,increase,risk
Omalizumab,Olaratumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab.,increase,risk
Omalizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Omalizumab,Ublituximab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ublituximab.,increase,risk
Omalizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab.,increase,risk
Omalizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab.,increase,risk
Insulin lispro,Gatifloxacin,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin lispro,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin lispro.,increase,risk
Insulin lispro,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin lispro.,increase,risk
Insulin lispro,Gemifloxacin,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin lispro,Gestrinone,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin lispro,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin lispro.,increase,risk
Insulin lispro,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin lispro.,increase,risk
Insulin lispro,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin lispro.,increase,risk
Insulin lispro,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin lispro.,increase,risk
Insulin lispro,Glucagon,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin lispro,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin lispro.,increase,risk
Insulin lispro,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin lispro.,increase,risk
Insulin lispro,Goserelin,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin lispro,Grepafloxacin,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin lispro,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin lispro.,increase,risk
Insulin lispro,Haloperidol,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin lispro,Histrelin,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin lispro,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin lispro.,increase,risk
Insulin lispro,Hydroxychloroquine,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin lispro,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin lispro,Octreotide,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin lispro,Ofloxacin,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin lispro,Olanzapine,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin lispro,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin lispro.,increase,risk
Insulin lispro,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin lispro.,increase,no risk
Insulin lispro,Oxprenolol,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin lispro,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin lispro.,increase,no risk
Insulin lispro,Quetiapine,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin lispro,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin lispro.,increase,risk
Insulin lispro,Quinestrol,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin lispro,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin lispro.,increase,risk
Insulin lispro,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin lispro.,increase,risk
Insulin lispro,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin lispro.,decrease,no risk
Insulin lispro,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin lispro.,increase,risk
Insulin lispro,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin lispro.,increase,risk
Insulin lispro,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin lispro.,increase,risk
Insulin lispro,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin lispro.,increase,risk
Insulin lispro,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin lispro.,increase,risk
Insulin lispro,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin lispro.,increase,risk
Insulin lispro,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin lispro.,increase,risk
Insulin lispro,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin lispro.,increase,risk
Insulin lispro,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin lispro.,increase,risk
Insulin lispro,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Insulin lispro.,increase,risk
Insulin lispro,Vorinostat,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Vorinostat.,decrease,no risk
Insulin lispro,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin lispro.,increase,risk
Insulin lispro,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin lispro.,increase,risk
Insulin lispro,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Insulin lispro.,increase,risk
Insulin lispro,Ziprasidone,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ziprasidone.,decrease,no risk
Insulin lispro,Zofenopril,The risk or severity of hypoglycemia can be increased when Zofenopril is combined with Insulin lispro.,increase,risk
Insulin lispro,Zonisamide,The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Insulin lispro.,increase,risk
Insulin lispro,Zotepine,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Zotepine.,decrease,no risk
Insulin glargine,Gatifloxacin,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin glargine,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin glargine.,increase,risk
Insulin glargine,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin glargine.,increase,risk
Insulin glargine,Gemifloxacin,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin glargine,Gestrinone,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin glargine,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin glargine.,increase,risk
Insulin glargine,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin glargine.,increase,risk
Insulin glargine,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin glargine.,increase,risk
Insulin glargine,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin glargine.,increase,risk
Insulin glargine,Glucagon,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin glargine,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin glargine.,increase,risk
Insulin glargine,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin glargine.,increase,risk
Insulin glargine,Goserelin,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin glargine,Grepafloxacin,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin glargine,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin glargine.,increase,risk
Insulin glargine,Haloperidol,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin glargine,Histrelin,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin glargine,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin glargine.,increase,risk
Insulin glargine,Hydroxychloroquine,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin glargine,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin glargine,Octreotide,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin glargine,Ofloxacin,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin glargine,Olanzapine,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin glargine,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin glargine.,increase,risk
Insulin glargine,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin glargine.,increase,no risk
Insulin glargine,Oxprenolol,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin glargine,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin glargine.,increase,no risk
Insulin glargine,Quetiapine,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin glargine,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin glargine.,increase,risk
Insulin glargine,Quinestrol,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin glargine,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin glargine.,increase,risk
Insulin glargine,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin glargine.,increase,risk
Insulin glargine,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin glargine.,decrease,no risk
Insulin glargine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin glargine.,increase,risk
Insulin glargine,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin glargine.,increase,risk
Insulin glargine,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glargine.,increase,risk
Insulin glargine,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin glargine.,increase,risk
Insulin glargine,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin glargine.,increase,risk
Insulin glargine,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin glargine.,increase,risk
Insulin glargine,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin glargine.,increase,risk
Insulin glargine,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin glargine.,increase,risk
Insulin glargine,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin glargine.,increase,risk
Insulin glargine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Insulin glargine.,increase,risk
Collagenase clostridium histolyticum,Bemiparin,The risk or severity of adverse effects can be increased when Bemiparin is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Betrixaban,The risk or severity of adverse effects can be increased when Betrixaban is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Bivalirudin,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Heparin,The risk or severity of adverse effects can be increased when Heparin is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Omadacycline,The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Omadacycline.,decrease,no risk
Collagenase clostridium histolyticum,Oxytetracycline,The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Oxytetracycline.,decrease,no risk
Collagenase clostridium histolyticum,Urokinase,The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Warfarin,The risk or severity of adverse effects can be increased when Warfarin is combined with Collagenase clostridium histolyticum.,increase,risk
Collagenase clostridium histolyticum,Ximelagatran,The risk or severity of adverse effects can be increased when Ximelagatran is combined with Collagenase clostridium histolyticum.,increase,risk
Rasburicase,Bendroflumethiazide,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Rasburicase,Benzocaine,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Benzocaine.,increase,risk
Rasburicase,Benzthiazide,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Benzthiazide.,decrease,no risk
Rasburicase,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Bupivacaine.,increase,risk
Rasburicase,Butalbital,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Butalbital.,increase,risk
Rasburicase,Hydrochlorothiazide,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Rasburicase,Hydroflumethiazide,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Rasburicase,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Hydroxyurea.,increase,risk
Rasburicase,Quinine,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Quinine.,increase,risk
Rasburicase,Valproic acid,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Valproic acid.,increase,risk
Rasburicase,Zopiclone,The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Zopiclone.,increase,risk
Adalimumab,Besilesomab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Besilesomab.,increase,risk
Adalimumab,Betamethasone,The risk or severity of adverse effects can be increased when Adalimumab is combined with Betamethasone.,increase,risk
Adalimumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bevacizumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab.,increase,risk
Adalimumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bezlotoxumab.,increase,risk
Adalimumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bimekizumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimekizumab.,increase,risk
Adalimumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bleomycin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleomycin.,increase,risk
Adalimumab,Blinatumomab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blinatumomab.,increase,risk
Adalimumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Adalimumab.",decrease,no risk
Adalimumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bosentan,The metabolism of Bosentan can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Brodalumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brodalumab.,increase,risk
Adalimumab,Brolucizumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brolucizumab.,increase,risk
Adalimumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Adalimumab.,decrease,no risk
Adalimumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Budesonide,The risk or severity of adverse effects can be increased when Adalimumab is combined with Budesonide.,increase,risk
Adalimumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Bupropion,The metabolism of Bupropion can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Burosumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Burosumab.,increase,risk
Adalimumab,Buspirone,The metabolism of Buspirone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Busulfan,The metabolism of Busulfan can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Galantamine,The metabolism of Galantamine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Galcanezumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galcanezumab.,increase,risk
Adalimumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Gemcitabine,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemcitabine.,increase,risk
Adalimumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemtuzumab ozogamicin.,increase,risk
Adalimumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Glatiramer,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glatiramer.,increase,risk
Adalimumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Glipizide,The metabolism of Glipizide can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Glofitamab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glofitamab.,increase,risk
Adalimumab,Glyburide,The metabolism of Glyburide can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Golimumab,The risk or severity of infection can be increased when Adalimumab is combined with Golimumab.,increase,risk
Adalimumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Guselkumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Guselkumab.,increase,risk
Adalimumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Halothane,The metabolism of Halothane can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hepatitis B immune globulin.,increase,risk
Adalimumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human adenovirus e serotype 4 strain cl-68578 antigen.,increase,risk
Adalimumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Adalimumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.,increase,risk
Adalimumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human Rho(D) immune globulin.,increase,risk
Adalimumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human varicella-zoster immune globulin.,increase,risk
Adalimumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydrocortisone succinate.,increase,risk
Adalimumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxyurea.,increase,risk
Adalimumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Ketamine,The metabolism of Ketamine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obiltoxaximab.,increase,risk
Adalimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obinutuzumab.,increase,risk
Adalimumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Adalimumab.,increase,no risk
Adalimumab,Odesivimab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Odesivimab.,increase,risk
Adalimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ofatumumab.,increase,risk
Adalimumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Olaparib,The metabolism of Olaparib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Olaratumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olaratumab.,increase,risk
Adalimumab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.,increase,risk
Adalimumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Opium,The metabolism of Opium can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oxaliplatin.,increase,risk
Adalimumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Adalimumab.,decrease,no risk
Adalimumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Ozanimod,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanimod.,increase,risk
Adalimumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Adalimumab.,increase,risk
Adalimumab,Udenafil,The metabolism of Udenafil can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Upadacitinib,The risk or severity of adverse effects can be increased when Adalimumab is combined with Upadacitinib.,increase,risk
Adalimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ustekinumab.,increase,risk
Adalimumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Valsartan,The metabolism of Valsartan can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Adalimumab is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Adalimumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Vedolizumab,The risk or severity of infection can be increased when Adalimumab is combined with Vedolizumab.,increase,risk
Adalimumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Verapamil,The metabolism of Verapamil can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Adalimumab.,decrease,no risk
Adalimumab,Vilanterol,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vilanterol.,increase,risk
Adalimumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vincristine,The metabolism of Vincristine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vindesine,The metabolism of Vindesine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Voclosporin,The risk or severity of adverse effects can be increased when Adalimumab is combined with Voclosporin.,increase,risk
Adalimumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Vorinostat,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vorinostat.,increase,risk
Adalimumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Warfarin,The serum concentration of Warfarin can be decreased when it is combined with Adalimumab.,decrease,no risk
Adalimumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Yellow fever vaccine,The risk or severity of adverse effects can be increased when Adalimumab is combined with Yellow fever vaccine.,increase,risk
Adalimumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zileuton,The metabolism of Zileuton can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zotepine,The metabolism of Zotepine can be increased when combined with Adalimumab.,increase,no risk
Adalimumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Adalimumab.,increase,no risk
Somatotropin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir.",increase,risk
Somatotropin,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Gemfibrozil.",increase,risk
Somatotropin,Gliclazide,Somatotropin may decrease the hypoglycemic activities of Gliclazide.,decrease,no risk
Somatotropin,Glimepiride,Somatotropin may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Somatotropin,Glipizide,Somatotropin may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Somatotropin,Gliquidone,Somatotropin may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Somatotropin,Glyburide,Somatotropin may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Somatotropin,Glymidine,Somatotropin may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Somatotropin,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Guanabenz,The metabolism of Guanabenz can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Haloperidol,The metabolism of Haloperidol can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ubidecarenone.",increase,risk
Somatotropin,Verapamil,The metabolism of Verapamil can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Vildagliptin,Somatotropin may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Somatotropin,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Vincristine.",increase,risk
Somatotropin,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Warfarin,The metabolism of Warfarin can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine.",increase,risk
Somatotropin,Zileuton,The metabolism of Zileuton can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Zotepine,The metabolism of Zotepine can be increased when combined with Somatotropin.,increase,no risk
Abciximab,Galcanezumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Galcanezumab.,increase,risk
Abciximab,Gemcitabine,The risk or severity of bleeding can be increased when Abciximab is combined with Gemcitabine.,increase,risk
Abciximab,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Abciximab is combined with Gemtuzumab ozogamicin.,increase,risk
Abciximab,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Abciximab.,increase,risk
Abciximab,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Abciximab.,increase,no risk
Abciximab,Glofitamab,The risk or severity of adverse effects can be increased when Abciximab is combined with Glofitamab.,increase,risk
Abciximab,Glucosamine,Glucosamine may increase the antiplatelet activities of Abciximab.,increase,no risk
Abciximab,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Abciximab.,increase,risk
Abciximab,Golimumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Golimumab.,increase,risk
Abciximab,Guselkumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Guselkumab.,increase,risk
Abciximab,Hemin,Hemin may increase the anticoagulant activities of Abciximab.,increase,no risk
Abciximab,Heparin,The risk or severity of bleeding can be increased when Abciximab is combined with Heparin.,increase,risk
Abciximab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Abciximab is combined with Hepatitis B immune globulin.,increase,risk
Abciximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Abciximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Abciximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.,increase,risk
Abciximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Abciximab is combined with Human Rho(D) immune globulin.,increase,risk
Abciximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Abciximab is combined with Human varicella-zoster immune globulin.,increase,risk
Abciximab,Hydrochlorothiazide,The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Abciximab,Hydroflumethiazide,The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Abciximab,Hydroxyprogesterone caproate,The therapeutic efficacy of Abciximab can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Abciximab,Hydroxyurea,The risk or severity of bleeding can be increased when Abciximab is combined with Hydroxyurea.,increase,risk
Abciximab,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Abciximab.,increase,risk
Abciximab,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Abciximab.,increase,risk
Abciximab,Obeticholic acid,The risk or severity of adverse effects can be increased when Abciximab is combined with Obeticholic acid.,increase,risk
Abciximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Abciximab is combined with Obiltoxaximab.,increase,risk
Abciximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Obinutuzumab.,increase,risk
Abciximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Ocrelizumab.,increase,risk
Abciximab,Odesivimab,The risk or severity of adverse effects can be increased when Abciximab is combined with Odesivimab.,increase,risk
Abciximab,Ofatumumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Ofatumumab.,increase,risk
Abciximab,Olaparib,The risk or severity of bleeding can be increased when Abciximab is combined with Olaparib.,increase,risk
Abciximab,Olaratumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Olaratumab.,increase,risk
Abciximab,Olive oil,The therapeutic efficacy of Abciximab can be decreased when used in combination with Olive oil.,decrease,no risk
Abciximab,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Abciximab.,increase,risk
Abciximab,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Abciximab is combined with Omacetaxine mepesuccinate.,increase,risk
Abciximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.,increase,risk
Abciximab,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Abciximab.,increase,no risk
Abciximab,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Abciximab.,increase,risk
Abciximab,Omega-3-carboxylic acids,The therapeutic efficacy of Abciximab can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Abciximab,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Abciximab.,increase,risk
Abciximab,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Abciximab.,increase,risk
Abciximab,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Abciximab.,increase,risk
Abciximab,Quinestrol,Quinestrol may decrease the anticoagulant activities of Abciximab.,decrease,no risk
Abciximab,Quinidine,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine.,increase,no risk
Abciximab,Quinine,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinine.,increase,no risk
Abciximab,Ublituximab,The risk or severity of adverse effects can be increased when Abciximab is combined with Ublituximab.,increase,risk
Abciximab,Ulipristal,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ulipristal.,decrease,no risk
Abciximab,Urokinase,Urokinase may increase the anticoagulant activities of Abciximab.,increase,no risk
Abciximab,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Abciximab is combined with Ursodeoxycholic acid.,increase,risk
Abciximab,Ustekinumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Ustekinumab.,increase,risk
Abciximab,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Abciximab.,increase,risk
Abciximab,Vedolizumab,The risk or severity of adverse effects can be increased when Abciximab is combined with Vedolizumab.,increase,risk
Abciximab,Venlafaxine,The risk or severity of bleeding can be increased when Abciximab is combined with Venlafaxine.,increase,risk
Abciximab,Vinblastine,The risk or severity of bleeding can be increased when Abciximab is combined with Vinblastine.,increase,risk
Abciximab,Vindesine,The risk or severity of bleeding can be increased when Abciximab is combined with Vindesine.,increase,risk
Abciximab,Vinorelbine,The risk or severity of bleeding can be increased when Abciximab is combined with Vinorelbine.,increase,risk
Abciximab,Vitamin E,Vitamin E may increase the antiplatelet activities of Abciximab.,increase,no risk
Abciximab,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Abciximab.,decrease,no risk
Abciximab,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Abciximab.,increase,risk
Abciximab,Vorinostat,The risk or severity of bleeding can be increased when Abciximab is combined with Vorinostat.,increase,risk
Abciximab,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Abciximab.,increase,risk
Abciximab,Warfarin,The risk or severity of bleeding can be increased when Abciximab is combined with Warfarin.,increase,risk
Abciximab,Ximelagatran,The risk or severity of bleeding can be increased when Abciximab is combined with Ximelagatran.,increase,risk
Abciximab,Zidovudine,The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine.,increase,risk
Abciximab,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Abciximab.,increase,risk
Drotrecogin alfa,Gemcitabine,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Gemcitabine.,increase,risk
Drotrecogin alfa,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Gemtuzumab ozogamicin.,increase,risk
Drotrecogin alfa,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Drotrecogin alfa.,increase,no risk
Drotrecogin alfa,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Hemin,Hemin may increase the anticoagulant activities of Drotrecogin alfa.,increase,no risk
Drotrecogin alfa,Heparin,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Heparin.,increase,risk
Drotrecogin alfa,Hydrochlorothiazide,The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Drotrecogin alfa,Hydroflumethiazide,The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Drotrecogin alfa,Hydroxyprogesterone caproate,The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Drotrecogin alfa,Hydroxyurea,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Hydroxyurea.,increase,risk
Drotrecogin alfa,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Drotrecogin alfa is combined with Obeticholic acid.,increase,risk
Drotrecogin alfa,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Drotrecogin alfa is combined with Obinutuzumab.,increase,risk
Drotrecogin alfa,Olaparib,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Olaparib.,increase,risk
Drotrecogin alfa,Olive oil,The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Olive oil.,decrease,no risk
Drotrecogin alfa,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Omacetaxine mepesuccinate.,increase,risk
Drotrecogin alfa,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Drotrecogin alfa.,increase,no risk
Drotrecogin alfa,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Omega-3-carboxylic acids,The therapeutic efficacy of Drotrecogin alfa can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Drotrecogin alfa,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Quinestrol,Quinestrol may decrease the anticoagulant activities of Drotrecogin alfa.,decrease,no risk
Drotrecogin alfa,Quinidine,The therapeutic efficacy of Drotrecogin alfa can be increased when used in combination with Quinidine.,increase,no risk
Drotrecogin alfa,Quinine,The therapeutic efficacy of Drotrecogin alfa can be increased when used in combination with Quinine.,increase,no risk
Drotrecogin alfa,Ulipristal,The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Ulipristal.,decrease,no risk
Drotrecogin alfa,Urokinase,Urokinase may increase the anticoagulant activities of Drotrecogin alfa.,increase,no risk
Drotrecogin alfa,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Drotrecogin alfa is combined with Ursodeoxycholic acid.,increase,risk
Drotrecogin alfa,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Venlafaxine,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Venlafaxine.,increase,risk
Drotrecogin alfa,Vinblastine,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Vinblastine.,increase,risk
Drotrecogin alfa,Vindesine,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Vindesine.,increase,risk
Drotrecogin alfa,Vinorelbine,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Vinorelbine.,increase,risk
Drotrecogin alfa,Vitamin E,Vitamin E may increase the anticoagulant activities of Drotrecogin alfa.,increase,no risk
Drotrecogin alfa,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Drotrecogin alfa.,decrease,no risk
Drotrecogin alfa,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Drotrecogin alfa.,increase,risk
Drotrecogin alfa,Vorinostat,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Vorinostat.,increase,risk
Drotrecogin alfa,Warfarin,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Warfarin.,increase,risk
Drotrecogin alfa,Ximelagatran,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Ximelagatran.,increase,risk
Drotrecogin alfa,Zidovudine,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Zidovudine.,increase,risk
Drotrecogin alfa,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Drotrecogin alfa.,increase,risk
Indium In-111 satumomab pendetide,Obiltoxaximab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Obiltoxaximab.,increase,risk
Indium In-111 satumomab pendetide,Obinutuzumab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Obinutuzumab.,increase,risk
Indium In-111 satumomab pendetide,Ocrelizumab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Ocrelizumab.,increase,risk
Indium In-111 satumomab pendetide,Odesivimab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Odesivimab.,increase,risk
Indium In-111 satumomab pendetide,Ofatumumab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Ofatumumab.,increase,risk
Indium In-111 satumomab pendetide,Olaratumab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Olaratumab.,increase,risk
Indium In-111 satumomab pendetide,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indium In-111 satumomab pendetide.,increase,risk
Indium In-111 satumomab pendetide,Quinestrol,Quinestrol may increase the thrombogenic activities of Indium In-111 satumomab pendetide.,increase,no risk
Indium In-111 satumomab pendetide,Ublituximab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Ublituximab.,increase,risk
Indium In-111 satumomab pendetide,Ustekinumab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Ustekinumab.,increase,risk
Indium In-111 satumomab pendetide,Vedolizumab,The risk or severity of adverse effects can be increased when Indium In-111 satumomab pendetide is combined with Vedolizumab.,increase,risk
Alpha-1-proteinase inhibitor,Beroctocog alfa,Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Beroctocog alfa.,increase,no risk
Alpha-1-proteinase inhibitor,Hydrogen peroxide,Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Hydrogen peroxide.,increase,no risk
Alpha-1-proteinase inhibitor,Urokinase,The therapeutic efficacy of Alpha-1-proteinase inhibitor can be decreased when used in combination with Urokinase.,decrease,no risk
Alpha-1-proteinase inhibitor,Von Willebrand factor human,Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Von Willebrand factor human.,increase,no risk
Pegaspargase,Gemcitabine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Gemcitabine.,increase,risk
Pegaspargase,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pegaspargase.,increase,risk
Pegaspargase,Glatiramer,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Glatiramer.,increase,risk
Pegaspargase,Golimumab,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Golimumab.,increase,risk
Pegaspargase,Guselkumab,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Guselkumab.,increase,risk
Pegaspargase,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Pegaspargase.,increase,no risk
Pegaspargase,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Pegaspargase.,increase,risk
Pegaspargase,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Hydrocortisone acetate.,increase,risk
Pegaspargase,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Hydrocortisone butyrate.,increase,risk
Pegaspargase,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Hydrocortisone succinate.,increase,risk
Pegaspargase,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Hydroxychloroquine.,increase,risk
Pegaspargase,Hydroxyurea,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Hydroxyurea.,increase,risk
Pegaspargase,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Obinutuzumab,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Obinutuzumab.,increase,risk
Pegaspargase,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Pegaspargase.,increase,no risk
Pegaspargase,Ofatumumab,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Ofatumumab.,increase,risk
Pegaspargase,Olaparib,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Olaparib.,increase,risk
Pegaspargase,Oxaliplatin,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Oxaliplatin.,increase,risk
Pegaspargase,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Oxetacaine.,increase,risk
Pegaspargase,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Oxybuprocaine.,increase,risk
Pegaspargase,Ozanimod,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Ozanimod.,increase,risk
Pegaspargase,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Pegaspargase.,increase,risk
Pegaspargase,Upadacitinib,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Upadacitinib.,increase,risk
Pegaspargase,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Pegaspargase.,increase,risk
Pegaspargase,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Vedolizumab,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vedolizumab.,increase,risk
Pegaspargase,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pegaspargase.,decrease,no risk
Pegaspargase,Vilanterol,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vilanterol.,increase,risk
Pegaspargase,Vinblastine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vinblastine.,increase,risk
Pegaspargase,Vincristine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vincristine.,increase,risk
Pegaspargase,Vindesine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vindesine.,increase,risk
Pegaspargase,Vinorelbine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vinorelbine.,increase,risk
Pegaspargase,Voclosporin,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Voclosporin.,increase,risk
Pegaspargase,Vorinostat,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vorinostat.,increase,risk
Pegaspargase,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Pegaspargase.,increase,risk
Pegaspargase,Zidovudine,The risk or severity of adverse effects can be increased when Pegaspargase is combined with Zidovudine.,increase,risk
Interferon beta-1a,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon beta-1a.,decrease,no risk
Interferon beta-1a,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Interferon beta-1a.,decrease,no risk
Eptifibatide,Gemcitabine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Gemcitabine.,increase,risk
Eptifibatide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Eptifibatide is combined with Gemtuzumab ozogamicin.,increase,risk
Eptifibatide,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Eptifibatide.,increase,no risk
Eptifibatide,Glucosamine,Glucosamine may increase the antiplatelet activities of Eptifibatide.,increase,no risk
Eptifibatide,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Eptifibatide.,increase,risk
Eptifibatide,Heparin,The risk or severity of bleeding can be increased when Eptifibatide is combined with Heparin.,increase,risk
Eptifibatide,Hydroxyurea,The risk or severity of bleeding can be increased when Eptifibatide is combined with Hydroxyurea.,increase,risk
Eptifibatide,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Eptifibatide.,increase,risk
Eptifibatide,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Eptifibatide.,increase,risk
Eptifibatide,Obeticholic acid,The risk or severity of adverse effects can be increased when Eptifibatide is combined with Obeticholic acid.,increase,risk
Eptifibatide,Obinutuzumab,The risk or severity of adverse effects can be increased when Eptifibatide is combined with Obinutuzumab.,increase,risk
Eptifibatide,Olaparib,The risk or severity of bleeding can be increased when Eptifibatide is combined with Olaparib.,increase,risk
Eptifibatide,Olsalazine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Olsalazine.,increase,risk
Eptifibatide,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Eptifibatide.,increase,no risk
Eptifibatide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Eptifibatide.,increase,risk
Eptifibatide,Oxaliplatin,The risk or severity of bleeding can be increased when Eptifibatide is combined with Oxaliplatin.,increase,risk
Eptifibatide,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Eptifibatide.,increase,risk
Eptifibatide,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Eptifibatide.,increase,risk
Eptifibatide,Urokinase,Eptifibatide may increase the anticoagulant activities of Urokinase.,increase,no risk
Eptifibatide,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Eptifibatide is combined with Ursodeoxycholic acid.,increase,risk
Eptifibatide,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Eptifibatide.,increase,risk
Eptifibatide,Venlafaxine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Venlafaxine.,increase,risk
Eptifibatide,Vinblastine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Vinblastine.,increase,risk
Eptifibatide,Vindesine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Vindesine.,increase,risk
Eptifibatide,Vinorelbine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Vinorelbine.,increase,risk
Eptifibatide,Vitamin E,Vitamin E may increase the antiplatelet activities of Eptifibatide.,increase,no risk
Eptifibatide,Vorapaxar,The risk or severity of bleeding can be increased when Eptifibatide is combined with Vorapaxar.,increase,risk
Eptifibatide,Vorinostat,The risk or severity of bleeding can be increased when Eptifibatide is combined with Vorinostat.,increase,risk
Eptifibatide,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Eptifibatide.,increase,risk
Eptifibatide,Warfarin,The risk or severity of bleeding can be increased when Eptifibatide is combined with Warfarin.,increase,risk
Eptifibatide,Ximelagatran,The risk or severity of bleeding can be increased when Eptifibatide is combined with Ximelagatran.,increase,risk
Eptifibatide,Zidovudine,The risk or severity of bleeding can be increased when Eptifibatide is combined with Zidovudine.,increase,risk
Eptifibatide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Eptifibatide.,increase,risk
Infliximab,Benzatropine,The metabolism of Benzatropine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Benzocaine,The metabolism of Benzocaine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bepridil,The metabolism of Bepridil can be increased when combined with Infliximab.,increase,no risk
Infliximab,Besilesomab,The risk or severity of adverse effects can be increased when Infliximab is combined with Besilesomab.,increase,risk
Infliximab,Betamethasone,The risk or severity of adverse effects can be increased when Infliximab is combined with Betamethasone.,increase,risk
Infliximab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bevacizumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Bevacizumab.,increase,risk
Infliximab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Bezafibrate.",increase,risk
Infliximab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Bezlotoxumab.,increase,risk
Infliximab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bimekizumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Bimekizumab.,increase,risk
Infliximab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bleomycin,The risk or severity of adverse effects can be increased when Infliximab is combined with Bleomycin.,increase,risk
Infliximab,Blinatumomab,The risk or severity of adverse effects can be increased when Infliximab is combined with Blinatumomab.,increase,risk
Infliximab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Infliximab.,increase,no risk
Infliximab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Infliximab.",decrease,no risk
Infliximab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bosentan,The metabolism of Bosentan can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Infliximab.,increase,no risk
Infliximab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Infliximab.,increase,no risk
Infliximab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Infliximab.,increase,no risk
Infliximab,Brodalumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Brodalumab.,increase,risk
Infliximab,Brolucizumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Brolucizumab.,increase,risk
Infliximab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Infliximab.,increase,no risk
Infliximab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Budesonide,The risk or severity of adverse effects can be increased when Infliximab is combined with Budesonide.,increase,risk
Infliximab,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Bumetanide.",increase,risk
Infliximab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Bupropion,The metabolism of Bupropion can be increased when combined with Infliximab.,increase,no risk
Infliximab,Burosumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Burosumab.,increase,risk
Infliximab,Buspirone,The metabolism of Buspirone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Busulfan,The metabolism of Busulfan can be increased when combined with Infliximab.,increase,no risk
Infliximab,Galantamine,The metabolism of Galantamine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Galcanezumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Galcanezumab.,increase,risk
Infliximab,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ganciclovir.",increase,risk
Infliximab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Gemcitabine,The risk or severity of adverse effects can be increased when Infliximab is combined with Gemcitabine.,increase,risk
Infliximab,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Gemfibrozil.",increase,risk
Infliximab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Infliximab.,increase,risk
Infliximab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Glatiramer,The risk or severity of adverse effects can be increased when Infliximab is combined with Glatiramer.,increase,risk
Infliximab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Infliximab.,increase,no risk
Infliximab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Infliximab.,increase,no risk
Infliximab,Glipizide,The metabolism of Glipizide can be increased when combined with Infliximab.,increase,no risk
Infliximab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Glofitamab,The risk or severity of adverse effects can be increased when Infliximab is combined with Glofitamab.,increase,risk
Infliximab,Glyburide,The metabolism of Glyburide can be increased when combined with Infliximab.,increase,no risk
Infliximab,Golimumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Golimumab.,increase,risk
Infliximab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Infliximab.,increase,no risk
Infliximab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Infliximab.,increase,no risk
Infliximab,Guselkumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Guselkumab.,increase,risk
Infliximab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Infliximab.,decrease,no risk
Infliximab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Infliximab.,increase,no risk
Infliximab,Halothane,The metabolism of Halothane can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Infliximab.,decrease,no risk
Infliximab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Infliximab is combined with Hepatitis B immune globulin.,increase,risk
Infliximab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Infliximab.,decrease,no risk
Infliximab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Infliximab.,increase,risk
Infliximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Infliximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Infliximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Infliximab.,increase,risk
Infliximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Infliximab is combined with Human Rho(D) immune globulin.,increase,risk
Infliximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Infliximab is combined with Human varicella-zoster immune globulin.,increase,risk
Infliximab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Infliximab is combined with Hydrocortisone succinate.,increase,risk
Infliximab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Infliximab.,increase,no risk
Infliximab,Hydroxyurea,The risk or severity of adverse effects can be increased when Infliximab is combined with Hydroxyurea.,increase,risk
Infliximab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Infliximab.,decrease,no risk
Infliximab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Infliximab.,decrease,no risk
Infliximab,Ketamine,The metabolism of Ketamine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Infliximab.,increase,no risk
Infliximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Infliximab is combined with Obiltoxaximab.,increase,risk
Infliximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Obinutuzumab.,increase,risk
Infliximab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Infliximab.,increase,no risk
Infliximab,Odesivimab,The risk or severity of adverse effects can be increased when Infliximab is combined with Odesivimab.,increase,risk
Infliximab,Ofatumumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Ofatumumab.,increase,risk
Infliximab,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ofloxacin.",increase,risk
Infliximab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Olaparib,The metabolism of Olaparib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Olaratumab,The risk or severity of adverse effects can be increased when Infliximab is combined with Olaratumab.,increase,risk
Infliximab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Infliximab.,increase,no risk
Infliximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Infliximab.,increase,risk
Infliximab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Infliximab.,increase,no risk
Infliximab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Infliximab.,increase,no risk
Infliximab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Infliximab.,increase,no risk
Infliximab,Opium,The metabolism of Opium can be increased when combined with Infliximab.,increase,no risk
Infliximab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Infliximab.,increase,no risk
Infliximab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Infliximab.,increase,no risk
Infliximab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Infliximab.,increase,no risk
Infliximab,Oxaliplatin,The risk or severity of adverse effects can be increased when Infliximab is combined with Oxaliplatin.,increase,risk
Infliximab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Infliximab.,increase,no risk
Infliximab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Infliximab.,increase,no risk
Infliximab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Infliximab.,increase,no risk
Infliximab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Infliximab.,increase,no risk
Infliximab,Ozanimod,The risk or severity of adverse effects can be increased when Infliximab is combined with Ozanimod.,increase,risk
Infliximab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Infliximab.,increase,no risk
Infliximab,Quinidine,The metabolism of Quinidine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Quinine,The metabolism of Quinine can be increased when combined with Infliximab.,increase,no risk
Infliximab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Infliximab.,increase,no risk
Follitropin,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Follitropin.,increase,risk
Follitropin,Osimertinib,The therapeutic efficacy of Follitropin can be decreased when used in combination with Osimertinib.,decrease,no risk
Follitropin,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Follitropin.,increase,risk
Follitropin,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Follitropin is combined with Quinupramine.,increase,risk
Follitropin,Quizartinib,The therapeutic efficacy of Follitropin can be decreased when used in combination with Quizartinib.,decrease,no risk
Follitropin,Vandetanib,The therapeutic efficacy of Follitropin can be decreased when used in combination with Vandetanib.,decrease,no risk
Follitropin,Vemurafenib,The therapeutic efficacy of Follitropin can be decreased when used in combination with Vemurafenib.,decrease,no risk
Follitropin,Zanubrutinib,The therapeutic efficacy of Follitropin can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Follitropin,Zimelidine,The therapeutic efficacy of Follitropin can be decreased when used in combination with Zimelidine.,decrease,no risk
Vasopressin,Bemiparin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Bemiparin.,decrease,no risk
Vasopressin,Botulinum toxin type A,Botulinum toxin type A may increase the hypertensive activities of Vasopressin.,increase,no risk
Vasopressin,Botulinum toxin type B,Botulinum toxin type B may increase the hypertensive activities of Vasopressin.,increase,no risk
Vasopressin,Butriptyline,Butriptyline may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Vasopressin,Haloperidol,Haloperidol may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Vasopressin,Heparin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Heparin.,decrease,no risk
Vasopressin,Orciprenaline,Vasopressin may increase the hypertensive activities of Orciprenaline.,increase,no risk
Vasopressin,Oxytocin,The risk or severity of hypertension can be increased when Vasopressin is combined with Oxytocin.,increase,risk
Vasopressin,Quinupramine,Quinupramine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Vasopressin,Vincristine,Vincristine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Vasopressin,Zimelidine,Zimelidine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Interferon beta-1b,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Gemcitabine.,increase,risk
Interferon beta-1b,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Glatiramer,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Glatiramer.,increase,risk
Interferon beta-1b,Golimumab,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Golimumab.,increase,risk
Interferon beta-1b,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Guselkumab,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Guselkumab.,increase,risk
Interferon beta-1b,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Hydrocortisone acetate.,increase,risk
Interferon beta-1b,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Hydrocortisone butyrate.,increase,risk
Interferon beta-1b,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Hydrocortisone succinate.,increase,risk
Interferon beta-1b,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Hydroxychloroquine.,increase,risk
Interferon beta-1b,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Hydroxyurea.,increase,risk
Interferon beta-1b,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Obinutuzumab.,increase,risk
Interferon beta-1b,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Ocrelizumab.,increase,risk
Interferon beta-1b,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Ofatumumab.,increase,risk
Interferon beta-1b,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Olaparib,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Olaparib.,increase,risk
Interferon beta-1b,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Oxaliplatin.,increase,risk
Interferon beta-1b,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Ozanimod,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Ozanimod.,increase,risk
Interferon beta-1b,Quinine,The metabolism of Quinine can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Upadacitinib.,increase,risk
Interferon beta-1b,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vedolizumab.,increase,risk
Interferon beta-1b,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Vilanterol,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vilanterol.,increase,risk
Interferon beta-1b,Vinblastine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vinblastine.,increase,risk
Interferon beta-1b,Vincristine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vincristine.,increase,risk
Interferon beta-1b,Vindesine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vindesine.,increase,risk
Interferon beta-1b,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vinorelbine.,increase,risk
Interferon beta-1b,Voclosporin,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Voclosporin.,increase,risk
Interferon beta-1b,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Vorinostat,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vorinostat.,increase,risk
Interferon beta-1b,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon beta-1b.,increase,risk
Interferon beta-1b,Zidovudine,The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Zidovudine.,increase,risk
Interferon beta-1b,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon beta-1b,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon beta-1b.,decrease,no risk
Interferon alfacon-1,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Gemcitabine.,increase,risk
Interferon alfacon-1,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Glatiramer,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Glatiramer.,increase,risk
Interferon alfacon-1,Golimumab,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Golimumab.,increase,risk
Interferon alfacon-1,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Guselkumab,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Guselkumab.,increase,risk
Interferon alfacon-1,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Hydrocortisone acetate.,increase,risk
Interferon alfacon-1,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Hydrocortisone butyrate.,increase,risk
Interferon alfacon-1,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Hydrocortisone succinate.,increase,risk
Interferon alfacon-1,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Hydroxychloroquine.,increase,risk
Interferon alfacon-1,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Hydroxyurea.,increase,risk
Interferon alfacon-1,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Obinutuzumab.,increase,risk
Interferon alfacon-1,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Ocrelizumab.,increase,risk
Interferon alfacon-1,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Ofatumumab.,increase,risk
Interferon alfacon-1,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Olaparib,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Olaparib.,increase,risk
Interferon alfacon-1,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Oxaliplatin.,increase,risk
Interferon alfacon-1,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Ozanimod,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Ozanimod.,increase,risk
Interferon alfacon-1,Quinine,The metabolism of Quinine can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Upadacitinib.,increase,risk
Interferon alfacon-1,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vedolizumab.,increase,risk
Interferon alfacon-1,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Vilanterol,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vilanterol.,increase,risk
Interferon alfacon-1,Vinblastine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vinblastine.,increase,risk
Interferon alfacon-1,Vincristine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vincristine.,increase,risk
Interferon alfacon-1,Vindesine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vindesine.,increase,risk
Interferon alfacon-1,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vinorelbine.,increase,risk
Interferon alfacon-1,Voclosporin,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Voclosporin.,increase,risk
Interferon alfacon-1,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Vorinostat,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Vorinostat.,increase,risk
Interferon alfacon-1,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon alfacon-1.,increase,risk
Interferon alfacon-1,Zidovudine,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Zidovudine.,increase,risk
Interferon alfacon-1,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Interferon alfacon-1,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon alfacon-1.,decrease,no risk
Hyaluronidase (ovine),Quinestrol,The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Quinestrol.,decrease,no risk
Hyaluronidase (ovine),Ziprasidone,The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Ziprasidone.,decrease,no risk
Hyaluronidase (ovine),Zuclopenthixol,The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Insulin pork,Gatifloxacin,The therapeutic efficacy of Insulin pork can be increased when used in combination with Gatifloxacin.,increase,no risk
Insulin pork,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with Insulin pork.,increase,risk
Insulin pork,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with Insulin pork.,increase,risk
Insulin pork,Gemifloxacin,The therapeutic efficacy of Insulin pork can be increased when used in combination with Gemifloxacin.,increase,no risk
Insulin pork,Gestrinone,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Gestrinone.,decrease,no risk
Insulin pork,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Insulin pork.,increase,risk
Insulin pork,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Insulin pork.,increase,risk
Insulin pork,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Insulin pork.,increase,risk
Insulin pork,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Insulin pork.,increase,risk
Insulin pork,Glucagon,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Glucagon.,decrease,no risk
Insulin pork,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Insulin pork.,increase,risk
Insulin pork,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Insulin pork.,increase,risk
Insulin pork,Goserelin,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Goserelin.,decrease,no risk
Insulin pork,Grepafloxacin,The therapeutic efficacy of Insulin pork can be increased when used in combination with Grepafloxacin.,increase,no risk
Insulin pork,Guanabenz,The metabolism of Guanabenz can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin pork.,increase,risk
Insulin pork,Haloperidol,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Haloperidol.,decrease,no risk
Insulin pork,Histrelin,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Histrelin.,decrease,no risk
Insulin pork,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin pork.,increase,risk
Insulin pork,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin pork.,increase,risk
Insulin pork,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with Insulin pork.,increase,risk
Insulin pork,Hydroxychloroquine,The therapeutic efficacy of Insulin pork can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Insulin pork,Hydroxyprogesterone caproate,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Insulin pork,Octreotide,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Octreotide.,decrease,no risk
Insulin pork,Ofloxacin,The therapeutic efficacy of Insulin pork can be increased when used in combination with Ofloxacin.,increase,no risk
Insulin pork,Olanzapine,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Olanzapine.,decrease,no risk
Insulin pork,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with Insulin pork.,increase,risk
Insulin pork,Ondansetron,The metabolism of Ondansetron can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Insulin pork.,increase,no risk
Insulin pork,Oxprenolol,The therapeutic efficacy of Insulin pork can be increased when used in combination with Oxprenolol.,increase,no risk
Insulin pork,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Insulin pork.,increase,no risk
Insulin pork,Quetiapine,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Quetiapine.,decrease,no risk
Insulin pork,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with Insulin pork.,increase,risk
Insulin pork,Quinestrol,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Quinestrol.,decrease,no risk
Insulin pork,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with Insulin pork.,increase,risk
Insulin pork,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Insulin pork.,increase,risk
Insulin pork,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Insulin pork.,decrease,no risk
Insulin pork,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Insulin pork.,increase,risk
Insulin pork,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with Insulin pork.,increase,risk
Insulin pork,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin pork.,increase,risk
Insulin pork,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with Insulin pork.,increase,risk
Insulin pork,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with Insulin pork.,increase,risk
Insulin pork,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Insulin pork.,increase,risk
Insulin pork,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with Insulin pork.,increase,risk
Insulin pork,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Insulin pork.,increase,risk
Insulin pork,Verapamil,The metabolism of Verapamil can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Insulin pork.,increase,risk
Insulin pork,Vorinostat,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Vorinostat.,decrease,no risk
Insulin pork,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Warfarin,The metabolism of Warfarin can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin pork.,increase,risk
Insulin pork,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin pork.,increase,risk
Insulin pork,Zileuton,The metabolism of Zileuton can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Insulin pork.,increase,risk
Insulin pork,Ziprasidone,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Ziprasidone.,decrease,no risk
Insulin pork,Zofenopril,The risk or severity of hypoglycemia can be increased when Zofenopril is combined with Insulin pork.,increase,risk
Insulin pork,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Zolpidem,The metabolism of Zolpidem can be increased when combined with Insulin pork.,increase,no risk
Insulin pork,Zonisamide,The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Insulin pork.,increase,risk
Trastuzumab,Galcanezumab,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Galcanezumab.,increase,risk
Trastuzumab,Gemcitabine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Gemcitabine.,increase,risk
Trastuzumab,Gemtuzumab ozogamicin,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Gemtuzumab ozogamicin.,increase,risk
Trastuzumab,Glatiramer,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Glatiramer.,increase,risk
Trastuzumab,Glofitamab,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Glofitamab.,increase,risk
Trastuzumab,Golimumab,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Golimumab.,increase,risk
Trastuzumab,Guselkumab,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Guselkumab.,increase,risk
Trastuzumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Halcinonide,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Halcinonide.,increase,risk
Trastuzumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Hepatitis B immune globulin.,increase,risk
Trastuzumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Trastuzumab.,increase,risk
Trastuzumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Trastuzumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab.,increase,risk
Trastuzumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Human Rho(D) immune globulin.,increase,risk
Trastuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Trastuzumab,Hydrocortisone,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydrocortisone.,increase,risk
Trastuzumab,Hydrocortisone acetate,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydrocortisone acetate.,increase,risk
Trastuzumab,Hydrocortisone butyrate,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydrocortisone butyrate.,increase,risk
Trastuzumab,Hydrocortisone probutate,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydrocortisone probutate.,increase,risk
Trastuzumab,Hydrocortisone succinate,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydrocortisone succinate.,increase,risk
Trastuzumab,Hydrocortisone valerate,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydrocortisone valerate.,increase,risk
Trastuzumab,Hydroxychloroquine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydroxychloroquine.,increase,risk
Trastuzumab,Hydroxyurea,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Hydroxyurea.,increase,risk
Trastuzumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Obiltoxaximab.,increase,risk
Trastuzumab,Obinutuzumab,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Obinutuzumab.,increase,risk
Trastuzumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Trastuzumab.,increase,no risk
Trastuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Odesivimab.,increase,risk
Trastuzumab,Ofatumumab,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Ofatumumab.,increase,risk
Trastuzumab,Olaparib,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Olaparib.,increase,risk
Trastuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Olaratumab.,increase,risk
Trastuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab.,increase,risk
Trastuzumab,Ouabain,Ouabain may decrease the cardiotoxic activities of Trastuzumab.,decrease,no risk
Trastuzumab,Oxaliplatin,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Oxaliplatin.,increase,risk
Trastuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trastuzumab is combined with Oxetacaine.,increase,risk
Trastuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trastuzumab is combined with Oxybuprocaine.,increase,risk
Trastuzumab,Ozanimod,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Ozanimod.,increase,risk
Trastuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Trastuzumab.,increase,no risk
Trastuzumab,Ublituximab,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Ublituximab.,increase,risk
Trastuzumab,Ulobetasol,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Ulobetasol.,increase,risk
Trastuzumab,Upadacitinib,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Upadacitinib.,increase,risk
Trastuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ustekinumab.,increase,risk
Trastuzumab,Valrubicin,The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Valrubicin.,increase,risk
Trastuzumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Trastuzumab.,increase,risk
Trastuzumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Vedolizumab,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vedolizumab.,increase,risk
Trastuzumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Trastuzumab.,decrease,no risk
Trastuzumab,Vilanterol,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vilanterol.,increase,risk
Trastuzumab,Vinblastine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vinblastine.,increase,risk
Trastuzumab,Vincristine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vincristine.,increase,risk
Trastuzumab,Vindesine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vindesine.,increase,risk
Trastuzumab,Vinorelbine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vinorelbine.,increase,risk
Trastuzumab,Voclosporin,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Voclosporin.,increase,risk
Trastuzumab,Vorinostat,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Vorinostat.,increase,risk
Trastuzumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Trastuzumab.,increase,risk
Trastuzumab,Zidovudine,The risk or severity of neutropenia can be increased when Trastuzumab is combined with Zidovudine.,increase,risk
Rituximab,Galcanezumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Galcanezumab.,increase,risk
Rituximab,Gemcitabine,The risk or severity of adverse effects can be increased when Rituximab is combined with Gemcitabine.,increase,risk
Rituximab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Rituximab.,increase,risk
Rituximab,Glatiramer,The risk or severity of adverse effects can be increased when Rituximab is combined with Glatiramer.,increase,risk
Rituximab,Glofitamab,The risk or severity of adverse effects can be increased when Rituximab is combined with Glofitamab.,increase,risk
Rituximab,Golimumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Golimumab.,increase,risk
Rituximab,Guanabenz,Guanabenz may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Guanadrel,Guanadrel may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Guanethidine,Guanethidine may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Guanfacine,Guanfacine may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Guanoxan,Guanoxan may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Guselkumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Guselkumab.,increase,risk
Rituximab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Rituximab.,increase,risk
Rituximab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Rituximab is combined with Hepatitis B immune globulin.,increase,risk
Rituximab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Rituximab.,increase,risk
Rituximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Rituximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Rituximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rituximab.,increase,risk
Rituximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Rituximab is combined with Human Rho(D) immune globulin.,increase,risk
Rituximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Rituximab is combined with Human varicella-zoster immune globulin.,increase,risk
Rituximab,Hydralazine,Hydralazine may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Hydrochlorothiazide,Hydrochlorothiazide may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Rituximab is combined with Hydrocortisone acetate.,increase,risk
Rituximab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Rituximab is combined with Hydrocortisone butyrate.,increase,risk
Rituximab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Rituximab is combined with Hydrocortisone succinate.,increase,risk
Rituximab,Hydroflumethiazide,Hydroflumethiazide may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Rituximab is combined with Hydroxychloroquine.,increase,risk
Rituximab,Hydroxyurea,The risk or severity of adverse effects can be increased when Rituximab is combined with Hydroxyurea.,increase,risk
Rituximab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Rituximab is combined with Obiltoxaximab.,increase,risk
Rituximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Obinutuzumab.,increase,risk
Rituximab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Rituximab.,increase,no risk
Rituximab,Odesivimab,The risk or severity of adverse effects can be increased when Rituximab is combined with Odesivimab.,increase,risk
Rituximab,Ofatumumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Ofatumumab.,increase,risk
Rituximab,Olaparib,The risk or severity of adverse effects can be increased when Rituximab is combined with Olaparib.,increase,risk
Rituximab,Olaratumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Olaratumab.,increase,risk
Rituximab,Olmesartan,Olmesartan may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rituximab.,increase,risk
Rituximab,Oxaliplatin,The risk or severity of adverse effects can be increased when Rituximab is combined with Oxaliplatin.,increase,risk
Rituximab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rituximab is combined with Oxetacaine.,increase,risk
Rituximab,Oxprenolol,Oxprenolol may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rituximab is combined with Oxybuprocaine.,increase,risk
Rituximab,Ozanimod,The risk or severity of adverse effects can be increased when Rituximab is combined with Ozanimod.,increase,risk
Rituximab,Quinapril,Quinapril may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Rituximab.,increase,no risk
Rituximab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Rituximab.,increase,risk
Rituximab,Upadacitinib,The risk or severity of adverse effects can be increased when Rituximab is combined with Upadacitinib.,increase,risk
Rituximab,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Rituximab.,increase,risk
Rituximab,Ustekinumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Ustekinumab.,increase,risk
Rituximab,Valsartan,Valsartan may increase the hypotensive activities of Rituximab.,increase,no risk
Rituximab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Rituximab.,increase,risk
Rituximab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Vedolizumab,The risk or severity of adverse effects can be increased when Rituximab is combined with Vedolizumab.,increase,risk
Rituximab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rituximab.,decrease,no risk
Rituximab,Vilanterol,The risk or severity of adverse effects can be increased when Rituximab is combined with Vilanterol.,increase,risk
Rituximab,Vinblastine,The risk or severity of adverse effects can be increased when Rituximab is combined with Vinblastine.,increase,risk
Rituximab,Vincristine,The risk or severity of adverse effects can be increased when Rituximab is combined with Vincristine.,increase,risk
Rituximab,Vindesine,The risk or severity of adverse effects can be increased when Rituximab is combined with Vindesine.,increase,risk
Rituximab,Vinorelbine,The risk or severity of adverse effects can be increased when Rituximab is combined with Vinorelbine.,increase,risk
Rituximab,Voclosporin,The risk or severity of adverse effects can be increased when Rituximab is combined with Voclosporin.,increase,risk
Rituximab,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Rituximab.,increase,risk
Rituximab,Vorinostat,The risk or severity of adverse effects can be increased when Rituximab is combined with Vorinostat.,increase,risk
Rituximab,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Rituximab.,increase,risk
Rituximab,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Rituximab.,increase,risk
Rituximab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Rituximab.,increase,risk
Rituximab,Zidovudine,The risk or severity of adverse effects can be increased when Rituximab is combined with Zidovudine.,increase,risk
Rituximab,Zofenopril,Zofenopril may increase the hypotensive activities of Rituximab.,increase,no risk
Basiliximab,Galcanezumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Galcanezumab.,increase,risk
Basiliximab,Gemcitabine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Gemcitabine.,increase,risk
Basiliximab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Basiliximab.,increase,risk
Basiliximab,Glatiramer,The risk or severity of adverse effects can be increased when Basiliximab is combined with Glatiramer.,increase,risk
Basiliximab,Glofitamab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Glofitamab.,increase,risk
Basiliximab,Golimumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Golimumab.,increase,risk
Basiliximab,Guselkumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Guselkumab.,increase,risk
Basiliximab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Basiliximab is combined with Hepatitis B immune globulin.,increase,risk
Basiliximab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Basiliximab.,increase,risk
Basiliximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Basiliximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Basiliximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Basiliximab.,increase,risk
Basiliximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Basiliximab is combined with Human Rho(D) immune globulin.,increase,risk
Basiliximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Basiliximab is combined with Human varicella-zoster immune globulin.,increase,risk
Basiliximab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Basiliximab is combined with Hydrocortisone acetate.,increase,risk
Basiliximab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Basiliximab is combined with Hydrocortisone butyrate.,increase,risk
Basiliximab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Basiliximab is combined with Hydrocortisone succinate.,increase,risk
Basiliximab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Hydroxychloroquine.,increase,risk
Basiliximab,Hydroxyurea,The risk or severity of adverse effects can be increased when Basiliximab is combined with Hydroxyurea.,increase,risk
Basiliximab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Obiltoxaximab.,increase,risk
Basiliximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Obinutuzumab.,increase,risk
Basiliximab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Basiliximab.,increase,no risk
Basiliximab,Odesivimab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Odesivimab.,increase,risk
Basiliximab,Ofatumumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Ofatumumab.,increase,risk
Basiliximab,Olaparib,The risk or severity of adverse effects can be increased when Basiliximab is combined with Olaparib.,increase,risk
Basiliximab,Olaratumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Olaratumab.,increase,risk
Basiliximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Basiliximab.,increase,risk
Basiliximab,Oxaliplatin,The risk or severity of adverse effects can be increased when Basiliximab is combined with Oxaliplatin.,increase,risk
Basiliximab,Ozanimod,The risk or severity of adverse effects can be increased when Basiliximab is combined with Ozanimod.,increase,risk
Basiliximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Basiliximab.,increase,no risk
Basiliximab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Basiliximab.,increase,risk
Basiliximab,Upadacitinib,The risk or severity of adverse effects can be increased when Basiliximab is combined with Upadacitinib.,increase,risk
Basiliximab,Ustekinumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Ustekinumab.,increase,risk
Basiliximab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Basiliximab.,increase,risk
Basiliximab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Vedolizumab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vedolizumab.,increase,risk
Basiliximab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Basiliximab.,decrease,no risk
Basiliximab,Vilanterol,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vilanterol.,increase,risk
Basiliximab,Vinblastine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vinblastine.,increase,risk
Basiliximab,Vincristine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vincristine.,increase,risk
Basiliximab,Vindesine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vindesine.,increase,risk
Basiliximab,Vinorelbine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vinorelbine.,increase,risk
Basiliximab,Voclosporin,The risk or severity of adverse effects can be increased when Basiliximab is combined with Voclosporin.,increase,risk
Basiliximab,Vorinostat,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vorinostat.,increase,risk
Basiliximab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Basiliximab.,increase,risk
Basiliximab,Zidovudine,The risk or severity of adverse effects can be increased when Basiliximab is combined with Zidovudine.,increase,risk
Muromonab,Galcanezumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Galcanezumab.,increase,risk
Muromonab,Gemcitabine,The risk or severity of adverse effects can be increased when Muromonab is combined with Gemcitabine.,increase,risk
Muromonab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Muromonab.,increase,risk
Muromonab,Glatiramer,The risk or severity of adverse effects can be increased when Muromonab is combined with Glatiramer.,increase,risk
Muromonab,Glofitamab,The risk or severity of adverse effects can be increased when Muromonab is combined with Glofitamab.,increase,risk
Muromonab,Golimumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Golimumab.,increase,risk
Muromonab,Guselkumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Guselkumab.,increase,risk
Muromonab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Muromonab is combined with Hepatitis B immune globulin.,increase,risk
Muromonab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Muromonab.,increase,risk
Muromonab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Muromonab is combined with Human cytomegalovirus immune globulin.,increase,risk
Muromonab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Muromonab.,increase,risk
Muromonab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Muromonab is combined with Human Rho(D) immune globulin.,increase,risk
Muromonab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Muromonab is combined with Human varicella-zoster immune globulin.,increase,risk
Muromonab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Muromonab is combined with Hydrocortisone acetate.,increase,risk
Muromonab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Muromonab is combined with Hydrocortisone butyrate.,increase,risk
Muromonab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Muromonab is combined with Hydrocortisone succinate.,increase,risk
Muromonab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Muromonab is combined with Hydroxychloroquine.,increase,risk
Muromonab,Hydroxyurea,The risk or severity of adverse effects can be increased when Muromonab is combined with Hydroxyurea.,increase,risk
Muromonab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Muromonab is combined with Obiltoxaximab.,increase,risk
Muromonab,Obinutuzumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Obinutuzumab.,increase,risk
Muromonab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Muromonab.,increase,no risk
Muromonab,Odesivimab,The risk or severity of adverse effects can be increased when Muromonab is combined with Odesivimab.,increase,risk
Muromonab,Ofatumumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Ofatumumab.,increase,risk
Muromonab,Olaparib,The risk or severity of adverse effects can be increased when Muromonab is combined with Olaparib.,increase,risk
Muromonab,Olaratumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Olaratumab.,increase,risk
Muromonab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Muromonab.,increase,risk
Muromonab,Oxaliplatin,The risk or severity of adverse effects can be increased when Muromonab is combined with Oxaliplatin.,increase,risk
Muromonab,Ozanimod,The risk or severity of adverse effects can be increased when Muromonab is combined with Ozanimod.,increase,risk
Muromonab,Quinestrol,Quinestrol may increase the thrombogenic activities of Muromonab.,increase,no risk
Muromonab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Muromonab.,increase,risk
Muromonab,Upadacitinib,The risk or severity of adverse effects can be increased when Muromonab is combined with Upadacitinib.,increase,risk
Muromonab,Ustekinumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Ustekinumab.,increase,risk
Muromonab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Muromonab.,increase,risk
Muromonab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Vedolizumab,The risk or severity of adverse effects can be increased when Muromonab is combined with Vedolizumab.,increase,risk
Muromonab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Muromonab.,decrease,no risk
Muromonab,Vilanterol,The risk or severity of adverse effects can be increased when Muromonab is combined with Vilanterol.,increase,risk
Muromonab,Vinblastine,The risk or severity of adverse effects can be increased when Muromonab is combined with Vinblastine.,increase,risk
Muromonab,Vincristine,The risk or severity of adverse effects can be increased when Muromonab is combined with Vincristine.,increase,risk
Muromonab,Vindesine,The risk or severity of adverse effects can be increased when Muromonab is combined with Vindesine.,increase,risk
Muromonab,Vinorelbine,The risk or severity of adverse effects can be increased when Muromonab is combined with Vinorelbine.,increase,risk
Muromonab,Voclosporin,The risk or severity of adverse effects can be increased when Muromonab is combined with Voclosporin.,increase,risk
Muromonab,Vorinostat,The risk or severity of adverse effects can be increased when Muromonab is combined with Vorinostat.,increase,risk
Muromonab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Muromonab.,increase,risk
Muromonab,Zidovudine,The risk or severity of adverse effects can be increased when Muromonab is combined with Zidovudine.,increase,risk
Digoxin Immune Fab (Ovine),Obiltoxaximab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Obiltoxaximab.,increase,risk
Digoxin Immune Fab (Ovine),Obinutuzumab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Obinutuzumab.,increase,risk
Digoxin Immune Fab (Ovine),Ocrelizumab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Ocrelizumab.,increase,risk
Digoxin Immune Fab (Ovine),Odesivimab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Odesivimab.,increase,risk
Digoxin Immune Fab (Ovine),Ofatumumab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Ofatumumab.,increase,risk
Digoxin Immune Fab (Ovine),Olaratumab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Olaratumab.,increase,risk
Digoxin Immune Fab (Ovine),Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Digoxin Immune Fab (Ovine).,increase,risk
Digoxin Immune Fab (Ovine),Quinestrol,Quinestrol may increase the thrombogenic activities of Digoxin Immune Fab (Ovine).,increase,no risk
Digoxin Immune Fab (Ovine),Ublituximab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Ublituximab.,increase,risk
Digoxin Immune Fab (Ovine),Ustekinumab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Ustekinumab.,increase,risk
Digoxin Immune Fab (Ovine),Vedolizumab,The risk or severity of adverse effects can be increased when Digoxin Immune Fab (Ovine) is combined with Vedolizumab.,increase,risk
Ibritumomab tiuxetan,Galcanezumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Galcanezumab.,increase,risk
Ibritumomab tiuxetan,Gemcitabine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Gemcitabine.,increase,risk
Ibritumomab tiuxetan,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Glatiramer,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Glatiramer.,increase,risk
Ibritumomab tiuxetan,Glofitamab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Glofitamab.,increase,risk
Ibritumomab tiuxetan,Golimumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Golimumab.,increase,risk
Ibritumomab tiuxetan,Guselkumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Guselkumab.,increase,risk
Ibritumomab tiuxetan,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Heparin,The risk or severity of adverse effects can be increased when Heparin is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Hepatitis B immune globulin.,increase,risk
Ibritumomab tiuxetan,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Human cytomegalovirus immune globulin.,increase,risk
Ibritumomab tiuxetan,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Human Rho(D) immune globulin.,increase,risk
Ibritumomab tiuxetan,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Human varicella-zoster immune globulin.,increase,risk
Ibritumomab tiuxetan,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Hydrocortisone acetate.,increase,risk
Ibritumomab tiuxetan,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Hydrocortisone butyrate.,increase,risk
Ibritumomab tiuxetan,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Hydrocortisone succinate.,increase,risk
Ibritumomab tiuxetan,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Hydroxychloroquine.,increase,risk
Ibritumomab tiuxetan,Hydroxyurea,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Hydroxyurea.,increase,risk
Ibritumomab tiuxetan,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Obiltoxaximab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Obiltoxaximab.,increase,risk
Ibritumomab tiuxetan,Obinutuzumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Obinutuzumab.,increase,risk
Ibritumomab tiuxetan,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Ibritumomab tiuxetan.,increase,no risk
Ibritumomab tiuxetan,Odesivimab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Odesivimab.,increase,risk
Ibritumomab tiuxetan,Ofatumumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Ofatumumab.,increase,risk
Ibritumomab tiuxetan,Olaparib,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Olaparib.,increase,risk
Ibritumomab tiuxetan,Olaratumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Olaratumab.,increase,risk
Ibritumomab tiuxetan,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Oxaliplatin,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Oxaliplatin.,increase,risk
Ibritumomab tiuxetan,Ozanimod,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Ozanimod.,increase,risk
Ibritumomab tiuxetan,Quinestrol,Quinestrol may increase the thrombogenic activities of Ibritumomab tiuxetan.,increase,no risk
Ibritumomab tiuxetan,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Upadacitinib,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Upadacitinib.,increase,risk
Ibritumomab tiuxetan,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Ustekinumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Ustekinumab.,increase,risk
Ibritumomab tiuxetan,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Vedolizumab,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vedolizumab.,increase,risk
Ibritumomab tiuxetan,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ibritumomab tiuxetan.,decrease,no risk
Ibritumomab tiuxetan,Vilanterol,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vilanterol.,increase,risk
Ibritumomab tiuxetan,Vinblastine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vinblastine.,increase,risk
Ibritumomab tiuxetan,Vincristine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vincristine.,increase,risk
Ibritumomab tiuxetan,Vindesine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vindesine.,increase,risk
Ibritumomab tiuxetan,Vinorelbine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vinorelbine.,increase,risk
Ibritumomab tiuxetan,Voclosporin,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Voclosporin.,increase,risk
Ibritumomab tiuxetan,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Vorinostat,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vorinostat.,increase,risk
Ibritumomab tiuxetan,Warfarin,The risk or severity of adverse effects can be increased when Warfarin is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Ximelagatran,The risk or severity of adverse effects can be increased when Ximelagatran is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ibritumomab tiuxetan.,increase,risk
Ibritumomab tiuxetan,Zidovudine,The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Zidovudine.,increase,risk
Daptomycin,Budesonide,Daptomycin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Daptomycin,Bumadizone,Bumadizone may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Bumetanide,Bumetanide may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Daptomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Bupivacaine.,increase,risk
Daptomycin,Bupropion,Daptomycin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Daptomycin,Buspirone,Daptomycin may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Daptomycin,Butabarbital,Daptomycin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Daptomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Butacaine.,increase,risk
Daptomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Butamben.,increase,risk
Daptomycin,Gabapentin enacarbil,Daptomycin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Daptomycin,Gadobenic acid,Daptomycin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Daptomycin,Gadodiamide,Daptomycin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Daptomycin,Gadofosveset trisodium,Daptomycin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Daptomycin,Gadopentetic acid,Daptomycin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Daptomycin,Gadoteric acid,Daptomycin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Daptomycin,Gadoteridol,Daptomycin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Daptomycin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ganciclovir.",increase,risk
Daptomycin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Gemfibrozil.",increase,risk
Daptomycin,Gentamicin,Daptomycin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Daptomycin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Gimeracil,Daptomycin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Daptomycin,Givosiran,Givosiran may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Glasdegib,The serum concentration of Daptomycin can be increased when it is combined with Glasdegib.,increase,no risk
Daptomycin,Glecaprevir,The serum concentration of Daptomycin can be increased when it is combined with Glecaprevir.,increase,no risk
Daptomycin,Glipizide,Daptomycin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Daptomycin,Glycerol phenylbutyrate,Daptomycin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Daptomycin,Golodirsen,Daptomycin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Daptomycin,Goserelin,Goserelin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Guanethidine,Daptomycin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Daptomycin,Guanfacine,Daptomycin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Daptomycin,Haloperidol,Daptomycin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Daptomycin,Hydralazine,Daptomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Daptomycin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Daptomycin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Daptomycin,Hydromorphone,Daptomycin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Daptomycin,Hydroxocobalamin,Daptomycin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Daptomycin,Hydroxyethyl Starch,Daptomycin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Daptomycin,Kanamycin,Daptomycin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Ketamine,Daptomycin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Daptomycin,Ketazolam,Daptomycin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Daptomycin,Ketoconazole,The serum concentration of Daptomycin can be increased when it is combined with Ketoconazole.,increase,no risk
Daptomycin,Ketoprofen,Ketoprofen may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Ketorolac,Ketorolac may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Octinoxate,Daptomycin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Daptomycin,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ofloxacin.",increase,risk
Daptomycin,Olsalazine,Olsalazine may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Opium,Daptomycin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Daptomycin,Oseltamivir,Daptomycin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Daptomycin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Oxacillin,Daptomycin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Daptomycin,Oxaprozin,Oxaprozin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Oxazepam,Daptomycin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Daptomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Oxetacaine.,increase,risk
Daptomycin,Oxybenzone,Daptomycin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Daptomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Oxybuprocaine.,increase,risk
Daptomycin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Oxyquinoline,Daptomycin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Daptomycin,Quetiapine,Daptomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Daptomycin,Quinethazone,Quinethazone may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Daptomycin,Quinidine,Daptomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Daptomycin,Quinine,The serum concentration of Daptomycin can be increased when it is combined with Quinine.,increase,no risk
Daptomycin,Quizartinib,The serum concentration of Daptomycin can be increased when it is combined with Quizartinib.,increase,no risk
Daptomycin,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ubidecarenone.",increase,risk
Daptomycin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Umbralisib,The serum concentration of Daptomycin can be increased when it is combined with Umbralisib.,increase,no risk
Daptomycin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Vaborbactam,Daptomycin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Daptomycin,Valaciclovir,Valaciclovir may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Valbenazine,Daptomycin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Daptomycin,Valdecoxib,Valdecoxib may decrease the excretion rate of Daptomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Valganciclovir,Daptomycin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Daptomycin,Vancomycin,Daptomycin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Daptomycin,Vandetanib,The serum concentration of Daptomycin can be increased when it is combined with Vandetanib.,increase,no risk
Daptomycin,Vardenafil,The serum concentration of Daptomycin can be increased when it is combined with Vardenafil.,increase,no risk
Daptomycin,Varenicline,Daptomycin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Daptomycin,Velpatasvir,The serum concentration of Daptomycin can be increased when it is combined with Velpatasvir.,increase,no risk
Daptomycin,Vemurafenib,The serum concentration of Daptomycin can be increased when it is combined with Vemurafenib.,increase,no risk
Daptomycin,Venetoclax,The serum concentration of Daptomycin can be increased when it is combined with Venetoclax.,increase,no risk
Daptomycin,Venlafaxine,Daptomycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Daptomycin,Verapamil,The serum concentration of Daptomycin can be increased when it is combined with Verapamil.,increase,no risk
Daptomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Daptomycin.,decrease,no risk
Daptomycin,Vilanterol,Daptomycin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Daptomycin,Viloxazine,Daptomycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Daptomycin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Vincristine.",increase,risk
Daptomycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Daptomycin.,increase,no risk
Daptomycin,Voclosporin,The serum concentration of Daptomycin can be increased when it is combined with Voclosporin.,increase,no risk
Daptomycin,Vorapaxar,The serum concentration of Daptomycin can be increased when it is combined with Vorapaxar.,increase,no risk
Daptomycin,Vortioxetine,Daptomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Daptomycin,Voxilaprevir,The serum concentration of Daptomycin can be increased when it is combined with Voxilaprevir.,increase,no risk
Daptomycin,Warfarin,Daptomycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Daptomycin,Zaleplon,Daptomycin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Daptomycin,Zanamivir,Daptomycin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Daptomycin,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Zidovudine.",increase,risk
Daptomycin,Zonisamide,The serum concentration of Daptomycin can be increased when it is combined with Zonisamide.,increase,no risk
Tositumomab,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Benorilate,Benorilate may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Benralizumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Benralizumab.,increase,risk
Tositumomab,Benserazide,Tositumomab may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Tositumomab,Benzatropine,Tositumomab may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Tositumomab,Benznidazole,Tositumomab may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Tositumomab,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Benzocaine.,increase,risk
Tositumomab,Benzthiazide,Benzthiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Benzydamine,Benzydamine may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Benzyl alcohol.,increase,risk
Tositumomab,Bepotastine,Tositumomab may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Tositumomab,Besilesomab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Besilesomab.,increase,risk
Tositumomab,Betamethasone,The risk or severity of adverse effects can be increased when Tositumomab is combined with Betamethasone.,increase,risk
Tositumomab,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Tositumomab.,increase,risk
Tositumomab,Bevacizumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bevacizumab.,increase,risk
Tositumomab,Bexarotene,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bexarotene.,increase,risk
Tositumomab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bezlotoxumab.,increase,risk
Tositumomab,Bicisate,Tositumomab may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tositumomab,Bimekizumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bimekizumab.,increase,risk
Tositumomab,Bismuth subgallate,Tositumomab may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tositumomab,Bisoprolol,Tositumomab may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Tositumomab,Bisoxatin,Tositumomab may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tositumomab,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Tositumomab.,increase,risk
Tositumomab,Bleomycin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bleomycin.,increase,risk
Tositumomab,Blinatumomab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Blinatumomab.,increase,risk
Tositumomab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Tositumomab.",decrease,no risk
Tositumomab,Bortezomib,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bortezomib.,increase,risk
Tositumomab,Bosutinib,The risk or severity of adverse effects can be increased when Tositumomab is combined with Bosutinib.,increase,risk
Tositumomab,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Brentuximab vedotin.,increase,risk
Tositumomab,Brivaracetam,Tositumomab may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Tositumomab,Brodalumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Brodalumab.,increase,risk
Tositumomab,Brolucizumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Brolucizumab.,increase,risk
Tositumomab,Bromazepam,Tositumomab may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Tositumomab,Bromotheophylline,Bromotheophylline may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Budesonide,The risk or severity of adverse effects can be increased when Tositumomab is combined with Budesonide.,increase,risk
Tositumomab,Bumadizone,Bumadizone may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Bumetanide,Bumetanide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Bupivacaine.,increase,risk
Tositumomab,Bupropion,Tositumomab may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Tositumomab,Burosumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Burosumab.,increase,risk
Tositumomab,Buspirone,Tositumomab may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Tositumomab,Busulfan,The risk or severity of adverse effects can be increased when Tositumomab is combined with Busulfan.,increase,risk
Tositumomab,Butabarbital,Tositumomab may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Tositumomab,Butacaine,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Butacaine.,increase,risk
Tositumomab,Butamben,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Butamben.,increase,risk
Tositumomab,Gabapentin enacarbil,Tositumomab may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tositumomab,Gadobenic acid,Tositumomab may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Tositumomab,Gadodiamide,Tositumomab may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Tositumomab,Gadofosveset trisodium,Tositumomab may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tositumomab,Gadopentetic acid,Tositumomab may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Tositumomab,Gadoteric acid,Tositumomab may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tositumomab,Gadoteridol,Tositumomab may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Tositumomab,Galcanezumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Galcanezumab.,increase,risk
Tositumomab,Ganciclovir,Tositumomab may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tositumomab,Gemcitabine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Gemcitabine.,increase,risk
Tositumomab,Gemfibrozil,Tositumomab may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Tositumomab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tositumomab.,increase,risk
Tositumomab,Gentamicin,Tositumomab may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tositumomab,Gimeracil,Tositumomab may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tositumomab,Givosiran,Givosiran may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Glatiramer,The risk or severity of adverse effects can be increased when Tositumomab is combined with Glatiramer.,increase,risk
Tositumomab,Glipizide,Tositumomab may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tositumomab,Glofitamab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Glofitamab.,increase,risk
Tositumomab,Glycerol phenylbutyrate,Tositumomab may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tositumomab,Golimumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Golimumab.,increase,risk
Tositumomab,Golodirsen,Tositumomab may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tositumomab,Goserelin,Goserelin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Guanethidine,Tositumomab may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tositumomab,Guanfacine,Tositumomab may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Tositumomab,Guselkumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Guselkumab.,increase,risk
Tositumomab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Haloperidol,Tositumomab may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Tositumomab,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Heparin is combined with Tositumomab.,increase,risk
Tositumomab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Hepatitis B immune globulin.,increase,risk
Tositumomab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Tositumomab.,increase,risk
Tositumomab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Human cytomegalovirus immune globulin.,increase,risk
Tositumomab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tositumomab.,increase,risk
Tositumomab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Human Rho(D) immune globulin.,increase,risk
Tositumomab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Human varicella-zoster immune globulin.,increase,risk
Tositumomab,Hydralazine,Tositumomab may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Tositumomab,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydrocortisone acetate.,increase,risk
Tositumomab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydrocortisone butyrate.,increase,risk
Tositumomab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydrocortisone succinate.,increase,risk
Tositumomab,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Hydromorphone,Tositumomab may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Tositumomab,Hydroxocobalamin,Tositumomab may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Tositumomab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydroxychloroquine.,increase,risk
Tositumomab,Hydroxyethyl Starch,Tositumomab may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tositumomab,Hydroxyurea,The risk or severity of adverse effects can be increased when Tositumomab is combined with Hydroxyurea.,increase,risk
Tositumomab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Kanamycin,Tositumomab may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tositumomab,Ketamine,Tositumomab may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Tositumomab,Ketazolam,Tositumomab may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Tositumomab,Ketoprofen,Ketoprofen may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Ketorolac,Ketorolac may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Obiltoxaximab.,increase,risk
Tositumomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Obinutuzumab.,increase,risk
Tositumomab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Tositumomab.,increase,no risk
Tositumomab,Octinoxate,Tositumomab may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tositumomab,Odesivimab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Odesivimab.,increase,risk
Tositumomab,Ofatumumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Ofatumumab.,increase,risk
Tositumomab,Olaparib,The risk or severity of adverse effects can be increased when Tositumomab is combined with Olaparib.,increase,risk
Tositumomab,Olaratumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Olaratumab.,increase,risk
Tositumomab,Olsalazine,Olsalazine may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tositumomab.,increase,risk
Tositumomab,Opium,Tositumomab may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tositumomab,Oseltamivir,Tositumomab may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Tositumomab,Oxacillin,Tositumomab may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Tositumomab,Oxaliplatin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Oxaliplatin.,increase,risk
Tositumomab,Oxaprozin,Oxaprozin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Oxazepam,Tositumomab may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Tositumomab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Oxetacaine.,increase,risk
Tositumomab,Oxybenzone,Tositumomab may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tositumomab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tositumomab is combined with Oxybuprocaine.,increase,risk
Tositumomab,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Oxyquinoline,Tositumomab may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tositumomab,Ozanimod,The risk or severity of adverse effects can be increased when Tositumomab is combined with Ozanimod.,increase,risk
Tositumomab,Quetiapine,Tositumomab may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Tositumomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Tositumomab.,increase,no risk
Tositumomab,Quinethazone,Quinethazone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tositumomab,Quinidine,Tositumomab may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tositumomab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Tositumomab.,increase,risk
Tositumomab,Upadacitinib,The risk or severity of adverse effects can be increased when Tositumomab is combined with Upadacitinib.,increase,risk
Tositumomab,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Tositumomab.,increase,risk
Tositumomab,Ustekinumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Ustekinumab.,increase,risk
Tositumomab,Vaborbactam,Tositumomab may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tositumomab,Valaciclovir,Valaciclovir may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Valbenazine,Tositumomab may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tositumomab,Valdecoxib,Valdecoxib may decrease the excretion rate of Tositumomab which could result in a higher serum level.,decrease,no risk
Tositumomab,Valganciclovir,Tositumomab may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tositumomab,Vancomycin,Tositumomab may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tositumomab,Varenicline,Tositumomab may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tositumomab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Tositumomab.,increase,risk
Tositumomab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Vedolizumab,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vedolizumab.,increase,risk
Tositumomab,Venlafaxine,Tositumomab may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Tositumomab,Verapamil,Tositumomab may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Tositumomab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tositumomab.,decrease,no risk
Tositumomab,Vilanterol,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vilanterol.,increase,risk
Tositumomab,Viloxazine,Tositumomab may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Tositumomab,Vinblastine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vinblastine.,increase,risk
Tositumomab,Vincristine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vincristine.,increase,risk
Tositumomab,Vindesine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vindesine.,increase,risk
Tositumomab,Vinorelbine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vinorelbine.,increase,risk
Tositumomab,Voclosporin,The risk or severity of adverse effects can be increased when Tositumomab is combined with Voclosporin.,increase,risk
Tositumomab,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Tositumomab.,increase,risk
Tositumomab,Vorinostat,The risk or severity of adverse effects can be increased when Tositumomab is combined with Vorinostat.,increase,risk
Tositumomab,Vortioxetine,Tositumomab may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Tositumomab,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Warfarin is combined with Tositumomab.,increase,risk
Tositumomab,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ximelagatran is combined with Tositumomab.,increase,risk
Tositumomab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Tositumomab.,increase,risk
Tositumomab,Zaleplon,Tositumomab may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Tositumomab,Zanamivir,Tositumomab may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Tositumomab,Zidovudine,The risk or severity of adverse effects can be increased when Tositumomab is combined with Zidovudine.,increase,risk
Tositumomab,Zonisamide,Zonisamide may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pegvisomant,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Gatifloxacin.,increase,risk
Pegvisomant,Gliclazide,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Gliclazide.,increase,risk
Pegvisomant,Glimepiride,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glimepiride.,increase,risk
Pegvisomant,Glipizide,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glipizide.,increase,risk
Pegvisomant,Gliquidone,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Gliquidone.,increase,risk
Pegvisomant,Glyburide,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glyburide.,increase,risk
Pegvisomant,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Glymidine,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Glymidine.,increase,risk
Pegvisomant,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Hydrocodone,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydrocodone.,decrease,no risk
Pegvisomant,Hydrocortisone,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Pegvisomant,Hydrocortisone acetate,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Pegvisomant,Hydrocortisone butyrate,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Pegvisomant,Hydrocortisone cypionate,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Pegvisomant,Hydrocortisone succinate,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Pegvisomant,Hydromorphone,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Hydromorphone.,decrease,no risk
Pegvisomant,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Octreotide,The risk or severity of increased transaminases can be increased when Octreotide is combined with Pegvisomant.,increase,risk
Pegvisomant,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Pegvisomant.,decrease,no risk
Pegvisomant,Opium,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Opium.,decrease,no risk
Pegvisomant,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Oxprenolol,Pegvisomant may increase the bradycardic activities of Oxprenolol.,increase,no risk
Pegvisomant,Oxybuprocaine,Pegvisomant may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Pegvisomant,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Oxycodone,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Oxycodone.,decrease,no risk
Pegvisomant,Oxymorphone,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Oxymorphone.,decrease,no risk
Pegvisomant,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Pegvisomant.,decrease,no risk
Pegvisomant,Quinine,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Quinine.,increase,risk
Botulinum toxin type A,Gabapentin,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Gabapentin.,increase,risk
Botulinum toxin type A,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Gabapentin enacarbil.,increase,risk
Botulinum toxin type A,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Botulinum toxin type A is combined with Ganaxolone.",increase,risk
Botulinum toxin type A,Gentamicin,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Gentamicin.,increase,no risk
Botulinum toxin type A,Gepirone,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Gepirone.,increase,risk
Botulinum toxin type A,Glutethimide,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Glutethimide.,increase,risk
Botulinum toxin type A,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Granisetron,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Granisetron.,increase,risk
Botulinum toxin type A,Guanfacine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Guanfacine.,increase,risk
Botulinum toxin type A,Halazepam,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Halazepam.,increase,risk
Botulinum toxin type A,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Halothane,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Halothane.,increase,risk
Botulinum toxin type A,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Hydrocodone,Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Botulinum toxin type A,Hydrocortisone,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Hydrocortisone.,increase,risk
Botulinum toxin type A,Hydrocortisone acetate,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Hydrocortisone acetate.,increase,risk
Botulinum toxin type A,Hydrocortisone butyrate,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Hydrocortisone butyrate.,increase,risk
Botulinum toxin type A,Hydrocortisone cypionate,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Hydrocortisone cypionate.,increase,risk
Botulinum toxin type A,Hydrocortisone succinate,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Hydrocortisone succinate.,increase,risk
Botulinum toxin type A,Hydromorphone,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Hydromorphone.,increase,risk
Botulinum toxin type A,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Botulinum toxin type A.,increase,no risk
Botulinum toxin type A,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Kanamycin,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Kanamycin.,increase,no risk
Botulinum toxin type A,Ketamine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ketamine.,increase,risk
Botulinum toxin type A,Ketazolam,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ketazolam.,increase,risk
Botulinum toxin type A,Ketoconazole,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Ketoconazole.,increase,no risk
Botulinum toxin type A,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Botulinum toxin type A is combined with Oliceridine.",increase,risk
Botulinum toxin type A,Ondansetron,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ondansetron.,increase,risk
Botulinum toxin type A,Opium,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Opium.,increase,risk
Botulinum toxin type A,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Botulinum toxin type A is combined with Ouabain.,increase,risk
Botulinum toxin type A,Oxazepam,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxazepam.,increase,risk
Botulinum toxin type A,Oxcarbazepine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxcarbazepine.,increase,risk
Botulinum toxin type A,Oxitriptan,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxitriptan.,increase,risk
Botulinum toxin type A,Oxprenolol,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxprenolol.,increase,risk
Botulinum toxin type A,Oxybuprocaine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxybuprocaine.,increase,risk
Botulinum toxin type A,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Oxycodone,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxycodone.,increase,risk
Botulinum toxin type A,Oxymorphone,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Oxymorphone.,increase,risk
Botulinum toxin type A,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Oxytetracycline,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Oxytetracycline.,increase,no risk
Botulinum toxin type A,Quazepam,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Quazepam.,increase,risk
Botulinum toxin type A,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Quinine,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Quinine.,increase,no risk
Botulinum toxin type A,Quinupramine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Quinupramine.,increase,risk
Botulinum toxin type A,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Urethane,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Urethane.,increase,risk
Botulinum toxin type A,Valproic acid,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Valproic acid.,increase,risk
Botulinum toxin type A,Vamorolone,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Vamorolone.,increase,risk
Botulinum toxin type A,Vancomycin,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Vancomycin.,increase,no risk
Botulinum toxin type A,Vasopressin,Botulinum toxin type A may increase the hypertensive activities of Vasopressin.,increase,no risk
Botulinum toxin type A,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Venlafaxine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Venlafaxine.,increase,risk
Botulinum toxin type A,Vigabatrin,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Vigabatrin.,increase,risk
Botulinum toxin type A,Vilazodone,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Vilazodone.,increase,risk
Botulinum toxin type A,Viloxazine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Viloxazine.,increase,risk
Botulinum toxin type A,Viomycin,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Viomycin.,increase,no risk
Botulinum toxin type A,Vortioxetine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Vortioxetine.,increase,risk
Botulinum toxin type A,Yohimbine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Yohimbine.,increase,risk
Botulinum toxin type A,Zaleplon,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zaleplon.,increase,risk
Botulinum toxin type A,Ziconotide,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ziconotide.,increase,risk
Botulinum toxin type A,Zimelidine,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Zimelidine.,increase,risk
Botulinum toxin type A,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Botulinum toxin type A.,increase,risk
Botulinum toxin type A,Zolmitriptan,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zolmitriptan.,increase,risk
Botulinum toxin type A,Zolpidem,Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Botulinum toxin type A,Zonisamide,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zonisamide.,increase,risk
Botulinum toxin type A,Zopiclone,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Zopiclone.,increase,risk
Botulinum toxin type A,Zotepine,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zotepine.,increase,risk
Botulinum toxin type A,Zuclopenthixol,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zuclopenthixol.,increase,risk
Streptokinase,Gemcitabine,The risk or severity of bleeding can be increased when Streptokinase is combined with Gemcitabine.,increase,risk
Streptokinase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Streptokinase is combined with Gemtuzumab ozogamicin.,increase,risk
Streptokinase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Streptokinase.,increase,risk
Streptokinase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Streptokinase.,increase,no risk
Streptokinase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Streptokinase.,increase,risk
Streptokinase,Guanabenz,Streptokinase may increase the hypotensive activities of Guanabenz.,increase,no risk
Streptokinase,Guanadrel,Streptokinase may increase the hypotensive activities of Guanadrel.,increase,no risk
Streptokinase,Guanethidine,Streptokinase may increase the hypotensive activities of Guanethidine.,increase,no risk
Streptokinase,Guanfacine,The risk or severity of adverse effects can be increased when Streptokinase is combined with Guanfacine.,increase,risk
Streptokinase,Guanoxan,Streptokinase may increase the hypotensive activities of Guanoxan.,increase,no risk
Streptokinase,Halothane,The risk or severity of adverse effects can be increased when Streptokinase is combined with Halothane.,increase,risk
Streptokinase,Hemin,Hemin may increase the anticoagulant activities of Streptokinase.,increase,no risk
Streptokinase,Heparin,Streptokinase may increase the anticoagulant activities of Heparin.,increase,no risk
Streptokinase,Hydralazine,The risk or severity of adverse effects can be increased when Streptokinase is combined with Hydralazine.,increase,risk
Streptokinase,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Streptokinase is combined with Hydrochlorothiazide.,increase,risk
Streptokinase,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Streptokinase is combined with Hydroflumethiazide.,increase,risk
Streptokinase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Streptokinase.,decrease,no risk
Streptokinase,Hydroxyprogesterone caproate,The therapeutic efficacy of Streptokinase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Streptokinase,Hydroxyurea,The risk or severity of bleeding can be increased when Streptokinase is combined with Hydroxyurea.,increase,risk
Streptokinase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Streptokinase.,increase,risk
Streptokinase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Streptokinase.,increase,risk
Streptokinase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Streptokinase is combined with Obeticholic acid.,increase,risk
Streptokinase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Streptokinase is combined with Obinutuzumab.,increase,risk
Streptokinase,Olanzapine,The risk or severity of adverse effects can be increased when Streptokinase is combined with Olanzapine.,increase,risk
Streptokinase,Olaparib,The risk or severity of bleeding can be increased when Streptokinase is combined with Olaparib.,increase,risk
Streptokinase,Olive oil,The therapeutic efficacy of Streptokinase can be decreased when used in combination with Olive oil.,decrease,no risk
Streptokinase,Olmesartan,The risk or severity of adverse effects can be increased when Streptokinase is combined with Olmesartan.,increase,risk
Streptokinase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Streptokinase.,increase,risk
Streptokinase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Streptokinase is combined with Omacetaxine mepesuccinate.,increase,risk
Streptokinase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Streptokinase.,increase,no risk
Streptokinase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Streptokinase.,increase,risk
Streptokinase,Omega-3-carboxylic acids,The therapeutic efficacy of Streptokinase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Streptokinase,Opicapone,The risk or severity of adverse effects can be increased when Streptokinase is combined with Opicapone.,increase,risk
Streptokinase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Streptokinase.,increase,risk
Streptokinase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Streptokinase.,increase,risk
Streptokinase,Oxprenolol,The risk or severity of adverse effects can be increased when Streptokinase is combined with Oxprenolol.,increase,risk
Streptokinase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Streptokinase.,increase,risk
Streptokinase,Quetiapine,The risk or severity of adverse effects can be increased when Streptokinase is combined with Quetiapine.,increase,risk
Streptokinase,Quinapril,The risk or severity of angioedema can be increased when Streptokinase is combined with Quinapril.,increase,risk
Streptokinase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Streptokinase.,decrease,no risk
Streptokinase,Quinidine,The therapeutic efficacy of Streptokinase can be increased when used in combination with Quinidine.,increase,no risk
Streptokinase,Quinine,The therapeutic efficacy of Streptokinase can be increased when used in combination with Quinine.,increase,no risk
Streptokinase,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Streptokinase.,increase,risk
Streptokinase,Ulipristal,The therapeutic efficacy of Streptokinase can be decreased when used in combination with Ulipristal.,decrease,no risk
Streptokinase,Urokinase,Urokinase may increase the anticoagulant activities of Streptokinase.,increase,no risk
Streptokinase,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Streptokinase is combined with Ursodeoxycholic acid.,increase,risk
Streptokinase,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Streptokinase.,increase,risk
Streptokinase,Valsartan,The risk or severity of angioedema can be increased when Streptokinase is combined with Valsartan.,increase,risk
Streptokinase,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Streptokinase.,increase,risk
Streptokinase,Venlafaxine,The risk or severity of bleeding can be increased when Streptokinase is combined with Venlafaxine.,increase,risk
Streptokinase,Verapamil,The risk or severity of adverse effects can be increased when Streptokinase is combined with Verapamil.,increase,risk
Streptokinase,Vericiguat,The risk or severity of adverse effects can be increased when Streptokinase is combined with Vericiguat.,increase,risk
Streptokinase,Vildagliptin,The risk or severity of angioedema can be increased when Streptokinase is combined with Vildagliptin.,increase,risk
Streptokinase,Vinblastine,The risk or severity of bleeding can be increased when Streptokinase is combined with Vinblastine.,increase,risk
Streptokinase,Vindesine,The risk or severity of bleeding can be increased when Streptokinase is combined with Vindesine.,increase,risk
Streptokinase,Vinorelbine,The risk or severity of bleeding can be increased when Streptokinase is combined with Vinorelbine.,increase,risk
Streptokinase,Vitamin E,Vitamin E may increase the anticoagulant activities of Streptokinase.,increase,no risk
Streptokinase,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Streptokinase.,decrease,no risk
Streptokinase,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Streptokinase.,increase,risk
Streptokinase,Vorinostat,The risk or severity of bleeding can be increased when Streptokinase is combined with Vorinostat.,increase,risk
Streptokinase,Warfarin,The risk or severity of bleeding can be increased when Streptokinase is combined with Warfarin.,increase,risk
Streptokinase,Ximelagatran,The risk or severity of bleeding can be increased when Streptokinase is combined with Ximelagatran.,increase,risk
Streptokinase,Zidovudine,The risk or severity of bleeding can be increased when Streptokinase is combined with Zidovudine.,increase,risk
Streptokinase,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Streptokinase.,increase,risk
Streptokinase,Zofenopril,The risk or severity of angioedema can be increased when Streptokinase is combined with Zofenopril.,increase,risk
Alemtuzumab,Galcanezumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Galcanezumab.,increase,risk
Alemtuzumab,Gemcitabine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Gemcitabine.,increase,risk
Alemtuzumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Glatiramer,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Glatiramer.,increase,risk
Alemtuzumab,Glofitamab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Glofitamab.,increase,risk
Alemtuzumab,Golimumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Golimumab.,increase,risk
Alemtuzumab,Guselkumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Guselkumab.,increase,risk
Alemtuzumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Hepatitis B immune globulin.,increase,risk
Alemtuzumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Alemtuzumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Human Rho(D) immune globulin.,increase,risk
Alemtuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Alemtuzumab,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Hydrocortisone acetate.,increase,risk
Alemtuzumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Hydrocortisone butyrate.,increase,risk
Alemtuzumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Hydrocortisone succinate.,increase,risk
Alemtuzumab,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Hydroxychloroquine.,increase,risk
Alemtuzumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Hydroxyurea.,increase,risk
Alemtuzumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Obiltoxaximab.,increase,risk
Alemtuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Obinutuzumab.,increase,risk
Alemtuzumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Alemtuzumab.,increase,no risk
Alemtuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Odesivimab.,increase,risk
Alemtuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Ofatumumab.,increase,risk
Alemtuzumab,Olaparib,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Olaparib.,increase,risk
Alemtuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Olaratumab.,increase,risk
Alemtuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Oxaliplatin.,increase,risk
Alemtuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Alemtuzumab is combined with Oxetacaine.,increase,risk
Alemtuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Alemtuzumab is combined with Oxybuprocaine.,increase,risk
Alemtuzumab,Ozanimod,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Ozanimod.,increase,risk
Alemtuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Alemtuzumab.,increase,no risk
Alemtuzumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Upadacitinib,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Upadacitinib.,increase,risk
Alemtuzumab,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Ustekinumab.,increase,risk
Alemtuzumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vedolizumab.,increase,risk
Alemtuzumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Alemtuzumab.,decrease,no risk
Alemtuzumab,Vilanterol,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vilanterol.,increase,risk
Alemtuzumab,Vinblastine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vinblastine.,increase,risk
Alemtuzumab,Vincristine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vincristine.,increase,risk
Alemtuzumab,Vindesine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vindesine.,increase,risk
Alemtuzumab,Vinorelbine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vinorelbine.,increase,risk
Alemtuzumab,Voclosporin,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Voclosporin.,increase,risk
Alemtuzumab,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Vorinostat,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vorinostat.,increase,risk
Alemtuzumab,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Alemtuzumab.,increase,risk
Alemtuzumab,Zidovudine,The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Zidovudine.,increase,risk
Capromab pendetide,Obiltoxaximab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Obiltoxaximab.,increase,risk
Capromab pendetide,Obinutuzumab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Obinutuzumab.,increase,risk
Capromab pendetide,Ocrelizumab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Ocrelizumab.,increase,risk
Capromab pendetide,Odesivimab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Odesivimab.,increase,risk
Capromab pendetide,Ofatumumab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Ofatumumab.,increase,risk
Capromab pendetide,Olaratumab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Olaratumab.,increase,risk
Capromab pendetide,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Capromab pendetide.,increase,risk
Capromab pendetide,Quinestrol,Quinestrol may increase the thrombogenic activities of Capromab pendetide.,increase,no risk
Capromab pendetide,Ublituximab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Ublituximab.,increase,risk
Capromab pendetide,Ustekinumab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Ustekinumab.,increase,risk
Capromab pendetide,Vedolizumab,The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Vedolizumab.,increase,risk
Cyclosporine,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Cyclosporine.,increase,risk
Cyclosporine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Cyclosporine.,increase,risk
Cyclosporine,Bacitracin,The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Bacitracin.,increase,risk
Cyclosporine,Baclofen,Cyclosporine may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Cyclosporine,Balsalazide,The risk or severity of renal failure and hypertension can be increased when Balsalazide is combined with Cyclosporine.,increase,risk
Cyclosporine,Baricitinib,Baricitinib may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Basiliximab,Basiliximab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Cyclosporine.,increase,risk
Cyclosporine,Beclomethasone dipropionate,Beclomethasone dipropionate may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Belantamab mafodotin,Cyclosporine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Belatacept,Belatacept may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Belimumab,Belimumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Belinostat,Belinostat may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Belumosudil,Belumosudil may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Belzutifan,The serum concentration of Cyclosporine can be decreased when it is combined with Belzutifan.,decrease,no risk
Cyclosporine,Bemiparin,The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Bemiparin.,increase,risk
Cyclosporine,Bempedoic acid,The excretion of Bempedoic acid can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Benazepril,Cyclosporine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Cyclosporine,Bendamustine,Bendamustine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bendroflumethiazide,The risk or severity of renal failure can be increased when Bendroflumethiazide is combined with Cyclosporine.,increase,risk
Cyclosporine,Benorilate,The risk or severity of renal failure and hypertension can be increased when Benorilate is combined with Cyclosporine.,increase,risk
Cyclosporine,Benoxaprofen,The risk or severity of renal failure and hypertension can be increased when Benoxaprofen is combined with Cyclosporine.,increase,risk
Cyclosporine,Benperidol,Cyclosporine may increase the neurotoxic activities of Benperidol.,increase,no risk
Cyclosporine,Benserazide,Cyclosporine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Cyclosporine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Benznidazole,Cyclosporine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Cyclosporine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Benzthiazide,The risk or severity of renal failure can be increased when Benzthiazide is combined with Cyclosporine.,increase,risk
Cyclosporine,Benzydamine,The risk or severity of renal failure and hypertension can be increased when Benzydamine is combined with Cyclosporine.,increase,risk
Cyclosporine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Bepotastine,Cyclosporine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Cyclosporine,Bepridil,The metabolism of Bepridil can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Betamethasone,Betamethasone may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Betamethasone phosphate,The risk or severity of adverse effects can be increased when Betamethasone phosphate is combined with Cyclosporine.,increase,risk
Cyclosporine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Bethanidine,Cyclosporine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Cyclosporine,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Bexarotene,Bexarotene may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bezafibrate,The risk or severity of renal failure can be increased when Cyclosporine is combined with Bezafibrate.,increase,risk
Cyclosporine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Bicisate,Cyclosporine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Cyclosporine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Bifonazole,The metabolism of Cyclosporine can be decreased when combined with Bifonazole.,decrease,no risk
Cyclosporine,Bimekizumab,Bimekizumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Bismuth subcitrate potassium,Cyclosporine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Cyclosporine,Bismuth subgallate,Cyclosporine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Cyclosporine,Bismuth subnitrate,Cyclosporine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Cyclosporine,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Bisoxatin,Cyclosporine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Bleomycin,Bleomycin may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Blinatumomab,Blinatumomab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Boceprevir,The serum concentration of Cyclosporine can be increased when it is combined with Boceprevir.,increase,no risk
Cyclosporine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Cyclosporine.",decrease,no risk
Cyclosporine,Bortezomib,Bortezomib may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Bosutinib,Bosutinib may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Cyclosporine.,increase,no risk
Cyclosporine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum toxin type B.,increase,risk
Cyclosporine,Brentuximab vedotin,Brentuximab vedotin may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bretylium,Cyclosporine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Cyclosporine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Brodalumab,Brodalumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bromazepam,Cyclosporine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Cyclosporine,Bromocriptine,The serum concentration of Cyclosporine can be increased when it is combined with Bromocriptine.,increase,no risk
Cyclosporine,Bromperidol,Cyclosporine may increase the neurotoxic activities of Bromperidol.,increase,no risk
Cyclosporine,Budesonide,Budesonide may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Bumadizone,The risk or severity of renal failure and hypertension can be increased when Bumadizone is combined with Cyclosporine.,increase,risk
Cyclosporine,Bumetanide,The risk or severity of renal failure can be increased when Bumetanide is combined with Cyclosporine.,increase,risk
Cyclosporine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Cyclosporine.,increase,risk
Cyclosporine,Buspirone,The metabolism of Buspirone can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Busulfan,Busulfan may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Butabarbital,The metabolism of Cyclosporine can be increased when combined with Butabarbital.,increase,no risk
Cyclosporine,Butalbital,The metabolism of Cyclosporine can be increased when combined with Butalbital.,increase,no risk
Cyclosporine,Butaperazine,Cyclosporine may increase the neurotoxic activities of Butaperazine.,increase,no risk
Cyclosporine,Butriptyline,The risk or severity of hypertension can be increased when Cyclosporine is combined with Butriptyline.,increase,risk
Cyclosporine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Gabapentin enacarbil,Cyclosporine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadobenic acid,Cyclosporine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadodiamide,Cyclosporine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadofosveset trisodium,Cyclosporine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadopentetic acid,Cyclosporine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadoteric acid,Cyclosporine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadoteridol,Cyclosporine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Galantamine,The metabolism of Galantamine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Cyclosporine.,increase,no risk
Cyclosporine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Ganciclovir.",increase,risk
Cyclosporine,Gatifloxacin,The risk or severity of nephrotoxicity can be increased when Gatifloxacin is combined with Cyclosporine.,increase,risk
Cyclosporine,Gefapixant,The risk or severity of renal failure can be increased when Gefapixant is combined with Cyclosporine.,increase,risk
Cyclosporine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Gemcitabine,Gemcitabine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Gemfibrozil,The risk or severity of renal failure can be increased when Cyclosporine is combined with Gemfibrozil.,increase,risk
Cyclosporine,Gemifloxacin,The risk or severity of nephrotoxicity can be increased when Gemifloxacin is combined with Cyclosporine.,increase,risk
Cyclosporine,Gemtuzumab ozogamicin,Gemtuzumab ozogamicin may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Gentamicin,Cyclosporine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Gestrinone,The metabolism of Cyclosporine can be decreased when combined with Gestrinone.,decrease,no risk
Cyclosporine,Gilteritinib,The metabolism of Cyclosporine can be decreased when combined with Gilteritinib.,decrease,no risk
Cyclosporine,Gimeracil,Cyclosporine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cyclosporine,Ginkgo biloba,The metabolism of Cyclosporine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Cyclosporine,Givosiran,The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Givosiran.,increase,risk
Cyclosporine,Glasdegib,The serum concentration of Cyclosporine can be increased when it is combined with Glasdegib.,increase,no risk
Cyclosporine,Glatiramer,Glatiramer may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Glecaprevir,The serum concentration of Cyclosporine can be increased when it is combined with Glecaprevir.,increase,no risk
Cyclosporine,Gliclazide,The risk or severity of renal failure can be increased when Gliclazide is combined with Cyclosporine.,increase,risk
Cyclosporine,Glimepiride,Cyclosporine may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Cyclosporine,Glipizide,Cyclosporine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cyclosporine,Glofitamab,The serum concentration of Cyclosporine can be increased when it is combined with Glofitamab.,increase,no risk
Cyclosporine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Glycerol phenylbutyrate,The metabolism of Cyclosporine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Cyclosporine,Glycol salicylate,The risk or severity of renal failure and hypertension can be increased when Glycol salicylate is combined with Cyclosporine.,increase,risk
Cyclosporine,Glycyrrhizic acid,Cyclosporine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Cyclosporine,Glymidine,The risk or severity of renal failure can be increased when Glymidine is combined with Cyclosporine.,increase,risk
Cyclosporine,Golimumab,Golimumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Golodirsen,Cyclosporine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cyclosporine,Goserelin,Cyclosporine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Granisetron,The metabolism of Granisetron can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Grapefruit,The serum concentration of Cyclosporine can be increased when it is combined with Grapefruit.,increase,no risk
Cyclosporine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Grepafloxacin,The risk or severity of nephrotoxicity can be increased when Grepafloxacin is combined with Cyclosporine.,increase,risk
Cyclosporine,Griseofulvin,The serum concentration of Cyclosporine can be decreased when it is combined with Griseofulvin.,decrease,no risk
Cyclosporine,Guanabenz,Cyclosporine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Cyclosporine,Guanadrel,Cyclosporine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Cyclosporine,Guanethidine,Cyclosporine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Cyclosporine,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Guanoxan,Cyclosporine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Cyclosporine,Guselkumab,Guselkumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Halcinonide,The risk or severity of adverse effects can be increased when Halcinonide is combined with Cyclosporine.,increase,risk
Cyclosporine,Halofantrine,The metabolism of Cyclosporine can be decreased when combined with Halofantrine.,decrease,no risk
Cyclosporine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Halothane,The risk or severity of hypertension can be increased when Cyclosporine is combined with Halothane.,increase,risk
Cyclosporine,Heparin,The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Heparin.,increase,risk
Cyclosporine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Cyclosporine.,increase,risk
Cyclosporine,Hydralazine,The serum concentration of Cyclosporine can be increased when it is combined with Hydralazine.,increase,no risk
Cyclosporine,Hydrochlorothiazide,The risk or severity of renal failure can be increased when Hydrochlorothiazide is combined with Cyclosporine.,increase,risk
Cyclosporine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Hydrocortamate,The metabolism of Cyclosporine can be increased when combined with Hydrocortamate.,increase,no risk
Cyclosporine,Hydrocortisone,Hydrocortisone may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Hydrocortisone acetate,Hydrocortisone acetate may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Hydrocortisone cypionate,The risk or severity of adverse effects can be increased when Hydrocortisone cypionate is combined with Cyclosporine.,increase,risk
Cyclosporine,Hydrocortisone phosphate,The metabolism of Cyclosporine can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Cyclosporine,Hydrocortisone probutate,The risk or severity of adverse effects can be increased when Hydrocortisone probutate is combined with Cyclosporine.,increase,risk
Cyclosporine,Hydrocortisone succinate,Hydrocortisone succinate may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Hydrocortisone valerate,The risk or severity of adverse effects can be increased when Hydrocortisone valerate is combined with Cyclosporine.,increase,risk
Cyclosporine,Hydroflumethiazide,The risk or severity of renal failure can be increased when Hydroflumethiazide is combined with Cyclosporine.,increase,risk
Cyclosporine,Hydromorphone,Cyclosporine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cyclosporine,Hydroxocobalamin,Cyclosporine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Hydroxychloroquine,The serum concentration of Cyclosporine can be increased when it is combined with Hydroxychloroquine.,increase,no risk
Cyclosporine,Hydroxyethyl Starch,Cyclosporine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cyclosporine,Hydroxyprogesterone caproate,The metabolism of Cyclosporine can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Cyclosporine,Hydroxyurea,Hydroxyurea may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Hydroxyzine,The metabolism of Cyclosporine can be decreased when combined with Hydroxyzine.,decrease,no risk
Cyclosporine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Kanamycin,Cyclosporine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Ketamine,The metabolism of Ketamine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Ketazolam,The serum concentration of Cyclosporine can be increased when it is combined with Ketazolam.,increase,no risk
Cyclosporine,Ketoconazole,Ketoconazole may increase the nephrotoxic activities of Cyclosporine.,increase,no risk
Cyclosporine,Ketoprofen,The risk or severity of renal failure and hypertension can be increased when Ketoprofen is combined with Cyclosporine.,increase,risk
Cyclosporine,Ketorolac,The risk or severity of renal failure and hypertension can be increased when Ketorolac is combined with Cyclosporine.,increase,risk
Cyclosporine,Obeticholic acid,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Obeticholic acid.,increase,risk
Cyclosporine,Obinutuzumab,Obinutuzumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Octinoxate,Cyclosporine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cyclosporine,Octreotide,The serum concentration of Cyclosporine can be increased when it is combined with Octreotide.,increase,no risk
Cyclosporine,Ofatumumab,Ofatumumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Ofloxacin,The risk or severity of nephrotoxicity can be increased when Ofloxacin is combined with Cyclosporine.,increase,risk
Cyclosporine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Olaparib,Olaparib may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Cyclosporine.,increase,risk
Cyclosporine,Olodaterol,The risk or severity of hypertension can be increased when Cyclosporine is combined with Olodaterol.,increase,risk
Cyclosporine,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Olsalazine.,increase,risk
Cyclosporine,Olutasidenib,The metabolism of Cyclosporine can be increased when combined with Olutasidenib.,increase,no risk
Cyclosporine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Ombitasvir,Cyclosporine may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Cyclosporine,Omeprazole,The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.,increase,no risk
Cyclosporine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Opium,The metabolism of Opium can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Orciprenaline,The risk or severity of hypertension can be increased when Cyclosporine is combined with Orciprenaline.,increase,risk
Cyclosporine,Oritavancin,The metabolism of Cyclosporine can be increased when combined with Oritavancin.,increase,no risk
Cyclosporine,Orlistat,Orlistat can cause a decrease in the absorption of Cyclosporine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cyclosporine,Orphenadrine,The metabolism of Cyclosporine can be decreased when combined with Orphenadrine.,decrease,no risk
Cyclosporine,Oseltamivir,Cyclosporine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cyclosporine,Osilodrostat,The metabolism of Cyclosporine can be decreased when combined with Osilodrostat.,decrease,no risk
Cyclosporine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Ouabain,The excretion of Ouabain can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Oxacillin,Cyclosporine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Oxaliplatin,Oxaliplatin may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Oxandrolone,The risk or severity of liver damage can be increased when Oxandrolone is combined with Cyclosporine.,increase,risk
Cyclosporine,Oxaprozin,The risk or severity of renal failure and hypertension can be increased when Oxaprozin is combined with Cyclosporine.,increase,risk
Cyclosporine,Oxazepam,Cyclosporine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cyclosporine,Oxcarbazepine,The metabolism of Cyclosporine can be increased when combined with Oxcarbazepine.,increase,no risk
Cyclosporine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Oxybenzone,Cyclosporine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cyclosporine,Oxybutynin,The serum concentration of Cyclosporine can be increased when it is combined with Oxybutynin.,increase,no risk
Cyclosporine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Oxymetazoline,The risk or severity of hypertension can be increased when Cyclosporine is combined with Oxymetazoline.,increase,risk
Cyclosporine,Oxymetholone,The risk or severity of liver damage can be increased when Oxymetholone is combined with Cyclosporine.,increase,risk
Cyclosporine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Oxyphenbutazone,The risk or severity of renal failure and hypertension can be increased when Oxyphenbutazone is combined with Cyclosporine.,increase,risk
Cyclosporine,Oxyquinoline,Cyclosporine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cyclosporine,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Oxytetracycline.,increase,risk
Cyclosporine,Ozanimod,Ozanimod may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Quazepam,The metabolism of Quazepam can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Quinapril,Cyclosporine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Cyclosporine,Quinethazone,The risk or severity of renal failure can be increased when Quinethazone is combined with Cyclosporine.,increase,risk
Cyclosporine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Quinine,The metabolism of Quinine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Quinupramine,The risk or severity of hypertension can be increased when Cyclosporine is combined with Quinupramine.,increase,risk
Cyclosporine,Quinupristin,The serum concentration of Cyclosporine can be increased when it is combined with Quinupristin.,increase,no risk
Cyclosporine,Quizartinib,The serum concentration of Cyclosporine can be increased when it is combined with Quizartinib.,increase,no risk
Cyclosporine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Ubidecarenone.",increase,risk
Cyclosporine,Ublituximab,Ublituximab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Udenafil,The risk or severity of renal failure can be increased when Udenafil is combined with Cyclosporine.,increase,risk
Cyclosporine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Ulobetasol,The risk or severity of adverse effects can be increased when Ulobetasol is combined with Cyclosporine.,increase,risk
Cyclosporine,Umbralisib,The serum concentration of Cyclosporine can be increased when it is combined with Umbralisib.,increase,no risk
Cyclosporine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Upadacitinib,Upadacitinib may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Ursodeoxycholic acid,Cyclosporine may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Cyclosporine,Vaborbactam,Cyclosporine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cyclosporine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Valaciclovir.,increase,risk
Cyclosporine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Valdecoxib,The risk or severity of renal failure can be increased when Valdecoxib is combined with Cyclosporine.,increase,risk
Cyclosporine,Valganciclovir,Cyclosporine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cyclosporine,Valproate bismuth,Cyclosporine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Cyclosporine,Valproic acid,The serum concentration of Cyclosporine can be increased when it is combined with Valproic acid.,increase,no risk
Cyclosporine,Valsartan,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Cyclosporine.,increase,risk
Cyclosporine,Vamorolone,The risk or severity of adverse effects can be increased when Vamorolone is combined with Cyclosporine.,increase,risk
Cyclosporine,Vancomycin,Cyclosporine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cyclosporine,Vandetanib,The serum concentration of Cyclosporine can be increased when it is combined with Vandetanib.,increase,no risk
Cyclosporine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Varenicline,Cyclosporine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cyclosporine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Cyclosporine.,increase,risk
Cyclosporine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Cyclosporine.,increase,no risk
Cyclosporine,Vedolizumab,Vedolizumab may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Velpatasvir,The serum concentration of Cyclosporine can be increased when it is combined with Velpatasvir.,increase,no risk
Cyclosporine,Vemurafenib,The risk or severity of renal failure can be increased when Vemurafenib is combined with Cyclosporine.,increase,risk
Cyclosporine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Verapamil,The serum concentration of Cyclosporine can be increased when it is combined with Verapamil.,increase,no risk
Cyclosporine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Cyclosporine.,decrease,no risk
Cyclosporine,Vilanterol,Vilanterol may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Viloxazine,The metabolism of Cyclosporine can be decreased when combined with Viloxazine.,decrease,no risk
Cyclosporine,Vinblastine,Vinblastine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Vincristine,Vincristine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Vindesine,Vindesine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Vinorelbine,Vinorelbine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Viomycin,The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Viomycin.,increase,risk
Cyclosporine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Vitamin E,The serum concentration of Cyclosporine can be decreased when it is combined with Vitamin E.,decrease,no risk
Cyclosporine,Voclosporin,Voclosporin may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Vonoprazan,The metabolism of Cyclosporine can be decreased when combined with Vonoprazan.,decrease,no risk
Cyclosporine,Vorapaxar,The serum concentration of Cyclosporine can be increased when it is combined with Vorapaxar.,increase,no risk
Cyclosporine,Voriconazole,The serum concentration of Cyclosporine can be increased when it is combined with Voriconazole.,increase,no risk
Cyclosporine,Vorinostat,Vorinostat may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Voxelotor,The serum concentration of Cyclosporine can be increased when it is combined with Voxelotor.,increase,no risk
Cyclosporine,Voxilaprevir,The serum concentration of Cyclosporine can be increased when it is combined with Voxilaprevir.,increase,no risk
Cyclosporine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Xamoterol,The risk or severity of hypertension can be increased when Cyclosporine is combined with Xamoterol.,increase,risk
Cyclosporine,Xylometazoline,The risk or severity of hypertension can be increased when Cyclosporine is combined with Xylometazoline.,increase,risk
Cyclosporine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Cyclosporine.,increase,risk
Cyclosporine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zafirlukast,The serum concentration of Cyclosporine can be increased when it is combined with Zafirlukast.,increase,no risk
Cyclosporine,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zaleplon,The metabolism of Cyclosporine can be decreased when combined with Zaleplon.,decrease,no risk
Cyclosporine,Zanamivir,Cyclosporine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cyclosporine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Cyclosporine.,increase,no risk
Cyclosporine,Zidovudine,Zidovudine may increase the immunosuppressive activities of Cyclosporine.,increase,no risk
Cyclosporine,Zileuton,The metabolism of Zileuton can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zimelidine,The metabolism of Cyclosporine can be decreased when combined with Zimelidine.,decrease,no risk
Cyclosporine,Ziprasidone,The metabolism of Cyclosporine can be decreased when combined with Ziprasidone.,decrease,no risk
Cyclosporine,Zofenopril,Cyclosporine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Cyclosporine,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Zoledronic acid.,increase,risk
Cyclosporine,Zolmitriptan,The risk or severity of hypertension can be increased when Cyclosporine is combined with Zolmitriptan.,increase,risk
Cyclosporine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zonisamide,The risk or severity of renal failure can be increased when Zonisamide is combined with Cyclosporine.,increase,risk
Cyclosporine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zotepine,The metabolism of Zotepine can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Cyclosporine.,decrease,no risk
Cyclosporine,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Cyclosporine.,decrease,no risk
Alefacept,Gemcitabine,The risk or severity of adverse effects can be increased when Alefacept is combined with Gemcitabine.,increase,risk
Alefacept,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Alefacept.,increase,risk
Alefacept,Glatiramer,The risk or severity of adverse effects can be increased when Alefacept is combined with Glatiramer.,increase,risk
Alefacept,Golimumab,The risk or severity of adverse effects can be increased when Alefacept is combined with Golimumab.,increase,risk
Alefacept,Guselkumab,The risk or severity of adverse effects can be increased when Alefacept is combined with Guselkumab.,increase,risk
Alefacept,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Alefacept.,increase,risk
Alefacept,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Alefacept is combined with Hydrocortisone acetate.,increase,risk
Alefacept,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Alefacept is combined with Hydrocortisone butyrate.,increase,risk
Alefacept,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Alefacept is combined with Hydrocortisone succinate.,increase,risk
Alefacept,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Alefacept is combined with Hydroxychloroquine.,increase,risk
Alefacept,Hydroxyurea,The risk or severity of adverse effects can be increased when Alefacept is combined with Hydroxyurea.,increase,risk
Alefacept,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Obinutuzumab,The risk or severity of adverse effects can be increased when Alefacept is combined with Obinutuzumab.,increase,risk
Alefacept,Ocrelizumab,The risk or severity of adverse effects can be increased when Alefacept is combined with Ocrelizumab.,increase,risk
Alefacept,Ofatumumab,The risk or severity of adverse effects can be increased when Alefacept is combined with Ofatumumab.,increase,risk
Alefacept,Olaparib,The risk or severity of adverse effects can be increased when Alefacept is combined with Olaparib.,increase,risk
Alefacept,Oxaliplatin,The risk or severity of adverse effects can be increased when Alefacept is combined with Oxaliplatin.,increase,risk
Alefacept,Ozanimod,The risk or severity of adverse effects can be increased when Alefacept is combined with Ozanimod.,increase,risk
Alefacept,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Alefacept.,increase,risk
Alefacept,Upadacitinib,The risk or severity of adverse effects can be increased when Alefacept is combined with Upadacitinib.,increase,risk
Alefacept,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Alefacept.,increase,risk
Alefacept,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Vedolizumab,The risk or severity of adverse effects can be increased when Alefacept is combined with Vedolizumab.,increase,risk
Alefacept,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Alefacept.,decrease,no risk
Alefacept,Vilanterol,The risk or severity of adverse effects can be increased when Alefacept is combined with Vilanterol.,increase,risk
Alefacept,Vinblastine,The risk or severity of adverse effects can be increased when Alefacept is combined with Vinblastine.,increase,risk
Alefacept,Vincristine,The risk or severity of adverse effects can be increased when Alefacept is combined with Vincristine.,increase,risk
Alefacept,Vindesine,The risk or severity of adverse effects can be increased when Alefacept is combined with Vindesine.,increase,risk
Alefacept,Vinorelbine,The risk or severity of adverse effects can be increased when Alefacept is combined with Vinorelbine.,increase,risk
Alefacept,Voclosporin,The risk or severity of adverse effects can be increased when Alefacept is combined with Voclosporin.,increase,risk
Alefacept,Vorinostat,The risk or severity of adverse effects can be increased when Alefacept is combined with Vorinostat.,increase,risk
Alefacept,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Alefacept.,increase,risk
Alefacept,Zidovudine,The risk or severity of adverse effects can be increased when Alefacept is combined with Zidovudine.,increase,risk
Felypressin,Oxytocin,The risk or severity of hypertension can be increased when Felypressin is combined with Oxytocin.,increase,risk
Efalizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Galcanezumab.,increase,risk
Efalizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Gemcitabine.,increase,risk
Efalizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Efalizumab.,increase,risk
Efalizumab,Glatiramer,The risk or severity of adverse effects can be increased when Efalizumab is combined with Glatiramer.,increase,risk
Efalizumab,Glofitamab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Glofitamab.,increase,risk
Efalizumab,Golimumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Golimumab.,increase,risk
Efalizumab,Guselkumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Guselkumab.,increase,risk
Efalizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Efalizumab is combined with Hepatitis B immune globulin.,increase,risk
Efalizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Efalizumab.,increase,risk
Efalizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Efalizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Efalizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Efalizumab.,increase,risk
Efalizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Efalizumab is combined with Human Rho(D) immune globulin.,increase,risk
Efalizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Efalizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Efalizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Efalizumab is combined with Hydrocortisone acetate.,increase,risk
Efalizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Efalizumab is combined with Hydrocortisone butyrate.,increase,risk
Efalizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Efalizumab is combined with Hydrocortisone succinate.,increase,risk
Efalizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Hydroxychloroquine.,increase,risk
Efalizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Efalizumab is combined with Hydroxyurea.,increase,risk
Efalizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Obiltoxaximab.,increase,risk
Efalizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Obinutuzumab.,increase,risk
Efalizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Ocrelizumab.,increase,risk
Efalizumab,Odesivimab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Odesivimab.,increase,risk
Efalizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Ofatumumab.,increase,risk
Efalizumab,Olaparib,The risk or severity of adverse effects can be increased when Efalizumab is combined with Olaparib.,increase,risk
Efalizumab,Olaratumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Olaratumab.,increase,risk
Efalizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Efalizumab.,increase,risk
Efalizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Efalizumab is combined with Oxaliplatin.,increase,risk
Efalizumab,Ozanimod,The risk or severity of adverse effects can be increased when Efalizumab is combined with Ozanimod.,increase,risk
Efalizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Efalizumab.,increase,no risk
Efalizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Efalizumab.,increase,risk
Efalizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Efalizumab is combined with Upadacitinib.,increase,risk
Efalizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Ustekinumab.,increase,risk
Efalizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Efalizumab.,increase,risk
Efalizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vedolizumab.,increase,risk
Efalizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Efalizumab.,decrease,no risk
Efalizumab,Vilanterol,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vilanterol.,increase,risk
Efalizumab,Vinblastine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vinblastine.,increase,risk
Efalizumab,Vincristine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vincristine.,increase,risk
Efalizumab,Vindesine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vindesine.,increase,risk
Efalizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vinorelbine.,increase,risk
Efalizumab,Voclosporin,The risk or severity of adverse effects can be increased when Efalizumab is combined with Voclosporin.,increase,risk
Efalizumab,Vorinostat,The risk or severity of adverse effects can be increased when Efalizumab is combined with Vorinostat.,increase,risk
Efalizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Efalizumab.,increase,risk
Efalizumab,Zidovudine,The risk or severity of adverse effects can be increased when Efalizumab is combined with Zidovudine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Galcanezumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Galcanezumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Gemcitabine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Gemcitabine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Glatiramer,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Glatiramer.,increase,risk
Antithymocyte immunoglobulin (rabbit),Glofitamab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Glofitamab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Golimumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Golimumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Guselkumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Guselkumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Hepatitis B immune globulin.,increase,risk
Antithymocyte immunoglobulin (rabbit),Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Human cytomegalovirus immune globulin.,increase,risk
Antithymocyte immunoglobulin (rabbit),Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Human Rho(D) immune globulin.,increase,risk
Antithymocyte immunoglobulin (rabbit),Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Human varicella-zoster immune globulin.,increase,risk
Antithymocyte immunoglobulin (rabbit),Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Hydrocortisone acetate.,increase,risk
Antithymocyte immunoglobulin (rabbit),Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Hydrocortisone butyrate.,increase,risk
Antithymocyte immunoglobulin (rabbit),Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Hydrocortisone succinate.,increase,risk
Antithymocyte immunoglobulin (rabbit),Hydroxychloroquine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Hydroxychloroquine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Hydroxyurea,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Hydroxyurea.,increase,risk
Antithymocyte immunoglobulin (rabbit),Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Obiltoxaximab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Obiltoxaximab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Obinutuzumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Obinutuzumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Antithymocyte immunoglobulin (rabbit).,increase,no risk
Antithymocyte immunoglobulin (rabbit),Odesivimab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Odesivimab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Ofatumumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Ofatumumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Olaparib,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Olaparib.,increase,risk
Antithymocyte immunoglobulin (rabbit),Olaratumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Olaratumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Oxaliplatin,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Oxaliplatin.,increase,risk
Antithymocyte immunoglobulin (rabbit),Ozanimod,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Ozanimod.,increase,risk
Antithymocyte immunoglobulin (rabbit),Quinestrol,Quinestrol may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit).,increase,no risk
Antithymocyte immunoglobulin (rabbit),Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Upadacitinib,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Upadacitinib.,increase,risk
Antithymocyte immunoglobulin (rabbit),Ustekinumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Ustekinumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Vedolizumab,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vedolizumab.,increase,risk
Antithymocyte immunoglobulin (rabbit),Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).,decrease,no risk
Antithymocyte immunoglobulin (rabbit),Vilanterol,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vilanterol.,increase,risk
Antithymocyte immunoglobulin (rabbit),Vinblastine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vinblastine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Vincristine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vincristine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Vindesine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vindesine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Vinorelbine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vinorelbine.,increase,risk
Antithymocyte immunoglobulin (rabbit),Voclosporin,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Voclosporin.,increase,risk
Antithymocyte immunoglobulin (rabbit),Vorinostat,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Vorinostat.,increase,risk
Antithymocyte immunoglobulin (rabbit),Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Antithymocyte immunoglobulin (rabbit).,increase,risk
Antithymocyte immunoglobulin (rabbit),Zidovudine,The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Zidovudine.,increase,risk
Filgrastim,Bleomycin,The risk or severity of pulmonary toxicity can be increased when Filgrastim is combined with Bleomycin.,increase,risk
Filgrastim,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vinblastine.,increase,risk
Filgrastim,Vincristine,The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vincristine.,increase,risk
Filgrastim,Vindesine,The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vindesine.,increase,risk
Filgrastim,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vinflunine.,increase,risk
Filgrastim,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vinorelbine.,increase,risk
Coagulation Factor IX (Recombinant),Bemiparin,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Bemiparin.,decrease,no risk
Coagulation Factor IX (Recombinant),Betrixaban,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Betrixaban.,decrease,no risk
Coagulation Factor IX (Recombinant),Bivalirudin,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Bivalirudin.,decrease,no risk
Coagulation Factor IX (Recombinant),Heparin,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Heparin.,decrease,no risk
Coagulation Factor IX (Recombinant),Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Coagulation Factor IX (Recombinant).,increase,no risk
Coagulation Factor IX (Recombinant),Urokinase,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Urokinase.,decrease,no risk
Coagulation Factor IX (Recombinant),Vorapaxar,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Vorapaxar.,decrease,no risk
Coagulation Factor IX (Recombinant),Warfarin,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Warfarin.,decrease,no risk
Coagulation Factor IX (Recombinant),Ximelagatran,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Ximelagatran.,decrease,no risk
Agalsidase beta,Gentamicin,The therapeutic efficacy of Agalsidase beta can be decreased when used in combination with Gentamicin.,decrease,no risk
Octreotide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Gadobenic acid.,increase,risk
Octreotide,Galantamine,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Galantamine.,increase,no risk
Octreotide,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Gatifloxacin.,increase,risk
Octreotide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Gemifloxacin.,increase,risk
Octreotide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Octreotide.,increase,no risk
Octreotide,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Octreotide.,decrease,no risk
Octreotide,Glasdegib,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Glasdegib.,increase,risk
Octreotide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Goserelin,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Goserelin.,increase,risk
Octreotide,Granisetron,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Granisetron.,increase,risk
Octreotide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Grepafloxacin.,increase,risk
Octreotide,Guanfacine,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Guanfacine.,increase,no risk
Octreotide,Halofantrine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Halofantrine.,increase,risk
Octreotide,Haloperidol,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Haloperidol.,increase,risk
Octreotide,Histrelin,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Histrelin.,increase,risk
Octreotide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hydrochlorothiazide.,increase,risk
Octreotide,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Octreotide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hydroxychloroquine.,increase,risk
Octreotide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hydroxyzine.,increase,risk
Octreotide,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hyoscyamine.,increase,risk
Octreotide,Ketoconazole,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ketoconazole.,increase,risk
Octreotide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ofloxacin.,increase,risk
Octreotide,Olanzapine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Olanzapine.,increase,risk
Octreotide,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Octreotide.,increase,no risk
Octreotide,Olodaterol,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Olodaterol.,increase,risk
Octreotide,Omeprazole,Omeprazole can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Octreotide,Ondansetron,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ondansetron.,increase,risk
Octreotide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Orphenadrine.,increase,risk
Octreotide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Octreotide.,increase,no risk
Octreotide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Octreotide.,increase,risk
Octreotide,Oxatomide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Oxatomide.,increase,risk
Octreotide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Oxetacaine.,increase,risk
Octreotide,Oxprenolol,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Oxprenolol.,increase,no risk
Octreotide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Oxybuprocaine.,increase,risk
Octreotide,Oxytocin,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Oxytocin.,increase,risk
Octreotide,Quetiapine,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Quetiapine.,increase,risk
Octreotide,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Octreotide.,increase,no risk
Octreotide,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Octreotide.,decrease,no risk
Octreotide,Quizartinib,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Quizartinib.,increase,risk
Interferon alfa-2b,Gemcitabine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Gemcitabine.,increase,risk
Interferon alfa-2b,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Glatiramer,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Glatiramer.,increase,risk
Interferon alfa-2b,Golimumab,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Golimumab.,increase,risk
Interferon alfa-2b,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Guselkumab,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Guselkumab.,increase,risk
Interferon alfa-2b,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Hydrocortisone acetate.,increase,risk
Interferon alfa-2b,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Hydrocortisone butyrate.,increase,risk
Interferon alfa-2b,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Hydrocortisone succinate.,increase,risk
Interferon alfa-2b,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Hydroxychloroquine.,increase,risk
Interferon alfa-2b,Hydroxyurea,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Hydroxyurea.,increase,risk
Interferon alfa-2b,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Obinutuzumab.,increase,risk
Interferon alfa-2b,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Interferon alfa-2b.,increase,no risk
Interferon alfa-2b,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Ofatumumab.,increase,risk
Interferon alfa-2b,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Olaparib,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Olaparib.,increase,risk
Interferon alfa-2b,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Oxaliplatin,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Oxaliplatin.,increase,risk
Interferon alfa-2b,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Interferon alfa-2b is combined with Oxetacaine.,increase,risk
Interferon alfa-2b,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Interferon alfa-2b is combined with Oxybuprocaine.,increase,risk
Interferon alfa-2b,Ozanimod,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Ozanimod.,increase,risk
Interferon alfa-2b,Quinine,The metabolism of Quinine can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Upadacitinib.,increase,risk
Interferon alfa-2b,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vedolizumab.,increase,risk
Interferon alfa-2b,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Vilanterol,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vilanterol.,increase,risk
Interferon alfa-2b,Vinblastine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vinblastine.,increase,risk
Interferon alfa-2b,Vincristine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vincristine.,increase,risk
Interferon alfa-2b,Vindesine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vindesine.,increase,risk
Interferon alfa-2b,Vinorelbine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vinorelbine.,increase,risk
Interferon alfa-2b,Voclosporin,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Voclosporin.,increase,risk
Interferon alfa-2b,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Vorinostat,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vorinostat.,increase,risk
Interferon alfa-2b,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon alfa-2b.,increase,risk
Interferon alfa-2b,Zidovudine,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Zidovudine.,increase,risk
Interferon alfa-2b,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Interferon alfa-2b,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon alfa-2b.,decrease,no risk
Oxytocin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Gadobenic acid.,increase,risk
Oxytocin,Galantamine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Galantamine.,increase,risk
Oxytocin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Gatifloxacin.,increase,risk
Oxytocin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Gemifloxacin.,increase,risk
Oxytocin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Oxytocin.,increase,risk
Oxytocin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Gilteritinib.,increase,risk
Oxytocin,Glasdegib,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Glasdegib.,increase,risk
Oxytocin,Goserelin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Goserelin.,increase,risk
Oxytocin,Granisetron,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Granisetron.,increase,risk
Oxytocin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Grepafloxacin.,increase,risk
Oxytocin,Halofantrine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Halofantrine.,increase,risk
Oxytocin,Haloperidol,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Haloperidol.,increase,risk
Oxytocin,Histrelin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Histrelin.,increase,risk
Oxytocin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hydrochlorothiazide.,increase,risk
Oxytocin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hydroxychloroquine.,increase,risk
Oxytocin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hydroxyzine.,increase,risk
Oxytocin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hyoscyamine.,increase,risk
Oxytocin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ketoconazole.,increase,risk
Oxytocin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Oxytocin.,increase,risk
Oxytocin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ofloxacin.,increase,risk
Oxytocin,Olanzapine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Olanzapine.,increase,risk
Oxytocin,Olodaterol,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Olodaterol.,increase,risk
Oxytocin,Ondansetron,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ondansetron.,increase,risk
Oxytocin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Orphenadrine.,increase,risk
Oxytocin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Oxytocin.,increase,risk
Oxytocin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Oxatomide.,increase,risk
Oxytocin,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxytocin.,increase,risk
Oxytocin,Quetiapine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quetiapine.,increase,risk
Oxytocin,Quinidine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quinidine.,increase,risk
Oxytocin,Quinine,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quinine.,increase,risk
Oxytocin,Quizartinib,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quizartinib.,increase,risk
Oxytocin,Ulobetasol,The risk or severity of hypertension can be increased when Ulobetasol is combined with Oxytocin.,increase,risk
Oxytocin,Valproic acid,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Valproic acid.,increase,risk
Oxytocin,Vandetanib,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vandetanib.,increase,risk
Oxytocin,Vardenafil,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vardenafil.,increase,risk
Oxytocin,Vasopressin,The risk or severity of hypertension can be increased when Vasopressin is combined with Oxytocin.,increase,risk
Oxytocin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Oxytocin.,increase,risk
Oxytocin,Vernakalant,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vernakalant.,increase,risk
Oxytocin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Oxytocin.,increase,risk
Oxytocin,Voriconazole,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Voriconazole.,increase,risk
Oxytocin,Vorinostat,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vorinostat.,increase,risk
Oxytocin,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Oxytocin.,increase,risk
Oxytocin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ziprasidone.,increase,risk
Oxytocin,Zonisamide,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Zonisamide.,increase,risk
Oxytocin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Zuclopenthixol.,increase,risk
Natalizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Galcanezumab.,increase,risk
Natalizumab,Gemcitabine,The risk or severity of immunosuppression can be increased when Gemcitabine is combined with Natalizumab.,increase,risk
Natalizumab,Gemtuzumab ozogamicin,The risk or severity of immunosuppression can be increased when Gemtuzumab ozogamicin is combined with Natalizumab.,increase,risk
Natalizumab,Glatiramer,The risk or severity of immunosuppression can be increased when Glatiramer is combined with Natalizumab.,increase,risk
Natalizumab,Glofitamab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Glofitamab.,increase,risk
Natalizumab,Golimumab,The risk or severity of immunosuppression can be increased when Golimumab is combined with Natalizumab.,increase,risk
Natalizumab,Guselkumab,The risk or severity of immunosuppression can be increased when Guselkumab is combined with Natalizumab.,increase,risk
Natalizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Natalizumab is combined with Hepatitis B immune globulin.,increase,risk
Natalizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Natalizumab.,increase,risk
Natalizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Natalizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Natalizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Natalizumab.,increase,risk
Natalizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Natalizumab is combined with Human Rho(D) immune globulin.,increase,risk
Natalizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Natalizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Natalizumab,Hydrocortisone,The risk or severity of immunosuppression can be increased when Hydrocortisone is combined with Natalizumab.,increase,risk
Natalizumab,Hydrocortisone acetate,The risk or severity of immunosuppression can be increased when Hydrocortisone acetate is combined with Natalizumab.,increase,risk
Natalizumab,Hydrocortisone butyrate,The risk or severity of immunosuppression can be increased when Hydrocortisone butyrate is combined with Natalizumab.,increase,risk
Natalizumab,Hydrocortisone succinate,The risk or severity of immunosuppression can be increased when Hydrocortisone succinate is combined with Natalizumab.,increase,risk
Natalizumab,Hydroxychloroquine,The risk or severity of immunosuppression can be increased when Hydroxychloroquine is combined with Natalizumab.,increase,risk
Natalizumab,Hydroxyurea,The risk or severity of immunosuppression can be increased when Hydroxyurea is combined with Natalizumab.,increase,risk
Natalizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Obiltoxaximab.,increase,risk
Natalizumab,Obinutuzumab,The risk or severity of immunosuppression can be increased when Obinutuzumab is combined with Natalizumab.,increase,risk
Natalizumab,Ocrelizumab,The risk or severity of immunosuppression can be increased when Ocrelizumab is combined with Natalizumab.,increase,risk
Natalizumab,Odesivimab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Odesivimab.,increase,risk
Natalizumab,Ofatumumab,The risk or severity of immunosuppression can be increased when Ofatumumab is combined with Natalizumab.,increase,risk
Natalizumab,Olaparib,The risk or severity of immunosuppression can be increased when Olaparib is combined with Natalizumab.,increase,risk
Natalizumab,Olaratumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Olaratumab.,increase,risk
Natalizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Natalizumab.,increase,risk
Natalizumab,Oxaliplatin,The risk or severity of immunosuppression can be increased when Oxaliplatin is combined with Natalizumab.,increase,risk
Natalizumab,Ozanimod,The risk or severity of immunosuppression can be increased when Ozanimod is combined with Natalizumab.,increase,risk
Natalizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Natalizumab.,increase,no risk
Natalizumab,Ublituximab,The risk or severity of immunosuppression can be increased when Ublituximab is combined with Natalizumab.,increase,risk
Natalizumab,Upadacitinib,The risk or severity of immunosuppression can be increased when Upadacitinib is combined with Natalizumab.,increase,risk
Natalizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Natalizumab is combined with Ustekinumab.,increase,risk
Natalizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Natalizumab.,increase,risk
Natalizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Vedolizumab,The risk or severity of progressive multifocal leukoencephalopathy and immunosuppression can be increased when Vedolizumab is combined with Natalizumab.,increase,risk
Natalizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Natalizumab.,decrease,no risk
Natalizumab,Vilanterol,The risk or severity of immunosuppression can be increased when Vilanterol is combined with Natalizumab.,increase,risk
Natalizumab,Vinblastine,The risk or severity of immunosuppression can be increased when Vinblastine is combined with Natalizumab.,increase,risk
Natalizumab,Vincristine,The risk or severity of immunosuppression can be increased when Vincristine is combined with Natalizumab.,increase,risk
Natalizumab,Vindesine,The risk or severity of immunosuppression can be increased when Vindesine is combined with Natalizumab.,increase,risk
Natalizumab,Vinorelbine,The risk or severity of immunosuppression can be increased when Vinorelbine is combined with Natalizumab.,increase,risk
Natalizumab,Voclosporin,The risk or severity of immunosuppression can be increased when Voclosporin is combined with Natalizumab.,increase,risk
Natalizumab,Vorinostat,The risk or severity of immunosuppression can be increased when Vorinostat is combined with Natalizumab.,increase,risk
Natalizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Natalizumab.,increase,risk
Natalizumab,Zidovudine,The risk or severity of immunosuppression can be increased when Zidovudine is combined with Natalizumab.,increase,risk
Enfuvirtide,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Enfuvirtide,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Enfuvirtide.,decrease,no risk
Palivizumab,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Palivizumab.,decrease,no risk
Palivizumab,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Palivizumab.,decrease,no risk
Palivizumab,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Palivizumab.,decrease,no risk
Palivizumab,Bamlanivimab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Bamlanivimab.,increase,risk
Palivizumab,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Palivizumab.,increase,risk
Palivizumab,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Palivizumab.,decrease,no risk
Palivizumab,Belantamab mafodotin,The risk or severity of adverse effects can be increased when Palivizumab is combined with Belantamab mafodotin.,increase,risk
Palivizumab,Belimumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Belimumab.,increase,risk
Palivizumab,Benralizumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Benralizumab.,increase,risk
Palivizumab,Besilesomab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Besilesomab.,increase,risk
Palivizumab,Bevacizumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Bevacizumab.,increase,risk
Palivizumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Bezlotoxumab.,increase,risk
Palivizumab,Bimekizumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Bimekizumab.,increase,risk
Palivizumab,Blinatumomab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Blinatumomab.,increase,risk
Palivizumab,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Palivizumab is combined with Brentuximab vedotin.,increase,risk
Palivizumab,Brodalumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Brodalumab.,increase,risk
Palivizumab,Brolucizumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Brolucizumab.,increase,risk
Palivizumab,Burosumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Burosumab.,increase,risk
Palivizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Galcanezumab.,increase,risk
Palivizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Palivizumab.,increase,risk
Palivizumab,Glofitamab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Glofitamab.,increase,risk
Palivizumab,Golimumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Golimumab.,increase,risk
Palivizumab,Guselkumab,The risk or severity of adverse effects can be increased when Palivizumab is combined with Guselkumab.,increase,risk
Palivizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Palivizumab is combined with Hepatitis B immune globulin.,increase,risk
Palivizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Palivizumab.,decrease,no risk
Palivizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Palivizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Palivizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Palivizumab.,increase,risk
Palivizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Palivizumab is combined with Human Rho(D) immune globulin.,increase,risk
Palivizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Palivizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Daclizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Galcanezumab.,increase,risk
Daclizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Gemcitabine.,increase,risk
Daclizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Daclizumab.,increase,risk
Daclizumab,Glatiramer,The risk or severity of adverse effects can be increased when Daclizumab is combined with Glatiramer.,increase,risk
Daclizumab,Glofitamab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Glofitamab.,increase,risk
Daclizumab,Golimumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Golimumab.,increase,risk
Daclizumab,Guselkumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Guselkumab.,increase,risk
Daclizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Daclizumab is combined with Hepatitis B immune globulin.,increase,risk
Daclizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Daclizumab.,increase,risk
Daclizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Daclizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Daclizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daclizumab.,increase,risk
Daclizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Daclizumab is combined with Human Rho(D) immune globulin.,increase,risk
Daclizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Daclizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Daclizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Daclizumab is combined with Hydrocortisone acetate.,increase,risk
Daclizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Daclizumab is combined with Hydrocortisone butyrate.,increase,risk
Daclizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Daclizumab is combined with Hydrocortisone succinate.,increase,risk
Daclizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Hydroxychloroquine.,increase,risk
Daclizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Daclizumab is combined with Hydroxyurea.,increase,risk
Daclizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Obiltoxaximab.,increase,risk
Daclizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Obinutuzumab.,increase,risk
Daclizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Daclizumab.,increase,no risk
Daclizumab,Odesivimab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Odesivimab.,increase,risk
Daclizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Ofatumumab.,increase,risk
Daclizumab,Olaparib,The risk or severity of adverse effects can be increased when Daclizumab is combined with Olaparib.,increase,risk
Daclizumab,Olaratumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Olaratumab.,increase,risk
Daclizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daclizumab.,increase,risk
Daclizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Daclizumab is combined with Oxaliplatin.,increase,risk
Daclizumab,Ozanimod,The risk or severity of adverse effects can be increased when Daclizumab is combined with Ozanimod.,increase,risk
Daclizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Daclizumab.,increase,no risk
Daclizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Daclizumab.,increase,risk
Daclizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Daclizumab is combined with Upadacitinib.,increase,risk
Daclizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Ustekinumab.,increase,risk
Daclizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Daclizumab.,increase,risk
Daclizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vedolizumab.,increase,risk
Daclizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Daclizumab.,decrease,no risk
Daclizumab,Vilanterol,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vilanterol.,increase,risk
Daclizumab,Vinblastine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vinblastine.,increase,risk
Daclizumab,Vincristine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vincristine.,increase,risk
Daclizumab,Vindesine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vindesine.,increase,risk
Daclizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vinorelbine.,increase,risk
Daclizumab,Voclosporin,The risk or severity of adverse effects can be increased when Daclizumab is combined with Voclosporin.,increase,risk
Daclizumab,Vorinostat,The risk or severity of adverse effects can be increased when Daclizumab is combined with Vorinostat.,increase,risk
Daclizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Daclizumab.,increase,risk
Daclizumab,Zidovudine,The risk or severity of adverse effects can be increased when Daclizumab is combined with Zidovudine.,increase,risk
Bevacizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Galcanezumab.,increase,risk
Bevacizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bevacizumab.,increase,risk
Bevacizumab,Glofitamab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Glofitamab.,increase,risk
Bevacizumab,Golimumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Golimumab.,increase,risk
Bevacizumab,Guselkumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Guselkumab.,increase,risk
Bevacizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Hepatitis B immune globulin.,increase,risk
Bevacizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Bevacizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab.,increase,risk
Bevacizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Human Rho(D) immune globulin.,increase,risk
Bevacizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Bevacizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Obiltoxaximab.,increase,risk
Bevacizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Obinutuzumab.,increase,risk
Bevacizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Ocrelizumab.,increase,risk
Bevacizumab,Odesivimab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Odesivimab.,increase,risk
Bevacizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Ofatumumab.,increase,risk
Bevacizumab,Olaratumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Olaratumab.,increase,risk
Bevacizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab.,increase,risk
Bevacizumab,Ouabain,Ouabain may decrease the cardiotoxic activities of Bevacizumab.,decrease,no risk
Bevacizumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Oxetacaine.,increase,risk
Bevacizumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Oxybuprocaine.,increase,risk
Bevacizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Bevacizumab.,increase,no risk
Bevacizumab,Ublituximab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Ublituximab.,increase,risk
Bevacizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Ustekinumab.,increase,risk
Bevacizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Vedolizumab.,increase,risk
Bevacizumab,Vinblastine,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Vinblastine.,increase,risk
Bevacizumab,Vincristine,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Vincristine.,increase,risk
Bevacizumab,Vindesine,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Vindesine.,increase,risk
Bevacizumab,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Vinorelbine.,increase,risk
Bevacizumab,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Bevacizumab is combined with Zoledronic acid.,increase,risk
Technetium Tc-99m arcitumomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Obiltoxaximab.,increase,risk
Technetium Tc-99m arcitumomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Obinutuzumab.,increase,risk
Technetium Tc-99m arcitumomab,Ocrelizumab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Ocrelizumab.,increase,risk
Technetium Tc-99m arcitumomab,Odesivimab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Odesivimab.,increase,risk
Technetium Tc-99m arcitumomab,Ofatumumab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Ofatumumab.,increase,risk
Technetium Tc-99m arcitumomab,Olaratumab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Olaratumab.,increase,risk
Technetium Tc-99m arcitumomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Technetium Tc-99m arcitumomab.,increase,risk
Technetium Tc-99m arcitumomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Technetium Tc-99m arcitumomab.,increase,no risk
Technetium Tc-99m arcitumomab,Ublituximab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Ublituximab.,increase,risk
Technetium Tc-99m arcitumomab,Ustekinumab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Ustekinumab.,increase,risk
Technetium Tc-99m arcitumomab,Vedolizumab,The risk or severity of adverse effects can be increased when Technetium Tc-99m arcitumomab is combined with Vedolizumab.,increase,risk
Vitamin B12,Gabapentin enacarbil,Cyanocobalamin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gadobenic acid,Cyanocobalamin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gadodiamide,Cyanocobalamin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gadofosveset trisodium,Cyanocobalamin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gadopentetic acid,Cyanocobalamin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gadoteric acid,Cyanocobalamin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gadoteridol,Cyanocobalamin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Vitamin B12,Ganciclovir,Cyanocobalamin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gemcitabine,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Gemcitabine.,decrease,no risk
Vitamin B12,Gemfibrozil,Cyanocobalamin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gemtuzumab ozogamicin,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
Vitamin B12,Gentamicin,Cyanocobalamin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Gimeracil,Cyanocobalamin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Vitamin B12,Givosiran,Givosiran may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Glipizide,Cyanocobalamin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Vitamin B12,Glycerol phenylbutyrate,Cyanocobalamin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Vitamin B12,Golodirsen,Cyanocobalamin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Vitamin B12,Goserelin,Goserelin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Guanethidine,Cyanocobalamin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Vitamin B12,Guanfacine,Cyanocobalamin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Vitamin B12,Haloperidol,Cyanocobalamin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Vitamin B12,Hydralazine,Cyanocobalamin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Vitamin B12,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Cyanocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vitamin B12,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Cyanocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vitamin B12,Hydromorphone,Cyanocobalamin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Vitamin B12,Hydroxocobalamin,Cyanocobalamin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Hydroxyethyl Starch,Cyanocobalamin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Vitamin B12,Hydroxyurea,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Vitamin B12,Kanamycin,Cyanocobalamin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Ketamine,Cyanocobalamin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Vitamin B12,Ketazolam,Cyanocobalamin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Vitamin B12,Obinutuzumab,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Vitamin B12,Octinoxate,Cyanocobalamin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Vitamin B12,Olaparib,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Olaparib.,decrease,no risk
Vitamin B12,Olsalazine,Olsalazine may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Opium,Cyanocobalamin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oseltamivir,Cyanocobalamin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oxacillin,Cyanocobalamin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oxaliplatin,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Oxaliplatin.,decrease,no risk
Vitamin B12,Oxaprozin,Oxaprozin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oxazepam,Cyanocobalamin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oxybenzone,Cyanocobalamin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,decrease,no risk
Vitamin B12,Oxyquinoline,Cyanocobalamin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tetrahydrofolic acid,Glucarpidase,The serum concentration of the active metabolites of Tetrahydrofolic acid can be reduced when Tetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
Tetrahydrofolic acid,Valproic acid,The serum concentration of Tetrahydrofolic acid can be decreased when it is combined with Valproic acid.,decrease,no risk
Ademetionine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Ademetionine.,decrease,no risk
Ademetionine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Ademetionine.,decrease,no risk
Ademetionine,Halothane,The metabolism of Halothane can be decreased when combined with Ademetionine.,decrease,no risk
Phenylalanine,Gemcitabine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Gemcitabine.,increase,risk
Phenylalanine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Phenylalanine.,increase,risk
Phenylalanine,Glatiramer,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Glatiramer.,increase,risk
Phenylalanine,Golimumab,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Golimumab.,increase,risk
Phenylalanine,Guselkumab,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Guselkumab.,increase,risk
Phenylalanine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Phenylalanine.,increase,risk
Phenylalanine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Phenylalanine.,increase,risk
Phenylalanine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Phenylalanine.,increase,risk
Phenylalanine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Hydrocortisone acetate.,increase,risk
Phenylalanine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Hydrocortisone butyrate.,increase,risk
Phenylalanine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Hydrocortisone succinate.,increase,risk
Phenylalanine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Phenylalanine.,increase,risk
Phenylalanine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Hydroxychloroquine.,increase,risk
Phenylalanine,Hydroxyurea,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Hydroxyurea.,increase,risk
Phenylalanine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Obinutuzumab,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Obinutuzumab.,increase,risk
Phenylalanine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Phenylalanine.,increase,no risk
Phenylalanine,Ofatumumab,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Ofatumumab.,increase,risk
Phenylalanine,Olaparib,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Olaparib.,increase,risk
Phenylalanine,Oxaliplatin,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Oxaliplatin.,increase,risk
Phenylalanine,Ozanimod,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Ozanimod.,increase,risk
Phenylalanine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Phenylalanine.,increase,risk
Phenylalanine,Upadacitinib,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Upadacitinib.,increase,risk
Phenylalanine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Phenylalanine.,increase,risk
Phenylalanine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Phenylalanine.,increase,risk
Phenylalanine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Vedolizumab,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vedolizumab.,increase,risk
Phenylalanine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Phenylalanine.,decrease,no risk
Phenylalanine,Vilanterol,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vilanterol.,increase,risk
Phenylalanine,Vinblastine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vinblastine.,increase,risk
Phenylalanine,Vincristine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vincristine.,increase,risk
Phenylalanine,Vindesine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vindesine.,increase,risk
Phenylalanine,Vinorelbine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vinorelbine.,increase,risk
Phenylalanine,Voclosporin,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Voclosporin.,increase,risk
Phenylalanine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Phenylalanine.,increase,risk
Phenylalanine,Vorinostat,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Vorinostat.,increase,risk
Phenylalanine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Phenylalanine.,increase,risk
Phenylalanine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Phenylalanine.,increase,risk
Phenylalanine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Phenylalanine.,increase,risk
Phenylalanine,Zidovudine,The risk or severity of adverse effects can be increased when Phenylalanine is combined with Zidovudine.,increase,risk
Choline,Vandetanib,The serum concentration of Choline can be increased when it is combined with Vandetanib.,increase,no risk
Choline,Varenicline,The excretion of Varenicline can be decreased when combined with Choline.,decrease,no risk
Choline,Verapamil,The risk or severity of adverse effects can be increased when Choline is combined with Verapamil.,increase,risk
Vitamin C,Benzphetamine,The serum concentration of Benzphetamine can be decreased when it is combined with Ascorbic acid.,decrease,no risk
Vitamin C,Bleomycin,The therapeutic efficacy of Bleomycin can be decreased when used in combination with Ascorbic acid.,decrease,no risk
Vitamin C,Bortezomib,The therapeutic efficacy of Bortezomib can be decreased when used in combination with Ascorbic acid.,decrease,no risk
Vitamin C,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Ascorbic acid.,decrease,no risk
Vitamin C,Quinestrol,The serum concentration of Ascorbic acid can be decreased when it is combined with Quinestrol.,decrease,no risk
Spermine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Spermine.,increase,risk
Spermine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Spermine.,increase,risk
Spermine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Spermine.,increase,risk
Spermine,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Spermine.,increase,risk
Spermine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Spermine.,increase,risk
Spermine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Spermine.,increase,risk
Spermine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Spermine.,increase,risk
Calcitriol,Gestrinone,The metabolism of Gestrinone can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Glofitamab,The serum concentration of Calcitriol can be increased when it is combined with Glofitamab.,increase,no risk
Calcitriol,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Calcitriol.,increase,no risk
Calcitriol,Hydrochlorothiazide,The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Calcitriol.,increase,risk
Calcitriol,Hydrocortisone,The therapeutic efficacy of Calcitriol can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Calcitriol,Hydrocortisone acetate,The therapeutic efficacy of Calcitriol can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Calcitriol,Hydrocortisone butyrate,The therapeutic efficacy of Calcitriol can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Calcitriol,Hydrocortisone cypionate,The therapeutic efficacy of Calcitriol can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Calcitriol,Hydrocortisone succinate,The therapeutic efficacy of Calcitriol can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Calcitriol,Hydroflumethiazide,The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Calcitriol.,increase,risk
Calcitriol,Hydrotalcite,The serum concentration of Hydrotalcite can be increased when it is combined with Calcitriol.,increase,no risk
Calcitriol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Ketoconazole,The metabolism of Calcitriol can be decreased when combined with Ketoconazole.,decrease,no risk
Calcitriol,Olaparib,The metabolism of Olaparib can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Calcitriol.,decrease,no risk
Calcitriol,Omaveloxolone,The serum concentration of Calcitriol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Calcitriol,Orlistat,Orlistat can cause a decrease in the absorption of Calcitriol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcitriol,Osimertinib,The metabolism of Osimertinib can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcitriol is combined with Ouabain.,increase,risk
Calcitriol,Quinethazone,The risk or severity of hypokalemia can be increased when Calcitriol is combined with Quinethazone.,increase,risk
Calcitriol,Quinidine,The metabolism of Quinidine can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Ulipristal,The metabolism of Ulipristal can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vadadustat,The serum concentration of Calcitriol can be increased when it is combined with Vadadustat.,increase,no risk
Calcitriol,Vamorolone,The therapeutic efficacy of Calcitriol can be decreased when used in combination with Vamorolone.,decrease,no risk
Calcitriol,Vandetanib,The metabolism of Vandetanib can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Venetoclax,The metabolism of Venetoclax can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Verapamil,The metabolism of Calcitriol can be decreased when combined with Verapamil.,decrease,no risk
Calcitriol,Viloxazine,The metabolism of Calcitriol can be decreased when combined with Viloxazine.,decrease,no risk
Calcitriol,Vinblastine,The metabolism of Vinblastine can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vincristine,The metabolism of Vincristine can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vindesine,The metabolism of Vindesine can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vinflunine,The metabolism of Vinflunine can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Vitamin D,The risk or severity of adverse effects can be increased when Calcitriol is combined with Vitamin D.,increase,risk
Calcitriol,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Voriconazole,The metabolism of Calcitriol can be decreased when combined with Voriconazole.,decrease,no risk
Calcitriol,Warfarin,The metabolism of Warfarin can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Zimelidine,The metabolism of Calcitriol can be decreased when combined with Zimelidine.,decrease,no risk
Calcitriol,Ziprasidone,The metabolism of Calcitriol can be decreased when combined with Ziprasidone.,decrease,no risk
Calcitriol,Zolpidem,The metabolism of Zolpidem can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Calcitriol.,increase,no risk
Calcitriol,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Calcitriol.,decrease,no risk
Succinic acid,Benzoic acid,The excretion of Succinic acid can be decreased when combined with Benzoic acid.,decrease,no risk
Succinic acid,Benzylpenicillin,The excretion of Succinic acid can be decreased when combined with Benzylpenicillin.,decrease,no risk
Succinic acid,Bumetanide,The excretion of Succinic acid can be decreased when combined with Bumetanide.,decrease,no risk
Succinic acid,Ganciclovir,The excretion of Succinic acid can be decreased when combined with Ganciclovir.,decrease,no risk
Succinic acid,Gemfibrozil,The excretion of Succinic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Succinic acid,Guanidine,The excretion of Succinic acid can be decreased when combined with Guanidine.,decrease,no risk
Succinic acid,Ketoprofen,The excretion of Succinic acid can be decreased when combined with Ketoprofen.,decrease,no risk
Succinic acid,Ouabain,The excretion of Succinic acid can be decreased when combined with Ouabain.,decrease,no risk
Succinic acid,Oxytetracycline,The excretion of Succinic acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Succinic acid,Quinidine,The excretion of Succinic acid can be decreased when combined with Quinidine.,decrease,no risk
Succinic acid,Vadadustat,The serum concentration of Succinic acid can be increased when it is combined with Vadadustat.,increase,no risk
Succinic acid,Valproic acid,The excretion of Succinic acid can be decreased when combined with Valproic acid.,decrease,no risk
Succinic acid,Zidovudine,The excretion of Succinic acid can be decreased when combined with Zidovudine.,decrease,no risk
Riboflavin,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Riboflavin.,decrease,no risk
Riboflavin,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Riboflavin.,increase,no risk
Riboflavin,Verteporfin,Riboflavin may increase the photosensitizing activities of Verteporfin.,increase,no risk
Riboflavin,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Riboflavin.,decrease,no risk
Riboflavin,Zidovudine,The excretion of Zidovudine can be decreased when combined with Riboflavin.,decrease,no risk
Glutamic acid,Benzphetamine,The serum concentration of Benzphetamine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Calcifediol,Vamorolone,The therapeutic efficacy of Calcifediol can be decreased when used in combination with Vamorolone.,decrease,no risk
Calcifediol,Vitamin D,The risk or severity of adverse effects can be increased when Calcifediol is combined with Vitamin D.,increase,risk
Tryptophan,Gabapentin,The risk or severity of CNS depression can be increased when Tryptophan is combined with Gabapentin.,increase,risk
Tryptophan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tryptophan is combined with Gabapentin enacarbil.,increase,risk
Tryptophan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Tryptophan is combined with Gallamine triethiodide.,increase,risk
Tryptophan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tryptophan is combined with Ganaxolone.",increase,risk
Tryptophan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Tryptophan.,increase,risk
Tryptophan,Glutethimide,The risk or severity of CNS depression can be increased when Tryptophan is combined with Glutethimide.,increase,risk
Tryptophan,Granisetron,The risk or severity of CNS depression can be increased when Tryptophan is combined with Granisetron.,increase,risk
Tryptophan,Guanfacine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Guanfacine.,increase,risk
Tryptophan,Halazepam,The risk or severity of CNS depression can be increased when Tryptophan is combined with Halazepam.,increase,risk
Tryptophan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tryptophan.,increase,risk
Tryptophan,Halothane,The risk or severity of CNS depression can be increased when Tryptophan is combined with Halothane.,increase,risk
Tryptophan,Hexafluronium,The risk or severity of CNS depression can be increased when Tryptophan is combined with Hexafluronium.,increase,risk
Tryptophan,Hydrocodone,Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tryptophan,Hydromorphone,The risk or severity of CNS depression can be increased when Tryptophan is combined with Hydromorphone.,increase,risk
Tryptophan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tryptophan.,increase,no risk
Tryptophan,Ketamine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Ketamine.,increase,risk
Tryptophan,Ketazolam,The risk or severity of CNS depression can be increased when Tryptophan is combined with Ketazolam.,increase,risk
Tryptophan,Olanzapine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Olanzapine.,increase,risk
Tryptophan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tryptophan is combined with Oliceridine.",increase,risk
Tryptophan,Ondansetron,The risk or severity of CNS depression can be increased when Tryptophan is combined with Ondansetron.,increase,risk
Tryptophan,Opium,The risk or severity of CNS depression can be increased when Tryptophan is combined with Opium.,increase,risk
Tryptophan,Orphenadrine,Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tryptophan,Oxazepam,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxazepam.,increase,risk
Tryptophan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxcarbazepine.,increase,risk
Tryptophan,Oxitriptan,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxitriptan.,increase,risk
Tryptophan,Oxprenolol,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxprenolol.,increase,risk
Tryptophan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxybuprocaine.,increase,risk
Tryptophan,Oxycodone,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxycodone.,increase,risk
Tryptophan,Oxymorphone,The risk or severity of CNS depression can be increased when Tryptophan is combined with Oxymorphone.,increase,risk
Tryptophan,Quazepam,The risk or severity of CNS depression can be increased when Tryptophan is combined with Quazepam.,increase,risk
Tryptophan,Quetiapine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Quetiapine.,increase,risk
Tryptophan,Quinine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Quinine.,increase,risk
Tryptophan,Quinupramine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Quinupramine.,increase,risk
Tryptophan,Urethane,The risk or severity of CNS depression can be increased when Tryptophan is combined with Urethane.,increase,risk
Tryptophan,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Tryptophan is combined with Valproate bismuth.,increase,risk
Tryptophan,Valproic acid,The risk or severity of CNS depression can be increased when Tryptophan is combined with Valproic acid.,increase,risk
Tryptophan,Vecuronium,The risk or severity of CNS depression can be increased when Tryptophan is combined with Vecuronium.,increase,risk
Tryptophan,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Tryptophan is combined with Venlafaxine.,increase,risk
Tryptophan,Vigabatrin,The risk or severity of CNS depression can be increased when Tryptophan is combined with Vigabatrin.,increase,risk
Tryptophan,Vilazodone,The risk or severity of CNS depression can be increased when Tryptophan is combined with Vilazodone.,increase,risk
Tryptophan,Viloxazine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Viloxazine.,increase,risk
Tryptophan,Vortioxetine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Vortioxetine.,increase,risk
Tryptophan,Warfarin,The risk or severity of adverse effects can be increased when Tryptophan is combined with Warfarin.,increase,risk
Tryptophan,Yohimbine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Yohimbine.,increase,risk
Tryptophan,Zaleplon,The risk or severity of CNS depression can be increased when Tryptophan is combined with Zaleplon.,increase,risk
Tryptophan,Ziconotide,The risk or severity of CNS depression can be increased when Tryptophan is combined with Ziconotide.,increase,risk
Tryptophan,Zimelidine,The risk or severity of adverse effects can be increased when Tryptophan is combined with Zimelidine.,increase,risk
Tryptophan,Ziprasidone,The risk or severity of adverse effects can be increased when Tryptophan is combined with Ziprasidone.,increase,risk
Tryptophan,Zolmitriptan,The risk or severity of CNS depression can be increased when Tryptophan is combined with Zolmitriptan.,increase,risk
Tryptophan,Zolpidem,Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tryptophan,Zonisamide,The risk or severity of CNS depression can be increased when Tryptophan is combined with Zonisamide.,increase,risk
Tryptophan,Zopiclone,The risk or severity of adverse effects can be increased when Tryptophan is combined with Zopiclone.,increase,risk
Tryptophan,Zotepine,The risk or severity of CNS depression can be increased when Tryptophan is combined with Zotepine.,increase,risk
Tryptophan,Zuclopenthixol,The risk or severity of CNS depression can be increased when Tryptophan is combined with Zuclopenthixol.,increase,risk
Tryptophan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tryptophan.,increase,risk
Thiamine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Thiamine.,increase,risk
Thiamine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Thiamine.,increase,no risk
Thiamine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Thiamine.,increase,risk
Thiamine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Thiamine.,increase,risk
Thiamine,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Thiamine.,increase,risk
Thiamine,Histamine,The serum concentration of Histamine can be increased when it is combined with Thiamine.,increase,no risk
Thiamine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Thiamine.,increase,no risk
Thiamine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Thiamine.,increase,risk
Thiamine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Thiamine.,increase,risk
Thiamine,Varenicline,The excretion of Varenicline can be decreased when combined with Thiamine.,decrease,no risk
Thiamine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Thiamine.,increase,risk
Ergocalciferol,Beclomethasone dipropionate,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Ergocalciferol,Bendroflumethiazide,The risk or severity of hypercalcemia can be increased when Bendroflumethiazide is combined with Ergocalciferol.,increase,risk
Ergocalciferol,Benzthiazide,The risk or severity of hypercalcemia can be increased when Benzthiazide is combined with Ergocalciferol.,increase,risk
Ergocalciferol,Betamethasone,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Betamethasone.,decrease,no risk
Ergocalciferol,Betamethasone phosphate,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Ergocalciferol,Budesonide,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Budesonide.,decrease,no risk
Ergocalciferol,Hydrochlorothiazide,The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Ergocalciferol.,increase,risk
Ergocalciferol,Hydrocortisone,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Ergocalciferol,Hydrocortisone acetate,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Ergocalciferol,Hydrocortisone butyrate,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Ergocalciferol,Hydrocortisone cypionate,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Ergocalciferol,Hydrocortisone succinate,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Ergocalciferol,Hydroflumethiazide,The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Ergocalciferol.,increase,risk
Ergocalciferol,Hydrotalcite,The serum concentration of Hydrotalcite can be increased when it is combined with Ergocalciferol.,increase,no risk
Ergocalciferol,Orlistat,Orlistat can cause a decrease in the absorption of Ergocalciferol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ergocalciferol,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Ouabain.,increase,risk
Ergocalciferol,Quinethazone,The risk or severity of hypokalemia can be increased when Ergocalciferol is combined with Quinethazone.,increase,risk
Ergocalciferol,Vamorolone,The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Vamorolone.,decrease,no risk
Citrulline,Quinidine,The excretion of Citrulline can be decreased when combined with Quinidine.,decrease,no risk
Citrulline,Vadadustat,The serum concentration of Citrulline can be increased when it is combined with Vadadustat.,increase,no risk
Citrulline,Valproic acid,The excretion of Citrulline can be decreased when combined with Valproic acid.,decrease,no risk
Citrulline,Zidovudine,The excretion of Citrulline can be decreased when combined with Zidovudine.,decrease,no risk
Folic acid,Gabapentin enacarbil,Folic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Folic acid,Gadobenic acid,Folic acid may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Gadodiamide,Folic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Folic acid,Gadofosveset trisodium,Folic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Folic acid,Gadopentetic acid,Folic acid may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Gadoteric acid,Folic acid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Folic acid,Gadoteridol,Folic acid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Folic acid,Ganciclovir,Folic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Folic acid,Gefitinib,Gefitinib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Gemcitabine,Folic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Folic acid,Gemfibrozil,Folic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Folic acid,Gentamicin,Folic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Folic acid,Gilteritinib,Gilteritinib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Gimeracil,Folic acid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Folic acid,Givosiran,Givosiran may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Glasdegib,Glasdegib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Glecaprevir,Glecaprevir may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Glipizide,Folic acid may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Folic acid,Glucarpidase,The serum concentration of the active metabolites of Folic acid can be reduced when Folic acid is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
Folic acid,Glycerol phenylbutyrate,Folic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Folic acid,Golodirsen,Folic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Folic acid,Goserelin,Goserelin may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Grazoprevir,Grazoprevir may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Folic acid.,decrease,no risk
Folic acid,Guanethidine,Folic acid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Folic acid,Guanfacine,Folic acid may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Folic acid,Haloperidol,Folic acid may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Folic acid,Hydralazine,Folic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Folic acid,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Folic acid,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Folic acid,Hydromorphone,Folic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Folic acid,Hydroxocobalamin,Folic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Folic acid,Hydroxyethyl Starch,Folic acid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Folic acid,Kanamycin,Folic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Folic acid,Ketamine,Folic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Folic acid,Ketazolam,Folic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Folic acid,Ketoprofen,Ketoprofen may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Ketorolac,Ketorolac may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Octinoxate,Folic acid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Folic acid,Olsalazine,Olsalazine may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Opium,Folic acid may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Folic acid,Oseltamivir,Folic acid may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Folic acid,Osimertinib,Osimertinib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Oteseconazole,The serum concentration of Folic acid can be increased when it is combined with Oteseconazole.,increase,no risk
Folic acid,Oxacillin,Folic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Folic acid,Oxaprozin,Oxaprozin may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Oxazepam,Folic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Folic acid,Oxybenzone,Folic acid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Folic acid,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Oxyquinoline,Folic acid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Folic acid,Quetiapine,Folic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Folic acid,Quinethazone,Quinethazone may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Folic acid,Quinidine,Folic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Folic acid,Vaborbactam,Folic acid may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Folic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Folic acid.,increase,no risk
Folic acid,Valaciclovir,Valaciclovir may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Valbenazine,Folic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Folic acid,Valdecoxib,Valdecoxib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Valganciclovir,Folic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Folic acid,Valproic acid,The serum concentration of Folic acid can be decreased when it is combined with Valproic acid.,decrease,no risk
Folic acid,Vancomycin,Folic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Folic acid,Vandetanib,Vandetanib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Varenicline,Folic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Folic acid,Velpatasvir,Velpatasvir may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Vemurafenib,Vemurafenib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Venetoclax,Venetoclax may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Venlafaxine,Venlafaxine may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Folic acid,Verapamil,Folic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Folic acid,Vilanterol,Folic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Folic acid,Viloxazine,Folic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Folic acid,Vismodegib,Vismodegib may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Vortioxetine,Folic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Folic acid,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Folic acid which could result in a higher serum level.,decrease,no risk
Folic acid,Warfarin,Folic acid may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Folic acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Folic acid.,decrease,no risk
Folic acid,Zaleplon,Folic acid may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Folic acid,Zanamivir,Folic acid may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Folic acid,Zidovudine,The excretion of Zidovudine can be decreased when combined with Folic acid.,decrease,no risk
Folic acid,Zonisamide,Zonisamide may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icosapent,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Bismuth subgallate,Icosapent may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Icosapent,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Bisoprolol,Icosapent may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Icosapent,Bisoxatin,Icosapent may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Icosapent,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Bivalirudin.,increase,risk
Icosapent,Bleomycin,Icosapent may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Icosapent,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Brexpiprazole,The risk or severity of hypertension can be increased when Icosapent is combined with Brexpiprazole.,increase,risk
Icosapent,Brivaracetam,Icosapent may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Icosapent,Bromazepam,Icosapent may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Icosapent,Bromfenac,The risk or severity of adverse effects can be increased when Icosapent is combined with Bromfenac.,increase,risk
Icosapent,Bromocriptine,The risk or severity of hypertension can be increased when Icosapent is combined with Bromocriptine.,increase,risk
Icosapent,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Icosapent.,increase,risk
Icosapent,Bufexamac,The risk or severity of adverse effects can be increased when Icosapent is combined with Bufexamac.,increase,risk
Icosapent,Bumadizone,The risk or severity of adverse effects can be increased when Icosapent is combined with Bumadizone.,increase,risk
Icosapent,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Bupropion,Icosapent may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Icosapent,Buspirone,The risk or severity of hypertension can be increased when Icosapent is combined with Buspirone.,increase,risk
Icosapent,Butabarbital,Icosapent may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Icosapent,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Icosapent.,increase,risk
Icosapent,Gabapentin enacarbil,Icosapent may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Icosapent,Gadobenic acid,Icosapent may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Icosapent,Gadodiamide,Icosapent may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Icosapent,Gadofosveset trisodium,Icosapent may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Icosapent,Gadopentetic acid,Icosapent may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Icosapent,Gadoteric acid,Icosapent may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Icosapent,Gadoteridol,Icosapent may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Icosapent,Ganciclovir,Icosapent may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Icosapent,Gatifloxacin,Icosapent may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Icosapent,Gemcitabine,Icosapent may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Icosapent,Gemfibrozil,Icosapent may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Icosapent,Gemifloxacin,Icosapent may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Icosapent,Gentamicin,Icosapent may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Icosapent,Gimeracil,Icosapent may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Icosapent,Givosiran,The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Givosiran.,increase,risk
Icosapent,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Icosapent.,decrease,no risk
Icosapent,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Icosapent.,decrease,no risk
Icosapent,Glipizide,The protein binding of Glipizide can be decreased when combined with Icosapent.,decrease,no risk
Icosapent,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Icosapent.,decrease,no risk
Icosapent,Glyburide,The protein binding of Glyburide can be decreased when combined with Icosapent.,decrease,no risk
Icosapent,Glycerol phenylbutyrate,Icosapent may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Icosapent,Glycol salicylate,The risk or severity of adverse effects can be increased when Icosapent is combined with Glycol salicylate.,increase,risk
Icosapent,Golodirsen,Icosapent may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Icosapent,Goserelin,Icosapent may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Icosapent,Grepafloxacin,Icosapent may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Icosapent,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Icosapent.,increase,no risk
Icosapent,Halothane,The risk or severity of hypertension can be increased when Icosapent is combined with Halothane.,increase,risk
Icosapent,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Heparin.,increase,risk
Icosapent,Hydralazine,Icosapent may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Icosapent,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Icosapent.,increase,risk
Icosapent,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Icosapent.,increase,risk
Icosapent,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Icosapent.,increase,risk
Icosapent,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Icosapent.,increase,risk
Icosapent,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Icosapent.,increase,risk
Icosapent,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Hydromorphone,Icosapent may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Icosapent,Hydroxocobalamin,Icosapent may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Icosapent,Hydroxyethyl Starch,Icosapent may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Icosapent,Kanamycin,Icosapent may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Icosapent,Ketamine,Icosapent may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Icosapent,Ketazolam,Icosapent may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Icosapent,Ketoconazole,The risk or severity of hyperkalemia can be increased when Icosapent is combined with Ketoconazole.,increase,risk
Icosapent,Ketoprofen,The risk or severity of adverse effects can be increased when Icosapent is combined with Ketoprofen.,increase,risk
Icosapent,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Icosapent.,increase,risk
Icosapent,Octinoxate,Icosapent may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Icosapent,Ofloxacin,Icosapent may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Icosapent,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Icosapent.",increase,risk
Icosapent,Olodaterol,The risk or severity of hypertension can be increased when Icosapent is combined with Olodaterol.,increase,risk
Icosapent,Olsalazine,The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Olsalazine.,increase,risk
Icosapent,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Icosapent is combined with Omacetaxine mepesuccinate.,increase,risk
Icosapent,Opium,Icosapent may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Icosapent,Orciprenaline,The risk or severity of hypertension can be increased when Icosapent is combined with Orciprenaline.,increase,risk
Icosapent,Oseltamivir,Icosapent may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Icosapent,Oxacillin,Icosapent may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Icosapent,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Icosapent.,increase,risk
Icosapent,Oxaprozin,The risk or severity of adverse effects can be increased when Icosapent is combined with Oxaprozin.,increase,risk
Icosapent,Oxazepam,Icosapent may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Icosapent,Oxprenolol,Icosapent may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Icosapent,Oxybenzone,Icosapent may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Icosapent,Oxymetazoline,The risk or severity of hypertension can be increased when Icosapent is combined with Oxymetazoline.,increase,risk
Icosapent,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Icosapent is combined with Oxyphenbutazone.,increase,risk
Icosapent,Oxyquinoline,Icosapent may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Icosapent,Quetiapine,The risk or severity of hypertension can be increased when Icosapent is combined with Quetiapine.,increase,risk
Icosapent,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Icosapent is combined with Quinapril.",increase,risk
Icosapent,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Quinidine,Icosapent may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Icosapent,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Icosapent.,increase,risk
Icosapent,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Icosapent.,decrease,no risk
Icosapent,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Urokinase.,increase,risk
Icosapent,Vaborbactam,Icosapent may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Icosapent,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Valaciclovir.,increase,risk
Icosapent,Valbenazine,Icosapent may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Icosapent,Valdecoxib,The risk or severity of adverse effects can be increased when Icosapent is combined with Valdecoxib.,increase,risk
Icosapent,Valganciclovir,Icosapent may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Icosapent,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Icosapent.,decrease,no risk
Icosapent,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Icosapent.",increase,risk
Icosapent,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Icosapent.,increase,risk
Icosapent,Vancomycin,Icosapent may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Icosapent,Varenicline,Icosapent may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Icosapent,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Icosapent.,increase,no risk
Icosapent,Verapamil,Icosapent may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Icosapent,Vilanterol,The risk or severity of hypertension can be increased when Icosapent is combined with Vilanterol.,increase,risk
Icosapent,Vilazodone,The risk or severity of hypertension can be increased when Icosapent is combined with Vilazodone.,increase,risk
Icosapent,Viloxazine,Icosapent may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Icosapent,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Vorapaxar.,increase,risk
Icosapent,Voriconazole,The serum concentration of Icosapent can be increased when it is combined with Voriconazole.,increase,no risk
Icosapent,Vortioxetine,The risk or severity of hypertension can be increased when Icosapent is combined with Vortioxetine.,increase,risk
Icosapent,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Warfarin.,increase,risk
Icosapent,Xamoterol,The risk or severity of hypertension can be increased when Icosapent is combined with Xamoterol.,increase,risk
Icosapent,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Ximelagatran.,increase,risk
Icosapent,Xylometazoline,The risk or severity of hypertension can be increased when Icosapent is combined with Xylometazoline.,increase,risk
Icosapent,Yohimbine,The risk or severity of hypertension can be increased when Icosapent is combined with Yohimbine.,increase,risk
Icosapent,Zaleplon,Icosapent may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Icosapent,Zanamivir,Icosapent may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Icosapent,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Icosapent.,increase,risk
Icosapent,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Icosapent.,increase,risk
Icosapent,Ziprasidone,The risk or severity of hypertension can be increased when Icosapent is combined with Ziprasidone.,increase,risk
Icosapent,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Icosapent is combined with Zofenopril.",increase,risk
Icosapent,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Icosapent is combined with Zoledronic acid.,increase,risk
Icosapent,Zolmitriptan,The risk or severity of hypertension can be increased when Icosapent is combined with Zolmitriptan.,increase,risk
Vitamin A,Bexarotene,The risk or severity of adverse effects can be increased when Vitamin A is combined with Bexarotene.,increase,risk
Vitamin A,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Vitamin A.,decrease,no risk
Vitamin A,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Vitamin A.,decrease,no risk
Vitamin A,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Omadacycline.,increase,risk
Vitamin A,Orlistat,Orlistat can cause a decrease in the absorption of Vitamin A resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Vitamin A,Oxymetazoline,The absorption of Vitamin A can be decreased when combined with Oxymetazoline.,decrease,no risk
Vitamin A,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Oxytetracycline.,increase,risk
Vitamin A,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Vitamin A.,increase,no risk
Vitamin E,Gestrinone,The metabolism of Gestrinone can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Glofitamab,The serum concentration of Vitamin E can be increased when it is combined with Glofitamab.,increase,no risk
Vitamin E,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Vitamin E.,increase,no risk
Vitamin E,Heparin,Vitamin E may increase the anticoagulant activities of Heparin.,increase,no risk
Vitamin E,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Ketoconazole,The metabolism of Vitamin E can be decreased when combined with Ketoconazole.,decrease,no risk
Vitamin E,Olaparib,The metabolism of Olaparib can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Vitamin E.,decrease,no risk
Vitamin E,Omaveloxolone,The serum concentration of Vitamin E can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vitamin E,Orlistat,Orlistat can cause a decrease in the absorption of Vitamin E resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Vitamin E,Osimertinib,The metabolism of Osimertinib can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Quinidine,The metabolism of Quinidine can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Ulipristal,The metabolism of Ulipristal can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Urokinase,Vitamin E may increase the anticoagulant activities of Urokinase.,increase,no risk
Vitamin E,Vadadustat,The serum concentration of Vitamin E can be increased when it is combined with Vadadustat.,increase,no risk
Vitamin E,Vandetanib,The metabolism of Vandetanib can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Venetoclax,The metabolism of Venetoclax can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Verapamil,The metabolism of Vitamin E can be decreased when combined with Verapamil.,decrease,no risk
Vitamin E,Viloxazine,The metabolism of Vitamin E can be decreased when combined with Viloxazine.,decrease,no risk
Vitamin E,Vinblastine,The metabolism of Vinblastine can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Vincristine,The metabolism of Vincristine can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Vindesine,The metabolism of Vindesine can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Vinflunine,The metabolism of Vinflunine can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Vorapaxar,Vitamin E may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vitamin E,Voriconazole,The metabolism of Vitamin E can be decreased when combined with Voriconazole.,decrease,no risk
Vitamin E,Warfarin,Vitamin E may increase the anticoagulant activities of Warfarin.,increase,no risk
Vitamin E,Ximelagatran,Vitamin E may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Vitamin E,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Zimelidine,The metabolism of Vitamin E can be decreased when combined with Zimelidine.,decrease,no risk
Vitamin E,Ziprasidone,The metabolism of Vitamin E can be decreased when combined with Ziprasidone.,decrease,no risk
Vitamin E,Zolpidem,The metabolism of Zolpidem can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Vitamin E.,increase,no risk
Vitamin E,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Vitamin E.,decrease,no risk
Pyridoxine,Gabapentin enacarbil,Pyridoxine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gadobenic acid,Pyridoxine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gadodiamide,Pyridoxine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gadofosveset trisodium,Pyridoxine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gadopentetic acid,Pyridoxine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gadoteric acid,Pyridoxine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gadoteridol,Pyridoxine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Pyridoxine,Ganciclovir,Pyridoxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gemcitabine,Pyridoxine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gemfibrozil,Pyridoxine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gentamicin,Pyridoxine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pyridoxine,Gimeracil,Pyridoxine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pyridoxine,Givosiran,Givosiran may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Glipizide,Pyridoxine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Pyridoxine,Glycerol phenylbutyrate,Pyridoxine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pyridoxine,Golodirsen,Pyridoxine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pyridoxine,Goserelin,Goserelin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Guanethidine,Pyridoxine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Guanfacine,Pyridoxine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Haloperidol,Pyridoxine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Pyridoxine,Hydralazine,Pyridoxine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pyridoxine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pyridoxine,Hydromorphone,Pyridoxine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Pyridoxine,Hydroxyethyl Starch,Pyridoxine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pyridoxine,Kanamycin,Pyridoxine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pyridoxine,Ketamine,Pyridoxine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Ketazolam,Pyridoxine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Pyridoxine,Octinoxate,Pyridoxine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pyridoxine,Olsalazine,Olsalazine may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Opium,Pyridoxine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oseltamivir,Pyridoxine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oxacillin,Pyridoxine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oxaprozin,Oxaprozin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oxazepam,Pyridoxine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oxybenzone,Pyridoxine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Oxyquinoline,Pyridoxine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pyridoxine,Quetiapine,Pyridoxine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Pyridoxine,Quinethazone,Quinethazone may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pyridoxine,Quinidine,Pyridoxine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Lipoic acid,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Bexagliflozin.,increase,risk
Lipoic acid,Bromocriptine,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Bromocriptine.,increase,risk
Lipoic acid,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Gatifloxacin.,increase,risk
Lipoic acid,Gliclazide,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Gliclazide.,increase,risk
Lipoic acid,Glimepiride,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glimepiride.,increase,risk
Lipoic acid,Glipizide,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glipizide.,increase,risk
Lipoic acid,Gliquidone,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Gliquidone.,increase,risk
Lipoic acid,Glyburide,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glyburide.,increase,risk
Lipoic acid,Glymidine,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Glymidine.,increase,risk
Lipoic acid,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Lipoic acid.,increase,risk
Lipoic acid,Quinine,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Quinine.,increase,risk
Lipoic acid,Venlafaxine,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Venlafaxine.,increase,risk
Lipoic acid,Vildagliptin,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Vildagliptin.,increase,risk
Lipoic acid,Zimelidine,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Zimelidine.,increase,risk
Aspartame,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Aspartame.,increase,no risk
Aspartame,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Bumetanide,The excretion of Bumetanide can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Quinapril,The excretion of Quinapril can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Aspartame.,increase,no risk
Aspartame,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Valproic acid,The excretion of Valproic acid can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Aspartame.,decrease,no risk
Aspartame,Zidovudine,The excretion of Zidovudine can be decreased when combined with Aspartame.,decrease,no risk
Vitamin D3,Galantamine,The metabolism of Galantamine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Glofitamab,The serum concentration of Cholecalciferol can be increased when it is combined with Glofitamab.,increase,no risk
Vitamin D3,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cholecalciferol.,increase,no risk
Vitamin D3,Hydrochlorothiazide,The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Cholecalciferol.,increase,risk
Vitamin D3,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Hydrocortisone,The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Vitamin D3,Hydrocortisone acetate,The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Vitamin D3,Hydrocortisone butyrate,The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Vitamin D3,Hydrocortisone cypionate,The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Vitamin D3,Hydrocortisone succinate,The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Vitamin D3,Hydroflumethiazide,The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Cholecalciferol.,increase,risk
Vitamin D3,Hydrotalcite,The serum concentration of Hydrotalcite can be increased when it is combined with Cholecalciferol.,increase,no risk
Vitamin D3,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Ketoconazole,The metabolism of Cholecalciferol can be decreased when combined with Ketoconazole.,decrease,no risk
Vitamin D3,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Cholecalciferol.,increase,no risk
Vitamin D3,Omaveloxolone,The serum concentration of Cholecalciferol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vitamin D3,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Opium,The metabolism of Opium can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Orlistat,Orlistat can cause a decrease in the absorption of Cholecalciferol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Vitamin D3,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Cholecalciferol is combined with Ouabain.,increase,risk
Vitamin D3,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Quinethazone,The risk or severity of hypokalemia can be increased when Cholecalciferol is combined with Quinethazone.,increase,risk
Vitamin D3,Quinine,The metabolism of Quinine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Vadadustat,The serum concentration of Cholecalciferol can be increased when it is combined with Vadadustat.,increase,no risk
Vitamin D3,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Vamorolone,The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Vamorolone.,decrease,no risk
Vitamin D3,Venetoclax,The metabolism of Cholecalciferol can be decreased when combined with Venetoclax.,decrease,no risk
Vitamin D3,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Verapamil,The metabolism of Cholecalciferol can be decreased when combined with Verapamil.,decrease,no risk
Vitamin D3,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Viloxazine,The metabolism of Cholecalciferol can be decreased when combined with Viloxazine.,decrease,no risk
Vitamin D3,Voriconazole,The metabolism of Cholecalciferol can be decreased when combined with Voriconazole.,decrease,no risk
Vitamin D3,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Zimelidine,The metabolism of Cholecalciferol can be decreased when combined with Zimelidine.,decrease,no risk
Vitamin D3,Ziprasidone,The metabolism of Cholecalciferol can be decreased when combined with Ziprasidone.,decrease,no risk
Vitamin D3,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Cholecalciferol.,decrease,no risk
Vitamin D3,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Cholecalciferol.,decrease,no risk
Adenine,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Adenine.,decrease,no risk
Adenine,Belinostat,The metabolism of Belinostat can be decreased when combined with Adenine.,decrease,no risk
Adenine,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Adenine.,decrease,no risk
Adenine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Adenine.,decrease,no risk
Adenine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Adenine.,decrease,no risk
Adenine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Adenine.,decrease,no risk
Adenine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Adenine.,decrease,no risk
Adenine,Glipizide,The metabolism of Glipizide can be decreased when combined with Adenine.,decrease,no risk
Adenine,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Adenine.,decrease,no risk
Adenine,Vadadustat,The metabolism of Vadadustat can be decreased when combined with Adenine.,decrease,no risk
Adenine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Adenine.,decrease,no risk
Adenine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Adenine.,decrease,no risk
Adenine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Adenine.,decrease,no risk
Pravastatin,Ganciclovir,The excretion of Pravastatin can be decreased when combined with Ganciclovir.,decrease,no risk
Pravastatin,Gefitinib,Pravastatin may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Pravastatin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Pravastatin.,increase,no risk
Pravastatin,Gemfibrozil,"The risk or severity of rhabdomyolysis, myoglobinuria, and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.",increase,risk
Pravastatin,Gilteritinib,Gilteritinib may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Glasdegib,Pravastatin may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Pravastatin,Glecaprevir,Pravastatin may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Pravastatin,Glimepiride,Pravastatin may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Pravastatin,Glipizide,Pravastatin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Pravastatin,Glyburide,Glyburide may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Glycyrrhizic acid,Pravastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Pravastatin,Grazoprevir,Grazoprevir may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Guanidine,The excretion of Pravastatin can be decreased when combined with Guanidine.,decrease,no risk
Pravastatin,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Ketoconazole,Ketoconazole may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Ketoprofen,The excretion of Pravastatin can be decreased when combined with Ketoprofen.,decrease,no risk
Pravastatin,Ofloxacin,Pravastatin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Pravastatin,Olmesartan,Olmesartan may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Pravastatin.,increase,no risk
Pravastatin,Ombitasvir,Pravastatin may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Pravastatin,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Osimertinib,Pravastatin may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Pravastatin,Oteseconazole,The serum concentration of Pravastatin can be increased when it is combined with Oteseconazole.,increase,no risk
Pravastatin,Ouabain,The excretion of Pravastatin can be decreased when combined with Ouabain.,decrease,no risk
Pravastatin,Oxaliplatin,Pravastatin may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Ozanimod,Pravastatin may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Pravastatin,Quinapril,The excretion of Quinapril can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Quinidine,Quinidine may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Quinine,The serum concentration of Pravastatin can be increased when it is combined with Quinine.,increase,no risk
Pravastatin,Quizartinib,The serum concentration of Pravastatin can be increased when it is combined with Quizartinib.,increase,no risk
Pravastatin,Ubidecarenone,The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Pravastatin.,decrease,risk
Pravastatin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Pravastatin.,increase,no risk
Pravastatin,Umbralisib,The serum concentration of Pravastatin can be increased when it is combined with Umbralisib.,increase,no risk
Pravastatin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Pravastatin.,increase,no risk
Pravastatin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Pravastatin.,increase,no risk
Pravastatin,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Valproic acid,The excretion of Valproic acid can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Valsartan,The excretion of Pravastatin can be decreased when combined with Valsartan.,decrease,no risk
Pravastatin,Vandetanib,Vandetanib may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Vardenafil,The serum concentration of Pravastatin can be increased when it is combined with Vardenafil.,increase,no risk
Pravastatin,Velpatasvir,Pravastatin may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Pravastatin,Vemurafenib,The serum concentration of Pravastatin can be increased when it is combined with Vemurafenib.,increase,no risk
Pravastatin,Venetoclax,Pravastatin may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Pravastatin,Venlafaxine,Venlafaxine may increase the excretion rate of Pravastatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pravastatin,Verapamil,The serum concentration of Pravastatin can be increased when it is combined with Verapamil.,increase,no risk
Pravastatin,Vinblastine,Vinblastine may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Vincristine,Pravastatin may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Pravastatin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Pravastatin.,increase,no risk
Pravastatin,Vismodegib,Vismodegib may decrease the excretion rate of Pravastatin which could result in a higher serum level.,decrease,no risk
Pravastatin,Voclosporin,The serum concentration of Pravastatin can be increased when it is combined with Voclosporin.,increase,no risk
Pravastatin,Vorapaxar,The serum concentration of Pravastatin can be increased when it is combined with Vorapaxar.,increase,no risk
Pravastatin,Voxilaprevir,Pravastatin may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Pravastatin,Warfarin,The risk or severity of bleeding can be increased when Pravastatin is combined with Warfarin.,increase,risk
Pravastatin,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Zidovudine,The excretion of Zidovudine can be decreased when combined with Pravastatin.,decrease,no risk
Pravastatin,Zonisamide,The serum concentration of Pravastatin can be increased when it is combined with Zonisamide.,increase,no risk
Fluvoxamine,Bacitracin,Bacitracin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.,increase,no risk
Fluvoxamine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Balsalazide.,increase,risk
Fluvoxamine,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Belantamab mafodotin,Fluvoxamine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Belinostat,The metabolism of Fluvoxamine can be increased when combined with Belinostat.,increase,no risk
Fluvoxamine,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Bemiparin,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Bemiparin.,increase,risk
Fluvoxamine,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Bendroflumethiazide,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Bendroflumethiazide.,increase,risk
Fluvoxamine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Benorilate.,increase,risk
Fluvoxamine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Benoxaprofen.,increase,risk
Fluvoxamine,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Benserazide,Fluvoxamine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Benznidazole,Fluvoxamine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Benzthiazide,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Benzthiazide.,increase,risk
Fluvoxamine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Benzydamine.,increase,risk
Fluvoxamine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bepotastine,Fluvoxamine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Bepridil,The metabolism of Bepridil can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Berotralstat,The metabolism of Fluvoxamine can be decreased when combined with Berotralstat.,decrease,no risk
Fluvoxamine,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Betrixaban,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Betrixaban.,increase,risk
Fluvoxamine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Bexagliflozin.,increase,risk
Fluvoxamine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bicisate,Fluvoxamine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bimekizumab,The metabolism of Fluvoxamine can be increased when combined with Bimekizumab.,increase,no risk
Fluvoxamine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Biperiden,The metabolism of Fluvoxamine can be decreased when combined with Biperiden.,decrease,no risk
Fluvoxamine,Bismuth subgallate,Fluvoxamine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bisoxatin,Fluvoxamine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Bivalirudin,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Bivalirudin.,increase,risk
Fluvoxamine,Bleomycin,Fluvoxamine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Boceprevir,The metabolism of Fluvoxamine can be decreased when combined with Boceprevir.,decrease,no risk
Fluvoxamine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bosentan,Bosentan may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.,increase,no risk
Fluvoxamine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Bromazepam,The serum concentration of Bromazepam can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Budesonide,The metabolism of Budesonide can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Bumadizone.,increase,risk
Fluvoxamine,Bumetanide,Bumetanide may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluvoxamine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Buprenorphine,Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Fluvoxamine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Buspirone,The metabolism of Buspirone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Busulfan,The metabolism of Busulfan can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Gadobenic acid,Fluvoxamine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gadodiamide,Fluvoxamine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gadofosveset trisodium,Fluvoxamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gadopentetic acid,Fluvoxamine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gadoteric acid,Fluvoxamine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gadoteridol,Fluvoxamine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Galantamine,The metabolism of Galantamine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Fluvoxamine is combined with Ganaxolone.",increase,risk
Fluvoxamine,Ganciclovir,Fluvoxamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gatifloxacin,The metabolism of Fluvoxamine can be decreased when combined with Gatifloxacin.,decrease,no risk
Fluvoxamine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Gemcitabine,Fluvoxamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Gemifloxacin,The metabolism of Fluvoxamine can be decreased when combined with Gemifloxacin.,decrease,no risk
Fluvoxamine,Gentamicin,Fluvoxamine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Gilteritinib,The therapeutic efficacy of Fluvoxamine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Fluvoxamine,Gimeracil,Fluvoxamine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Givosiran,The serum concentration of Fluvoxamine can be increased when it is combined with Givosiran.,increase,no risk
Fluvoxamine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Glimepiride,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Glimepiride.,increase,risk
Fluvoxamine,Glipizide,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Glipizide.,increase,risk
Fluvoxamine,Gliquidone,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Gliquidone.,increase,risk
Fluvoxamine,Glofitamab,The serum concentration of Fluvoxamine can be increased when it is combined with Glofitamab.,increase,no risk
Fluvoxamine,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Glyburide,The metabolism of Glyburide can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Glycerol phenylbutyrate,The metabolism of Fluvoxamine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Fluvoxamine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Glycol salicylate.,increase,risk
Fluvoxamine,Glycyrrhizic acid,Fluvoxamine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Glymidine,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Glymidine.,increase,risk
Fluvoxamine,Golimumab,The metabolism of Fluvoxamine can be increased when combined with Golimumab.,increase,no risk
Fluvoxamine,Golodirsen,Fluvoxamine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Goserelin,Goserelin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Guanethidine,Fluvoxamine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Halofantrine,The metabolism of Fluvoxamine can be decreased when combined with Halofantrine.,decrease,no risk
Fluvoxamine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Heparin,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Heparin.,increase,risk
Fluvoxamine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Hydralazine,Fluvoxamine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Hydrochlorothiazide,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Hydrochlorothiazide.,increase,risk
Fluvoxamine,Hydrocodone,Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Fluvoxamine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Hydroflumethiazide.,increase,risk
Fluvoxamine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Hydroxocobalamin,Fluvoxamine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydroxyethyl Starch,Fluvoxamine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.,increase,no risk
Fluvoxamine,Kanamycin,Fluvoxamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Ketoconazole,The metabolism of Fluvoxamine can be decreased when combined with Ketoconazole.,decrease,no risk
Fluvoxamine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Ketoprofen.,increase,risk
Fluvoxamine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Ketorolac.,increase,risk
Fluvoxamine,Obeticholic acid,The metabolism of Fluvoxamine can be decreased when combined with Obeticholic acid.,decrease,no risk
Fluvoxamine,Octinoxate,Fluvoxamine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Ofloxacin,Fluvoxamine may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Olaparib,The metabolism of Olaparib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Fluvoxamine is combined with Oliceridine.",increase,risk
Fluvoxamine,Olmesartan,Olmesartan may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Olsalazine,Olsalazine may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oritavancin,The metabolism of Fluvoxamine can be decreased when combined with Oritavancin.,decrease,no risk
Fluvoxamine,Orphenadrine,Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Fluvoxamine,Oseltamivir,Fluvoxamine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Osimertinib,The serum concentration of Fluvoxamine can be decreased when it is combined with Osimertinib.,decrease,no risk
Fluvoxamine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Oxacillin,Fluvoxamine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Oxamniquine,The metabolism of Fluvoxamine can be decreased when combined with Oxamniquine.,decrease,no risk
Fluvoxamine,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Oxaprozin.,increase,risk
Fluvoxamine,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Oxybenzone,Fluvoxamine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Oxyphenbutazone.,increase,risk
Fluvoxamine,Oxyquinoline,Fluvoxamine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Quinethazone,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Quinethazone.,increase,risk
Fluvoxamine,Quinidine,The metabolism of Quinidine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Quinine,The metabolism of Quinine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Ubidecarenone.,increase,risk
Fluvoxamine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Udenafil,The metabolism of Udenafil can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Urokinase,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Urokinase.,increase,risk
Fluvoxamine,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Vaborbactam,Fluvoxamine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Vadadustat,The serum concentration of Fluvoxamine can be increased when it is combined with Vadadustat.,increase,no risk
Fluvoxamine,Valaciclovir,Valaciclovir may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Valdecoxib.,increase,risk
Fluvoxamine,Valganciclovir,Fluvoxamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Valproate bismuth.,increase,risk
Fluvoxamine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Valsartan,The metabolism of Valsartan can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vancomycin,Fluvoxamine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Varenicline,Fluvoxamine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Vasopressin,Fluvoxamine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Fluvoxamine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vemurafenib,The serum concentration of Fluvoxamine can be increased when it is combined with Vemurafenib.,increase,no risk
Fluvoxamine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Venlafaxine.,increase,risk
Fluvoxamine,Verapamil,The metabolism of Verapamil can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Vildagliptin.,increase,risk
Fluvoxamine,Viloxazine,The metabolism of Fluvoxamine can be decreased when combined with Viloxazine.,decrease,no risk
Fluvoxamine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vincristine,The metabolism of Vincristine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vindesine,The metabolism of Vindesine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Vorapaxar,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Vorapaxar.,increase,risk
Fluvoxamine,Voriconazole,The metabolism of Fluvoxamine can be decreased when combined with Voriconazole.,decrease,no risk
Fluvoxamine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Fluvoxamine.,increase,no risk
Fluvoxamine,Ximelagatran,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Ximelagatran.,increase,risk
Fluvoxamine,Yohimbine,The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Yohimbine.,increase,no risk
Fluvoxamine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Zanamivir,Fluvoxamine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Fluvoxamine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Ziconotide,The risk or severity of adverse effects can be increased when Ziconotide is combined with Fluvoxamine.,increase,risk
Fluvoxamine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zileuton,The metabolism of Zileuton can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zimelidine,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Zimelidine.,increase,risk
Fluvoxamine,Ziprasidone,The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Ziprasidone.,increase,risk
Fluvoxamine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Zolmitriptan.,increase,risk
Fluvoxamine,Zolpidem,Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Fluvoxamine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zotepine,The metabolism of Zotepine can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Fluvoxamine.,decrease,no risk
Fluvoxamine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Fluvoxamine.,increase,risk
Valsartan,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Valsartan.,increase,no risk
Valsartan,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Valsartan,Bumadizone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Bumadizone.",increase,risk
Valsartan,Bumetanide,The risk or severity of adverse effects can be increased when Valsartan is combined with Bumetanide.,increase,risk
Valsartan,Bupivacaine,The risk or severity of adverse effects can be increased when Valsartan is combined with Bupivacaine.,increase,risk
Valsartan,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Bupropion,The metabolism of Bupropion can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Buspirone,Buspirone may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Valsartan,Butabarbital,Butabarbital may increase the hypotensive activities of Valsartan.,increase,no risk
Valsartan,Butalbital,Butalbital may increase the hypotensive activities of Valsartan.,increase,no risk
Valsartan,Butriptyline,Butriptyline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Valsartan,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Gemfibrozil,The metabolism of Valsartan can be decreased when combined with Gemfibrozil.,decrease,no risk
Valsartan,Ginkgo biloba,The metabolism of Valsartan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Valsartan,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Glipizide,The metabolism of Glipizide can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Glofitamab,The serum concentration of Valsartan can be increased when it is combined with Glofitamab.,increase,no risk
Valsartan,Glyburide,The metabolism of Glyburide can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Glycol salicylate.",increase,risk
Valsartan,Golimumab,The metabolism of Valsartan can be increased when combined with Golimumab.,increase,no risk
Valsartan,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Valsartan,Guanadrel,Valsartan may increase the hypotensive activities of Guanadrel.,increase,no risk
Valsartan,Guanethidine,Valsartan may increase the hypotensive activities of Guanethidine.,increase,no risk
Valsartan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Valsartan,Guanoxan,Valsartan may increase the hypotensive activities of Guanoxan.,increase,no risk
Valsartan,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Halothane,The metabolism of Halothane can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Valsartan.,increase,risk
Valsartan,Hydralazine,Valsartan may increase the hypotensive activities of Hydralazine.,increase,no risk
Valsartan,Hydroflumethiazide,The therapeutic efficacy of Valsartan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Valsartan,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Ketamine,The metabolism of Ketamine can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Ketoconazole,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Ketoconazole.,increase,risk
Valsartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Ketoprofen.",increase,risk
Valsartan,Ketorolac,The therapeutic efficacy of Valsartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Valsartan,Obinutuzumab,Valsartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Valsartan,Olanzapine,The risk or severity of adverse effects can be increased when Valsartan is combined with Olanzapine.,increase,risk
Valsartan,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Olmesartan.",increase,risk
Valsartan,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Opicapone,The risk or severity of adverse effects can be increased when Valsartan is combined with Opicapone.,increase,risk
Valsartan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Valsartan,Oritavancin,The metabolism of Valsartan can be decreased when combined with Oritavancin.,decrease,no risk
Valsartan,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Ouabain,The excretion of Ouabain can be decreased when combined with Valsartan.,decrease,no risk
Valsartan,Oxandrolone,The metabolism of Valsartan can be decreased when combined with Oxandrolone.,decrease,no risk
Valsartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Oxaprozin.",increase,risk
Valsartan,Oxprenolol,Valsartan may increase the hypotensive activities of Oxprenolol.,increase,no risk
Valsartan,Oxymetazoline,The therapeutic efficacy of Valsartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Valsartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Oxyphenbutazone.",increase,risk
Ramipril,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Ramipril.",increase,risk
Ramipril,Guanabenz,Guanabenz may decrease the antihypertensive activities of Ramipril.,decrease,no risk
Ramipril,Guanadrel,Ramipril may increase the hypotensive activities of Guanadrel.,increase,no risk
Ramipril,Guanethidine,Ramipril may increase the hypotensive activities of Guanethidine.,increase,no risk
Ramipril,Guanfacine,Guanfacine may decrease the antihypertensive activities of Ramipril.,decrease,no risk
Ramipril,Guanoxan,Ramipril may increase the hypotensive activities of Guanoxan.,increase,no risk
Ramipril,Halothane,Halothane may decrease the antihypertensive activities of Ramipril.,decrease,no risk
Ramipril,Heparin,The risk or severity of hyperkalemia can be increased when Ramipril is combined with Heparin.,increase,risk
Ramipril,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Ramipril is combined with Holcus lanatus pollen.,increase,risk
Ramipril,Hydralazine,Ramipril may increase the hypotensive activities of Hydralazine.,increase,no risk
Ramipril,Hydroflumethiazide,The therapeutic efficacy of Ramipril can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Ramipril,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ramipril is combined with Ketoconazole.,increase,risk
Ramipril,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Ramipril.",increase,risk
Ramipril,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Ramipril.",increase,risk
Ramipril,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Ramipril is combined with Koeleria macrantha pollen.,increase,risk
Ramipril,Obinutuzumab,Ramipril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Ramipril,Olanzapine,The risk or severity of adverse effects can be increased when Ramipril is combined with Olanzapine.,increase,risk
Ramipril,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ramipril is combined with Olmesartan.",increase,risk
Ramipril,Olodaterol,Olodaterol may decrease the antihypertensive activities of Ramipril.,decrease,no risk
Ramipril,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Ramipril.,increase,risk
Ramipril,Opicapone,The risk or severity of adverse effects can be increased when Ramipril is combined with Opicapone.,increase,risk
Ramipril,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Ramipril.,decrease,no risk
Ramipril,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Ramipril.",increase,risk
Ramipril,Oxprenolol,Ramipril may increase the hypotensive activities of Oxprenolol.,increase,no risk
Ramipril,Oxymetazoline,The therapeutic efficacy of Ramipril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Ramipril,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Ramipril.",increase,risk
Masoprocol,Benzocaine,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Benzocaine.,increase,risk
Masoprocol,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Benzyl alcohol.,increase,risk
Masoprocol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Bupivacaine.,increase,risk
Masoprocol,Butacaine,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Butacaine.,increase,risk
Masoprocol,Butamben,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Butamben.,increase,risk
Masoprocol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Oxetacaine.,increase,risk
Masoprocol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Oxybuprocaine.,increase,risk
Flunisolide,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Bumadizone.,increase,risk
Flunisolide,Busulfan,The metabolism of Busulfan can be increased when combined with Flunisolide.,increase,no risk
Flunisolide,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Gatifloxacin,The risk or severity of tendinopathy can be increased when Flunisolide is combined with Gatifloxacin.,increase,risk
Flunisolide,Gemcitabine,The risk or severity of adverse effects can be increased when Flunisolide is combined with Gemcitabine.,increase,risk
Flunisolide,Gemifloxacin,The risk or severity of tendinopathy can be increased when Flunisolide is combined with Gemifloxacin.,increase,risk
Flunisolide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Flunisolide.,increase,risk
Flunisolide,Gestrinone,The serum concentration of Flunisolide can be increased when it is combined with Gestrinone.,increase,no risk
Flunisolide,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Flunisolide.,increase,no risk
Flunisolide,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Glatiramer,The risk or severity of adverse effects can be increased when Flunisolide is combined with Glatiramer.,increase,risk
Flunisolide,Gliclazide,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Gliclazide.,increase,risk
Flunisolide,Glimepiride,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Glimepiride.,increase,risk
Flunisolide,Glipizide,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Glipizide.,increase,risk
Flunisolide,Gliquidone,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Gliquidone.,increase,risk
Flunisolide,Glofitamab,The serum concentration of Flunisolide can be increased when it is combined with Glofitamab.,increase,no risk
Flunisolide,Glyburide,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Glyburide.,increase,risk
Flunisolide,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Glycol salicylate.,increase,risk
Flunisolide,Glymidine,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Glymidine.,increase,risk
Flunisolide,Golimumab,The risk or severity of adverse effects can be increased when Flunisolide is combined with Golimumab.,increase,risk
Flunisolide,Grepafloxacin,The risk or severity of tendinopathy can be increased when Flunisolide is combined with Grepafloxacin.,increase,risk
Flunisolide,Guselkumab,The risk or severity of adverse effects can be increased when Flunisolide is combined with Guselkumab.,increase,risk
Flunisolide,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Flunisolide.,increase,no risk
Flunisolide,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Flunisolide is combined with Hydrochlorothiazide.,increase,risk
Flunisolide,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydrocortisone acetate.,increase,risk
Flunisolide,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydrocortisone butyrate.,increase,risk
Flunisolide,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydrocortisone succinate.,increase,risk
Flunisolide,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Flunisolide is combined with Hydroflumethiazide.,increase,risk
Flunisolide,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydroxychloroquine.,increase,risk
Flunisolide,Hydroxyprogesterone caproate,The serum concentration of Flunisolide can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Flunisolide,Hydroxyurea,The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydroxyurea.,increase,risk
Flunisolide,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Flunisolide.,decrease,no risk
Flunisolide,Ketoconazole,The metabolism of Flunisolide can be decreased when combined with Ketoconazole.,decrease,no risk
Flunisolide,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Ketoprofen.,increase,risk
Flunisolide,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Ketorolac.,increase,risk
Flunisolide,Obinutuzumab,The risk or severity of adverse effects can be increased when Flunisolide is combined with Obinutuzumab.,increase,risk
Flunisolide,Ocrelizumab,The risk or severity of adverse effects can be increased when Flunisolide is combined with Ocrelizumab.,increase,risk
Flunisolide,Ofatumumab,The risk or severity of adverse effects can be increased when Flunisolide is combined with Ofatumumab.,increase,risk
Flunisolide,Ofloxacin,The risk or severity of tendinopathy can be increased when Flunisolide is combined with Ofloxacin.,increase,risk
Flunisolide,Olaparib,The metabolism of Olaparib can be increased when combined with Flunisolide.,increase,no risk
Flunisolide,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Flunisolide.,decrease,no risk
Flunisolide,Olodaterol,The risk or severity of hypokalemia can be increased when Flunisolide is combined with Olodaterol.,increase,risk
Flunisolide,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Flunisolide.,decrease,no risk
Flunisolide,Omaveloxolone,The serum concentration of Flunisolide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Flunisolide,Orciprenaline,The risk or severity of hypokalemia can be increased when Flunisolide is combined with Orciprenaline.,increase,risk
Flunisolide,Osimertinib,The metabolism of Osimertinib can be increased when combined with Flunisolide.,increase,no risk
Flunisolide,Oxaliplatin,The risk or severity of adverse effects can be increased when Flunisolide is combined with Oxaliplatin.,increase,risk
Flunisolide,Oxandrolone,The risk or severity of fluid retention can be increased when Flunisolide is combined with Oxandrolone.,increase,risk
Flunisolide,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Oxaprozin.,increase,risk
Flunisolide,Oxymetazoline,The absorption of Flunisolide can be decreased when combined with Oxymetazoline.,decrease,no risk
Flunisolide,Oxymetholone,The risk or severity of fluid retention can be increased when Flunisolide is combined with Oxymetholone.,increase,risk
Flunisolide,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Flunisolide is combined with Oxyphenbutazone.,increase,risk
Flunisolide,Ozanimod,The risk or severity of adverse effects can be increased when Flunisolide is combined with Ozanimod.,increase,risk
Flunisolide,Quinestrol,The serum concentration of Flunisolide can be increased when it is combined with Quinestrol.,increase,no risk
Baclofen,Bethanidine,The risk or severity of adverse effects can be increased when Baclofen is combined with Bethanidine.,increase,risk
Baclofen,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Bezafibrate.",increase,risk
Baclofen,Bicisate,Baclofen may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Baclofen,Bismuth subgallate,Baclofen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Baclofen,Bisoprolol,The risk or severity of adverse effects can be increased when Baclofen is combined with Bisoprolol.,increase,risk
Baclofen,Bisoxatin,Baclofen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Baclofen,Bleomycin,Baclofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Baclofen,Bosentan,The risk or severity of adverse effects can be increased when Baclofen is combined with Bosentan.,increase,risk
Baclofen,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Baclofen.,increase,no risk
Baclofen,Botulinum toxin type B,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Botulinum toxin type B.,increase,no risk
Baclofen,Bretylium,The risk or severity of adverse effects can be increased when Baclofen is combined with Bretylium.,increase,risk
Baclofen,Brexanolone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brexanolone.,increase,no risk
Baclofen,Brexpiprazole,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.,increase,no risk
Baclofen,Brimonidine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.,increase,no risk
Baclofen,Brivaracetam,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.,increase,no risk
Baclofen,Bromazepam,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.,increase,no risk
Baclofen,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Bromotheophylline,Bromotheophylline may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Baclofen,Bromperidol,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.,increase,no risk
Baclofen,Brompheniramine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.,increase,no risk
Baclofen,Budesonide,Baclofen may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Baclofen,Bumadizone,Bumadizone may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Bumetanide,Bumetanide may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Bupivacaine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.,increase,no risk
Baclofen,Buprenorphine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Baclofen,Bupropion,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bupropion.,increase,no risk
Baclofen,Buspirone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Buspirone.,increase,no risk
Baclofen,Butabarbital,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Baclofen,Butalbital,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butalbital.,increase,no risk
Baclofen,Butamben,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butamben.,increase,no risk
Baclofen,Butaperazine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butaperazine.,increase,no risk
Baclofen,Butobarbital,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.,increase,no risk
Baclofen,Butorphanol,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.,increase,no risk
Baclofen,Butriptyline,The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Butriptyline.,increase,risk
Baclofen,Gabapentin,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Baclofen,Gabapentin enacarbil,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Baclofen,Gadobenic acid,Baclofen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Baclofen,Gadodiamide,Baclofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Baclofen,Gadofosveset trisodium,Baclofen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Baclofen,Gadopentetic acid,Baclofen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Baclofen,Gadoteric acid,Baclofen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Baclofen,Gadoteridol,Baclofen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Baclofen,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Baclofen.,increase,no risk
Baclofen,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Baclofen is combined with Ganaxolone.",increase,risk
Baclofen,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ganciclovir.",increase,risk
Baclofen,Gemcitabine,Baclofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Baclofen,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Gemfibrozil.",increase,risk
Baclofen,Gentamicin,Gentamicin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Gepirone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Gepirone.,increase,no risk
Baclofen,Gimeracil,Baclofen may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Baclofen,Givosiran,Givosiran may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Glutethimide,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Baclofen,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Glycerol phenylbutyrate,Baclofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Baclofen,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Golodirsen,Baclofen may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Baclofen,Goserelin,Goserelin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Granisetron,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Baclofen,Guanabenz,The risk or severity of adverse effects can be increased when Baclofen is combined with Guanabenz.,increase,risk
Baclofen,Guanadrel,The risk or severity of adverse effects can be increased when Baclofen is combined with Guanadrel.,increase,risk
Baclofen,Guanethidine,The risk or severity of adverse effects can be increased when Baclofen is combined with Guanethidine.,increase,risk
Baclofen,Guanfacine,The risk or severity of adverse effects can be increased when Baclofen is combined with Guanfacine.,increase,risk
Baclofen,Guanoxan,The risk or severity of adverse effects can be increased when Baclofen is combined with Guanoxan.,increase,risk
Baclofen,Halazepam,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Baclofen,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Baclofen.,increase,risk
Baclofen,Halothane,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Baclofen,Hexafluronium,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Baclofen,Hydralazine,The risk or severity of adverse effects can be increased when Baclofen is combined with Hydralazine.,increase,risk
Baclofen,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Baclofen is combined with Hydrochlorothiazide.,increase,risk
Baclofen,Hydrocodone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Baclofen,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Baclofen is combined with Hydroflumethiazide.,increase,risk
Baclofen,Hydromorphone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Baclofen,Hydroxocobalamin,Baclofen may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Baclofen,Hydroxyethyl Starch,Baclofen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Baclofen,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Baclofen.,increase,no risk
Baclofen,Kanamycin,Kanamycin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Ketamine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Baclofen,Ketazolam,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Baclofen,Ketoprofen,Ketoprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Ketorolac,Ketorolac may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Octinoxate,Baclofen may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Baclofen,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ofloxacin.",increase,risk
Baclofen,Olanzapine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Baclofen,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Baclofen is combined with Oliceridine.",increase,risk
Baclofen,Olmesartan,The risk or severity of adverse effects can be increased when Baclofen is combined with Olmesartan.,increase,risk
Baclofen,Olsalazine,Olsalazine may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Ondansetron,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Baclofen,Opium,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Baclofen,Orphenadrine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Baclofen,Oseltamivir,Baclofen may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Baclofen,Oxacillin,Baclofen may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Baclofen,Oxaprozin,Oxaprozin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Oxazepam,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Baclofen,Oxcarbazepine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Baclofen,Oxitriptan,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Baclofen,Oxprenolol,The risk or severity of adverse effects can be increased when Baclofen is combined with Oxprenolol.,increase,risk
Baclofen,Oxybenzone,Baclofen may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Baclofen,Oxybuprocaine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Baclofen,Oxycodone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Baclofen,Oxymorphone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Baclofen,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Oxyquinoline,Baclofen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Baclofen,Quazepam,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Baclofen,Quetiapine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Baclofen,Quinapril,The risk or severity of adverse effects can be increased when Baclofen is combined with Quinapril.,increase,risk
Baclofen,Quinethazone,Quinethazone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Baclofen,Quinidine,Baclofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Baclofen,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Quinupramine,The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Quinupramine.,increase,risk
Baclofen,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ubidecarenone.",increase,risk
Baclofen,Urethane,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Baclofen,Vaborbactam,Baclofen may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Baclofen,Valaciclovir,Valaciclovir may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Valbenazine,Baclofen may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Baclofen,Valdecoxib,Valdecoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Valganciclovir,Baclofen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Baclofen,Valproic acid,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Baclofen,Valsartan,The risk or severity of adverse effects can be increased when Baclofen is combined with Valsartan.,increase,risk
Baclofen,Vancomycin,Vancomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Baclofen,Varenicline,Baclofen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Baclofen,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Baclofen.,increase,no risk
Baclofen,Venlafaxine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Baclofen,Verapamil,Baclofen may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Baclofen,Vigabatrin,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Baclofen,Vilanterol,Baclofen may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Baclofen,Vilazodone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Baclofen,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Baclofen.,decrease,no risk
Baclofen,Viloxazine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.,increase,no risk
Baclofen,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Vincristine.",increase,risk
Baclofen,Vortioxetine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Baclofen,Warfarin,Baclofen may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Baclofen,Yohimbine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Baclofen,Zaleplon,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Baclofen,Zanamivir,Baclofen may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Baclofen,Ziconotide,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Baclofen,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Zidovudine.",increase,risk
Baclofen,Zimelidine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Baclofen,Ziprasidone,The risk or severity of adverse effects can be increased when Baclofen is combined with Ziprasidone.,increase,risk
Baclofen,Zofenopril,The risk or severity of adverse effects can be increased when Baclofen is combined with Zofenopril.,increase,risk
Baclofen,Zolmitriptan,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Baclofen,Zolpidem,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Baclofen,Zonisamide,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Baclofen,Zopiclone,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Baclofen,Zotepine,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Baclofen,Zuclopenthixol,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Baclofen,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Baclofen.,increase,risk
Amphetamine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Benzphetamine.,increase,risk
Amphetamine,Benzthiazide,Benzthiazide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amphetamine,Benzydamine,The risk or severity of hypertension can be increased when Amphetamine is combined with Benzydamine.,increase,risk
Amphetamine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Bepotastine,Amphetamine may decrease the sedative activities of Bepotastine.,decrease,no risk
Amphetamine,Bepridil,The metabolism of Amphetamine can be decreased when combined with Bepridil.,decrease,no risk
Amphetamine,Berotralstat,The metabolism of Amphetamine can be decreased when combined with Berotralstat.,decrease,no risk
Amphetamine,Betahistine,Amphetamine may decrease the sedative activities of Betahistine.,decrease,no risk
Amphetamine,Betaxolol,The therapeutic efficacy of Betaxolol can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Bethanidine,Amphetamine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Amphetamine,Bicisate,Amphetamine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Amphetamine,Bilastine,Amphetamine may decrease the sedative activities of Bilastine.,decrease,no risk
Amphetamine,Bimekizumab,The metabolism of Amphetamine can be increased when combined with Bimekizumab.,increase,no risk
Amphetamine,Biperiden,The metabolism of Amphetamine can be decreased when combined with Biperiden.,decrease,no risk
Amphetamine,Bismuth subgallate,Amphetamine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Amphetamine,Bismuth subnitrate,The serum concentration of Amphetamine can be increased when it is combined with Bismuth subnitrate.,increase,no risk
Amphetamine,Bisoprolol,The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Bisoxatin,Amphetamine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Amphetamine,Bleomycin,Amphetamine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Amphetamine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Bosentan,Amphetamine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Amphetamine,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Brexpiprazole,The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Bromazepam,Amphetamine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Amphetamine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Bromotheophylline,The risk or severity of adverse effects can be increased when Amphetamine is combined with Bromotheophylline.,increase,risk
Amphetamine,Bromperidol,Bromperidol may decrease the stimulatory activities of Amphetamine.,decrease,no risk
Amphetamine,Brompheniramine,Amphetamine may decrease the sedative activities of Brompheniramine.,decrease,no risk
Amphetamine,Buclizine,Amphetamine may decrease the sedative activities of Buclizine.,decrease,no risk
Amphetamine,Budesonide,Amphetamine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Amphetamine,Bumadizone,The risk or severity of hypertension can be increased when Amphetamine is combined with Bumadizone.,increase,risk
Amphetamine,Bumetanide,Bumetanide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amphetamine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Buprenorphine,Amphetamine may increase the analgesic activities of Buprenorphine.,increase,no risk
Amphetamine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Amphetamine.,increase,risk
Amphetamine,Buspirone,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Buspirone.,increase,risk
Amphetamine,Butabarbital,Amphetamine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Amphetamine,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Butaperazine,Butaperazine may decrease the stimulatory activities of Amphetamine.,decrease,no risk
Amphetamine,Butorphanol,Amphetamine may increase the analgesic activities of Butorphanol.,increase,no risk
Amphetamine,Butriptyline,Amphetamine may decrease the sedative activities of Butriptyline.,decrease,no risk
Amphetamine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Butylscopolamine.,increase,risk
Amphetamine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Gabapentin enacarbil,Amphetamine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Amphetamine,Gadobenic acid,Amphetamine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Amphetamine,Gadodiamide,Amphetamine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Amphetamine,Gadofosveset trisodium,Amphetamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Amphetamine,Gadopentetic acid,Amphetamine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Amphetamine,Gadoteric acid,Amphetamine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Amphetamine,Gadoteridol,Amphetamine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Amphetamine,Galantamine,The metabolism of Galantamine can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Gallamine triethiodide.,increase,risk
Amphetamine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Ganciclovir,Amphetamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Amphetamine,Gefitinib,The metabolism of Amphetamine can be decreased when combined with Gefitinib.,decrease,no risk
Amphetamine,Gemcitabine,Amphetamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Amphetamine,Gemfibrozil,Amphetamine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Amphetamine,Gentamicin,Amphetamine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Amphetamine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Amphetamine.,increase,risk
Amphetamine,Gimeracil,Amphetamine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Amphetamine,Givosiran,The serum concentration of Amphetamine can be increased when it is combined with Givosiran.,increase,no risk
Amphetamine,Glipizide,Amphetamine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Amphetamine,Glutamic acid,The serum concentration of Amphetamine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Amphetamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Glycerol phenylbutyrate,The metabolism of Amphetamine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Amphetamine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Glycopyrronium.,increase,risk
Amphetamine,Golimumab,The metabolism of Amphetamine can be increased when combined with Golimumab.,increase,no risk
Amphetamine,Golodirsen,Amphetamine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Amphetamine,Goserelin,Goserelin may decrease the excretion rate of Amphetamine which could result in a higher serum level.,decrease,no risk
Amphetamine,Granisetron,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Granisetron.,increase,risk
Amphetamine,Guanabenz,Amphetamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Amphetamine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Guanethidine,The serum concentration of Amphetamine can be decreased when it is combined with Guanethidine.,decrease,no risk
Amphetamine,Guanfacine,Amphetamine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Amphetamine,Guanoxan,Amphetamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Amphetamine,Halofantrine,The metabolism of Amphetamine can be decreased when combined with Halofantrine.,decrease,no risk
Amphetamine,Haloperidol,The therapeutic efficacy of Amphetamine can be decreased when used in combination with Haloperidol.,decrease,no risk
Amphetamine,Halothane,The risk or severity of hypertension can be increased when Amphetamine is combined with Halothane.,increase,risk
Amphetamine,Hexocyclium,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Hexocyclium.,increase,risk
Amphetamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Homatropine methylbromide.,increase,risk
Amphetamine,Hydralazine,Amphetamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Amphetamine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amphetamine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Amphetamine.,increase,risk
Amphetamine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amphetamine,Hydromorphone,Amphetamine may increase the analgesic activities of Hydromorphone.,increase,no risk
Amphetamine,Hydrotalcite,The serum concentration of Amphetamine can be increased when it is combined with Hydrotalcite.,increase,no risk
Amphetamine,Hydroxocobalamin,Amphetamine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Amphetamine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Amphetamine.,increase,risk
Amphetamine,Hydroxyethyl Starch,Amphetamine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Amphetamine,Hydroxyzine,Amphetamine may decrease the sedative activities of Hydroxyzine.,decrease,no risk
Amphetamine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Hyoscyamine.,increase,risk
Amphetamine,Kanamycin,Amphetamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Amphetamine,Ketamine,Amphetamine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Amphetamine,Ketazolam,Amphetamine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Amphetamine,Ketoconazole,The metabolism of Amphetamine can be decreased when combined with Ketoconazole.,decrease,no risk
Amphetamine,Ketoprofen,The risk or severity of hypertension can be increased when Amphetamine is combined with Ketoprofen.,increase,risk
Amphetamine,Ketorolac,The risk or severity of hypertension can be increased when Amphetamine is combined with Ketorolac.,increase,risk
Amphetamine,Ketotifen,Amphetamine may decrease the sedative activities of Ketotifen.,decrease,no risk
Amphetamine,Octinoxate,Amphetamine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Amphetamine,Olanzapine,Amphetamine may decrease the sedative activities of Olanzapine.,decrease,no risk
Amphetamine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Oliceridine.,increase,risk
Amphetamine,Olmesartan,Amphetamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Amphetamine,Olodaterol,The risk or severity of hypertension can be increased when Amphetamine is combined with Olodaterol.,increase,risk
Amphetamine,Olsalazine,Olsalazine may decrease the excretion rate of Amphetamine which could result in a higher serum level.,decrease,no risk
Amphetamine,Omeprazole,Omeprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Amphetamine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Ondansetron.,increase,risk
Amphetamine,Opium,Amphetamine may increase the analgesic activities of Opium.,increase,no risk
Amphetamine,Orciprenaline,The risk or severity of hypertension can be increased when Amphetamine is combined with Orciprenaline.,increase,risk
Amphetamine,Oritavancin,The metabolism of Amphetamine can be decreased when combined with Oritavancin.,decrease,no risk
Amphetamine,Orphenadrine,Amphetamine may decrease the sedative activities of Orphenadrine.,decrease,no risk
Amphetamine,Oseltamivir,Amphetamine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Amphetamine,Osilodrostat,The metabolism of Amphetamine can be decreased when combined with Osilodrostat.,decrease,no risk
Amphetamine,Ospemifene,The metabolism of Amphetamine can be decreased when combined with Ospemifene.,decrease,no risk
Amphetamine,Oxacillin,Amphetamine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Amphetamine,Oxamniquine,The metabolism of Amphetamine can be decreased when combined with Oxamniquine.,decrease,no risk
Amphetamine,Oxaprozin,The risk or severity of hypertension can be increased when Amphetamine is combined with Oxaprozin.,increase,risk
Amphetamine,Oxatomide,Amphetamine may decrease the sedative activities of Oxatomide.,decrease,no risk
Amphetamine,Oxazepam,Amphetamine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Amphetamine,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Oxtriphylline,The risk or severity of adverse effects can be increased when Amphetamine is combined with Oxtriphylline.,increase,risk
Amphetamine,Oxybenzone,Amphetamine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Amphetamine,Oxybutynin,The metabolism of Amphetamine can be decreased when combined with Oxybutynin.,decrease,no risk
Amphetamine,Oxycodone,Amphetamine may increase the analgesic activities of Oxycodone.,increase,no risk
Amphetamine,Oxymetazoline,The risk or severity of hypertension can be increased when Amphetamine is combined with Oxymetazoline.,increase,risk
Amphetamine,Oxymorphone,Amphetamine may increase the analgesic activities of Oxymorphone.,increase,no risk
Amphetamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Amphetamine is combined with Oxyphenbutazone.,increase,risk
Amphetamine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Oxyphencyclimine.,increase,risk
Amphetamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Amphetamine is combined with Oxyphenonium.,increase,risk
Amphetamine,Oxyquinoline,Amphetamine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Amphetamine,Quetiapine,Amphetamine may decrease the sedative activities of Quetiapine.,decrease,no risk
Amphetamine,Quinapril,Amphetamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Amphetamine,Quinethazone,Quinethazone may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amphetamine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Quinine,The metabolism of Amphetamine can be decreased when combined with Quinine.,decrease,no risk
Amphetamine,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Amphetamine.,increase,no risk
Amphetamine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Vaborbactam,Amphetamine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Amphetamine,Valaciclovir,Valaciclovir may decrease the excretion rate of Amphetamine which could result in a higher serum level.,decrease,no risk
Amphetamine,Valbenazine,Amphetamine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Amphetamine,Valdecoxib,The risk or severity of hypertension can be increased when Amphetamine is combined with Valdecoxib.,increase,risk
Amphetamine,Valganciclovir,Amphetamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Amphetamine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Valproate bismuth.,increase,risk
Amphetamine,Valproic acid,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Valproic acid.,increase,risk
Amphetamine,Valsartan,Amphetamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Amphetamine,Vancomycin,Amphetamine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Amphetamine,Varenicline,Amphetamine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Amphetamine,Vemurafenib,The metabolism of Amphetamine can be decreased when combined with Vemurafenib.,decrease,no risk
Amphetamine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Venlafaxine.,increase,risk
Amphetamine,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Vilanterol,The risk or severity of hypertension can be increased when Amphetamine is combined with Vilanterol.,increase,risk
Amphetamine,Vilazodone,The metabolism of Amphetamine can be decreased when combined with Vilazodone.,decrease,no risk
Amphetamine,Viloxazine,The metabolism of Amphetamine can be decreased when combined with Viloxazine.,decrease,no risk
Amphetamine,Vinblastine,The metabolism of Amphetamine can be decreased when combined with Vinblastine.,decrease,no risk
Amphetamine,Vinorelbine,The metabolism of Amphetamine can be decreased when combined with Vinorelbine.,decrease,no risk
Amphetamine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Vortioxetine.,increase,risk
Amphetamine,Warfarin,Amphetamine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Amphetamine,Xamoterol,The risk or severity of hypertension can be increased when Amphetamine is combined with Xamoterol.,increase,risk
Amphetamine,Xylometazoline,The risk or severity of hypertension can be increased when Amphetamine is combined with Xylometazoline.,increase,risk
Amphetamine,Yohimbine,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Amphetamine.,decrease,no risk
Amphetamine,Zanamivir,Amphetamine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Amphetamine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Zimelidine.,increase,risk
Amphetamine,Zinc ascorbate,The serum concentration of Amphetamine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Amphetamine,Ziprasidone,Amphetamine may decrease the sedative activities of Ziprasidone.,decrease,no risk
Amphetamine,Zofenopril,Amphetamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Amphetamine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Zolmitriptan.,increase,risk
Amphetamine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Amphetamine.,decrease,no risk
Amphetamine,Zonisamide,Zonisamide may decrease the excretion rate of Amphetamine which could result in a higher serum level.,decrease,no risk
Amphetamine,Zotepine,Zotepine may decrease the stimulatory activities of Amphetamine.,decrease,no risk
Amphetamine,Zuclopenthixol,Amphetamine may decrease the sedative activities of Zuclopenthixol.,decrease,no risk
Pentagastrin,Histamine,The serum concentration of Histamine can be increased when it is combined with Pentagastrin.,increase,no risk
Nicotine,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Nicotine.,increase,risk
Nicotine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Nicotine.,increase,risk
Nicotine,Ganciclovir,The risk or severity of adverse effects can be increased when Nicotine is combined with Ganciclovir.,increase,risk
Nicotine,Gefapixant,The risk or severity of adverse effects can be increased when Gefapixant is combined with Nicotine.,increase,risk
Nicotine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Nicotine.,increase,no risk
Nicotine,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Nicotine.,increase,risk
Nicotine,Gliclazide,The risk or severity of adverse effects can be increased when Gliclazide is combined with Nicotine.,increase,risk
Nicotine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Nicotine is combined with Glycopyrronium.,increase,risk
Nicotine,Glymidine,The risk or severity of adverse effects can be increased when Glymidine is combined with Nicotine.,increase,risk
Nicotine,Golimumab,The metabolism of Nicotine can be increased when combined with Golimumab.,increase,no risk
Nicotine,Guanabenz,The risk or severity of Tachycardia can be increased when Nicotine is combined with Guanabenz.,increase,risk
Nicotine,Guanfacine,The risk or severity of adverse effects can be increased when Nicotine is combined with Guanfacine.,increase,risk
Nicotine,Halothane,The metabolism of Halothane can be increased when combined with Nicotine.,increase,no risk
Nicotine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Nicotine.,increase,risk
Nicotine,Hexocyclium,The risk or severity of Tachycardia can be increased when Nicotine is combined with Hexocyclium.,increase,risk
Nicotine,Histamine,The serum concentration of Histamine can be increased when it is combined with Nicotine.,increase,no risk
Nicotine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Nicotine is combined with Homatropine methylbromide.,increase,risk
Nicotine,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Nicotine.,increase,risk
Nicotine,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Nicotine.,increase,risk
Nicotine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Hydrocortisone,The metabolism of Nicotine can be increased when combined with Hydrocortisone.,increase,no risk
Nicotine,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Nicotine.,increase,risk
Nicotine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Hyoscyamine.,increase,risk
Nicotine,Kanamycin,The risk or severity of adverse effects can be increased when Kanamycin is combined with Nicotine.,increase,risk
Nicotine,Ketamine,The metabolism of Ketamine can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Ketoconazole,The metabolism of Nicotine can be decreased when combined with Ketoconazole.,decrease,no risk
Nicotine,Olanzapine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Olanzapine.,increase,risk
Nicotine,Olodaterol,The risk or severity of Tachycardia can be increased when Nicotine is combined with Olodaterol.,increase,risk
Nicotine,Orciprenaline,The risk or severity of Tachycardia can be increased when Nicotine is combined with Orciprenaline.,increase,risk
Nicotine,Orphenadrine,The metabolism of Nicotine can be decreased when combined with Orphenadrine.,decrease,no risk
Nicotine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Nicotine.,increase,no risk
Nicotine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Nicotine.,increase,risk
Nicotine,Oxybutynin,The risk or severity of Tachycardia can be increased when Nicotine is combined with Oxybutynin.,increase,risk
Nicotine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Nicotine is combined with Oxymetazoline.,increase,risk
Nicotine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Oxyphencyclimine.,increase,risk
Nicotine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Nicotine is combined with Oxyphenonium.,increase,risk
Nicotine,Oxytetracycline,The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Nicotine.,increase,risk
Nicotine,Quetiapine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Quetiapine.,increase,risk
Nicotine,Quinethazone,The risk or severity of adverse effects can be increased when Quinethazone is combined with Nicotine.,increase,risk
Nicotine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Nicotine.,increase,risk
Nicotine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Nicotine.,increase,risk
Nicotine,Udenafil,The risk or severity of adverse effects can be increased when Udenafil is combined with Nicotine.,increase,risk
Nicotine,Umeclidinium,The risk or severity of Tachycardia can be increased when Nicotine is combined with Umeclidinium.,increase,risk
Nicotine,Vadadustat,The serum concentration of Nicotine can be decreased when it is combined with Vadadustat.,decrease,no risk
Nicotine,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Nicotine.,increase,risk
Nicotine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Vancomycin,The risk or severity of adverse effects can be increased when Vancomycin is combined with Nicotine.,increase,risk
Nicotine,Varenicline,The risk or severity of adverse effects can be increased when Varenicline is combined with Nicotine.,increase,risk
Nicotine,Vasopressin,Nicotine may increase the hypertensive activities of Vasopressin.,increase,no risk
Nicotine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Vemurafenib,The risk or severity of adverse effects can be increased when Vemurafenib is combined with Nicotine.,increase,risk
Nicotine,Venlafaxine,The risk or severity of Tachycardia can be increased when Nicotine is combined with Venlafaxine.,increase,risk
Nicotine,Vilanterol,The risk or severity of Tachycardia can be increased when Nicotine is combined with Vilanterol.,increase,risk
Nicotine,Viomycin,The risk or severity of adverse effects can be increased when Viomycin is combined with Nicotine.,increase,risk
Nicotine,Voriconazole,The metabolism of Nicotine can be decreased when combined with Voriconazole.,decrease,no risk
Nicotine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Xamoterol,The risk or severity of Tachycardia can be increased when Nicotine is combined with Xamoterol.,increase,risk
Nicotine,Xylometazoline,The risk or severity of Tachycardia can be increased when Nicotine is combined with Xylometazoline.,increase,risk
Nicotine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Nicotine.,decrease,no risk
Nicotine,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Nicotine.,increase,risk
Cevimeline,Bumadizone,Bumadizone may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Bumetanide,Bumetanide may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cevimeline,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Cevimeline.,decrease,no risk
Cevimeline,Buprenorphine,The metabolism of Cevimeline can be decreased when combined with Buprenorphine.,decrease,no risk
Cevimeline,Bupropion,The metabolism of Cevimeline can be decreased when combined with Bupropion.,decrease,no risk
Cevimeline,Buspirone,Cevimeline may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Cevimeline,Butabarbital,Cevimeline may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Cevimeline,Gabapentin enacarbil,Cevimeline may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cevimeline,Gadobenic acid,Cevimeline may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cevimeline,Gadodiamide,Cevimeline may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cevimeline,Gadofosveset trisodium,Cevimeline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cevimeline,Gadopentetic acid,Cevimeline may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cevimeline,Gadoteric acid,Cevimeline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cevimeline,Gadoteridol,Cevimeline may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cevimeline,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Cevimeline.,increase,risk
Cevimeline,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Cevimeline.,increase,risk
Cevimeline,Ganciclovir,Cevimeline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cevimeline,Gefitinib,The metabolism of Cevimeline can be decreased when combined with Gefitinib.,decrease,no risk
Cevimeline,Gemcitabine,Cevimeline may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cevimeline,Gemfibrozil,Cevimeline may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cevimeline,Gentamicin,Cevimeline may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cevimeline,Gimeracil,Cevimeline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cevimeline,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Cevimeline.,increase,risk
Cevimeline,Givosiran,The serum concentration of Cevimeline can be increased when it is combined with Givosiran.,increase,no risk
Cevimeline,Glipizide,Cevimeline may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cevimeline,Glofitamab,The serum concentration of Cevimeline can be increased when it is combined with Glofitamab.,increase,no risk
Cevimeline,Glycerol phenylbutyrate,The metabolism of Cevimeline can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Cevimeline,Golimumab,The metabolism of Cevimeline can be increased when combined with Golimumab.,increase,no risk
Cevimeline,Golodirsen,Cevimeline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cevimeline,Goserelin,Goserelin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Guanethidine,Cevimeline may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cevimeline,Guanfacine,Cevimeline may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cevimeline,Halofantrine,The metabolism of Cevimeline can be decreased when combined with Halofantrine.,decrease,no risk
Cevimeline,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cevimeline.,increase,no risk
Cevimeline,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Cevimeline.,increase,risk
Cevimeline,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Cevimeline.,increase,risk
Cevimeline,Hydralazine,Cevimeline may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cevimeline,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cevimeline,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cevimeline,Hydromorphone,Cevimeline may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cevimeline,Hydroxocobalamin,Cevimeline may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cevimeline,Hydroxychloroquine,The metabolism of Cevimeline can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Cevimeline,Hydroxyethyl Starch,Cevimeline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cevimeline,Hydroxyzine,The metabolism of Cevimeline can be decreased when combined with Hydroxyzine.,decrease,no risk
Cevimeline,Kanamycin,Cevimeline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cevimeline,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Cevimeline.,increase,risk
Cevimeline,Ketazolam,Cevimeline may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cevimeline,Ketoconazole,The metabolism of Cevimeline can be decreased when combined with Ketoconazole.,decrease,no risk
Cevimeline,Ketoprofen,Ketoprofen may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Ketorolac,Ketorolac may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Octinoxate,Cevimeline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cevimeline,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Cevimeline.,decrease,no risk
Cevimeline,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Cevimeline.,decrease,no risk
Cevimeline,Olsalazine,Olsalazine may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Omaveloxolone,The serum concentration of Cevimeline can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cevimeline,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Cevimeline.,decrease,no risk
Cevimeline,Opium,Cevimeline may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cevimeline,Oritavancin,The metabolism of Cevimeline can be decreased when combined with Oritavancin.,decrease,no risk
Cevimeline,Orphenadrine,The metabolism of Cevimeline can be decreased when combined with Orphenadrine.,decrease,no risk
Cevimeline,Oseltamivir,Cevimeline may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cevimeline,Osilodrostat,The metabolism of Cevimeline can be decreased when combined with Osilodrostat.,decrease,no risk
Cevimeline,Ospemifene,The metabolism of Cevimeline can be decreased when combined with Ospemifene.,decrease,no risk
Cevimeline,Oxacillin,Cevimeline may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cevimeline,Oxamniquine,The metabolism of Cevimeline can be decreased when combined with Oxamniquine.,decrease,no risk
Cevimeline,Oxaprozin,Oxaprozin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Oxazepam,Cevimeline may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cevimeline,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Cevimeline.,increase,risk
Cevimeline,Oxybenzone,Cevimeline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cevimeline,Oxybutynin,The metabolism of Cevimeline can be decreased when combined with Oxybutynin.,decrease,no risk
Cevimeline,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Cevimeline.,decrease,no risk
Cevimeline,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Cevimeline.,decrease,no risk
Cevimeline,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Cevimeline which could result in a higher serum level.,decrease,no risk
Cevimeline,Oxyquinoline,Cevimeline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cevimeline,Quetiapine,Cevimeline may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cevimeline,Quinethazone,Quinethazone may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cevimeline,Quinidine,The metabolism of Cevimeline can be decreased when combined with Quinidine.,decrease,no risk
Cevimeline,Quinine,The metabolism of Cevimeline can be decreased when combined with Quinine.,decrease,no risk
Lorazepam,Borage oil,The therapeutic efficacy of Lorazepam can be decreased when used in combination with Borage oil.,decrease,no risk
Lorazepam,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Lorazepam.,increase,risk
Lorazepam,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Lorazepam.,increase,risk
Lorazepam,Brexanolone,The risk or severity of CNS depression can be increased when Lorazepam is combined with Brexanolone.,increase,risk
Lorazepam,Brexpiprazole,The risk or severity of CNS depression can be increased when Lorazepam is combined with Brexpiprazole.,increase,risk
Lorazepam,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Lorazepam.,increase,no risk
Lorazepam,Brivaracetam,The risk or severity of CNS depression can be increased when Lorazepam is combined with Brivaracetam.,increase,risk
Lorazepam,Bromazepam,The risk or severity of CNS depression can be increased when Lorazepam is combined with Bromazepam.,increase,risk
Lorazepam,Bromocriptine,The risk or severity of CNS depression can be increased when Lorazepam is combined with Bromocriptine.,increase,risk
Lorazepam,Bromotheophylline,The therapeutic efficacy of Lorazepam can be decreased when used in combination with Bromotheophylline.,decrease,no risk
Lorazepam,Bromperidol,The risk or severity of CNS depression can be increased when Lorazepam is combined with Bromperidol.,increase,risk
Lorazepam,Brompheniramine,The risk or severity of CNS depression can be increased when Lorazepam is combined with Brompheniramine.,increase,risk
Lorazepam,Budesonide,Lorazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Lorazepam,Bumadizone,Bumadizone may decrease the excretion rate of Lorazepam which could result in a higher serum level.,decrease,no risk
Lorazepam,Bumetanide,Bumetanide may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorazepam,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Lorazepam is combined with Bupivacaine.,increase,risk
Lorazepam,Buprenorphine,Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Lorazepam,Bupropion,The risk or severity of CNS depression can be increased when Lorazepam is combined with Bupropion.,increase,risk
Lorazepam,Buspirone,The risk or severity of CNS depression can be increased when Lorazepam is combined with Buspirone.,increase,risk
Lorazepam,Butabarbital,The risk or severity of CNS depression can be increased when Lorazepam is combined with Butabarbital.,increase,risk
Lorazepam,Butacaine,The risk or severity of methemoglobinemia can be increased when Lorazepam is combined with Butacaine.,increase,risk
Lorazepam,Butalbital,The risk or severity of CNS depression can be increased when Lorazepam is combined with Butalbital.,increase,risk
Lorazepam,Butamben,The risk or severity of methemoglobinemia can be increased when Lorazepam is combined with Butamben.,increase,risk
Lorazepam,Butaperazine,The risk or severity of CNS depression can be increased when Lorazepam is combined with Butaperazine.,increase,risk
Lorazepam,Butobarbital,The risk or severity of CNS depression can be increased when Lorazepam is combined with Butobarbital.,increase,risk
Lorazepam,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Lorazepam.,increase,risk
Lorazepam,Butriptyline,The risk or severity of CNS depression can be increased when Lorazepam is combined with Butriptyline.,increase,risk
Esmolol,Bimatoprost,Esmolol may increase the hypotensive activities of Bimatoprost.,increase,no risk
Esmolol,Bimekizumab,The metabolism of Esmolol can be increased when combined with Bimekizumab.,increase,no risk
Esmolol,Bioallethrin,Esmolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Esmolol,Biperiden,The metabolism of Esmolol can be decreased when combined with Biperiden.,decrease,no risk
Esmolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Esmolol.,increase,risk
Esmolol,Bortezomib,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Bortezomib.,increase,risk
Esmolol,Bosentan,Esmolol may increase the hypotensive activities of Bosentan.,increase,no risk
Esmolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Esmolol.,increase,risk
Esmolol,Bretylium,Esmolol may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Esmolol,Brexpiprazole,Esmolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Esmolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Esmolol.,increase,no risk
Esmolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Esmolol.,decrease,no risk
Esmolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Esmolol is combined with Bromotheophylline.,increase,risk
Esmolol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Brompheniramine.,increase,risk
Esmolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Esmolol.,increase,risk
Esmolol,Buclizine,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Buclizine.,increase,risk
Esmolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Esmolol.,decrease,no risk
Esmolol,Bumetanide,The risk or severity of adverse effects can be increased when Esmolol is combined with Bumetanide.,increase,risk
Esmolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Esmolol.,increase,no risk
Esmolol,Buprenorphine,The metabolism of Esmolol can be decreased when combined with Buprenorphine.,decrease,no risk
Esmolol,Bupropion,The metabolism of Esmolol can be decreased when combined with Bupropion.,decrease,no risk
Esmolol,Buserelin,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Buserelin.,increase,risk
Esmolol,Buspirone,Buspirone may decrease the antihypertensive activities of Esmolol.,decrease,no risk
Esmolol,Butabarbital,Butabarbital may increase the hypotensive activities of Esmolol.,increase,no risk
Esmolol,Butalbital,Butalbital may increase the hypotensive activities of Esmolol.,increase,no risk
Esmolol,Butaperazine,The serum concentration of Esmolol can be increased when it is combined with Butaperazine.,increase,no risk
Esmolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Esmolol.,decrease,no risk
Esmolol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Gadobenic acid.,increase,risk
Esmolol,Galantamine,Galantamine may increase the bradycardic activities of Esmolol.,increase,no risk
Esmolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Esmolol.,increase,no risk
Esmolol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Gatifloxacin.,increase,risk
Esmolol,Gefitinib,The metabolism of Esmolol can be decreased when combined with Gefitinib.,decrease,no risk
Esmolol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Gemifloxacin.,increase,risk
Esmolol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Esmolol.,increase,risk
Esmolol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Gilteritinib.,increase,risk
Esmolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Esmolol.,increase,no risk
Esmolol,Givosiran,The serum concentration of Esmolol can be increased when it is combined with Givosiran.,increase,no risk
Esmolol,Glasdegib,The risk or severity of QTc prolongation can be increased when Esmolol is combined with Glasdegib.,increase,risk
Esmolol,Gliclazide,Esmolol may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Esmolol,Glimepiride,Esmolol may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Esmolol,Glipizide,Esmolol may increase the hypoglycemic activities of Glipizide.,increase,no risk
Esmolol,Gliquidone,Esmolol may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Esmolol,Glucagon,The therapeutic efficacy of Esmolol can be decreased when used in combination with Glucagon.,decrease,no risk
Esmolol,Glyburide,Esmolol may increase the hypoglycemic activities of Glyburide.,increase,no risk
Esmolol,Glycerol phenylbutyrate,The metabolism of Esmolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Esmolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Esmolol.,decrease,no risk
Bortezomib,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Bortezomib.,increase,risk
Bortezomib,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Bortezomib.,decrease,no risk
Bortezomib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Bortezomib.,increase,risk
Bortezomib,Baricitinib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Baricitinib.,increase,risk
Bortezomib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Bortezomib.,increase,risk
Bortezomib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Bortezomib.,increase,risk
Bortezomib,Beclomethasone dipropionate,The metabolism of Bortezomib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Bortezomib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bedaquiline.,increase,risk
Bortezomib,Belantamab mafodotin,The serum concentration of Bortezomib can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Bortezomib,Belatacept,The risk or severity of adverse effects can be increased when Bortezomib is combined with Belatacept.,increase,risk
Bortezomib,Belimumab,The risk or severity of adverse effects can be increased when Bortezomib is combined with Belimumab.,increase,risk
Bortezomib,Belinostat,The risk or severity of adverse effects can be increased when Bortezomib is combined with Belinostat.,increase,risk
Bortezomib,Belumosudil,The serum concentration of Bortezomib can be increased when it is combined with Belumosudil.,increase,no risk
Bortezomib,Belzutifan,The serum concentration of Bortezomib can be decreased when it is combined with Belzutifan.,decrease,no risk
Bortezomib,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Bortezomib.,increase,risk
Bortezomib,Bendamustine,The risk or severity of adverse effects can be increased when Bortezomib is combined with Bendamustine.,increase,risk
Bortezomib,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Bortezomib.,increase,risk
Bortezomib,Benzatropine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Benzatropine.,increase,risk
Bortezomib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Benzocaine.,increase,risk
Bortezomib,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Bortezomib.,increase,risk
Bortezomib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Benzyl alcohol.,increase,risk
Bortezomib,Bepridil,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bepridil.,increase,risk
Bortezomib,Berotralstat,The serum concentration of Bortezomib can be increased when it is combined with Berotralstat.,increase,no risk
Bortezomib,Betamethasone,The metabolism of Bortezomib can be increased when combined with Betamethasone.,increase,no risk
Bortezomib,Betamethasone phosphate,The metabolism of Bortezomib can be increased when combined with Betamethasone phosphate.,increase,no risk
Bortezomib,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Betrixaban,The serum concentration of Bortezomib can be increased when it is combined with Betrixaban.,increase,no risk
Bortezomib,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Bortezomib.,increase,risk
Bortezomib,Bexarotene,The metabolism of Bortezomib can be increased when combined with Bexarotene.,increase,no risk
Bortezomib,Bicalutamide,The metabolism of Bortezomib can be decreased when combined with Bicalutamide.,decrease,no risk
Bortezomib,Bifonazole,The metabolism of Bortezomib can be decreased when combined with Bifonazole.,decrease,no risk
Bortezomib,Bilastine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bilastine.,increase,risk
Bortezomib,Bimekizumab,The metabolism of Bortezomib can be increased when combined with Bimekizumab.,increase,no risk
Bortezomib,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Biperiden,The metabolism of Bortezomib can be decreased when combined with Biperiden.,decrease,no risk
Bortezomib,Bisoprolol,The serum concentration of Bortezomib can be increased when it is combined with Bisoprolol.,increase,no risk
Bortezomib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bortezomib.,increase,risk
Bortezomib,Bleomycin,The risk or severity of adverse effects can be increased when Bortezomib is combined with Bleomycin.,increase,risk
Bortezomib,Blinatumomab,The risk or severity of adverse effects can be increased when Bortezomib is combined with Blinatumomab.,increase,risk
Bortezomib,Boceprevir,The metabolism of Bortezomib can be decreased when combined with Boceprevir.,decrease,no risk
Bortezomib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Bortezomib.",decrease,no risk
Bortezomib,Bosentan,The metabolism of Bortezomib can be increased when combined with Bosentan.,increase,no risk
Bortezomib,Bosutinib,The metabolism of Bortezomib can be decreased when combined with Bosutinib.,decrease,no risk
Bortezomib,Brentuximab vedotin,The serum concentration of Bortezomib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Bortezomib,Bretylium,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bretylium.,increase,risk
Bortezomib,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Brodalumab,The risk or severity of adverse effects can be increased when Bortezomib is combined with Brodalumab.,increase,risk
Bortezomib,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Brompheniramine.,increase,risk
Bortezomib,Buclizine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Buclizine.,increase,risk
Bortezomib,Budesonide,The metabolism of Bortezomib can be increased when combined with Budesonide.,increase,no risk
Bortezomib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Bupivacaine.,increase,risk
Bortezomib,Buprenorphine,The metabolism of Bortezomib can be decreased when combined with Buprenorphine.,decrease,no risk
Bortezomib,Bupropion,The metabolism of Bortezomib can be decreased when combined with Bupropion.,decrease,no risk
Bortezomib,Buserelin,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Buserelin.,increase,risk
Bortezomib,Buspirone,The metabolism of Buspirone can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Busulfan,The risk or severity of adverse effects can be increased when Bortezomib is combined with Busulfan.,increase,risk
Bortezomib,Butacaine,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Butacaine.,increase,risk
Bortezomib,Butalbital,The metabolism of Bortezomib can be increased when combined with Butalbital.,increase,no risk
Bortezomib,Butamben,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Butamben.,increase,risk
Bortezomib,Butriptyline,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Butriptyline.,increase,risk
Bortezomib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Gadobenic acid.,increase,risk
Bortezomib,Galantamine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Galantamine.,increase,risk
Bortezomib,Gatifloxacin,The metabolism of Bortezomib can be decreased when combined with Gatifloxacin.,decrease,no risk
Bortezomib,Gefitinib,The metabolism of Bortezomib can be decreased when combined with Gefitinib.,decrease,no risk
Bortezomib,Gemcitabine,The risk or severity of adverse effects can be increased when Bortezomib is combined with Gemcitabine.,increase,risk
Bortezomib,Gemfibrozil,The metabolism of Bortezomib can be decreased when combined with Gemfibrozil.,decrease,no risk
Bortezomib,Gemifloxacin,The metabolism of Bortezomib can be decreased when combined with Gemifloxacin.,decrease,no risk
Bortezomib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bortezomib.,increase,risk
Bortezomib,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Bortezomib.,increase,risk
Bortezomib,Gilteritinib,The metabolism of Bortezomib can be decreased when combined with Gilteritinib.,decrease,no risk
Bortezomib,Ginkgo biloba,The metabolism of Bortezomib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Bortezomib,Givosiran,The serum concentration of Bortezomib can be increased when it is combined with Givosiran.,increase,no risk
Bortezomib,Glasdegib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Glasdegib.,increase,risk
Bortezomib,Glatiramer,The risk or severity of adverse effects can be increased when Bortezomib is combined with Glatiramer.,increase,risk
Bortezomib,Glecaprevir,The serum concentration of Bortezomib can be increased when it is combined with Glecaprevir.,increase,no risk
Bortezomib,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Glipizide,The metabolism of Glipizide can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Glofitamab,The serum concentration of Bortezomib can be increased when it is combined with Glofitamab.,increase,no risk
Bortezomib,Glyburide,The metabolism of Bortezomib can be decreased when combined with Glyburide.,decrease,no risk
Bortezomib,Glycerol phenylbutyrate,The metabolism of Bortezomib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Bortezomib,Golimumab,The metabolism of Bortezomib can be increased when combined with Golimumab.,increase,no risk
Bortezomib,Goserelin,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Goserelin.,increase,risk
Bortezomib,Granisetron,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Granisetron.,increase,risk
Bortezomib,Grapefruit,The serum concentration of Bortezomib can be increased when it is combined with Grapefruit.,increase,no risk
Bortezomib,Grazoprevir,The serum concentration of Bortezomib can be increased when it is combined with Grazoprevir.,increase,no risk
Bortezomib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Grepafloxacin.,increase,risk
Bortezomib,Griseofulvin,The metabolism of Bortezomib can be increased when combined with Griseofulvin.,increase,no risk
Bortezomib,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Guselkumab,The risk or severity of adverse effects can be increased when Bortezomib is combined with Guselkumab.,increase,risk
Bortezomib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Bortezomib.,decrease,no risk
Bortezomib,Halofantrine,The metabolism of Bortezomib can be decreased when combined with Halofantrine.,decrease,no risk
Bortezomib,Haloperidol,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Haloperidol.,increase,risk
Bortezomib,Halothane,The metabolism of Halothane can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Bortezomib.,increase,risk
Bortezomib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Bortezomib.,decrease,no risk
Bortezomib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bortezomib.,decrease,no risk
Bortezomib,Histrelin,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Histrelin.,increase,risk
Bortezomib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Bortezomib.,increase,risk
Bortezomib,Hydralazine,The serum concentration of Bortezomib can be increased when it is combined with Hydralazine.,increase,no risk
Bortezomib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hydrochlorothiazide.,increase,risk
Bortezomib,Hydrocortamate,The metabolism of Bortezomib can be increased when combined with Hydrocortamate.,increase,no risk
Bortezomib,Hydrocortisone,The metabolism of Bortezomib can be increased when combined with Hydrocortisone.,increase,no risk
Bortezomib,Hydrocortisone acetate,The metabolism of Bortezomib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Bortezomib,Hydrocortisone butyrate,The metabolism of Bortezomib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Bortezomib,Hydrocortisone succinate,The metabolism of Bortezomib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Bortezomib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Bortezomib.,increase,risk
Bortezomib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydroxychloroquine.,increase,risk
Bortezomib,Hydroxyurea,The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydroxyurea.,increase,risk
Bortezomib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hydroxyzine.,increase,risk
Bortezomib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hyoscyamine.,increase,risk
Bortezomib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bortezomib.,decrease,no risk
Bortezomib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Bortezomib.,decrease,no risk
Bortezomib,Ketamine,The metabolism of Ketamine can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Ketazolam,The serum concentration of Bortezomib can be increased when it is combined with Ketazolam.,increase,no risk
Bortezomib,Ketoconazole,The metabolism of Bortezomib can be decreased when combined with Ketoconazole.,decrease,no risk
Bortezomib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Obeticholic acid,The metabolism of Bortezomib can be decreased when combined with Obeticholic acid.,decrease,no risk
Bortezomib,Obinutuzumab,The risk or severity of adverse effects can be increased when Bortezomib is combined with Obinutuzumab.,increase,risk
Bortezomib,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Bortezomib.,increase,no risk
Bortezomib,Octreotide,The serum concentration of Bortezomib can be increased when it is combined with Octreotide.,increase,no risk
Bortezomib,Ofatumumab,The risk or severity of adverse effects can be increased when Bortezomib is combined with Ofatumumab.,increase,risk
Bortezomib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ofloxacin.,increase,risk
Bortezomib,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Olaparib,The metabolism of Bortezomib can be decreased when combined with Olaparib.,decrease,no risk
Bortezomib,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Olodaterol,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Olodaterol.,increase,risk
Bortezomib,Olutasidenib,The metabolism of Bortezomib can be increased when combined with Olutasidenib.,increase,no risk
Bortezomib,Omadacycline,The serum concentration of Bortezomib can be increased when it is combined with Omadacycline.,increase,no risk
Bortezomib,Omaveloxolone,The serum concentration of Bortezomib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Bortezomib,Ombitasvir,The serum concentration of Bortezomib can be increased when it is combined with Ombitasvir.,increase,no risk
Bortezomib,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Opium,The metabolism of Opium can be decreased when combined with Bortezomib.,decrease,no risk
Bortezomib,Oritavancin,The metabolism of Bortezomib can be increased when combined with Oritavancin.,increase,no risk
Ethchlorvynol,Gabapentin,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Gabapentin.,increase,risk
Ethchlorvynol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Gabapentin enacarbil.,increase,risk
Ethchlorvynol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Gallamine triethiodide.,increase,risk
Ethchlorvynol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ethchlorvynol is combined with Ganaxolone.",increase,risk
Ethchlorvynol,Gepirone,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Gepirone.,increase,risk
Ethchlorvynol,Glutethimide,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Glutethimide.,increase,risk
Ethchlorvynol,Granisetron,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Granisetron.,increase,risk
Ethchlorvynol,Guanfacine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Guanfacine.,increase,risk
Ethchlorvynol,Halazepam,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Halazepam.,increase,risk
Ethchlorvynol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ethchlorvynol.,increase,risk
Ethchlorvynol,Halothane,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Halothane.,increase,risk
Ethchlorvynol,Hexafluronium,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Hexafluronium.,increase,risk
Ethchlorvynol,Hydrocodone,Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ethchlorvynol,Hydromorphone,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Hydromorphone.,increase,risk
Ethchlorvynol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ethchlorvynol.,increase,no risk
Ethchlorvynol,Ketamine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Ketamine.,increase,risk
Ethchlorvynol,Ketazolam,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Ketazolam.,increase,risk
Ethchlorvynol,Olanzapine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Olanzapine.,increase,risk
Ethchlorvynol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ethchlorvynol is combined with Oliceridine.",increase,risk
Ethchlorvynol,Ondansetron,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Ondansetron.,increase,risk
Ethchlorvynol,Opium,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Opium.,increase,risk
Ethchlorvynol,Orphenadrine,Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ethchlorvynol,Oxazepam,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxazepam.,increase,risk
Ethchlorvynol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxcarbazepine.,increase,risk
Ethchlorvynol,Oxitriptan,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxitriptan.,increase,risk
Ethchlorvynol,Oxprenolol,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxprenolol.,increase,risk
Ethchlorvynol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxybuprocaine.,increase,risk
Ethchlorvynol,Oxycodone,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxycodone.,increase,risk
Ethchlorvynol,Oxymorphone,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Oxymorphone.,increase,risk
Ethchlorvynol,Quazepam,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Quazepam.,increase,risk
Ethchlorvynol,Quetiapine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Quetiapine.,increase,risk
Ethchlorvynol,Quinine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Quinine.,increase,risk
Ethchlorvynol,Quinupramine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Quinupramine.,increase,risk
Ethchlorvynol,Urethane,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Urethane.,increase,risk
Ethchlorvynol,Valproic acid,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Valproic acid.,increase,risk
Ethchlorvynol,Vecuronium,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Vecuronium.,increase,risk
Ethchlorvynol,Venlafaxine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Venlafaxine.,increase,risk
Ethchlorvynol,Vigabatrin,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Vigabatrin.,increase,risk
Ethchlorvynol,Vilazodone,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Vilazodone.,increase,risk
Ethchlorvynol,Viloxazine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Viloxazine.,increase,risk
Ethchlorvynol,Vortioxetine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Vortioxetine.,increase,risk
Ethchlorvynol,Yohimbine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Yohimbine.,increase,risk
Ethchlorvynol,Zaleplon,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Zaleplon.,increase,risk
Ethchlorvynol,Ziconotide,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Ziconotide.,increase,risk
Ethchlorvynol,Zimelidine,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Zimelidine.,increase,risk
Ethchlorvynol,Ziprasidone,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Ziprasidone.,increase,risk
Ethchlorvynol,Zolmitriptan,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Zolmitriptan.,increase,risk
Ethchlorvynol,Zolpidem,Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ethchlorvynol,Zonisamide,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Zonisamide.,increase,risk
Ethchlorvynol,Zopiclone,The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Zopiclone.,increase,risk
Ethchlorvynol,Zotepine,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Zotepine.,increase,risk
Ethchlorvynol,Zuclopenthixol,The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Zuclopenthixol.,increase,risk
Ethchlorvynol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ethchlorvynol.,increase,risk
Carbidopa,Gabapentin enacarbil,Carbidopa may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Carbidopa,Gadobenic acid,Carbidopa may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Carbidopa,Gadodiamide,Carbidopa may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Carbidopa,Gadofosveset trisodium,Carbidopa may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Carbidopa,Gadopentetic acid,Carbidopa may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Carbidopa,Gadoteric acid,Carbidopa may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Carbidopa,Gadoteridol,Carbidopa may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Carbidopa,Ganciclovir,Carbidopa may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Carbidopa,Gemcitabine,Carbidopa may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Carbidopa,Gemfibrozil,Carbidopa may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Carbidopa,Gentamicin,Carbidopa may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Carbidopa,Gimeracil,Carbidopa may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Carbidopa,Givosiran,Givosiran may decrease the excretion rate of Carbidopa which could result in a higher serum level.,decrease,no risk
Carbidopa,Glipizide,Carbidopa may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Carbidopa,Glycerol phenylbutyrate,Carbidopa may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Carbidopa,Golodirsen,Carbidopa may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Carbidopa,Goserelin,Goserelin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,decrease,no risk
Carbidopa,Guanabenz,The risk or severity of hypotension can be increased when Carbidopa is combined with Guanabenz.,increase,risk
Carbidopa,Guanadrel,The risk or severity of hypotension can be increased when Carbidopa is combined with Guanadrel.,increase,risk
Carbidopa,Guanethidine,The risk or severity of hypotension can be increased when Carbidopa is combined with Guanethidine.,increase,risk
Carbidopa,Guanfacine,The risk or severity of hypotension can be increased when Carbidopa is combined with Guanfacine.,increase,risk
Carbidopa,Guanoxan,The risk or severity of hypotension can be increased when Carbidopa is combined with Guanoxan.,increase,risk
Carbidopa,Haloperidol,The therapeutic efficacy of Carbidopa can be decreased when used in combination with Haloperidol.,decrease,no risk
Carbidopa,Hydralazine,The risk or severity of hypotension can be increased when Carbidopa is combined with Hydralazine.,increase,risk
Carbidopa,Hydrochlorothiazide,The risk or severity of hypotension can be increased when Carbidopa is combined with Hydrochlorothiazide.,increase,risk
Carbidopa,Hydroflumethiazide,The risk or severity of hypotension can be increased when Carbidopa is combined with Hydroflumethiazide.,increase,risk
Carbidopa,Hydromorphone,Carbidopa may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Carbidopa,Hydroxocobalamin,Carbidopa may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Carbidopa,Hydroxyethyl Starch,Carbidopa may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Carbidopa,Kanamycin,Carbidopa may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Carbidopa,Ketamine,Carbidopa may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Carbidopa,Ketazolam,Carbidopa may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Carbidopa,Ketoprofen,Ketoprofen may decrease the excretion rate of Carbidopa which could result in a higher serum level.,decrease,no risk
Carbidopa,Ketorolac,Ketorolac may decrease the excretion rate of Carbidopa which could result in a higher serum level.,decrease,no risk
Phentermine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Phentermine is combined with Gallamine triethiodide.,increase,risk
Phentermine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Phentermine.,increase,risk
Phentermine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Glofitamab,The serum concentration of Phentermine can be increased when it is combined with Glofitamab.,increase,no risk
Phentermine,Glutamic acid,The serum concentration of Phentermine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Phentermine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Phentermine is combined with Glycopyrronium.,increase,risk
Phentermine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Granisetron,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Granisetron.,increase,risk
Phentermine,Guanabenz,Phentermine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Phentermine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Phentermine.,decrease,no risk
Phentermine,Guanethidine,The serum concentration of Phentermine can be decreased when it is combined with Guanethidine.,decrease,no risk
Phentermine,Guanfacine,Phentermine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Phentermine,Guanoxan,Phentermine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Phentermine,Haloperidol,The therapeutic efficacy of Phentermine can be decreased when used in combination with Haloperidol.,decrease,no risk
Phentermine,Halothane,The risk or severity of hypertension can be increased when Phentermine is combined with Halothane.,increase,risk
Phentermine,Hexocyclium,The risk or severity of Tachycardia can be increased when Phentermine is combined with Hexocyclium.,increase,risk
Phentermine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Phentermine is combined with Homatropine methylbromide.,increase,risk
Phentermine,Hydralazine,Phentermine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Phentermine,Hydrochlorothiazide,Phentermine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Phentermine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Phentermine.,increase,risk
Phentermine,Hydroflumethiazide,Phentermine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Phentermine,Hydromorphone,Phentermine may increase the analgesic activities of Hydromorphone.,increase,no risk
Phentermine,Hydrotalcite,The serum concentration of Phentermine can be increased when it is combined with Hydrotalcite.,increase,no risk
Phentermine,Hydroxyzine,Phentermine may decrease the sedative activities of Hydroxyzine.,decrease,no risk
Phentermine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Phentermine is combined with Hyoscyamine.,increase,risk
Phentermine,Ketamine,The risk or severity of Tachycardia can be increased when Phentermine is combined with Ketamine.,increase,risk
Phentermine,Ketoconazole,The metabolism of Phentermine can be decreased when combined with Ketoconazole.,decrease,no risk
Phentermine,Ketoprofen,The risk or severity of hypertension can be increased when Phentermine is combined with Ketoprofen.,increase,risk
Phentermine,Ketorolac,The risk or severity of hypertension can be increased when Phentermine is combined with Ketorolac.,increase,risk
Phentermine,Ketotifen,Phentermine may decrease the sedative activities of Ketotifen.,decrease,no risk
Phentermine,Olanzapine,Phentermine may decrease the sedative activities of Olanzapine.,decrease,no risk
Phentermine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Oliceridine.,increase,risk
Phentermine,Olmesartan,Phentermine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Phentermine,Olodaterol,The risk or severity of hypertension can be increased when Phentermine is combined with Olodaterol.,increase,risk
Phentermine,Omaveloxolone,The serum concentration of Phentermine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Phentermine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Ondansetron.,increase,risk
Phentermine,Opium,Phentermine may increase the analgesic activities of Opium.,increase,no risk
Phentermine,Orciprenaline,The risk or severity of hypertension can be increased when Phentermine is combined with Orciprenaline.,increase,risk
Phentermine,Orphenadrine,Phentermine may decrease the sedative activities of Orphenadrine.,decrease,no risk
Phentermine,Oxaprozin,The risk or severity of hypertension can be increased when Phentermine is combined with Oxaprozin.,increase,risk
Phentermine,Oxatomide,Phentermine may decrease the sedative activities of Oxatomide.,decrease,no risk
Phentermine,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Phentermine.,decrease,no risk
Phentermine,Oxtriphylline,The risk or severity of adverse effects can be increased when Phentermine is combined with Oxtriphylline.,increase,risk
Phentermine,Oxybutynin,The risk or severity of Tachycardia can be increased when Phentermine is combined with Oxybutynin.,increase,risk
Phentermine,Oxycodone,Phentermine may increase the analgesic activities of Oxycodone.,increase,no risk
Phentermine,Oxymetazoline,The risk or severity of hypertension can be increased when Phentermine is combined with Oxymetazoline.,increase,risk
Phentermine,Oxymorphone,Phentermine may increase the analgesic activities of Oxymorphone.,increase,no risk
Phentermine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Phentermine is combined with Oxyphenbutazone.,increase,risk
Phentermine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Phentermine is combined with Oxyphencyclimine.,increase,risk
Phentermine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Phentermine is combined with Oxyphenonium.,increase,risk
Phentermine,Quetiapine,Phentermine may decrease the sedative activities of Quetiapine.,decrease,no risk
Phentermine,Quinapril,Phentermine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Phentermine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Phentermine.,decrease,no risk
Phentermine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Umeclidinium,The risk or severity of Tachycardia can be increased when Phentermine is combined with Umeclidinium.,increase,risk
Phentermine,Vadadustat,The serum concentration of Phentermine can be increased when it is combined with Vadadustat.,increase,no risk
Phentermine,Valdecoxib,The risk or severity of hypertension can be increased when Phentermine is combined with Valdecoxib.,increase,risk
Phentermine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Valproate bismuth.,increase,risk
Phentermine,Valproic acid,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Valproic acid.,increase,risk
Phentermine,Valsartan,Phentermine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Phentermine,Venetoclax,The metabolism of Phentermine can be decreased when combined with Venetoclax.,decrease,no risk
Phentermine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Venlafaxine.,increase,risk
Phentermine,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Phentermine.,decrease,no risk
Phentermine,Vilanterol,The risk or severity of hypertension can be increased when Phentermine is combined with Vilanterol.,increase,risk
Phentermine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Vilazodone.,increase,risk
Phentermine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Phentermine.,increase,no risk
Phentermine,Viloxazine,The metabolism of Phentermine can be decreased when combined with Viloxazine.,decrease,no risk
Phentermine,Voriconazole,The metabolism of Phentermine can be decreased when combined with Voriconazole.,decrease,no risk
Phentermine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Vortioxetine.,increase,risk
Phentermine,Xamoterol,The risk or severity of hypertension can be increased when Phentermine is combined with Xamoterol.,increase,risk
Phentermine,Xylometazoline,The risk or severity of hypertension can be increased when Phentermine is combined with Xylometazoline.,increase,risk
Phentermine,Yohimbine,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Phentermine.,decrease,no risk
Phentermine,Zimelidine,The metabolism of Phentermine can be decreased when combined with Zimelidine.,decrease,no risk
Phentermine,Zinc ascorbate,The serum concentration of Phentermine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Phentermine,Ziprasidone,Phentermine may decrease the sedative activities of Ziprasidone.,decrease,no risk
Phentermine,Zofenopril,Phentermine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Phentermine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Phentermine.,decrease,no risk
Phentermine,Zonisamide,Zonisamide may decrease the excretion rate of Phentermine which could result in a higher serum level.,decrease,no risk
Phentermine,Zotepine,Zotepine may decrease the stimulatory activities of Phentermine.,decrease,no risk
Phentermine,Zuclopenthixol,Phentermine may decrease the sedative activities of Zuclopenthixol.,decrease,no risk
Tramadol,Bacitracin,Bacitracin may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Baclofen,The risk or severity of CNS depression can be increased when Baclofen is combined with Tramadol.,increase,risk
Tramadol,Balsalazide,Balsalazide may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Baricitinib,Tramadol may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Tramadol,Beclomethasone dipropionate,The metabolism of Tramadol can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Tramadol,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Tramadol.,increase,risk
Tramadol,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Benorilate,Benorilate may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Benperidol,The risk or severity of CNS depression can be increased when Benperidol is combined with Tramadol.,increase,risk
Tramadol,Benserazide,Tramadol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Tramadol,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Tramadol.,increase,risk
Tramadol,Benzhydrocodone,The risk or severity of adverse effects can be increased when Tramadol is combined with Benzhydrocodone.,increase,risk
Tramadol,Benznidazole,Tramadol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Tramadol,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Tramadol.,increase,risk
Tramadol,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Tramadol.,increase,risk
Tramadol,Benzthiazide,Benzthiazide may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Benzydamine,Benzydamine may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Benzyl alcohol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Tramadol.,increase,risk
Tramadol,Bepotastine,Tramadol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Tramadol,Bepridil,The metabolism of Tramadol can be decreased when combined with Bepridil.,decrease,no risk
Tramadol,Berotralstat,The metabolism of Tramadol can be decreased when combined with Berotralstat.,decrease,no risk
Tramadol,Betaine,The therapeutic efficacy of Tramadol can be decreased when used in combination with Betaine.,decrease,no risk
Tramadol,Betamethasone,The metabolism of Tramadol can be increased when combined with Betamethasone.,increase,no risk
Tramadol,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Tramadol.,decrease,no risk
Tramadol,Bethanidine,The risk or severity of Tachycardia can be increased when Tramadol is combined with Bethanidine.,increase,risk
Tramadol,Bexarotene,The metabolism of Tramadol can be increased when combined with Bexarotene.,increase,no risk
Tramadol,Bicalutamide,The metabolism of Tramadol can be decreased when combined with Bicalutamide.,decrease,no risk
Tramadol,Bicisate,Tramadol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tramadol,Bifonazole,The metabolism of Tramadol can be decreased when combined with Bifonazole.,decrease,no risk
Tramadol,Bimekizumab,The metabolism of Tramadol can be increased when combined with Bimekizumab.,increase,no risk
Tramadol,Biperiden,The metabolism of Tramadol can be decreased when combined with Biperiden.,decrease,no risk
Tramadol,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Tramadol.,decrease,no risk
Tramadol,Bismuth subgallate,Tramadol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tramadol,Bisoprolol,Tramadol may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Tramadol,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Tramadol.,decrease,no risk
Tramadol,Bleomycin,Tramadol may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Tramadol,Boceprevir,The metabolism of Tramadol can be decreased when combined with Boceprevir.,decrease,no risk
Tramadol,Bortezomib,The metabolism of Tramadol can be decreased when combined with Bortezomib.,decrease,no risk
Tramadol,Bosentan,The metabolism of Tramadol can be increased when combined with Bosentan.,increase,no risk
Tramadol,Bosutinib,The metabolism of Tramadol can be decreased when combined with Bosutinib.,decrease,no risk
Tramadol,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Tramadol is combined with Botulinum toxin type A.,increase,risk
Tramadol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Tramadol.,increase,risk
Tramadol,Brentuximab vedotin,The metabolism of Tramadol can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Tramadol,Brexanolone,The risk or severity of CNS depression can be increased when Brexanolone is combined with Tramadol.,increase,risk
Tramadol,Brexpiprazole,The risk or severity of serotonin syndrome can be increased when Brexpiprazole is combined with Tramadol.,increase,risk
Tramadol,Brigatinib,The metabolism of Tramadol can be increased when combined with Brigatinib.,increase,no risk
Tramadol,Brimonidine,The risk or severity of CNS depression can be increased when Brimonidine is combined with Tramadol.,increase,risk
Tramadol,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Tramadol.,increase,risk
Tramadol,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Tramadol.,increase,risk
Tramadol,Bromocriptine,The metabolism of Tramadol can be decreased when combined with Bromocriptine.,decrease,no risk
Tramadol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Bromperidol,The risk or severity of CNS depression can be increased when Bromperidol is combined with Tramadol.,increase,risk
Tramadol,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Tramadol.,increase,risk
Tramadol,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Tramadol.,increase,risk
Tramadol,Budesonide,The metabolism of Tramadol can be increased when combined with Budesonide.,increase,no risk
Tramadol,Bumadizone,Bumadizone may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Bumetanide,Bumetanide may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Tramadol.,increase,risk
Tramadol,Buprenorphine,The risk or severity of serotonin syndrome can be increased when Buprenorphine is combined with Tramadol.,increase,risk
Tramadol,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Tramadol.,increase,risk
Tramadol,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Tramadol.,increase,risk
Tramadol,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Tramadol.,increase,risk
Tramadol,Butalbital,The metabolism of Tramadol can be increased when combined with Butalbital.,increase,no risk
Tramadol,Butamben,The risk or severity of CNS depression can be increased when Butamben is combined with Tramadol.,increase,risk
Tramadol,Butaperazine,The risk or severity of CNS depression can be increased when Butaperazine is combined with Tramadol.,increase,risk
Tramadol,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Tramadol.,increase,risk
Tramadol,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Tramadol.,increase,risk
Tramadol,Butriptyline,The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Tramadol.,increase,risk
Tramadol,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Tramadol.,increase,risk
Tramadol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Tramadol.,increase,risk
Tramadol,Gadobenic acid,Tramadol may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Tramadol,Gadodiamide,Tramadol may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Tramadol,Gadofosveset trisodium,Tramadol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tramadol,Gadopentetic acid,Tramadol may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Tramadol,Gadoteric acid,Tramadol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tramadol,Gadoteridol,Tramadol may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Tramadol,Galantamine,The therapeutic efficacy of Tramadol can be decreased when used in combination with Galantamine.,decrease,no risk
Tramadol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tramadol.,increase,risk
Tramadol,Ganaxolone,The risk or severity of CNS depression can be increased when Ganaxolone is combined with Tramadol.,increase,risk
Tramadol,Ganciclovir,Tramadol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tramadol,Gefitinib,The metabolism of Tramadol can be decreased when combined with Gefitinib.,decrease,no risk
Tramadol,Gemcitabine,Tramadol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Tramadol,Gemfibrozil,The metabolism of Tramadol can be decreased when combined with Gemfibrozil.,decrease,no risk
Tramadol,Gentamicin,Tramadol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tramadol,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Tramadol.,increase,risk
Tramadol,Gilteritinib,The therapeutic efficacy of Tramadol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Tramadol,Gimeracil,Tramadol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tramadol,Ginkgo biloba,The therapeutic efficacy of Tramadol can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Tramadol,Givosiran,The serum concentration of Tramadol can be increased when it is combined with Givosiran.,increase,no risk
Tramadol,Glecaprevir,The metabolism of Tramadol can be decreased when combined with Glecaprevir.,decrease,no risk
Tramadol,Glipizide,Tramadol may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tramadol,Glofitamab,The serum concentration of Tramadol can be increased when it is combined with Glofitamab.,increase,no risk
Tramadol,Glucagon,Tramadol may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Tramadol,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Tramadol.,decrease,no risk
Tramadol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tramadol.,increase,risk
Tramadol,Glyburide,The metabolism of Tramadol can be decreased when combined with Glyburide.,decrease,no risk
Tramadol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Tramadol.,decrease,no risk
Tramadol,Glycerol phenylbutyrate,The metabolism of Tramadol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Tramadol,Glycopyrronium,The risk or severity of adverse effects can be increased when Tramadol is combined with Glycopyrronium.,increase,risk
Tramadol,Golimumab,The metabolism of Tramadol can be increased when combined with Golimumab.,increase,no risk
Tramadol,Golodirsen,Tramadol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tramadol,Goserelin,Goserelin may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Tramadol.,increase,risk
Tramadol,Griseofulvin,The metabolism of Tramadol can be increased when combined with Griseofulvin.,increase,no risk
Tramadol,Guanabenz,The risk or severity of Tachycardia can be increased when Tramadol is combined with Guanabenz.,increase,risk
Tramadol,Guanethidine,Tramadol may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tramadol,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tramadol.,increase,risk
Tramadol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tramadol.,increase,risk
Tramadol,Halofantrine,The metabolism of Tramadol can be decreased when combined with Halofantrine.,decrease,no risk
Tramadol,Haloperidol,The metabolism of Tramadol can be decreased when combined with Haloperidol.,decrease,no risk
Tramadol,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tramadol.,increase,risk
Tramadol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tramadol.,increase,risk
Tramadol,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Tramadol.,increase,risk
Tramadol,Homatropine,The risk or severity of adverse effects can be increased when Tramadol is combined with Homatropine.,increase,risk
Tramadol,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Tramadol.,increase,risk
Tramadol,Huperzine A,The therapeutic efficacy of Tramadol can be decreased when used in combination with Huperzine A.,decrease,no risk
Tramadol,Hydralazine,The metabolism of Tramadol can be decreased when combined with Hydralazine.,decrease,no risk
Tramadol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Tramadol.,increase,risk
Tramadol,Hydrocortamate,The metabolism of Tramadol can be increased when combined with Hydrocortamate.,increase,no risk
Tramadol,Hydrocortisone,The metabolism of Tramadol can be increased when combined with Hydrocortisone.,increase,no risk
Tramadol,Hydrocortisone acetate,The metabolism of Tramadol can be increased when combined with Hydrocortisone acetate.,increase,no risk
Tramadol,Hydrocortisone butyrate,The metabolism of Tramadol can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Tramadol,Hydrocortisone succinate,The metabolism of Tramadol can be increased when combined with Hydrocortisone succinate.,increase,no risk
Tramadol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Tramadol.,increase,risk
Tramadol,Hydroxocobalamin,Tramadol may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Tramadol,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Tramadol.,increase,risk
Tramadol,Hydroxychloroquine,The metabolism of Tramadol can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Tramadol,Hydroxyethyl Starch,Tramadol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tramadol,Hydroxyurea,The metabolism of Tramadol can be decreased when combined with Hydroxyurea.,decrease,no risk
Tramadol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tramadol.,increase,no risk
Tramadol,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Tramadol.,increase,risk
Tramadol,Kanamycin,Tramadol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tramadol,Ketamine,The metabolism of Tramadol can be increased when combined with Ketamine.,increase,no risk
Tramadol,Ketazolam,The metabolism of Tramadol can be decreased when combined with Ketazolam.,decrease,no risk
Tramadol,Ketoconazole,The metabolism of Tramadol can be decreased when combined with Ketoconazole.,decrease,no risk
Tramadol,Ketoprofen,Ketoprofen may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Octinoxate,Tramadol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tramadol,Octreotide,The metabolism of Tramadol can be decreased when combined with Octreotide.,decrease,no risk
Tramadol,Olanzapine,The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Tramadol.,increase,risk
Tramadol,Olaparib,The metabolism of Tramadol can be decreased when combined with Olaparib.,decrease,no risk
Tramadol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tramadol is combined with Oliceridine.",increase,risk
Tramadol,Olodaterol,The risk or severity of Tachycardia can be increased when Tramadol is combined with Olodaterol.,increase,risk
Tramadol,Olsalazine,Olsalazine may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Olutasidenib,The metabolism of Tramadol can be increased when combined with Olutasidenib.,increase,no risk
Tramadol,Omaveloxolone,The metabolism of Tramadol can be increased when combined with Omaveloxolone.,increase,no risk
Tramadol,Ombitasvir,The metabolism of Tramadol can be decreased when combined with Ombitasvir.,decrease,no risk
Tramadol,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Tramadol.,increase,risk
Tramadol,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Tramadol.,increase,risk
Tramadol,Orciprenaline,The risk or severity of Tachycardia can be increased when Tramadol is combined with Orciprenaline.,increase,risk
Tramadol,Oritavancin,The metabolism of Tramadol can be decreased when combined with Oritavancin.,decrease,no risk
Tramadol,Orphenadrine,The metabolism of Tramadol can be decreased when combined with Orphenadrine.,decrease,no risk
Tramadol,Oseltamivir,Tramadol may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Tramadol,Osilodrostat,The metabolism of Tramadol can be decreased when combined with Osilodrostat.,decrease,no risk
Tramadol,Ospemifene,The metabolism of Tramadol can be decreased when combined with Ospemifene.,decrease,no risk
Tramadol,Oxacillin,Tramadol may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Tramadol,Oxamniquine,The metabolism of Tramadol can be decreased when combined with Oxamniquine.,decrease,no risk
Tramadol,Oxaprozin,Oxaprozin may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tramadol.,increase,risk
Tramadol,Oxcarbazepine,The metabolism of Tramadol can be increased when combined with Oxcarbazepine.,increase,no risk
Tramadol,Oxetacaine,The metabolism of Tramadol can be decreased when combined with Oxetacaine.,decrease,no risk
Tramadol,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tramadol.,increase,risk
Tramadol,Oxprenolol,The metabolism of Tramadol can be decreased when combined with Oxprenolol.,decrease,no risk
Tramadol,Oxybenzone,Tramadol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tramadol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Tramadol.,increase,risk
Tramadol,Oxybutynin,The metabolism of Tramadol can be decreased when combined with Oxybutynin.,decrease,no risk
Tramadol,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Tramadol.,increase,risk
Tramadol,Oxymetazoline,The risk or severity of Tachycardia can be increased when Tramadol is combined with Oxymetazoline.,increase,risk
Tramadol,Oxymetholone,The metabolism of Tramadol can be decreased when combined with Oxymetholone.,decrease,no risk
Tramadol,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Tramadol.,increase,risk
Tramadol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Tramadol.,increase,risk
Tramadol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Tramadol.,decrease,no risk
Tramadol,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Tramadol.,increase,risk
Tramadol,Oxyquinoline,Tramadol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tramadol,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tramadol.,increase,risk
Tramadol,Quetiapine,The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Tramadol.,increase,risk
Tramadol,Quinethazone,Quinethazone may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramadol,Quinidine,The metabolism of Tramadol can be decreased when combined with Quinidine.,decrease,no risk
Tramadol,Quinine,The metabolism of Tramadol can be decreased when combined with Quinine.,decrease,no risk
Tramadol,Quinupramine,The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Tramadol.,increase,risk
Tramadol,Quinupristin,The metabolism of Tramadol can be decreased when combined with Quinupristin.,decrease,no risk
Tramadol,Quizartinib,The metabolism of Tramadol can be decreased when combined with Quizartinib.,decrease,no risk
Tramadol,Umeclidinium,The risk or severity of adverse effects can be increased when Tramadol is combined with Umeclidinium.,increase,risk
Tramadol,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Tramadol.,increase,risk
Tramadol,Vaborbactam,Tramadol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tramadol,Vadadustat,The serum concentration of Tramadol can be decreased when it is combined with Vadadustat.,decrease,no risk
Tramadol,Valaciclovir,Valaciclovir may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Valbenazine,Tramadol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tramadol,Valdecoxib,Valdecoxib may decrease the excretion rate of Tramadol which could result in a higher serum level.,decrease,no risk
Tramadol,Valganciclovir,Tramadol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tramadol,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Tramadol.,increase,risk
Tramadol,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Tramadol.,increase,risk
Tramadol,Vancomycin,Tramadol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tramadol,Varenicline,Tramadol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tramadol,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tramadol.,increase,risk
Tramadol,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Tramadol.,decrease,no risk
Tramadol,Vemurafenib,The metabolism of Tramadol can be decreased when combined with Vemurafenib.,decrease,no risk
Tramadol,Venetoclax,The metabolism of Tramadol can be decreased when combined with Venetoclax.,decrease,no risk
Tramadol,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Tramadol.,increase,risk
Tramadol,Verapamil,The metabolism of Tramadol can be decreased when combined with Verapamil.,decrease,no risk
Tramadol,Vernakalant,The metabolism of Tramadol can be decreased when combined with Vernakalant.,decrease,no risk
Tramadol,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Tramadol.,increase,risk
Tramadol,Vilanterol,Tramadol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Tramadol,Vilazodone,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Tramadol.,increase,risk
Tramadol,Viloxazine,The metabolism of Tramadol can be decreased when combined with Viloxazine.,decrease,no risk
Tramadol,Vinblastine,The metabolism of Tramadol can be decreased when combined with Vinblastine.,decrease,no risk
Tramadol,Vinorelbine,The metabolism of Tramadol can be decreased when combined with Vinorelbine.,decrease,no risk
Tramadol,Vitamin E,The metabolism of Tramadol can be increased when combined with Vitamin E.,increase,no risk
Tramadol,Voriconazole,The metabolism of Tramadol can be decreased when combined with Voriconazole.,decrease,no risk
Tramadol,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Tramadol.,increase,risk
Tramadol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Tramadol.,decrease,no risk
Tramadol,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Tramadol.,increase,no risk
Tramadol,Xamoterol,The risk or severity of Tachycardia can be increased when Tramadol is combined with Xamoterol.,increase,risk
Tramadol,Xylometazoline,The risk or severity of Tachycardia can be increased when Tramadol is combined with Xylometazoline.,increase,risk
Tramadol,Yohimbine,The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Tramadol.,increase,risk
Tramadol,Zafirlukast,The metabolism of Tramadol can be decreased when combined with Zafirlukast.,decrease,no risk
Tramadol,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Tramadol.,increase,risk
Tramadol,Zanamivir,Tramadol may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Tramadol,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Tramadol.,decrease,no risk
Tramadol,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Tramadol.,increase,risk
Tramadol,Zidovudine,The metabolism of Tramadol can be increased when combined with Zidovudine.,increase,no risk
Tramadol,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Tramadol.,increase,risk
Tramadol,Ziprasidone,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Tramadol.,increase,risk
Tramadol,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Tramadol.,increase,risk
Tramadol,Zolpidem,Tramadol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tramadol,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Tramadol.,increase,risk
Tramadol,Zopiclone,The risk or severity of CNS depression can be increased when Zopiclone is combined with Tramadol.,increase,risk
Tramadol,Zotepine,The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Tramadol.,increase,risk
Tramadol,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Tramadol.,increase,risk
Tramadol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tramadol.,increase,risk
Betaxolol,Betaine,Betaine may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Bethanechol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Bethanechol.,increase,risk
Betaxolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Bimatoprost,Betaxolol may increase the hypotensive activities of Bimatoprost.,increase,no risk
Betaxolol,Bimekizumab,The metabolism of Betaxolol can be increased when combined with Bimekizumab.,increase,no risk
Betaxolol,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Bioallethrin,Betaxolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Betaxolol,Biperiden,The metabolism of Betaxolol can be decreased when combined with Biperiden.,decrease,no risk
Betaxolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Betaxolol.,increase,risk
Betaxolol,Bortezomib,The metabolism of Betaxolol can be decreased when combined with Bortezomib.,decrease,no risk
Betaxolol,Bosentan,Betaxolol may increase the hypotensive activities of Bosentan.,increase,no risk
Betaxolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Betaxolol.,increase,risk
Betaxolol,Bretylium,Betaxolol may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Betaxolol,Brexpiprazole,Betaxolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Betaxolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Betaxolol.,increase,no risk
Betaxolol,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Betaxolol is combined with Bromotheophylline.,increase,risk
Betaxolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Betaxolol.,increase,risk
Betaxolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Bumetanide,The risk or severity of adverse effects can be increased when Betaxolol is combined with Bumetanide.,increase,risk
Betaxolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Betaxolol.,increase,no risk
Betaxolol,Buprenorphine,The metabolism of Betaxolol can be decreased when combined with Buprenorphine.,decrease,no risk
Betaxolol,Bupropion,The metabolism of Betaxolol can be decreased when combined with Bupropion.,decrease,no risk
Betaxolol,Buspirone,Buspirone may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Butabarbital,Butabarbital may increase the hypotensive activities of Betaxolol.,increase,no risk
Betaxolol,Butalbital,Butalbital may increase the hypotensive activities of Betaxolol.,increase,no risk
Betaxolol,Butaperazine,The serum concentration of Betaxolol can be increased when it is combined with Butaperazine.,increase,no risk
Betaxolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Galantamine,Galantamine may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Gatifloxacin,The metabolism of Betaxolol can be decreased when combined with Gatifloxacin.,decrease,no risk
Betaxolol,Gefitinib,The metabolism of Betaxolol can be decreased when combined with Gefitinib.,decrease,no risk
Betaxolol,Gemfibrozil,The metabolism of Betaxolol can be decreased when combined with Gemfibrozil.,decrease,no risk
Betaxolol,Gemifloxacin,The metabolism of Betaxolol can be decreased when combined with Gemifloxacin.,decrease,no risk
Betaxolol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Betaxolol.,increase,risk
Betaxolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Givosiran,The serum concentration of Betaxolol can be increased when it is combined with Givosiran.,increase,no risk
Betaxolol,Glasdegib,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Glasdegib.,increase,risk
Betaxolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Glofitamab,The serum concentration of Betaxolol can be increased when it is combined with Glofitamab.,increase,no risk
Betaxolol,Glucagon,The therapeutic efficacy of Betaxolol can be decreased when used in combination with Glucagon.,decrease,no risk
Betaxolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Glycerol phenylbutyrate,The metabolism of Betaxolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Betaxolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Golimumab,The metabolism of Betaxolol can be increased when combined with Golimumab.,increase,no risk
Betaxolol,Grepafloxacin,The metabolism of Betaxolol can be decreased when combined with Grepafloxacin.,decrease,no risk
Betaxolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Guanadrel,Betaxolol may increase the hypotensive activities of Guanadrel.,increase,no risk
Betaxolol,Guanethidine,Guanethidine may increase the hypotensive activities of Betaxolol.,increase,no risk
Betaxolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Guanoxan,Betaxolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Betaxolol,Halofantrine,The metabolism of Betaxolol can be decreased when combined with Halofantrine.,decrease,no risk
Betaxolol,Haloperidol,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Haloperidol.,increase,risk
Betaxolol,Halothane,Halothane may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Heparin,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Heparin.,increase,risk
Betaxolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Betaxolol.,increase,risk
Betaxolol,Huperzine A,Huperzine A may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Hydralazine,Betaxolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Betaxolol,Hydrochlorothiazide,The therapeutic efficacy of Betaxolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Betaxolol,Hydroflumethiazide,The therapeutic efficacy of Betaxolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Betaxolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Betaxolol.,decrease,risk
Betaxolol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Hydroxyzine.,increase,risk
Betaxolol,Hyoscyamine,Betaxolol may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Betaxolol,Ketamine,Ketamine may increase the bradycardic activities of Betaxolol.,increase,no risk
Betaxolol,Ketoconazole,The metabolism of Betaxolol can be decreased when combined with Ketoconazole.,decrease,no risk
Betaxolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Betaxolol.,increase,risk
Betaxolol,Obeticholic acid,The metabolism of Betaxolol can be decreased when combined with Obeticholic acid.,decrease,no risk
Betaxolol,Obinutuzumab,Betaxolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Betaxolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Betaxolol.,increase,no risk
Betaxolol,Olanzapine,Betaxolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Betaxolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Olmesartan,Betaxolol may increase the hypotensive activities of Olmesartan.,increase,no risk
Betaxolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Opicapone,The risk or severity of adverse effects can be increased when Betaxolol is combined with Opicapone.,increase,risk
Betaxolol,Opium,The metabolism of Opium can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Oritavancin,The metabolism of Betaxolol can be decreased when combined with Oritavancin.,decrease,no risk
Betaxolol,Orphenadrine,The metabolism of Betaxolol can be decreased when combined with Orphenadrine.,decrease,no risk
Betaxolol,Osilodrostat,The metabolism of Betaxolol can be decreased when combined with Osilodrostat.,decrease,no risk
Betaxolol,Osimertinib,The serum concentration of Betaxolol can be decreased when it is combined with Osimertinib.,decrease,no risk
Betaxolol,Ospemifene,The metabolism of Betaxolol can be decreased when combined with Ospemifene.,decrease,no risk
Betaxolol,Ouabain,Betaxolol may increase the bradycardic activities of Ouabain.,increase,no risk
Betaxolol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Betaxolol.,increase,risk
Betaxolol,Oxamniquine,The metabolism of Betaxolol can be decreased when combined with Oxamniquine.,decrease,no risk
Betaxolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Oxprenolol,Betaxolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Betaxolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Betaxolol is combined with Oxtriphylline.,increase,risk
Betaxolol,Oxybutynin,The metabolism of Betaxolol can be decreased when combined with Oxybutynin.,decrease,no risk
Betaxolol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Oxymetazoline,The therapeutic efficacy of Betaxolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Betaxolol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Quetiapine,Quetiapine may increase the hypotensive activities of Betaxolol.,increase,no risk
Betaxolol,Quinapril,Betaxolol may increase the hypotensive activities of Quinapril.,increase,no risk
Betaxolol,Quinidine,Betaxolol may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Betaxolol,Quinine,The metabolism of Betaxolol can be decreased when combined with Quinine.,decrease,no risk
Betaxolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Quizartinib,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Quizartinib.,increase,risk
Betaxolol,Udenafil,Udenafil may increase the antihypertensive activities of Betaxolol.,increase,no risk
Betaxolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Unoprostone,Betaxolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Betaxolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Betaxolol.,increase,risk
Betaxolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Valproic acid,The metabolism of Betaxolol can be decreased when combined with Valproic acid.,decrease,no risk
Betaxolol,Valsartan,Valsartan may increase the hypotensive activities of Betaxolol.,increase,no risk
Betaxolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Betaxolol.,increase,no risk
Betaxolol,Varenicline,The risk or severity of adverse effects can be increased when Betaxolol is combined with Varenicline.,increase,risk
Betaxolol,Vemurafenib,The serum concentration of Betaxolol can be increased when it is combined with Vemurafenib.,increase,no risk
Betaxolol,Venlafaxine,The metabolism of Betaxolol can be decreased when combined with Venlafaxine.,decrease,no risk
Betaxolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Betaxolol.,increase,risk
Betaxolol,Vericiguat,The risk or severity of adverse effects can be increased when Betaxolol is combined with Vericiguat.,increase,risk
Betaxolol,Vernakalant,Betaxolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Betaxolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Vilazodone,The metabolism of Betaxolol can be decreased when combined with Vilazodone.,decrease,no risk
Betaxolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Betaxolol.,increase,no risk
Betaxolol,Viloxazine,The metabolism of Betaxolol can be decreased when combined with Viloxazine.,decrease,no risk
Betaxolol,Vinblastine,The metabolism of Betaxolol can be decreased when combined with Vinblastine.,decrease,no risk
Betaxolol,Vinorelbine,The metabolism of Betaxolol can be decreased when combined with Vinorelbine.,decrease,no risk
Betaxolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Warfarin,The metabolism of Warfarin can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Betaxolol.,decrease,no risk
Betaxolol,Xylometazoline,Betaxolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Betaxolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Betaxolol,Ziconotide,Betaxolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Betaxolol,Zileuton,The metabolism of Betaxolol can be decreased when combined with Zileuton.,decrease,no risk
Betaxolol,Zimelidine,The serum concentration of Betaxolol can be increased when it is combined with Zimelidine.,increase,no risk
Betaxolol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Ziprasidone.,increase,risk
Betaxolol,Zofenopril,Betaxolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Betaxolol,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Zonisamide,Betaxolol may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Betaxolol,Zotepine,The metabolism of Zotepine can be decreased when combined with Betaxolol.,decrease,no risk
Betaxolol,Zuclopenthixol,Betaxolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Fluconazole,Bacitracin,Bacitracin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,decrease,no risk
Fluconazole,Baclofen,Baclofen may decrease the excretion rate of Fluconazole which could result in a higher serum level.,decrease,no risk
Fluconazole,Balsalazide,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Balsalazide.,increase,risk
Fluconazole,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bedaquiline,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Bedaquiline.,increase,risk
Fluconazole,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Bemiparin,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Bemiparin.,increase,risk
Fluconazole,Benazepril,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Benazepril.,increase,risk
Fluconazole,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluconazole,Benorilate,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Benorilate.,increase,risk
Fluconazole,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Benoxaprofen.,increase,risk
Fluconazole,Benserazide,Fluconazole may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Fluconazole,Benzatropine,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Benzatropine.,increase,risk
Fluconazole,Benznidazole,Fluconazole may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Fluconazole,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Benzthiazide,Benzthiazide may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluconazole,Benzydamine,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Benzydamine.,increase,risk
Fluconazole,Bepotastine,Fluconazole may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Fluconazole,Bepridil,The metabolism of Bepridil can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Fluconazole.,increase,risk
Fluconazole,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Bexagliflozin is combined with Fluconazole.,increase,risk
Fluconazole,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bicisate,Fluconazole may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Fluconazole,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bilastine,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Bilastine.,increase,risk
Fluconazole,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Bismuth subgallate,Fluconazole may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Fluconazole,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bisoxatin,Fluconazole may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Fluconazole,Bleomycin,Fluconazole may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Fluconazole,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Bosentan,The metabolism of Bosentan can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Bretylium,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Bretylium.,increase,risk
Fluconazole,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bromazepam,Fluconazole may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Fluconazole,Bromocriptine,The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Fluconazole.,increase,risk
Fluconazole,Bromotheophylline,Bromotheophylline may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluconazole,Brompheniramine,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Brompheniramine.,increase,risk
Fluconazole,Buclizine,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Buclizine.,increase,risk
Fluconazole,Budesonide,The metabolism of Budesonide can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bumadizone,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Bumadizone.,increase,risk
Fluconazole,Bumetanide,Bumetanide may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluconazole,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Bupropion,The metabolism of Bupropion can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Buserelin,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Buserelin.,increase,risk
Fluconazole,Buspirone,The metabolism of Buspirone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Busulfan,The metabolism of Busulfan can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Butabarbital,Fluconazole may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Fluconazole,Butriptyline,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Butriptyline.,increase,risk
Fluconazole,Gabapentin enacarbil,Fluconazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Fluconazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Gadobenic acid.,increase,risk
Fluconazole,Gadodiamide,Fluconazole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Fluconazole,Gadofosveset trisodium,Fluconazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Fluconazole,Gadopentetic acid,Fluconazole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Fluconazole,Gadoteric acid,Fluconazole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Fluconazole,Gadoteridol,Fluconazole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Fluconazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Ganciclovir,Fluconazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Fluconazole,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Gatifloxacin.,increase,risk
Fluconazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Gemifloxacin.,increase,risk
Fluconazole,Gentamicin,Fluconazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fluconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Gestrinone,The bioavailability of Gestrinone can be increased when combined with Fluconazole.,increase,no risk
Fluconazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Gimeracil,Fluconazole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Fluconazole,Givosiran,Givosiran may decrease the excretion rate of Fluconazole which could result in a higher serum level.,decrease,no risk
Fluconazole,Glasdegib,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Glasdegib.,increase,risk
Fluconazole,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Glimepiride,The serum concentration of Glimepiride can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Glipizide,The serum concentration of Glipizide can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Gliquidone,The serum concentration of Gliquidone can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Glycerol phenylbutyrate,Fluconazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Fluconazole,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with Fluconazole.,increase,risk
Fluconazole,Golodirsen,Fluconazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Fluconazole,Goserelin,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Goserelin.,increase,risk
Fluconazole,Granisetron,The metabolism of Granisetron can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Guanethidine,Fluconazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Fluconazole,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Haloperidol.,increase,risk
Fluconazole,Halothane,The metabolism of Halothane can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Heparin,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Heparin.,increase,risk
Fluconazole,Histrelin,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Histrelin.,increase,risk
Fluconazole,Hydralazine,Fluconazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Fluconazole,Hydrochlorothiazide,The serum concentration of Fluconazole can be increased when it is combined with Hydrochlorothiazide.,increase,no risk
Fluconazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluconazole,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydroxocobalamin,Fluconazole may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Fluconazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydroxyethyl Starch,Fluconazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Fluconazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Hydroxyzine.,increase,risk
Fluconazole,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Hyoscyamine.,increase,risk
Fluconazole,Kanamycin,Fluconazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Fluconazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Ketoprofen,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Ketoprofen.,increase,risk
Fluconazole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Octinoxate,Fluconazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Fluconazole,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Fluconazole.,increase,risk
Fluconazole,Ofloxacin,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Ofloxacin.,increase,risk
Fluconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Fluconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fluconazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Olmesartan,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Olmesartan.,increase,risk
Fluconazole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Olsalazine,Olsalazine may decrease the excretion rate of Fluconazole which could result in a higher serum level.,decrease,no risk
Fluconazole,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Opium,The metabolism of Opium can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Oseltamivir,Fluconazole may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Fluconazole,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Oxacillin,Fluconazole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Fluconazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Fluconazole.,increase,risk
Fluconazole,Oxaprozin,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Oxaprozin.,increase,risk
Fluconazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Oxatomide.,increase,risk
Fluconazole,Oxazepam,Fluconazole may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Fluconazole,Oxprenolol,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Oxprenolol.,increase,risk
Fluconazole,Oxybenzone,Fluconazole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Fluconazole,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Oxyphenbutazone.,increase,risk
Fluconazole,Oxyquinoline,Fluconazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Fluconazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Fluconazole.,increase,risk
Fluconazole,Quazepam,The metabolism of Quazepam can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Quinapril,The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Quinapril.,increase,risk
Fluconazole,Quinethazone,Quinethazone may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fluconazole,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Fluconazole.,increase,risk
Fluconazole,Quizartinib,The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Quizartinib.,increase,risk
Fluconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Udenafil,The metabolism of Udenafil can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Fluconazole.,decrease,no risk
Fluconazole,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Fluconazole.,increase,no risk
Fluconazole,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Fluconazole.,decrease,no risk
Troglitazone,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Bromocriptine,The risk or severity of hypoglycemia can be increased when Troglitazone is combined with Bromocriptine.,increase,risk
Troglitazone,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Troglitazone.,increase,risk
Troglitazone,Bumetanide,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Bumetanide.,decrease,no risk
Troglitazone,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Bupropion,The metabolism of Bupropion can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Buserelin,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Buserelin.,decrease,no risk
Troglitazone,Buspirone,The metabolism of Buspirone can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Busulfan,The metabolism of Busulfan can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Troglitazone.,decrease,no risk
Troglitazone,Ketamine,The metabolism of Ketamine can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Ketoconazole,Troglitazone may decrease the excretion rate of Ketoconazole which could result in a higher serum level.,decrease,no risk
Troglitazone,Ketoprofen,The metabolism of Troglitazone can be decreased when combined with Ketoprofen.,decrease,no risk
Troglitazone,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Ketotifen,The risk or severity of thrombocytopenia can be increased when Troglitazone is combined with Ketotifen.,increase,risk
Troglitazone,Obeticholic acid,The risk or severity of adverse effects can be increased when Troglitazone is combined with Obeticholic acid.,increase,risk
Troglitazone,Octreotide,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Octreotide.,decrease,no risk
Troglitazone,Ofloxacin,Troglitazone may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Troglitazone,Olanzapine,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Olanzapine.,decrease,no risk
Troglitazone,Olaparib,The metabolism of Olaparib can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Troglitazone.,decrease,no risk
Troglitazone,Olmesartan,The risk or severity of liver damage can be increased when Troglitazone is combined with Olmesartan.,increase,risk
Troglitazone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Olsalazine,Olsalazine may increase the hypoglycemic activities of Troglitazone.,increase,no risk
Troglitazone,Omaveloxolone,The serum concentration of Troglitazone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Troglitazone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Oritavancin,The metabolism of Troglitazone can be decreased when combined with Oritavancin.,decrease,no risk
Troglitazone,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Ouabain,The excretion of Ouabain can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Oxandrolone,The metabolism of Troglitazone can be decreased when combined with Oxandrolone.,decrease,no risk
Troglitazone,Oxprenolol,The therapeutic efficacy of Troglitazone can be increased when used in combination with Oxprenolol.,increase,no risk
Troglitazone,Oxybutynin,The metabolism of Troglitazone can be decreased when combined with Oxybutynin.,decrease,no risk
Troglitazone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Troglitazone.,increase,no risk
Troglitazone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Quetiapine,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Quetiapine.,decrease,no risk
Troglitazone,Quinethazone,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Quinethazone.,decrease,no risk
Troglitazone,Quinidine,The metabolism of Quinidine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Troglitazone.,increase,risk
Troglitazone,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Troglitazone.,decrease,no risk
Troglitazone,Quizartinib,The metabolism of Troglitazone can be decreased when combined with Quizartinib.,decrease,no risk
Troglitazone,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Troglitazone.,increase,risk
Troglitazone,Udenafil,The therapeutic efficacy of Troglitazone can be increased when used in combination with Udenafil.,increase,no risk
Troglitazone,Ulipristal,The metabolism of Ulipristal can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Troglitazone.,increase,risk
Troglitazone,Ursodeoxycholic acid,Troglitazone may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Troglitazone,Vadadustat,The serum concentration of Troglitazone can be increased when it is combined with Vadadustat.,increase,no risk
Troglitazone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Valsartan,The metabolism of Valsartan can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Troglitazone.,increase,risk
Troglitazone,Vandetanib,The metabolism of Vandetanib can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Venetoclax,The metabolism of Venetoclax can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Troglitazone.,increase,risk
Troglitazone,Verapamil,The metabolism of Verapamil can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Vildagliptin,The risk or severity of hypoglycemia can be increased when Troglitazone is combined with Vildagliptin.,increase,risk
Troglitazone,Vinblastine,The metabolism of Vinblastine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Vincristine,The metabolism of Vincristine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Vindesine,The metabolism of Vindesine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Vinflunine,The metabolism of Vinflunine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Vorinostat,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Vorinostat.,decrease,no risk
Troglitazone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Warfarin,The metabolism of Warfarin can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Troglitazone.,increase,risk
Troglitazone,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Troglitazone.,increase,risk
Troglitazone,Zidovudine,The metabolism of Troglitazone can be increased when combined with Zidovudine.,increase,no risk
Troglitazone,Zileuton,The metabolism of Zileuton can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Troglitazone.,increase,risk
Troglitazone,Ziprasidone,The therapeutic efficacy of Troglitazone can be decreased when used in combination with Ziprasidone.,decrease,no risk
Troglitazone,Zolpidem,The metabolism of Zolpidem can be increased when combined with Troglitazone.,increase,no risk
Troglitazone,Zonisamide,The therapeutic efficacy of Troglitazone can be increased when used in combination with Zonisamide.,increase,no risk
Troglitazone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Troglitazone.,decrease,no risk
Troglitazone,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Troglitazone.,increase,no risk
Oseltamivir,Gabapentin enacarbil,Oseltamivir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gadobenic acid,Oseltamivir may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gadodiamide,Oseltamivir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gadofosveset trisodium,Oseltamivir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gadopentetic acid,Oseltamivir may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gadoteric acid,Oseltamivir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gadoteridol,Oseltamivir may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Oseltamivir,Ganciclovir,The excretion of Oseltamivir can be decreased when combined with Ganciclovir.,decrease,no risk
Oseltamivir,Gemcitabine,Oseltamivir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gemfibrozil,The excretion of Oseltamivir can be decreased when combined with Gemfibrozil.,decrease,no risk
Oseltamivir,Gentamicin,Oseltamivir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Oseltamivir,Gimeracil,Oseltamivir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Oseltamivir,Givosiran,Givosiran may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Glipizide,Oseltamivir may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Oseltamivir,Glycerol phenylbutyrate,Oseltamivir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Oseltamivir,Golodirsen,Oseltamivir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Oseltamivir,Goserelin,Goserelin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Guanethidine,Oseltamivir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Guanfacine,Oseltamivir may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Guanidine,The excretion of Oseltamivir can be decreased when combined with Guanidine.,decrease,no risk
Oseltamivir,Haloperidol,Oseltamivir may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Oseltamivir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Oseltamivir.,decrease,no risk
Oseltamivir,Hydralazine,Oseltamivir may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oseltamivir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oseltamivir,Hydromorphone,Oseltamivir may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Oseltamivir,Hydroxocobalamin,Oseltamivir may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Oseltamivir,Hydroxyethyl Starch,Oseltamivir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Oseltamivir,Kanamycin,Oseltamivir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Oseltamivir,Ketamine,Oseltamivir may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Ketazolam,Oseltamivir may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Oseltamivir,Ketoprofen,The excretion of Oseltamivir can be decreased when combined with Ketoprofen.,decrease,no risk
Oseltamivir,Ketorolac,Ketorolac may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Octinoxate,Oseltamivir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Oseltamivir,Olsalazine,Olsalazine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Opium,Oseltamivir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Oseltamivir,Ouabain,The excretion of Oseltamivir can be decreased when combined with Ouabain.,decrease,no risk
Oseltamivir,Oxacillin,Oseltamivir may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Oseltamivir,Oxaprozin,Oxaprozin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Oxazepam,Oseltamivir may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oseltamivir,Oxybenzone,Oseltamivir may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Oseltamivir,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Oxyquinoline,Oseltamivir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Oseltamivir,Oxytetracycline,The excretion of Oseltamivir can be decreased when combined with Oxytetracycline.,decrease,no risk
Oseltamivir,Quetiapine,Oseltamivir may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Quinethazone,Quinethazone may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oseltamivir,Quinidine,Oseltamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Vaborbactam,Oseltamivir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Oseltamivir,Vadadustat,The serum concentration of Oseltamivir can be increased when it is combined with Vadadustat.,increase,no risk
Oseltamivir,Valaciclovir,Valaciclovir may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Valbenazine,Oseltamivir may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Valdecoxib,Valdecoxib may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Valganciclovir,Oseltamivir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Valproic acid,The excretion of Oseltamivir can be decreased when combined with Valproic acid.,decrease,no risk
Oseltamivir,Vancomycin,Oseltamivir may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Oseltamivir,Varenicline,Oseltamivir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Oseltamivir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Oseltamivir.,decrease,no risk
Oseltamivir,Venlafaxine,Oseltamivir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Verapamil,Oseltamivir may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Oseltamivir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Oseltamivir.,decrease,no risk
Oseltamivir,Vilanterol,Oseltamivir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Oseltamivir,Viloxazine,Oseltamivir may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Vortioxetine,Oseltamivir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Oseltamivir,Warfarin,Oseltamivir may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Oseltamivir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Oseltamivir.,decrease,no risk
Oseltamivir,Zaleplon,Oseltamivir may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Oseltamivir,Zanamivir,Oseltamivir may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Oseltamivir,Zidovudine,The excretion of Oseltamivir can be decreased when combined with Zidovudine.,decrease,no risk
Oseltamivir,Zonisamide,Zonisamide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Erythromycin,Benzphetamine,The serum concentration of Benzphetamine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Benzyl alcohol.,increase,risk
Erythromycin,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bexarotene,The serum concentration of Bexarotene can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bezafibrate,The serum concentration of Bezafibrate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bictegravir,The serum concentration of Bictegravir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Erythromycin.,increase,risk
Erythromycin,Bimekizumab,The metabolism of Erythromycin can be increased when combined with Bimekizumab.,increase,no risk
Erythromycin,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bioallethrin,The serum concentration of Bioallethrin can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bivalirudin,The risk or severity of bleeding can be increased when Erythromycin is combined with Bivalirudin.,increase,risk
Erythromycin,Boceprevir,The serum concentration of Boceprevir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Erythromycin.,increase,risk
Erythromycin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Brinzolamide,The serum concentration of Brinzolamide can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Brivaracetam,The serum concentration of Brivaracetam can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Erythromycin.,increase,risk
Erythromycin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Erythromycin.,increase,risk
Erythromycin,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Erythromycin.,increase,risk
Erythromycin,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Butacaine.,increase,risk
Erythromycin,Butamben,The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Butamben.,increase,risk
Erythromycin,Butriptyline,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Butriptyline.,increase,risk
Erythromycin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Gadobenic acid.,increase,risk
Erythromycin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Erythromycin.,increase,risk
Erythromycin,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Gemfibrozil,The serum concentration of Gemfibrozil can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Gemifloxacin.,increase,risk
Erythromycin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Glasdegib,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Glasdegib.,increase,risk
Erythromycin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Glimepiride,Erythromycin may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Erythromycin,Glipizide,Erythromycin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Erythromycin,Glofitamab,The serum concentration of Erythromycin can be increased when it is combined with Glofitamab.,increase,no risk
Erythromycin,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Glycyrrhizic acid,Erythromycin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Erythromycin,Golimumab,The metabolism of Erythromycin can be increased when combined with Golimumab.,increase,no risk
Erythromycin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Erythromycin.,increase,risk
Erythromycin,Granisetron,The serum concentration of Granisetron can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Guanfacine,The serum concentration of Guanfacine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Halcinonide,The serum concentration of Halcinonide can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Halofantrine,The serum concentration of Halofantrine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Haloperidol,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Haloperidol.,increase,risk
Erythromycin,Halothane,The serum concentration of Halothane can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Heparin,The risk or severity of bleeding can be increased when Erythromycin is combined with Heparin.,increase,risk
Erythromycin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Erythromycin.,increase,risk
Erythromycin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Erythromycin.,increase,risk
Erythromycin,Hydrocodone,The serum concentration of Hydrocodone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Hydroxyzine.,increase,risk
Erythromycin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Erythromycin.,increase,risk
Erythromycin,Ketamine,The serum concentration of Ketamine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ketoconazole,The serum concentration of Ketoconazole can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Obeticholic acid,The risk or severity of adverse effects can be increased when Erythromycin is combined with Obeticholic acid.,increase,risk
Erythromycin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Erythromycin.,increase,risk
Erythromycin,Ofloxacin,Erythromycin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Erythromycin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Erythromycin.,increase,risk
Erythromycin,Olaparib,The metabolism of Olaparib can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Olmesartan,Olmesartan may decrease the excretion rate of Erythromycin which could result in a higher serum level.,decrease,no risk
Erythromycin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Erythromycin.,increase,risk
Erythromycin,Olutasidenib,The serum concentration of Olutasidenib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Opium,The serum concentration of Opium can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Orphenadrine,The serum concentration of Orphenadrine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ospemifene,The serum concentration of Ospemifene can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Erythromycin.,increase,risk
Erythromycin,Oxatomide,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Oxatomide.,increase,risk
Erythromycin,Oxcarbazepine,The metabolism of Erythromycin can be increased when combined with Oxcarbazepine.,increase,no risk
Erythromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Oxetacaine.,increase,risk
Erythromycin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Oxybuprocaine.,increase,risk
Erythromycin,Oxybutynin,The serum concentration of Oxybutynin can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Oxycodone,The serum concentration of Oxycodone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Oxymorphone,The serum concentration of Oxymorphone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Erythromycin.,increase,risk
Erythromycin,Quazepam,The serum concentration of Quazepam can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Quinidine,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinidine.,increase,risk
Erythromycin,Quinine,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinine.,increase,risk
Erythromycin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Udenafil,The serum concentration of Udenafil can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Upadacitinib,The serum concentration of Upadacitinib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Urokinase,The risk or severity of bleeding can be increased when Erythromycin is combined with Urokinase.,increase,risk
Erythromycin,Ursodeoxycholic acid,Erythromycin may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Erythromycin,Vadadustat,The serum concentration of Erythromycin can be increased when it is combined with Vadadustat.,increase,no risk
Erythromycin,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Valdecoxib,The serum concentration of Valdecoxib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Valproic acid,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Valproic acid.,increase,risk
Erythromycin,Valsartan,The excretion of Erythromycin can be decreased when combined with Valsartan.,decrease,no risk
Erythromycin,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Erythromycin.,increase,risk
Erythromycin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Verapamil,The risk or severity of adverse effects can be increased when Erythromycin is combined with Verapamil.,increase,risk
Erythromycin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Erythromycin.,increase,risk
Erythromycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Erythromycin.,decrease,no risk
Erythromycin,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Viloxazine,The metabolism of Erythromycin can be decreased when combined with Viloxazine.,decrease,no risk
Erythromycin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vitamin D,The serum concentration of Vitamin D can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vitamin E,The serum concentration of Vitamin E can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Vonoprazan,The serum concentration of Vonoprazan can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vorapaxar,The risk or severity of bleeding can be increased when Erythromycin is combined with Vorapaxar.,increase,risk
Erythromycin,Voriconazole,The serum concentration of Voriconazole can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Erythromycin.,increase,risk
Erythromycin,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Warfarin,The risk or severity of bleeding can be increased when Erythromycin is combined with Warfarin.,increase,risk
Erythromycin,Ximelagatran,The risk or severity of bleeding can be increased when Erythromycin is combined with Ximelagatran.,increase,risk
Erythromycin,Xylometazoline,The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Xylometazoline.,increase,risk
Erythromycin,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.,decrease,no risk
Erythromycin,Zaleplon,The serum concentration of Zaleplon can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Erythromycin.,decrease,no risk
Erythromycin,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Ziconotide,The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Ziconotide.,increase,risk
Erythromycin,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zimelidine,The metabolism of Erythromycin can be decreased when combined with Zimelidine.,decrease,no risk
Erythromycin,Zinc ascorbate,The therapeutic efficacy of Erythromycin can be decreased when used in combination with Zinc ascorbate.,decrease,no risk
Erythromycin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ziprasidone.,increase,risk
Erythromycin,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zopiclone,The serum concentration of Zopiclone can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Erythromycin.,increase,no risk
Erythromycin,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Erythromycin.,increase,no risk
Hydroxocobalamin,Gabapentin enacarbil,Hydroxocobalamin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gadobenic acid,Hydroxocobalamin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gadodiamide,Hydroxocobalamin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gadofosveset trisodium,Hydroxocobalamin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gadopentetic acid,Hydroxocobalamin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gadoteric acid,Hydroxocobalamin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gadoteridol,Hydroxocobalamin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Ganciclovir,Hydroxocobalamin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gemcitabine,Hydroxocobalamin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gemfibrozil,Hydroxocobalamin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gentamicin,Hydroxocobalamin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Gimeracil,Hydroxocobalamin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Givosiran,Givosiran may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Glipizide,Hydroxocobalamin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Glycerol phenylbutyrate,Hydroxocobalamin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Golodirsen,Hydroxocobalamin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Goserelin,Goserelin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Guanethidine,Hydroxocobalamin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Guanfacine,Hydroxocobalamin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Haloperidol,Hydroxocobalamin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Hydralazine,Hydroxocobalamin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydroxocobalamin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydroxocobalamin,Hydromorphone,Hydroxocobalamin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Hydroxyethyl Starch,Hydroxocobalamin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Kanamycin,Hydroxocobalamin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Ketamine,Hydroxocobalamin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Ketazolam,Hydroxocobalamin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Ketorolac,Ketorolac may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Octinoxate,Hydroxocobalamin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Olsalazine,Olsalazine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Opium,Hydroxocobalamin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oseltamivir,Oseltamivir may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oxacillin,Hydroxocobalamin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oxaprozin,Oxaprozin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oxazepam,Hydroxocobalamin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oxybenzone,Hydroxocobalamin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Oxyquinoline,Hydroxocobalamin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Quetiapine,Hydroxocobalamin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Quinethazone,Quinethazone may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydroxocobalamin,Quinidine,Hydroxocobalamin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Vaborbactam,Hydroxocobalamin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Valaciclovir,Valaciclovir may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Valbenazine,Hydroxocobalamin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Valdecoxib,Valdecoxib may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Valganciclovir,Hydroxocobalamin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Vancomycin,Hydroxocobalamin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Varenicline,Hydroxocobalamin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Venlafaxine,Hydroxocobalamin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Verapamil,Hydroxocobalamin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Vilanterol,Hydroxocobalamin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Viloxazine,Hydroxocobalamin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Vortioxetine,Hydroxocobalamin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Warfarin,Hydroxocobalamin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Zaleplon,Hydroxocobalamin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Zanamivir,Hydroxocobalamin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Hydroxocobalamin,Zonisamide,Zonisamide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Gabapentin,Gabapentin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Ganaxolone,Ganaxolone may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Gatifloxacin,The metabolism of Caffeine can be decreased when combined with Gatifloxacin.,decrease,no risk
Caffeine,Gefitinib,Caffeine may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Caffeine,Gemfibrozil,The metabolism of Caffeine can be decreased when combined with Gemfibrozil.,decrease,no risk
Caffeine,Gemifloxacin,The metabolism of Caffeine can be decreased when combined with Gemifloxacin.,decrease,no risk
Caffeine,Givosiran,The serum concentration of Caffeine can be increased when it is combined with Givosiran.,increase,no risk
Caffeine,Glasdegib,Caffeine may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Caffeine,Glecaprevir,Caffeine may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Caffeine,Glofitamab,The serum concentration of Caffeine can be increased when it is combined with Glofitamab.,increase,no risk
Caffeine,Glyburide,Caffeine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Caffeine,Golimumab,The metabolism of Caffeine can be increased when combined with Golimumab.,increase,no risk
Caffeine,Grepafloxacin,The metabolism of Caffeine can be decreased when combined with Grepafloxacin.,decrease,no risk
Caffeine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Caffeine.,decrease,no risk
Caffeine,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Human interferon beta,The metabolism of Caffeine can be decreased when combined with Human interferon beta.,decrease,no risk
Caffeine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Caffeine.,increase,risk
Caffeine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with Caffeine.,decrease,no risk
Caffeine,Ketoconazole,The metabolism of Caffeine can be decreased when combined with Ketoconazole.,decrease,no risk
Caffeine,Ketoprofen,Ketoprofen may decrease the diuretic activities of Caffeine.,decrease,no risk
Caffeine,Obeticholic acid,The metabolism of Caffeine can be decreased when combined with Obeticholic acid.,decrease,no risk
Caffeine,Ofloxacin,The metabolism of Caffeine can be decreased when combined with Ofloxacin.,decrease,no risk
Caffeine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Olodaterol,Caffeine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Caffeine,Ombitasvir,Caffeine may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Caffeine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Caffeine.,increase,risk
Caffeine,Osilodrostat,The metabolism of Caffeine can be decreased when combined with Osilodrostat.,decrease,no risk
Caffeine,Osimertinib,The serum concentration of Caffeine can be decreased when it is combined with Osimertinib.,decrease,no risk
Caffeine,Oxaliplatin,Caffeine may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Caffeine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Caffeine.,decrease,no risk
Caffeine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Caffeine.,increase,risk
Caffeine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Caffeine.,increase,risk
Caffeine,Ozanimod,Caffeine may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Caffeine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Caffeine.,decrease,no risk
Caffeine,Quinidine,The serum concentration of Caffeine can be increased when it is combined with Quinidine.,increase,no risk
Caffeine,Quinine,The serum concentration of Caffeine can be increased when it is combined with Quinine.,increase,no risk
Caffeine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Caffeine.,increase,no risk
Caffeine,Valproic acid,Valproic acid may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Velpatasvir,Caffeine may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Caffeine,Vemurafenib,The serum concentration of Caffeine can be increased when it is combined with Vemurafenib.,increase,no risk
Caffeine,Venetoclax,Caffeine may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Caffeine,Verapamil,The metabolism of Verapamil can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Vigabatrin,Vigabatrin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Vilanterol,The risk or severity of hypokalemia can be increased when Caffeine is combined with Vilanterol.,increase,risk
Caffeine,Viloxazine,The metabolism of Caffeine can be decreased when combined with Viloxazine.,decrease,no risk
Caffeine,Vincristine,Caffeine may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Caffeine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Warfarin,The metabolism of Warfarin can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Caffeine.,decrease,no risk
Caffeine,Zaleplon,Zaleplon may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Zidovudine,Caffeine may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Caffeine,Zileuton,The metabolism of Zileuton can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Caffeine.,decrease,no risk
Caffeine,Zonisamide,Zonisamide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Caffeine,Zotepine,The metabolism of Zotepine can be decreased when combined with Caffeine.,decrease,no risk
Succinylcholine,Gabapentin,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Gabapentin.,increase,risk
Succinylcholine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Gabapentin enacarbil.,increase,risk
Succinylcholine,Galantamine,The metabolism of Succinylcholine can be decreased when combined with Galantamine.,decrease,no risk
Succinylcholine,Gallamine triethiodide,The metabolism of Succinylcholine can be decreased when combined with Gallamine triethiodide.,decrease,no risk
Succinylcholine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Succinylcholine is combined with Ganaxolone.",increase,risk
Succinylcholine,Gentamicin,The therapeutic efficacy of Succinylcholine can be increased when used in combination with Gentamicin.,increase,no risk
Succinylcholine,Gepirone,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Gepirone.,increase,risk
Succinylcholine,Ginkgo biloba,The metabolism of Succinylcholine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Succinylcholine,Glutethimide,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Glutethimide.,increase,risk
Succinylcholine,Granisetron,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Granisetron.,increase,risk
Succinylcholine,Guanfacine,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Guanfacine.,increase,risk
Succinylcholine,Halazepam,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Halazepam.,increase,risk
Succinylcholine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Succinylcholine.,increase,risk
Succinylcholine,Halothane,The risk or severity of CNS depression can be increased when Succinylcholine is combined with Halothane.,increase,risk
Succinylcholine,Heparin,The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Heparin.,increase,risk
Succinylcholine,Hexafluronium,The metabolism of Succinylcholine can be decreased when combined with Hexafluronium.,decrease,no risk
Succinylcholine,Huperzine A,The metabolism of Succinylcholine can be decreased when combined with Huperzine A.,decrease,no risk
Sildenafil,Betamethasone phosphate,The metabolism of Sildenafil can be increased when combined with Betamethasone phosphate.,increase,no risk
Sildenafil,Betaxolol,Sildenafil may increase the antihypertensive activities of Betaxolol.,increase,no risk
Sildenafil,Bethanidine,Sildenafil may increase the antihypertensive activities of Bethanidine.,increase,no risk
Sildenafil,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Bexarotene,The therapeutic efficacy of Sildenafil can be decreased when used in combination with Bexarotene.,decrease,no risk
Sildenafil,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Bezafibrate.",increase,risk
Sildenafil,Bifonazole,The serum concentration of Sildenafil can be increased when it is combined with Bifonazole.,increase,no risk
Sildenafil,Bimekizumab,The metabolism of Sildenafil can be increased when combined with Bimekizumab.,increase,no risk
Sildenafil,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Biperiden,The metabolism of Sildenafil can be decreased when combined with Biperiden.,decrease,no risk
Sildenafil,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Bivalirudin,The risk or severity of hemorrhage can be increased when Bivalirudin is combined with Sildenafil.,increase,risk
Sildenafil,Boceprevir,The serum concentration of Sildenafil can be increased when it is combined with Boceprevir.,increase,no risk
Sildenafil,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Bosentan,The therapeutic efficacy of Sildenafil can be decreased when used in combination with Bosentan.,decrease,no risk
Sildenafil,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Bretylium,Sildenafil may increase the antihypertensive activities of Bretylium.,increase,no risk
Sildenafil,Brexpiprazole,The risk or severity of hypotension and syncope can be increased when Sildenafil is combined with Brexpiprazole.,increase,risk
Sildenafil,Brimonidine,The risk or severity of hypotension can be increased when Sildenafil is combined with Brimonidine.,increase,risk
Sildenafil,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Bromocriptine,The risk or severity of hypotension and syncope can be increased when Sildenafil is combined with Bromocriptine.,increase,risk
Sildenafil,Budesonide,The metabolism of Sildenafil can be increased when combined with Budesonide.,increase,no risk
Sildenafil,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Bumetanide.",increase,risk
Sildenafil,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Bupropion,The metabolism of Sildenafil can be decreased when combined with Bupropion.,decrease,no risk
Sildenafil,Buspirone,The metabolism of Buspirone can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Galantamine,The metabolism of Galantamine can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Ganciclovir.",increase,risk
Sildenafil,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Gemfibrozil,The metabolism of Sildenafil can be decreased when combined with Gemfibrozil.,decrease,no risk
Sildenafil,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Ginkgo biloba,The metabolism of Sildenafil can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sildenafil,Givosiran,The serum concentration of Sildenafil can be increased when it is combined with Givosiran.,increase,no risk
Sildenafil,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Glipizide,The metabolism of Glipizide can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Glofitamab,The serum concentration of Sildenafil can be increased when it is combined with Glofitamab.,increase,no risk
Sildenafil,Glyburide,The metabolism of Glyburide can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Glycerol phenylbutyrate,The metabolism of Sildenafil can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Sildenafil,Golimumab,The metabolism of Sildenafil can be increased when combined with Golimumab.,increase,no risk
Sildenafil,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Guanabenz,Sildenafil may increase the antihypertensive activities of Guanabenz.,increase,no risk
Sildenafil,Guanadrel,Sildenafil may increase the antihypertensive activities of Guanadrel.,increase,no risk
Sildenafil,Guanethidine,Sildenafil may increase the antihypertensive activities of Guanethidine.,increase,no risk
Sildenafil,Guanfacine,Sildenafil may increase the antihypertensive activities of Guanfacine.,increase,no risk
Sildenafil,Guanoxan,Sildenafil may increase the antihypertensive activities of Guanoxan.,increase,no risk
Sildenafil,Halofantrine,The metabolism of Sildenafil can be decreased when combined with Halofantrine.,decrease,no risk
Sildenafil,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Halothane,The metabolism of Halothane can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Heparin,The risk or severity of hemorrhage can be increased when Heparin is combined with Sildenafil.,increase,risk
Sildenafil,Hydralazine,Sildenafil may increase the antihypertensive activities of Hydralazine.,increase,no risk
Sildenafil,Hydrochlorothiazide,Sildenafil may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Sildenafil,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydroflumethiazide,Sildenafil may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Sildenafil,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydroxychloroquine,The metabolism of Sildenafil can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Sildenafil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Hydroxyzine,The metabolism of Sildenafil can be decreased when combined with Hydroxyzine.,decrease,no risk
Sildenafil,Ketamine,The metabolism of Ketamine can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Ketoconazole,The serum concentration of Sildenafil can be increased when it is combined with Ketoconazole.,increase,no risk
Sildenafil,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Obinutuzumab,The risk or severity of hypotension can be increased when Sildenafil is combined with Obinutuzumab.,increase,risk
Sildenafil,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Ofloxacin.",increase,risk
Sildenafil,Olanzapine,The risk or severity of hypotension and syncope can be increased when Sildenafil is combined with Olanzapine.,increase,risk
Sildenafil,Olaparib,The metabolism of Olaparib can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Olmesartan,Sildenafil may increase the antihypertensive activities of Olmesartan.,increase,no risk
Sildenafil,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Olutasidenib,The therapeutic efficacy of Sildenafil can be decreased when used in combination with Olutasidenib.,decrease,no risk
Sildenafil,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Omaveloxolone,The serum concentration of Sildenafil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sildenafil,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Opicapone,The risk or severity of hypotension can be increased when Sildenafil is combined with Opicapone.,increase,risk
Sildenafil,Opium,The metabolism of Opium can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Oritavancin,The metabolism of Sildenafil can be decreased when combined with Oritavancin.,decrease,no risk
Sildenafil,Orphenadrine,The metabolism of Sildenafil can be decreased when combined with Orphenadrine.,decrease,no risk
Sildenafil,Osilodrostat,The metabolism of Sildenafil can be decreased when combined with Osilodrostat.,decrease,no risk
Sildenafil,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sildenafil.,increase,no risk
Sildenafil,Ospemifene,The metabolism of Sildenafil can be decreased when combined with Ospemifene.,decrease,no risk
Sildenafil,Oteseconazole,The serum concentration of Sildenafil can be increased when it is combined with Oteseconazole.,increase,no risk
Sildenafil,Ouabain,The excretion of Ouabain can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Oxamniquine,The metabolism of Sildenafil can be decreased when combined with Oxamniquine.,decrease,no risk
Sildenafil,Oxandrolone,The metabolism of Sildenafil can be decreased when combined with Oxandrolone.,decrease,no risk
Sildenafil,Oxcarbazepine,The metabolism of Sildenafil can be increased when combined with Oxcarbazepine.,increase,no risk
Sildenafil,Oxprenolol,The metabolism of Sildenafil can be decreased when combined with Oxprenolol.,decrease,no risk
Sildenafil,Oxybutynin,The metabolism of Sildenafil can be decreased when combined with Oxybutynin.,decrease,no risk
Sildenafil,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Sildenafil.,decrease,no risk
Sildenafil,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Sildenafil.,decrease,no risk
Dofetilide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Dofetilide.,increase,risk
Dofetilide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dofetilide.,increase,risk
Dofetilide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Dofetilide.,increase,risk
Dofetilide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Dofetilide.,increase,risk
Dofetilide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Dofetilide.,increase,risk
Dofetilide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Dofetilide.,increase,risk
Dofetilide,Ginkgo biloba,The metabolism of Dofetilide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dofetilide,Glasdegib,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Glasdegib.,increase,risk
Dofetilide,Glecaprevir,The metabolism of Dofetilide can be decreased when combined with Glecaprevir.,decrease,no risk
Dofetilide,Glofitamab,The serum concentration of Dofetilide can be increased when it is combined with Glofitamab.,increase,no risk
Dofetilide,Glyburide,The metabolism of Dofetilide can be decreased when combined with Glyburide.,decrease,no risk
Dofetilide,Glycerol phenylbutyrate,The metabolism of Dofetilide can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Dofetilide,Golimumab,The metabolism of Dofetilide can be increased when combined with Golimumab.,increase,no risk
Dofetilide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dofetilide.,increase,risk
Dofetilide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Dofetilide.,increase,risk
Dofetilide,Grapefruit,The serum concentration of Dofetilide can be increased when it is combined with Grapefruit.,increase,no risk
Dofetilide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Grepafloxacin.,increase,risk
Dofetilide,Griseofulvin,The metabolism of Dofetilide can be increased when combined with Griseofulvin.,increase,no risk
Dofetilide,Guanidine,The serum concentration of Dofetilide can be increased when it is combined with Guanidine.,increase,no risk
Dofetilide,Halofantrine,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Halofantrine.,increase,risk
Dofetilide,Haloperidol,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Haloperidol.,increase,risk
Dofetilide,Histamine,The serum concentration of Dofetilide can be increased when it is combined with Histamine.,increase,no risk
Dofetilide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Dofetilide.,increase,risk
Dofetilide,Hydralazine,The serum concentration of Dofetilide can be increased when it is combined with Hydralazine.,increase,no risk
Dofetilide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Dofetilide.,increase,risk
Dofetilide,Hydrocortamate,The metabolism of Dofetilide can be increased when combined with Hydrocortamate.,increase,no risk
Dofetilide,Hydrocortisone,The metabolism of Dofetilide can be increased when combined with Hydrocortisone.,increase,no risk
Dofetilide,Hydrocortisone acetate,The metabolism of Dofetilide can be increased when combined with Hydrocortisone acetate.,increase,no risk
Dofetilide,Hydrocortisone butyrate,The metabolism of Dofetilide can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Dofetilide,Hydrocortisone succinate,The metabolism of Dofetilide can be increased when combined with Hydrocortisone succinate.,increase,no risk
Dofetilide,Hydroflumethiazide,The risk or severity of QTc prolongation can be increased when Hydroflumethiazide is combined with Dofetilide.,increase,risk
Dofetilide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Dofetilide.,increase,risk
Dofetilide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Hydroxyzine.,increase,risk
Dofetilide,Hyoscyamine,Dofetilide may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Dofetilide,Ketazolam,The serum concentration of Dofetilide can be increased when it is combined with Ketazolam.,increase,no risk
Dofetilide,Ketoconazole,The metabolism of Dofetilide can be decreased when combined with Ketoconazole.,decrease,no risk
Dofetilide,Octreotide,The serum concentration of Dofetilide can be increased when it is combined with Octreotide.,increase,no risk
Dofetilide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Dofetilide.,increase,risk
Dofetilide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Dofetilide.,increase,risk
Dofetilide,Olaparib,The metabolism of Dofetilide can be decreased when combined with Olaparib.,decrease,no risk
Dofetilide,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Dofetilide.,increase,risk
Dofetilide,Olutasidenib,The metabolism of Dofetilide can be increased when combined with Olutasidenib.,increase,no risk
Dofetilide,Omaveloxolone,The serum concentration of Dofetilide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dofetilide,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dofetilide.,increase,risk
Dofetilide,Oritavancin,The metabolism of Dofetilide can be increased when combined with Oritavancin.,increase,no risk
Dofetilide,Orphenadrine,The metabolism of Dofetilide can be decreased when combined with Orphenadrine.,decrease,no risk
Dofetilide,Osilodrostat,The metabolism of Dofetilide can be decreased when combined with Osilodrostat.,decrease,no risk
Dofetilide,Osimertinib,The metabolism of Dofetilide can be decreased when combined with Osimertinib.,decrease,no risk
Dofetilide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Dofetilide.,increase,risk
Dofetilide,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Dofetilide.,increase,risk
Dofetilide,Oxcarbazepine,The metabolism of Dofetilide can be increased when combined with Oxcarbazepine.,increase,no risk
Dofetilide,Oxprenolol,Dofetilide may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Dofetilide,Oxybutynin,The serum concentration of Dofetilide can be increased when it is combined with Oxybutynin.,increase,no risk
Dofetilide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dofetilide.,increase,risk
Dofetilide,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Dofetilide.,increase,risk
Dofetilide,Quinethazone,The risk or severity of QTc prolongation can be increased when Quinethazone is combined with Dofetilide.,increase,risk
Dofetilide,Quinidine,Dofetilide may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Dofetilide,Quinine,The metabolism of Dofetilide can be increased when combined with Quinine.,increase,no risk
Dofetilide,Quinupristin,The metabolism of Dofetilide can be decreased when combined with Quinupristin.,decrease,no risk
Dofetilide,Quizartinib,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Quizartinib.,increase,risk
Dofetilide,Vadadustat,The serum concentration of Dofetilide can be increased when it is combined with Vadadustat.,increase,no risk
Dofetilide,Valproic acid,The serum concentration of Dofetilide can be increased when it is combined with Valproic acid.,increase,no risk
Dofetilide,Vandetanib,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Vandetanib.,increase,risk
Dofetilide,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dofetilide.,increase,risk
Dofetilide,Varenicline,The serum concentration of Dofetilide can be increased when it is combined with Varenicline.,increase,no risk
Dofetilide,Vemurafenib,The metabolism of Dofetilide can be increased when combined with Vemurafenib.,increase,no risk
Dofetilide,Venetoclax,The metabolism of Dofetilide can be decreased when combined with Venetoclax.,decrease,no risk
Dofetilide,Verapamil,The serum concentration of Dofetilide can be increased when it is combined with Verapamil.,increase,no risk
Dofetilide,Vernakalant,Dofetilide may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Dofetilide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Dofetilide.,increase,risk
Dofetilide,Viloxazine,The metabolism of Dofetilide can be decreased when combined with Viloxazine.,decrease,no risk
Dofetilide,Vinblastine,The metabolism of Dofetilide can be increased when combined with Vinblastine.,increase,no risk
Dofetilide,Vitamin E,The metabolism of Dofetilide can be increased when combined with Vitamin E.,increase,no risk
Dofetilide,Vorapaxar,The metabolism of Dofetilide can be decreased when combined with Vorapaxar.,decrease,no risk
Dofetilide,Voriconazole,The metabolism of Dofetilide can be decreased when combined with Voriconazole.,decrease,no risk
Dofetilide,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dofetilide.,increase,risk
Dofetilide,Voxelotor,The serum concentration of Dofetilide can be increased when it is combined with Voxelotor.,increase,no risk
Dofetilide,Warfarin,The metabolism of Dofetilide can be increased when combined with Warfarin.,increase,no risk
Dofetilide,Xylometazoline,Dofetilide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Dofetilide,Zafirlukast,The serum concentration of Dofetilide can be increased when it is combined with Zafirlukast.,increase,no risk
Dofetilide,Ziconotide,Dofetilide may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Dofetilide,Zimelidine,The metabolism of Dofetilide can be decreased when combined with Zimelidine.,decrease,no risk
Dofetilide,Ziprasidone,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Ziprasidone.,increase,risk
Dofetilide,Zonisamide,Dofetilide may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Dofetilide,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Zuclopenthixol.,increase,risk
Pyrimethamine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pyrimethamine is combined with Oxetacaine.,increase,risk
Pyrimethamine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pyrimethamine is combined with Oxybuprocaine.,increase,risk
Pyrimethamine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Quinine,The metabolism of Quinine can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pyrimethamine.,increase,risk
Pyrimethamine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Pyrimethamine.,decrease,no risk
Pyrimethamine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Pyrimethamine.,decrease,no risk
Reserpine,Belantamab mafodotin,Reserpine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Reserpine,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Benazepril,Reserpine may increase the hypotensive activities of Benazepril.,increase,no risk
Reserpine,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Bendroflumethiazide,The therapeutic efficacy of Reserpine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Reserpine,Benorilate,The therapeutic efficacy of Reserpine can be decreased when used in combination with Benorilate.,decrease,no risk
Reserpine,Benoxaprofen,The therapeutic efficacy of Reserpine can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Reserpine,Benperidol,The risk or severity of CNS depression can be increased when Reserpine is combined with Benperidol.,increase,risk
Reserpine,Benserazide,Reserpine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Reserpine,Benzatropine,Reserpine may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Reserpine,Benznidazole,Reserpine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Reserpine,Benzocaine,The risk or severity of CNS depression can be increased when Reserpine is combined with Benzocaine.,increase,risk
Reserpine,Benzphetamine,The serum concentration of Benzphetamine can be decreased when it is combined with Reserpine.,decrease,no risk
Reserpine,Benzthiazide,The therapeutic efficacy of Reserpine can be increased when used in combination with Benzthiazide.,increase,no risk
Reserpine,Benzydamine,The therapeutic efficacy of Reserpine can be decreased when used in combination with Benzydamine.,decrease,no risk
Reserpine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Reserpine is combined with Benzyl alcohol.,increase,risk
Reserpine,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Reserpine.,decrease,no risk
Reserpine,Bepotastine,Reserpine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Reserpine,Bepridil,Reserpine may increase the hypotensive activities of Bepridil.,increase,no risk
Reserpine,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Betaxolol,Reserpine may increase the hypotensive activities of Betaxolol.,increase,no risk
Reserpine,Bethanidine,Bethanidine may decrease the antihypertensive activities of Reserpine.,decrease,no risk
Reserpine,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Bicisate,Reserpine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Reserpine,Bimatoprost,Reserpine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Reserpine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Bismuth subcitrate potassium,Reserpine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Reserpine,Bismuth subgallate,Reserpine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Reserpine,Bismuth subnitrate,Reserpine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Reserpine,Bisoprolol,The therapeutic efficacy of Reserpine can be increased when used in combination with Bisoprolol.,increase,no risk
Reserpine,Bisoxatin,Reserpine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Reserpine,Bleomycin,Reserpine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Reserpine,Boceprevir,The metabolism of Boceprevir can be increased when combined with Reserpine.,increase,no risk
Reserpine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Bosentan,The risk or severity of liver damage can be increased when Reserpine is combined with Bosentan.,increase,risk
Reserpine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Reserpine.,increase,risk
Reserpine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Reserpine.,increase,risk
Reserpine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Bretylium,Reserpine may increase the hypotensive activities of Bretylium.,increase,no risk
Reserpine,Brexanolone,The risk or severity of CNS depression can be increased when Reserpine is combined with Brexanolone.,increase,risk
Reserpine,Brexpiprazole,The risk or severity of CNS depression can be increased when Reserpine is combined with Brexpiprazole.,increase,risk
Reserpine,Brimonidine,Brimonidine may increase the antihypertensive activities of Reserpine.,increase,no risk
Reserpine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Brivaracetam,The risk or severity of CNS depression can be increased when Reserpine is combined with Brivaracetam.,increase,risk
Reserpine,Bromazepam,The risk or severity of CNS depression can be increased when Reserpine is combined with Bromazepam.,increase,risk
Reserpine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Reserpine.,increase,risk
Reserpine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Reserpine,Bromperidol,The risk or severity of CNS depression can be increased when Reserpine is combined with Bromperidol.,increase,risk
Reserpine,Brompheniramine,The risk or severity of CNS depression can be increased when Reserpine is combined with Brompheniramine.,increase,risk
Reserpine,Budesonide,Reserpine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Reserpine,Bumadizone,The therapeutic efficacy of Reserpine can be decreased when used in combination with Bumadizone.,decrease,no risk
Reserpine,Bumetanide,Bumetanide may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Reserpine,Bupivacaine,The risk or severity of CNS depression can be increased when Reserpine is combined with Bupivacaine.,increase,risk
Reserpine,Buprenorphine,Reserpine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Reserpine,Bupropion,The excretion of Reserpine can be decreased when combined with Bupropion.,decrease,no risk
Reserpine,Buspirone,The risk or severity of CNS depression can be increased when Reserpine is combined with Buspirone.,increase,risk
Reserpine,Butabarbital,Butabarbital may increase the hypotensive activities of Reserpine.,increase,no risk
Reserpine,Butalbital,Butalbital may increase the hypotensive activities of Reserpine.,increase,no risk
Reserpine,Butaperazine,The risk or severity of CNS depression can be increased when Reserpine is combined with Butaperazine.,increase,risk
Reserpine,Butobarbital,The risk or severity of CNS depression can be increased when Reserpine is combined with Butobarbital.,increase,risk
Reserpine,Butorphanol,The risk or severity of CNS depression can be increased when Reserpine is combined with Butorphanol.,increase,risk
Reserpine,Butriptyline,The risk or severity of CNS depression can be increased when Reserpine is combined with Butriptyline.,increase,risk
Reserpine,Gabapentin,The risk or severity of CNS depression can be increased when Reserpine is combined with Gabapentin.,increase,risk
Reserpine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Reserpine is combined with Gabapentin enacarbil.,increase,risk
Reserpine,Gadobenic acid,Reserpine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Reserpine,Gadodiamide,Reserpine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Reserpine,Gadofosveset trisodium,Reserpine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Reserpine,Gadopentetic acid,Reserpine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Reserpine,Gadoteric acid,Reserpine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Reserpine,Gadoteridol,Reserpine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Reserpine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Reserpine.,decrease,no risk
Reserpine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Reserpine is combined with Gallamine triethiodide.,increase,risk
Reserpine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Reserpine is combined with Ganaxolone.",increase,risk
Reserpine,Ganciclovir,The risk or severity of adverse effects can be increased when Reserpine is combined with Ganciclovir.,increase,risk
Reserpine,Gefitinib,The metabolism of Gefitinib can be increased when combined with Reserpine.,increase,no risk
Reserpine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Gemfibrozil,Reserpine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Reserpine,Gentamicin,Reserpine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Reserpine,Gepirone,The risk or severity of CNS depression can be increased when Reserpine is combined with Gepirone.,increase,risk
Reserpine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Gimeracil,Reserpine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Reserpine,Givosiran,Givosiran may decrease the excretion rate of Reserpine which could result in a higher serum level.,decrease,no risk
Reserpine,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Glimepiride,Reserpine may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Reserpine,Glipizide,Reserpine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Reserpine,Glutethimide,The risk or severity of CNS depression can be increased when Reserpine is combined with Glutethimide.,increase,risk
Reserpine,Glyburide,Reserpine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Reserpine,Glycerol phenylbutyrate,Reserpine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Reserpine,Glycol salicylate,The therapeutic efficacy of Reserpine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Reserpine,Glycyrrhizic acid,Reserpine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Reserpine,Golodirsen,Reserpine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Reserpine,Goserelin,Goserelin may decrease the excretion rate of Reserpine which could result in a higher serum level.,decrease,no risk
Reserpine,Granisetron,The risk or severity of CNS depression can be increased when Reserpine is combined with Granisetron.,increase,risk
Reserpine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Grepafloxacin,The serum concentration of Reserpine can be increased when it is combined with Grepafloxacin.,increase,no risk
Reserpine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Reserpine.,decrease,no risk
Reserpine,Guanadrel,Reserpine may increase the hypotensive activities of Guanadrel.,increase,no risk
Reserpine,Guanethidine,Reserpine may increase the hypotensive activities of Guanethidine.,increase,no risk
Reserpine,Guanfacine,The risk or severity of CNS depression can be increased when Reserpine is combined with Guanfacine.,increase,risk
Reserpine,Guanidine,The serum concentration of Reserpine can be increased when it is combined with Guanidine.,increase,no risk
Reserpine,Guanoxan,Reserpine may increase the hypotensive activities of Guanoxan.,increase,no risk
Reserpine,Halazepam,The risk or severity of CNS depression can be increased when Reserpine is combined with Halazepam.,increase,risk
Reserpine,Halofantrine,The metabolism of Halofantrine can be increased when combined with Reserpine.,increase,no risk
Reserpine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Reserpine.,increase,risk
Reserpine,Halothane,The risk or severity of CNS depression can be increased when Reserpine is combined with Halothane.,increase,risk
Reserpine,Hexafluronium,The risk or severity of CNS depression can be increased when Reserpine is combined with Hexafluronium.,increase,risk
Reserpine,Histamine,The serum concentration of Reserpine can be increased when it is combined with Histamine.,increase,no risk
Reserpine,Hydrocodone,Reserpine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Reserpine,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Reserpine.,increase,no risk
Reserpine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Reserpine.,increase,no risk
Reserpine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Reserpine.,increase,no risk
Reserpine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Reserpine.,increase,no risk
Reserpine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Reserpine.,increase,no risk
Reserpine,Hydroflumethiazide,The therapeutic efficacy of Reserpine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Reserpine,Hydromorphone,The risk or severity of CNS depression can be increased when Reserpine is combined with Hydromorphone.,increase,risk
Reserpine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Reserpine which could result in a higher serum level.,decrease,no risk
Reserpine,Hydroxyethyl Starch,Reserpine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Reserpine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Reserpine.,increase,no risk
Reserpine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Reserpine.,increase,no risk
Reserpine,Kanamycin,Reserpine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Reserpine,Ketamine,The risk or severity of CNS depression can be increased when Reserpine is combined with Ketamine.,increase,risk
Reserpine,Ketazolam,The risk or severity of CNS depression can be increased when Reserpine is combined with Ketazolam.,increase,risk
Reserpine,Ketoconazole,Reserpine may decrease the excretion rate of Ketoconazole which could result in a higher serum level.,decrease,no risk
Reserpine,Ketoprofen,The therapeutic efficacy of Reserpine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Reserpine,Ketorolac,The therapeutic efficacy of Reserpine can be decreased when used in combination with Ketorolac.,decrease,no risk
Reserpine,Obeticholic acid,The risk or severity of adverse effects can be increased when Reserpine is combined with Obeticholic acid.,increase,risk
Reserpine,Obinutuzumab,Reserpine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Reserpine,Octinoxate,Reserpine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Reserpine,Ofloxacin,Reserpine may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Reserpine,Olanzapine,The risk or severity of CNS depression can be increased when Reserpine is combined with Olanzapine.,increase,risk
Reserpine,Olaparib,The metabolism of Olaparib can be increased when combined with Reserpine.,increase,no risk
Reserpine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Reserpine is combined with Oliceridine.",increase,risk
Reserpine,Olmesartan,The risk or severity of liver damage can be increased when Reserpine is combined with Olmesartan.,increase,risk
Reserpine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Reserpine.,decrease,no risk
Reserpine,Olsalazine,Olsalazine may decrease the excretion rate of Reserpine which could result in a higher serum level.,decrease,no risk
Reserpine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Ondansetron,The risk or severity of CNS depression can be increased when Reserpine is combined with Ondansetron.,increase,risk
Reserpine,Opicapone,The risk or severity of adverse effects can be increased when Reserpine is combined with Opicapone.,increase,risk
Reserpine,Opium,The risk or severity of CNS depression can be increased when Reserpine is combined with Opium.,increase,risk
Reserpine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Reserpine.,decrease,no risk
Reserpine,Orphenadrine,Reserpine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Reserpine,Oseltamivir,Oseltamivir may decrease the excretion rate of Reserpine which could result in a higher serum level.,decrease,no risk
Reserpine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Reserpine.,increase,no risk
Reserpine,Ouabain,The risk or severity of adverse effects can be increased when Reserpine is combined with Ouabain.,increase,risk
Reserpine,Oxacillin,Reserpine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Reserpine,Oxaprozin,The therapeutic efficacy of Reserpine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Reserpine,Oxazepam,The risk or severity of CNS depression can be increased when Reserpine is combined with Oxazepam.,increase,risk
Reserpine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Reserpine is combined with Oxcarbazepine.,increase,risk
Reserpine,Oxitriptan,The risk or severity of CNS depression can be increased when Reserpine is combined with Oxitriptan.,increase,risk
Reserpine,Oxprenolol,Reserpine may increase the hypotensive activities of Oxprenolol.,increase,no risk
Azithromycin,Butalbital,The metabolism of Azithromycin can be increased when combined with Butalbital.,increase,no risk
Azithromycin,Butamben,The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Butamben.,increase,risk
Azithromycin,Butriptyline,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Butriptyline.,increase,risk
Azithromycin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Gadobenic acid.,increase,risk
Azithromycin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Azithromycin.,increase,risk
Azithromycin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Azithromycin.,increase,risk
Azithromycin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Gemifloxacin.,increase,risk
Azithromycin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Azithromycin.,increase,risk
Azithromycin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Gilteritinib.,increase,risk
Azithromycin,Ginkgo biloba,The metabolism of Azithromycin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Azithromycin,Glasdegib,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Glasdegib.,increase,risk
Azithromycin,Glecaprevir,The metabolism of Azithromycin can be decreased when combined with Glecaprevir.,decrease,no risk
Azithromycin,Glofitamab,The serum concentration of Azithromycin can be increased when it is combined with Glofitamab.,increase,no risk
Azithromycin,Glyburide,The metabolism of Azithromycin can be decreased when combined with Glyburide.,decrease,no risk
Azithromycin,Glycerol phenylbutyrate,The metabolism of Azithromycin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Azithromycin,Golimumab,The metabolism of Azithromycin can be increased when combined with Golimumab.,increase,no risk
Azithromycin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azithromycin.,increase,risk
Azithromycin,Granisetron,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Granisetron.,increase,risk
Azithromycin,Grapefruit,The metabolism of Azithromycin can be decreased when combined with Grapefruit.,decrease,no risk
Azithromycin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Grepafloxacin.,increase,risk
Azithromycin,Griseofulvin,The metabolism of Azithromycin can be increased when combined with Griseofulvin.,increase,no risk
Azithromycin,Halofantrine,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Halofantrine.,increase,risk
Azithromycin,Haloperidol,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Haloperidol.,increase,risk
Azithromycin,Heparin,The risk or severity of adverse effects can be increased when Azithromycin is combined with Heparin.,increase,risk
Azithromycin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Azithromycin.,increase,risk
Azithromycin,Hydralazine,The metabolism of Azithromycin can be decreased when combined with Hydralazine.,decrease,no risk
Azithromycin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Azithromycin.,increase,risk
Azithromycin,Hydrocortamate,The metabolism of Azithromycin can be increased when combined with Hydrocortamate.,increase,no risk
Azithromycin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Azithromycin.,increase,no risk
Azithromycin,Hydrocortisone acetate,The metabolism of Azithromycin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Azithromycin,Hydrocortisone butyrate,The metabolism of Azithromycin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Azithromycin,Hydrocortisone succinate,The metabolism of Azithromycin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Azithromycin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Azithromycin.,increase,risk
Azithromycin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Hydroxyzine.,increase,risk
Azithromycin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Azithromycin.,increase,risk
Azithromycin,Ketazolam,The metabolism of Azithromycin can be decreased when combined with Ketazolam.,decrease,no risk
Azithromycin,Ketoconazole,The metabolism of Azithromycin can be decreased when combined with Ketoconazole.,decrease,no risk
Ticlopidine,Bacitracin,Bacitracin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Baclofen,Baclofen may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Balsalazide,The risk or severity of bleeding can be increased when Balsalazide is combined with Ticlopidine.,increase,risk
Ticlopidine,Baricitinib,Ticlopidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Ticlopidine,Belinostat,The risk or severity of bleeding can be increased when Ticlopidine is combined with Belinostat.,increase,risk
Ticlopidine,Gabapentin enacarbil,Ticlopidine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gadobenic acid,Ticlopidine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gadodiamide,Ticlopidine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gadofosveset trisodium,Ticlopidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gadopentetic acid,Ticlopidine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gadoteric acid,Ticlopidine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gadoteridol,Ticlopidine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ticlopidine,Galantamine,The metabolism of Galantamine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Ganciclovir,Ticlopidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Gemcitabine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Gemcitabine.,increase,risk
Ticlopidine,Gemfibrozil,The metabolism of Ticlopidine can be decreased when combined with Gemfibrozil.,decrease,no risk
Ticlopidine,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ticlopidine is combined with Gemtuzumab ozogamicin.,increase,risk
Ticlopidine,Gentamicin,Ticlopidine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gimeracil,Ticlopidine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ticlopidine,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Ticlopidine.,increase,no risk
Ticlopidine,Givosiran,The serum concentration of Ticlopidine can be increased when it is combined with Givosiran.,increase,no risk
Ticlopidine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Glipizide,Ticlopidine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ticlopidine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Glofitamab,The serum concentration of Ticlopidine can be increased when it is combined with Glofitamab.,increase,no risk
Ticlopidine,Glucosamine,Glucosamine may increase the antiplatelet activities of Ticlopidine.,increase,no risk
Ticlopidine,Glyburide,The metabolism of Glyburide can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Glycerol phenylbutyrate,The metabolism of Ticlopidine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Ticlopidine,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Ticlopidine.,increase,risk
Ticlopidine,Golimumab,The metabolism of Ticlopidine can be increased when combined with Golimumab.,increase,no risk
Ticlopidine,Golodirsen,Ticlopidine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ticlopidine,Goserelin,Goserelin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Guanethidine,Ticlopidine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Guanfacine,Ticlopidine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Halofantrine,The metabolism of Ticlopidine can be decreased when combined with Halofantrine.,decrease,no risk
Ticlopidine,Haloperidol,The serum concentration of Ticlopidine can be increased when it is combined with Haloperidol.,increase,no risk
Ticlopidine,Halothane,The metabolism of Halothane can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Heparin,The risk or severity of bleeding can be increased when Ticlopidine is combined with Heparin.,increase,risk
Ticlopidine,Hydralazine,Ticlopidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ticlopidine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ticlopidine,Hydromorphone,Ticlopidine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ticlopidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Hydroxyethyl Starch,Ticlopidine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ticlopidine,Hydroxyurea,The risk or severity of bleeding can be increased when Ticlopidine is combined with Hydroxyurea.,increase,risk
Ticlopidine,Hydroxyzine,The metabolism of Ticlopidine can be decreased when combined with Hydroxyzine.,decrease,no risk
Ticlopidine,Kanamycin,Ticlopidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ticlopidine,Ketamine,The metabolism of Ketamine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Ketazolam,Ticlopidine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ticlopidine,Ketoconazole,The metabolism of Ticlopidine can be decreased when combined with Ketoconazole.,decrease,no risk
Ticlopidine,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Ticlopidine.,increase,risk
Ticlopidine,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Ticlopidine.,increase,risk
Ticlopidine,Obeticholic acid,The risk or severity of adverse effects can be increased when Ticlopidine is combined with Obeticholic acid.,increase,risk
Ticlopidine,Obinutuzumab,The risk or severity of adverse effects can be increased when Ticlopidine is combined with Obinutuzumab.,increase,risk
Ticlopidine,Octinoxate,Ticlopidine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ticlopidine,Olanzapine,The metabolism of Ticlopidine can be decreased when combined with Olanzapine.,decrease,no risk
Ticlopidine,Olaparib,The risk or severity of bleeding can be increased when Ticlopidine is combined with Olaparib.,increase,risk
Ticlopidine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Olsalazine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Olsalazine.,increase,risk
Ticlopidine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Ticlopidine.,increase,no risk
Ticlopidine,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ticlopidine.,increase,risk
Ticlopidine,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Opium,The metabolism of Opium can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Oritavancin,The metabolism of Ticlopidine can be decreased when combined with Oritavancin.,decrease,no risk
Ticlopidine,Orphenadrine,The metabolism of Ticlopidine can be decreased when combined with Orphenadrine.,decrease,no risk
Ticlopidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Oxacillin,Ticlopidine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ticlopidine,Oxaliplatin,The risk or severity of bleeding can be increased when Ticlopidine is combined with Oxaliplatin.,increase,risk
Ticlopidine,Oxamniquine,The metabolism of Ticlopidine can be decreased when combined with Oxamniquine.,decrease,no risk
Ticlopidine,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Ticlopidine.,increase,risk
Ticlopidine,Oxazepam,Ticlopidine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ticlopidine,Oxcarbazepine,The metabolism of Ticlopidine can be decreased when combined with Oxcarbazepine.,decrease,no risk
Ticlopidine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Oxybenzone,Ticlopidine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ticlopidine,Oxybutynin,The metabolism of Ticlopidine can be decreased when combined with Oxybutynin.,decrease,no risk
Ticlopidine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Ticlopidine.,increase,risk
Ticlopidine,Oxyquinoline,Ticlopidine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ticlopidine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Urokinase,Ticlopidine may increase the anticoagulant activities of Urokinase.,increase,no risk
Ticlopidine,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Ticlopidine is combined with Ursodeoxycholic acid.,increase,risk
Ticlopidine,Vaborbactam,Ticlopidine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ticlopidine,Valaciclovir,Valaciclovir may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,decrease,no risk
Ticlopidine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Ticlopidine.,increase,risk
Ticlopidine,Valganciclovir,Ticlopidine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ticlopidine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Valsartan,The metabolism of Valsartan can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Vancomycin,Ticlopidine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ticlopidine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Varenicline,Ticlopidine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ticlopidine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Vemurafenib,The metabolism of Ticlopidine can be decreased when combined with Vemurafenib.,decrease,no risk
Ticlopidine,Venlafaxine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Venlafaxine.,increase,risk
Ticlopidine,Verapamil,The metabolism of Verapamil can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Vilanterol,Ticlopidine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ticlopidine,Vilazodone,The metabolism of Ticlopidine can be decreased when combined with Vilazodone.,decrease,no risk
Ticlopidine,Viloxazine,The metabolism of Ticlopidine can be decreased when combined with Viloxazine.,decrease,no risk
Ticlopidine,Vinblastine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Vinblastine.,increase,risk
Ticlopidine,Vindesine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Vindesine.,increase,risk
Ticlopidine,Vinorelbine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Vinorelbine.,increase,risk
Ticlopidine,Vitamin E,Vitamin E may increase the antiplatelet activities of Ticlopidine.,increase,no risk
Ticlopidine,Vonoprazan,The metabolism of Ticlopidine can be decreased when combined with Vonoprazan.,decrease,no risk
Ticlopidine,Vorapaxar,The risk or severity of bleeding can be increased when Ticlopidine is combined with Vorapaxar.,increase,risk
Ticlopidine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Vorinostat,The risk or severity of bleeding can be increased when Ticlopidine is combined with Vorinostat.,increase,risk
Ticlopidine,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Ticlopidine.,increase,risk
Ticlopidine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Warfarin,The risk or severity of bleeding can be increased when Ticlopidine is combined with Warfarin.,increase,risk
Ticlopidine,Ximelagatran,The risk or severity of bleeding can be increased when Ticlopidine is combined with Ximelagatran.,increase,risk
Ticlopidine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zafirlukast,The metabolism of Ticlopidine can be decreased when combined with Zafirlukast.,decrease,no risk
Ticlopidine,Zaleplon,Ticlopidine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ticlopidine,Zanamivir,Ticlopidine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ticlopidine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zidovudine,The risk or severity of bleeding can be increased when Ticlopidine is combined with Zidovudine.,increase,risk
Ticlopidine,Zileuton,The metabolism of Zileuton can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ticlopidine.,increase,risk
Ticlopidine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zotepine,The metabolism of Zotepine can be decreased when combined with Ticlopidine.,decrease,no risk
Ticlopidine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ticlopidine.,decrease,no risk
Trospium,Galantamine,The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.,decrease,no risk
Trospium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Trospium is combined with Gallamine triethiodide.,increase,risk
Trospium,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Trospium.,decrease,no risk
Trospium,Ginkgo biloba,The therapeutic efficacy of Trospium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Trospium,Glucagon,Trospium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Trospium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Trospium.,decrease,no risk
Trospium,Glycopyrronium,The risk or severity of adverse effects can be increased when Trospium is combined with Glycopyrronium.,increase,risk
Trospium,Guanabenz,The risk or severity of Tachycardia can be increased when Trospium is combined with Guanabenz.,increase,risk
Trospium,Guanfacine,The risk or severity of Tachycardia can be increased when Trospium is combined with Guanfacine.,increase,risk
Trospium,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Trospium.,increase,no risk
Trospium,Hexafluronium,The risk or severity of adverse effects can be increased when Trospium is combined with Hexafluronium.,increase,risk
Trospium,Hexocyclium,The risk or severity of adverse effects can be increased when Trospium is combined with Hexocyclium.,increase,risk
Trospium,Homatropine,The risk or severity of adverse effects can be increased when Trospium is combined with Homatropine.,increase,risk
Trospium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Trospium is combined with Homatropine methylbromide.,increase,risk
Trospium,Huperzine A,The therapeutic efficacy of Trospium can be decreased when used in combination with Huperzine A.,decrease,no risk
Trospium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Trospium.,increase,no risk
Trospium,Hydrocodone,The risk or severity of adverse effects can be increased when Trospium is combined with Hydrocodone.,increase,risk
Trospium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Trospium.,increase,no risk
Trospium,Hydromorphone,The risk or severity of adverse effects can be increased when Trospium is combined with Hydromorphone.,increase,risk
Trospium,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Trospium.,decrease,no risk
Trospium,Hyoscyamine,The risk or severity of adverse effects can be increased when Trospium is combined with Hyoscyamine.,increase,risk
Trospium,Ketamine,The therapeutic efficacy of Trospium can be decreased when used in combination with Ketamine.,decrease,no risk
Trospium,Olanzapine,The risk or severity of adverse effects can be increased when Trospium is combined with Olanzapine.,increase,risk
Trospium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Trospium is combined with Oliceridine.",increase,risk
Trospium,Olodaterol,The risk or severity of Tachycardia can be increased when Trospium is combined with Olodaterol.,increase,risk
Trospium,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Trospium.,decrease,no risk
Trospium,Opium,The risk or severity of adverse effects can be increased when Trospium is combined with Opium.,increase,risk
Trospium,Orciprenaline,The risk or severity of Tachycardia can be increased when Trospium is combined with Orciprenaline.,increase,risk
Trospium,Orphenadrine,The risk or severity of adverse effects can be increased when Trospium is combined with Orphenadrine.,increase,risk
Trospium,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Trospium.,decrease,no risk
Trospium,Oxybutynin,The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.,increase,risk
Trospium,Oxycodone,The risk or severity of adverse effects can be increased when Trospium is combined with Oxycodone.,increase,risk
Trospium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Trospium is combined with Oxymetazoline.,increase,risk
Trospium,Oxymorphone,The risk or severity of adverse effects can be increased when Trospium is combined with Oxymorphone.,increase,risk
Trospium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Trospium is combined with Oxyphencyclimine.,increase,risk
Trospium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Trospium.,decrease,no risk
Trospium,Oxyphenonium,The risk or severity of adverse effects can be increased when Trospium is combined with Oxyphenonium.,increase,risk
Trospium,Quetiapine,The risk or severity of adverse effects can be increased when Trospium is combined with Quetiapine.,increase,risk
Trospium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Trospium.,increase,no risk
Trospium,Quinidine,The risk or severity of adverse effects can be increased when Trospium is combined with Quinidine.,increase,risk
Trospium,Quinine,The metabolism of Quinine can be decreased when combined with Trospium.,decrease,no risk
Trospium,Quinupramine,The risk or severity of adverse effects can be increased when Trospium is combined with Quinupramine.,increase,risk
Trospium,Umeclidinium,The risk or severity of adverse effects can be increased when Trospium is combined with Umeclidinium.,increase,risk
Trospium,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Trospium.,decrease,no risk
Trospium,Vecuronium,The risk or severity of adverse effects can be increased when Trospium is combined with Vecuronium.,increase,risk
Trospium,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Trospium.,decrease,no risk
Trospium,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Trospium.,decrease,no risk
Trospium,Vibegron,Trospium may increase the smooth muscle relaxing activities of Vibegron.,increase,no risk
Midodrine,Galantamine,Midodrine may increase the bradycardic activities of Galantamine.,increase,no risk
Midodrine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Midodrine is combined with Gallamine triethiodide.,increase,risk
Midodrine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Midodrine.,decrease,no risk
Midodrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Midodrine is combined with Glycopyrronium.,increase,risk
Midodrine,Guanabenz,Midodrine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Midodrine,Guanadrel,Midodrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Midodrine,Guanethidine,Midodrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Midodrine,Guanfacine,Midodrine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Midodrine,Guanoxan,Midodrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Midodrine,Halothane,The risk or severity of hypertension can be increased when Midodrine is combined with Halothane.,increase,risk
Midodrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Midodrine is combined with Hexocyclium.,increase,risk
Midodrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Midodrine is combined with Homatropine methylbromide.,increase,risk
Midodrine,Hydralazine,Midodrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Midodrine,Hydrochlorothiazide,Midodrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Midodrine,Hydroflumethiazide,Midodrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Midodrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Midodrine is combined with Hyoscyamine.,increase,risk
Midodrine,Ketamine,The risk or severity of Tachycardia can be increased when Midodrine is combined with Ketamine.,increase,risk
Midodrine,Ketoprofen,The risk or severity of hypertension can be increased when Midodrine is combined with Ketoprofen.,increase,risk
Midodrine,Ketorolac,The risk or severity of hypertension can be increased when Midodrine is combined with Ketorolac.,increase,risk
Midodrine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Midodrine.,increase,no risk
Midodrine,Olanzapine,The therapeutic efficacy of Midodrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Midodrine,Olmesartan,Midodrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Midodrine,Olodaterol,The risk or severity of hypertension can be increased when Midodrine is combined with Olodaterol.,increase,risk
Midodrine,Orciprenaline,The risk or severity of hypertension can be increased when Midodrine is combined with Orciprenaline.,increase,risk
Midodrine,Orphenadrine,The risk or severity of Tachycardia can be increased when Midodrine is combined with Orphenadrine.,increase,risk
Midodrine,Ouabain,"Ouabain may increase the bradycardic, atrioventricular blocking (AV block), and arrhythmogenic activities of Midodrine.",increase,no risk
Midodrine,Oxaprozin,The risk or severity of hypertension can be increased when Midodrine is combined with Oxaprozin.,increase,risk
Midodrine,Oxprenolol,The therapeutic efficacy of Midodrine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Midodrine,Oxtriphylline,The risk or severity of adverse effects can be increased when Midodrine is combined with Oxtriphylline.,increase,risk
Midodrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Midodrine is combined with Oxybutynin.,increase,risk
Midodrine,Oxymetazoline,Midodrine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Midodrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Midodrine is combined with Oxyphenbutazone.,increase,risk
Midodrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Midodrine is combined with Oxyphencyclimine.,increase,risk
Midodrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Midodrine is combined with Oxyphenonium.,increase,risk
Midodrine,Oxytocin,The risk or severity of hypertension can be increased when Midodrine is combined with Oxytocin.,increase,risk
Midodrine,Quetiapine,The therapeutic efficacy of Midodrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Midodrine,Quinapril,Midodrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Midodrine,Quinidine,The therapeutic efficacy of Midodrine can be decreased when used in combination with Quinidine.,decrease,no risk
Midodrine,Quinupramine,Quinupramine may increase the vasopressor activities of Midodrine.,increase,no risk
Midodrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Midodrine is combined with Umeclidinium.,increase,risk
Midodrine,Valdecoxib,The risk or severity of hypertension can be increased when Midodrine is combined with Valdecoxib.,increase,risk
Midodrine,Valsartan,Midodrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Midodrine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Midodrine.,increase,no risk
Midodrine,Verapamil,Midodrine may increase the bradycardic activities of Verapamil.,increase,no risk
Midodrine,Vilanterol,The risk or severity of hypertension can be increased when Midodrine is combined with Vilanterol.,increase,risk
Midodrine,Vilazodone,The risk or severity of hypertension can be increased when Midodrine is combined with Vilazodone.,increase,risk
Midodrine,Vortioxetine,The risk or severity of hypertension can be increased when Midodrine is combined with Vortioxetine.,increase,risk
Midodrine,Xamoterol,The risk or severity of hypertension can be increased when Midodrine is combined with Xamoterol.,increase,risk
Midodrine,Xylometazoline,The risk or severity of hypertension can be increased when Midodrine is combined with Xylometazoline.,increase,risk
Midodrine,Yohimbine,The risk or severity of hypertension can be increased when Midodrine is combined with Yohimbine.,increase,risk
Midodrine,Ziprasidone,The therapeutic efficacy of Midodrine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Midodrine,Zofenopril,Midodrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Midodrine,Zolmitriptan,The risk or severity of hypertension can be increased when Midodrine is combined with Zolmitriptan.,increase,risk
Midodrine,Zonisamide,Midodrine may increase the bradycardic activities of Zonisamide.,increase,no risk
Midodrine,Zuclopenthixol,The therapeutic efficacy of Midodrine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Remikiren,Glycol salicylate,The therapeutic efficacy of Remikiren can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Remikiren,Guanabenz,Guanabenz may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Guanadrel,Remikiren may increase the hypotensive activities of Guanadrel.,increase,no risk
Remikiren,Guanethidine,Remikiren may increase the hypotensive activities of Guanethidine.,increase,no risk
Remikiren,Guanfacine,Guanfacine may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Guanoxan,Remikiren may increase the hypotensive activities of Guanoxan.,increase,no risk
Remikiren,Halothane,Halothane may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Hydralazine,Remikiren may increase the hypotensive activities of Hydralazine.,increase,no risk
Remikiren,Hydrochlorothiazide,The therapeutic efficacy of Remikiren can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Remikiren,Hydroflumethiazide,The therapeutic efficacy of Remikiren can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Remikiren,Ketoprofen,The therapeutic efficacy of Remikiren can be decreased when used in combination with Ketoprofen.,decrease,no risk
Remikiren,Ketorolac,The therapeutic efficacy of Remikiren can be decreased when used in combination with Ketorolac.,decrease,no risk
Remikiren,Obinutuzumab,Remikiren may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Remikiren,Olanzapine,Olanzapine may increase the hypotensive activities of Remikiren.,increase,no risk
Remikiren,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Remikiren is combined with Olmesartan.",increase,risk
Remikiren,Olodaterol,Olodaterol may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Opicapone,Opicapone may increase the hypotensive activities of Remikiren.,increase,no risk
Remikiren,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Oxaprozin,The therapeutic efficacy of Remikiren can be decreased when used in combination with Oxaprozin.,decrease,no risk
Remikiren,Oxprenolol,Remikiren may increase the hypotensive activities of Oxprenolol.,increase,no risk
Remikiren,Oxymetazoline,The therapeutic efficacy of Remikiren can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Remikiren,Oxyphenbutazone,The therapeutic efficacy of Remikiren can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Remikiren,Quetiapine,Quetiapine may increase the hypotensive activities of Remikiren.,increase,no risk
Remikiren,Quinapril,Remikiren may increase the hypotensive activities of Quinapril.,increase,no risk
Remikiren,Quinidine,Quinidine may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Quinine,Quinine may increase the hypotensive activities of Remikiren.,increase,no risk
Remikiren,Quinupramine,Quinupramine may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Udenafil,Udenafil may increase the antihypertensive activities of Remikiren.,increase,no risk
Remikiren,Unoprostone,Remikiren may increase the hypotensive activities of Unoprostone.,increase,no risk
Remikiren,Valdecoxib,The therapeutic efficacy of Remikiren can be decreased when used in combination with Valdecoxib.,decrease,no risk
Remikiren,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Remikiren is combined with Valsartan.",increase,risk
Remikiren,Vardenafil,Vardenafil may increase the antihypertensive activities of Remikiren.,increase,no risk
Remikiren,Verapamil,Verapamil may increase the hypotensive activities of Remikiren.,increase,no risk
Remikiren,Vericiguat,Vericiguat may increase the hypotensive activities of Remikiren.,increase,no risk
Remikiren,Vilanterol,Vilanterol may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Vilazodone,Vilazodone may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Xamoterol,Xamoterol may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Yohimbine,Yohimbine may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Remikiren.,increase,no risk
Remikiren,Zofenopril,Remikiren may increase the hypotensive activities of Zofenopril.,increase,no risk
Remikiren,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Remikiren,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Remikiren.,decrease,no risk
Pantoprazole,Bleomycin,Pantoprazole may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Pantoprazole,Boceprevir,The metabolism of Pantoprazole can be decreased when combined with Boceprevir.,decrease,no risk
Pantoprazole,Bortezomib,The metabolism of Pantoprazole can be decreased when combined with Bortezomib.,decrease,no risk
Pantoprazole,Bosentan,The excretion of Bosentan can be decreased when combined with Pantoprazole.,decrease,no risk
Pantoprazole,Bosutinib,Pantoprazole can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Pantoprazole,Brigatinib,Pantoprazole may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Pantoprazole,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Pantoprazole.,increase,no risk
Pantoprazole,Brivaracetam,Pantoprazole may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Pantoprazole,Bromazepam,Pantoprazole may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Pantoprazole,Bromotheophylline,Bromotheophylline may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pantoprazole,Budesonide,Pantoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Pantoprazole,Bumadizone,Bumadizone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,decrease,no risk
Pantoprazole,Bumetanide,The excretion of Bumetanide can be decreased when combined with Pantoprazole.,decrease,no risk
Pantoprazole,Buprenorphine,The metabolism of Pantoprazole can be decreased when combined with Buprenorphine.,decrease,no risk
Pantoprazole,Bupropion,Pantoprazole may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Pantoprazole,Buspirone,Pantoprazole may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Pantoprazole,Butabarbital,Pantoprazole may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Pantoprazole,Gabapentin enacarbil,Pantoprazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pantoprazole,Gadobenic acid,Pantoprazole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Pantoprazole,Gadodiamide,Pantoprazole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Pantoprazole,Gadofosveset trisodium,Pantoprazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pantoprazole,Gadopentetic acid,Pantoprazole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Torasemide,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Torasemide.,increase,risk
Torasemide,Balsalazide,The therapeutic efficacy of Torasemide can be decreased when used in combination with Balsalazide.,decrease,no risk
Torasemide,Baricitinib,Torasemide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Beclomethasone dipropionate,The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Torasemide.,increase,risk
Torasemide,Belumosudil,The excretion of Torasemide can be decreased when combined with Belumosudil.,decrease,no risk
Torasemide,Bempedoic acid,The excretion of Torasemide can be decreased when combined with Bempedoic acid.,decrease,no risk
Torasemide,Benazepril,Torasemide may increase the hypotensive activities of Benazepril.,increase,no risk
Torasemide,Bendroflumethiazide,The therapeutic efficacy of Torasemide can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Torasemide,Benorilate,The therapeutic efficacy of Torasemide can be decreased when used in combination with Benorilate.,decrease,no risk
Torasemide,Benoxaprofen,The therapeutic efficacy of Torasemide can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Torasemide,Benserazide,Torasemide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Benzatropine,Torasemide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Benzhydrocodone,The therapeutic efficacy of Torasemide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Torasemide,Benznidazole,Torasemide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Torasemide.,decrease,no risk
Torasemide,Benzthiazide,The therapeutic efficacy of Torasemide can be increased when used in combination with Benzthiazide.,increase,no risk
Torasemide,Benzydamine,The therapeutic efficacy of Torasemide can be decreased when used in combination with Benzydamine.,decrease,no risk
Torasemide,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Benzylpenicillin,Torasemide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Torasemide,Bepotastine,Torasemide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bepridil,Torasemide may increase the hypotensive activities of Bepridil.,increase,no risk
Torasemide,Betamethasone,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Torasemide.,increase,risk
Torasemide,Betamethasone phosphate,The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Torasemide.,increase,risk
Torasemide,Betaxolol,Betaxolol may increase the hypotensive activities of Torasemide.,increase,no risk
Torasemide,Bethanidine,Bethanidine may decrease the antihypertensive activities of Torasemide.,decrease,no risk
Torasemide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Bexarotene,The metabolism of Torasemide can be decreased when combined with Bexarotene.,decrease,no risk
Torasemide,Bezafibrate,The metabolism of Torasemide can be decreased when combined with Bezafibrate.,decrease,no risk
Torasemide,Bicisate,Torasemide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bimatoprost,Torasemide may increase the hypotensive activities of Bimatoprost.,increase,no risk
Torasemide,Bimekizumab,The metabolism of Torasemide can be increased when combined with Bimekizumab.,increase,no risk
Torasemide,Bisacodyl,The risk or severity of dehydration can be increased when Torasemide is combined with Bisacodyl.,increase,risk
Torasemide,Bismuth subgallate,Torasemide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bismuth subsalicylate,The risk or severity of adverse effects can be increased when Torasemide is combined with Bismuth subsalicylate.,increase,risk
Torasemide,Bisoprolol,Torasemide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bisoxatin,The risk or severity of dehydration can be increased when Torasemide is combined with Bisoxatin.,increase,risk
Torasemide,Bleomycin,Torasemide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Bosentan,The metabolism of Torasemide can be increased when combined with Bosentan.,increase,no risk
Torasemide,Bosutinib,The metabolism of Torasemide can be decreased when combined with Bosutinib.,decrease,no risk
Torasemide,Bretylium,Torasemide may increase the hypotensive activities of Bretylium.,increase,no risk
Torasemide,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Torasemide.,decrease,no risk
Torasemide,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Brimonidine,Brimonidine may increase the antihypertensive activities of Torasemide.,increase,no risk
Torasemide,Brivaracetam,Torasemide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bromazepam,Torasemide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Torasemide.,increase,risk
Torasemide,Bumadizone,The therapeutic efficacy of Torasemide can be decreased when used in combination with Bumadizone.,decrease,no risk
Torasemide,Bumetanide,Torasemide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Bupivacaine,The risk or severity of adverse effects can be increased when Torasemide is combined with Bupivacaine.,increase,risk
Torasemide,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Bupropion,Torasemide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Buspirone,Torasemide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Butabarbital,Butabarbital may increase the hypotensive activities of Torasemide.,increase,no risk
Torasemide,Butalbital,Butalbital may increase the hypotensive activities of Torasemide.,increase,no risk
Torasemide,Butorphanol,The therapeutic efficacy of Torasemide can be decreased when used in combination with Butorphanol.,decrease,no risk
Torasemide,Butriptyline,Butriptyline may decrease the antihypertensive activities of Torasemide.,decrease,no risk
Torasemide,Gabapentin enacarbil,Torasemide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gadobenic acid,Torasemide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gadodiamide,Torasemide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gadofosveset trisodium,Torasemide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gadopentetic acid,Torasemide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gadoteric acid,Torasemide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gadoteridol,Torasemide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gallamine triethiodide,Torasemide may decrease the neuromuscular blocking activities of Gallamine triethiodide.,decrease,no risk
Torasemide,Ganciclovir,Torasemide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gemcitabine,Torasemide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Gemfibrozil,The metabolism of Torasemide can be decreased when combined with Gemfibrozil.,decrease,no risk
Torasemide,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Torasemide.,increase,no risk
Torasemide,Gimeracil,Torasemide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Ginkgo biloba,The metabolism of Torasemide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Torasemide,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Glecaprevir,The excretion of Torasemide can be decreased when combined with Glecaprevir.,decrease,no risk
Torasemide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Glofitamab,The serum concentration of Torasemide can be increased when it is combined with Glofitamab.,increase,no risk
Torasemide,Gluconic Acid,The risk or severity of dehydration can be increased when Torasemide is combined with Gluconic Acid.,increase,risk
Torasemide,Glycerin,The risk or severity of dehydration can be increased when Torasemide is combined with Glycerin.,increase,risk
Torasemide,Glycerol phenylbutyrate,Torasemide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Glycol salicylate,The therapeutic efficacy of Torasemide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Torasemide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Torasemide.,decrease,no risk
Torasemide,Golimumab,The metabolism of Torasemide can be increased when combined with Golimumab.,increase,no risk
Torasemide,Golodirsen,Torasemide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Goserelin,Torasemide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Guanabenz,Guanabenz may decrease the antihypertensive activities of Torasemide.,decrease,no risk
Torasemide,Guanadrel,Torasemide may increase the hypotensive activities of Guanadrel.,increase,no risk
Torasemide,Guanethidine,Torasemide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Guanfacine,Torasemide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Guanoxan,Torasemide may increase the hypotensive activities of Guanoxan.,increase,no risk
Torasemide,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Haloperidol,Torasemide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Halothane,The metabolism of Halothane can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Hydralazine,Torasemide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Hydrochlorothiazide,The therapeutic efficacy of Torasemide can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Torasemide,Hydrocodone,The therapeutic efficacy of Torasemide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Torasemide,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Torasemide.,increase,risk
Torasemide,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Torasemide.,increase,risk
Torasemide,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Torasemide.,increase,risk
Torasemide,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Torasemide.,increase,risk
Torasemide,Hydroflumethiazide,The therapeutic efficacy of Torasemide can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Torasemide,Hydromorphone,Torasemide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Hydroxocobalamin,Torasemide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Torasemide.,decrease,no risk
Torasemide,Hydroxyethyl Starch,Torasemide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Kanamycin,The serum concentration of Kanamycin can be increased when it is combined with Torasemide.,increase,no risk
Torasemide,Ketamine,Torasemide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Ketazolam,Torasemide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Torasemide,Ketoconazole,The metabolism of Torasemide can be decreased when combined with Ketoconazole.,decrease,no risk
Torasemide,Ketoprofen,The therapeutic efficacy of Torasemide can be decreased when used in combination with Ketoprofen.,decrease,no risk
Torasemide,Ketorolac,The therapeutic efficacy of Torasemide can be decreased when used in combination with Ketorolac.,decrease,no risk
Citalopram,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Citalopram.,increase,risk
Citalopram,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Bendroflumethiazide,The risk or severity of hyponatremia can be increased when Citalopram is combined with Bendroflumethiazide.,increase,risk
Citalopram,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Benorilate.,increase,risk
Citalopram,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Benoxaprofen.,increase,risk
Citalopram,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Citalopram.,increase,risk
Citalopram,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Citalopram.,increase,risk
Citalopram,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Citalopram.,increase,risk
Citalopram,Benzocaine,The risk or severity of adverse effects can be increased when Benzocaine is combined with Citalopram.,increase,risk
Citalopram,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Citalopram.,increase,risk
Citalopram,Benzthiazide,The risk or severity of hyponatremia can be increased when Citalopram is combined with Benzthiazide.,increase,risk
Citalopram,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Benzydamine.,increase,risk
Citalopram,Benzyl alcohol,The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Citalopram.,increase,risk
Citalopram,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Citalopram.,increase,risk
Citalopram,Berotralstat,The metabolism of Citalopram can be decreased when combined with Berotralstat.,decrease,no risk
Citalopram,Besifloxacin,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Citalopram.,increase,risk
Citalopram,Betaxolol,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Citalopram.,increase,risk
Citalopram,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Citalopram.,increase,risk
Citalopram,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Bexagliflozin.,increase,risk
Citalopram,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Citalopram.,increase,risk
Citalopram,Bimekizumab,The metabolism of Citalopram can be increased when combined with Bimekizumab.,increase,no risk
Citalopram,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Biperiden,The metabolism of Citalopram can be decreased when combined with Biperiden.,decrease,no risk
Citalopram,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Citalopram.,increase,risk
Citalopram,Boceprevir,The metabolism of Citalopram can be decreased when combined with Boceprevir.,decrease,no risk
Citalopram,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Citalopram.,increase,risk
Citalopram,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Citalopram.,increase,risk
Citalopram,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Citalopram.,increase,risk
Citalopram,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Citalopram.,increase,risk
Citalopram,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Citalopram.,increase,risk
Citalopram,Brexpiprazole,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Citalopram.,increase,risk
Citalopram,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Citalopram.,increase,no risk
Citalopram,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Citalopram.,increase,risk
Citalopram,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Citalopram.,increase,risk
Citalopram,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Citalopram.,increase,risk
Citalopram,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Citalopram.,increase,risk
Citalopram,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Citalopram.,increase,risk
Citalopram,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Citalopram.,increase,risk
Citalopram,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Bumadizone.,increase,risk
Citalopram,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Citalopram.,increase,risk
Citalopram,Buprenorphine,Citalopram may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Citalopram,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Citalopram.,increase,risk
Citalopram,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Citalopram.,increase,risk
Citalopram,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Citalopram.,increase,risk
Citalopram,Busulfan,The metabolism of Busulfan can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Citalopram.,increase,risk
Citalopram,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Citalopram.,increase,risk
Citalopram,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Citalopram.,increase,risk
Citalopram,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Citalopram.,increase,risk
Citalopram,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Citalopram.,increase,risk
Citalopram,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Citalopram.,increase,risk
Citalopram,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Citalopram.,increase,risk
Citalopram,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Citalopram.,increase,risk
Citalopram,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Citalopram.,increase,risk
Citalopram,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Citalopram.,increase,risk
Citalopram,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Citalopram.,increase,risk
Citalopram,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Citalopram is combined with Ganaxolone.",increase,risk
Citalopram,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Citalopram.,increase,risk
Citalopram,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Gemfibrozil,The serum concentration of Citalopram can be increased when it is combined with Gemfibrozil.,increase,no risk
Citalopram,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Citalopram.,increase,risk
Citalopram,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Citalopram.,increase,no risk
Citalopram,Gilteritinib,The therapeutic efficacy of Citalopram can be decreased when used in combination with Gilteritinib.,decrease,no risk
Citalopram,Ginkgo biloba,The metabolism of Citalopram can be decreased when combined with Ginkgo biloba.,decrease,no risk
Citalopram,Givosiran,The serum concentration of Citalopram can be increased when it is combined with Givosiran.,increase,no risk
Citalopram,Glasdegib,The risk or severity of QTc prolongation can be increased when Citalopram is combined with Glasdegib.,increase,risk
Citalopram,Gliclazide,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Gliclazide.,increase,risk
Citalopram,Glimepiride,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Glimepiride.,increase,risk
Citalopram,Glipizide,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Glipizide.,increase,risk
Citalopram,Gliquidone,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Gliquidone.,increase,risk
Citalopram,Glofitamab,The serum concentration of Citalopram can be increased when it is combined with Glofitamab.,increase,no risk
Citalopram,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Citalopram.,increase,risk
Citalopram,Glyburide,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Glyburide.,increase,risk
Citalopram,Glycerol phenylbutyrate,The metabolism of Citalopram can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Citalopram,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Glycol salicylate.,increase,risk
Citalopram,Glymidine,The risk or severity of hypoglycemia can be increased when Citalopram is combined with Glymidine.,increase,risk
Citalopram,Golimumab,The metabolism of Citalopram can be increased when combined with Golimumab.,increase,no risk
Citalopram,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Citalopram.,increase,risk
Citalopram,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Citalopram.,increase,risk
Citalopram,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Citalopram.,increase,risk
Citalopram,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Citalopram.,increase,risk
Citalopram,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Citalopram.,increase,risk
Citalopram,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Citalopram.,increase,risk
Citalopram,Haloperidol,The risk or severity of QTc prolongation can be increased when Citalopram is combined with Haloperidol.,increase,risk
Citalopram,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Citalopram.,increase,risk
Citalopram,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Citalopram.,increase,risk
Citalopram,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Citalopram.,increase,risk
Citalopram,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Citalopram.,increase,risk
Citalopram,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Citalopram.,increase,risk
Citalopram,Hydrocodone,Citalopram may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Citalopram,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Citalopram is combined with Hydroflumethiazide.,increase,risk
Citalopram,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Citalopram.,increase,risk
Citalopram,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Citalopram.,increase,risk
Citalopram,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Citalopram is combined with Hydroxyzine.,increase,risk
Citalopram,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Citalopram.,increase,risk
Citalopram,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Citalopram.,increase,risk
Citalopram,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Citalopram.,increase,risk
Citalopram,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Citalopram.,increase,risk
Citalopram,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Ketoprofen.,increase,risk
Citalopram,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Ketorolac.,increase,risk
Citalopram,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Citalopram.,increase,risk
Citalopram,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Citalopram.,increase,risk
Citalopram,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Citalopram.,increase,risk
Citalopram,Olaparib,The metabolism of Olaparib can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Citalopram is combined with Oliceridine.",increase,risk
Citalopram,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Citalopram.,increase,risk
Citalopram,Omaveloxolone,The serum concentration of Citalopram can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Citalopram,Omeprazole,The risk or severity of QTc prolongation can be increased when Omeprazole is combined with Citalopram.,increase,risk
Citalopram,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Citalopram.,increase,risk
Citalopram,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Citalopram.,increase,risk
Citalopram,Oritavancin,The risk or severity of QTc prolongation can be increased when Oritavancin is combined with Citalopram.,increase,risk
Citalopram,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Citalopram.,increase,risk
Citalopram,Osilodrostat,The risk or severity of QTc prolongation can be increased when Osilodrostat is combined with Citalopram.,increase,risk
Citalopram,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Ospemifene,The metabolism of Citalopram can be decreased when combined with Ospemifene.,decrease,no risk
Citalopram,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Citalopram.,increase,risk
Citalopram,Oxamniquine,The metabolism of Citalopram can be decreased when combined with Oxamniquine.,decrease,no risk
Citalopram,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Oxaprozin.,increase,risk
Citalopram,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Citalopram.,increase,risk
Citalopram,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Citalopram.,increase,risk
Citalopram,Oxcarbazepine,Oxcarbazepine may increase the QTc-prolonging activities of Citalopram.,increase,no risk
Citalopram,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Citalopram.,increase,risk
Citalopram,Oxprenolol,The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Citalopram.,increase,risk
Citalopram,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Citalopram.,decrease,no risk
Citalopram,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Citalopram.,increase,risk
Citalopram,Oxybutynin,The metabolism of Citalopram can be decreased when combined with Oxybutynin.,decrease,no risk
Citalopram,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Citalopram.,increase,risk
Citalopram,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Citalopram.,increase,risk
Citalopram,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Oxyphenbutazone.,increase,risk
Citalopram,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Citalopram.,increase,risk
Eletriptan,Brexanolone,The risk or severity of CNS depression can be increased when Eletriptan is combined with Brexanolone.,increase,risk
Eletriptan,Brexpiprazole,The risk or severity of adverse effects can be increased when Eletriptan is combined with Brexpiprazole.,increase,risk
Eletriptan,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eletriptan.,increase,no risk
Eletriptan,Brivaracetam,The risk or severity of CNS depression can be increased when Eletriptan is combined with Brivaracetam.,increase,risk
Eletriptan,Bromazepam,The risk or severity of CNS depression can be increased when Eletriptan is combined with Bromazepam.,increase,risk
Eletriptan,Bromocriptine,Bromocriptine may increase the vasoconstricting activities of Eletriptan.,increase,no risk
Eletriptan,Bromperidol,The risk or severity of adverse effects can be increased when Eletriptan is combined with Bromperidol.,increase,risk
Eletriptan,Brompheniramine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Brompheniramine.,increase,risk
Eletriptan,Bumadizone,The risk or severity of hypertension can be increased when Eletriptan is combined with Bumadizone.,increase,risk
Eletriptan,Bupivacaine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Bupivacaine.,increase,risk
Eletriptan,Buprenorphine,Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Eletriptan,Bupropion,The metabolism of Eletriptan can be decreased when combined with Bupropion.,decrease,no risk
Eletriptan,Buspirone,The risk or severity of CNS depression can be increased when Eletriptan is combined with Buspirone.,increase,risk
Eletriptan,Butabarbital,The risk or severity of CNS depression can be increased when Eletriptan is combined with Butabarbital.,increase,risk
Eletriptan,Butalbital,The risk or severity of CNS depression can be increased when Eletriptan is combined with Butalbital.,increase,risk
Eletriptan,Butaperazine,The risk or severity of adverse effects can be increased when Eletriptan is combined with Butaperazine.,increase,risk
Eletriptan,Butobarbital,The risk or severity of CNS depression can be increased when Eletriptan is combined with Butobarbital.,increase,risk
Eletriptan,Butorphanol,The risk or severity of CNS depression can be increased when Eletriptan is combined with Butorphanol.,increase,risk
Eletriptan,Butriptyline,The risk or severity of CNS depression can be increased when Eletriptan is combined with Butriptyline.,increase,risk
Eletriptan,Gabapentin,The risk or severity of CNS depression can be increased when Eletriptan is combined with Gabapentin.,increase,risk
Eletriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Eletriptan is combined with Gabapentin enacarbil.,increase,risk
Eletriptan,Galantamine,The metabolism of Galantamine can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Eletriptan is combined with Gallamine triethiodide.,increase,risk
Eletriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Eletriptan is combined with Ganaxolone.",increase,risk
Eletriptan,Gefitinib,The metabolism of Eletriptan can be decreased when combined with Gefitinib.,decrease,no risk
Eletriptan,Gemfibrozil,The metabolism of Eletriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Eletriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Eletriptan.,increase,risk
Eletriptan,Gilteritinib,The therapeutic efficacy of Eletriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Eletriptan,Ginkgo biloba,The metabolism of Eletriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Eletriptan,Givosiran,The serum concentration of Eletriptan can be increased when it is combined with Givosiran.,increase,no risk
Eletriptan,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Glipizide,The metabolism of Glipizide can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Glofitamab,The serum concentration of Eletriptan can be increased when it is combined with Glofitamab.,increase,no risk
Eletriptan,Glutethimide,The risk or severity of CNS depression can be increased when Eletriptan is combined with Glutethimide.,increase,risk
Eletriptan,Glyburide,The metabolism of Eletriptan can be decreased when combined with Glyburide.,decrease,no risk
Eletriptan,Glycerol phenylbutyrate,The metabolism of Eletriptan can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Eletriptan,Golimumab,The metabolism of Eletriptan can be increased when combined with Golimumab.,increase,no risk
Eletriptan,Granisetron,The risk or severity of CNS depression can be increased when Eletriptan is combined with Granisetron.,increase,risk
Eletriptan,Guanabenz,Eletriptan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Eletriptan,Guanadrel,Eletriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Eletriptan,Guanethidine,Eletriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Eletriptan,Guanfacine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Guanfacine.,increase,risk
Eletriptan,Guanoxan,Eletriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Eletriptan,Halazepam,The risk or severity of CNS depression can be increased when Eletriptan is combined with Halazepam.,increase,risk
Eletriptan,Halofantrine,The metabolism of Eletriptan can be decreased when combined with Halofantrine.,decrease,no risk
Eletriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Eletriptan.,increase,risk
Eletriptan,Halothane,The risk or severity of CNS depression can be increased when Eletriptan is combined with Halothane.,increase,risk
Eletriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Eletriptan is combined with Hexafluronium.,increase,risk
Eletriptan,Hydralazine,Eletriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Eletriptan,Hydrochlorothiazide,Eletriptan may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Eletriptan,Hydrocodone,Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Eletriptan,Hydroflumethiazide,Eletriptan may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Eletriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Eletriptan is combined with Hydromorphone.,increase,risk
Eletriptan,Hydroxychloroquine,The metabolism of Eletriptan can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Eletriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eletriptan.,increase,no risk
Eletriptan,Ketamine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Ketamine.,increase,risk
Eletriptan,Ketazolam,The risk or severity of CNS depression can be increased when Eletriptan is combined with Ketazolam.,increase,risk
Eletriptan,Ketoconazole,The metabolism of Eletriptan can be decreased when combined with Ketoconazole.,decrease,no risk
Eletriptan,Ketoprofen,The risk or severity of hypertension can be increased when Eletriptan is combined with Ketoprofen.,increase,risk
Eletriptan,Ketorolac,The risk or severity of hypertension can be increased when Eletriptan is combined with Ketorolac.,increase,risk
Eletriptan,Olanzapine,The risk or severity of adverse effects can be increased when Eletriptan is combined with Olanzapine.,increase,risk
Eletriptan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Eletriptan is combined with Oliceridine.",increase,risk
Eletriptan,Olmesartan,Eletriptan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Eletriptan,Olodaterol,The risk or severity of hypertension can be increased when Eletriptan is combined with Olodaterol.,increase,risk
Eletriptan,Olutasidenib,The therapeutic efficacy of Eletriptan can be decreased when used in combination with Olutasidenib.,decrease,no risk
Eletriptan,Omaveloxolone,The serum concentration of Eletriptan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Eletriptan,Ondansetron,The risk or severity of CNS depression can be increased when Eletriptan is combined with Ondansetron.,increase,risk
Eletriptan,Opium,The risk or severity of CNS depression can be increased when Eletriptan is combined with Opium.,increase,risk
Eletriptan,Orciprenaline,The risk or severity of hypertension can be increased when Eletriptan is combined with Orciprenaline.,increase,risk
Eletriptan,Oritavancin,The metabolism of Eletriptan can be decreased when combined with Oritavancin.,decrease,no risk
Eletriptan,Orphenadrine,Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Eletriptan,Osilodrostat,The metabolism of Eletriptan can be decreased when combined with Osilodrostat.,decrease,no risk
Eletriptan,Ospemifene,The metabolism of Eletriptan can be decreased when combined with Ospemifene.,decrease,no risk
Eletriptan,Oxamniquine,The metabolism of Eletriptan can be decreased when combined with Oxamniquine.,decrease,no risk
Eletriptan,Oxandrolone,The metabolism of Eletriptan can be decreased when combined with Oxandrolone.,decrease,no risk
Eletriptan,Oxaprozin,The risk or severity of hypertension can be increased when Eletriptan is combined with Oxaprozin.,increase,risk
Eletriptan,Oxazepam,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxazepam.,increase,risk
Eletriptan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxcarbazepine.,increase,risk
Eletriptan,Oxitriptan,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxitriptan.,increase,risk
Eletriptan,Oxprenolol,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxprenolol.,increase,risk
Eletriptan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxybuprocaine.,increase,risk
Eletriptan,Oxybutynin,The metabolism of Eletriptan can be decreased when combined with Oxybutynin.,decrease,no risk
Eletriptan,Oxycodone,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxycodone.,increase,risk
Eletriptan,Oxymetazoline,The risk or severity of hypertension can be increased when Eletriptan is combined with Oxymetazoline.,increase,risk
Eletriptan,Oxymorphone,The risk or severity of CNS depression can be increased when Eletriptan is combined with Oxymorphone.,increase,risk
Eletriptan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Eletriptan is combined with Oxyphenbutazone.,increase,risk
Eletriptan,Quazepam,The risk or severity of CNS depression can be increased when Eletriptan is combined with Quazepam.,increase,risk
Eletriptan,Quetiapine,The risk or severity of adverse effects can be increased when Eletriptan is combined with Quetiapine.,increase,risk
Eletriptan,Quinapril,Eletriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Eletriptan,Quinidine,The metabolism of Eletriptan can be decreased when combined with Quinidine.,decrease,no risk
Eletriptan,Quinine,The metabolism of Eletriptan can be decreased when combined with Quinine.,decrease,no risk
Eletriptan,Quinupramine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Quinupramine.,increase,risk
Eletriptan,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Urethane,The risk or severity of CNS depression can be increased when Eletriptan is combined with Urethane.,increase,risk
Eletriptan,Vadadustat,The serum concentration of Eletriptan can be increased when it is combined with Vadadustat.,increase,no risk
Eletriptan,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Valdecoxib,The risk or severity of hypertension can be increased when Eletriptan is combined with Valdecoxib.,increase,risk
Eletriptan,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Eletriptan is combined with Valproate bismuth.,increase,risk
Eletriptan,Valproic acid,The risk or severity of CNS depression can be increased when Eletriptan is combined with Valproic acid.,increase,risk
Eletriptan,Valsartan,The metabolism of Eletriptan can be decreased when combined with Valsartan.,decrease,no risk
Eletriptan,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Vecuronium,The risk or severity of CNS depression can be increased when Eletriptan is combined with Vecuronium.,increase,risk
Eletriptan,Vemurafenib,The metabolism of Eletriptan can be decreased when combined with Vemurafenib.,decrease,no risk
Eletriptan,Venetoclax,The metabolism of Eletriptan can be decreased when combined with Venetoclax.,decrease,no risk
Eletriptan,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Eletriptan is combined with Venlafaxine.,increase,risk
Eletriptan,Verapamil,The metabolism of Eletriptan can be decreased when combined with Verapamil.,decrease,no risk
Eletriptan,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Vigabatrin,The risk or severity of CNS depression can be increased when Eletriptan is combined with Vigabatrin.,increase,risk
Eletriptan,Vilanterol,The risk or severity of hypertension can be increased when Eletriptan is combined with Vilanterol.,increase,risk
Eletriptan,Vilazodone,The metabolism of Eletriptan can be decreased when combined with Vilazodone.,decrease,no risk
Eletriptan,Viloxazine,The metabolism of Eletriptan can be decreased when combined with Viloxazine.,decrease,no risk
Eletriptan,Vinblastine,The metabolism of Eletriptan can be decreased when combined with Vinblastine.,decrease,no risk
Eletriptan,Vinorelbine,The metabolism of Eletriptan can be decreased when combined with Vinorelbine.,decrease,no risk
Eletriptan,Voriconazole,The metabolism of Eletriptan can be decreased when combined with Voriconazole.,decrease,no risk
Eletriptan,Vortioxetine,The risk or severity of adverse effects can be increased when Eletriptan is combined with Vortioxetine.,increase,risk
Eletriptan,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Warfarin,The risk or severity of adverse effects can be increased when Eletriptan is combined with Warfarin.,increase,risk
Eletriptan,Xamoterol,The risk or severity of hypertension can be increased when Eletriptan is combined with Xamoterol.,increase,risk
Eletriptan,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Xylometazoline,The risk or severity of hypertension can be increased when Eletriptan is combined with Xylometazoline.,increase,risk
Eletriptan,Yohimbine,The risk or severity of CNS depression can be increased when Eletriptan is combined with Yohimbine.,increase,risk
Eletriptan,Zafirlukast,The metabolism of Eletriptan can be decreased when combined with Zafirlukast.,decrease,no risk
Eletriptan,Zaleplon,The risk or severity of CNS depression can be increased when Eletriptan is combined with Zaleplon.,increase,risk
Eletriptan,Ziconotide,The risk or severity of CNS depression can be increased when Eletriptan is combined with Ziconotide.,increase,risk
Eletriptan,Zidovudine,The metabolism of Zidovudine can be increased when combined with Eletriptan.,increase,no risk
Eletriptan,Zileuton,The metabolism of Zileuton can be decreased when combined with Eletriptan.,decrease,no risk
Eletriptan,Zimelidine,The risk or severity of adverse effects can be increased when Eletriptan is combined with Zimelidine.,increase,risk
Eletriptan,Ziprasidone,The risk or severity of adverse effects can be increased when Eletriptan is combined with Ziprasidone.,increase,risk
Eletriptan,Zofenopril,Eletriptan may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Eletriptan,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Eletriptan is combined with Zolmitriptan.,increase,risk
Eletriptan,Zolpidem,Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Eletriptan,Zonisamide,The risk or severity of CNS depression can be increased when Eletriptan is combined with Zonisamide.,increase,risk
Eletriptan,Zopiclone,The risk or severity of adverse effects can be increased when Eletriptan is combined with Zopiclone.,increase,risk
Eletriptan,Zotepine,The risk or severity of adverse effects can be increased when Eletriptan is combined with Zotepine.,increase,risk
Eletriptan,Zuclopenthixol,The risk or severity of adverse effects can be increased when Eletriptan is combined with Zuclopenthixol.,increase,risk
Eletriptan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Eletriptan.,increase,risk
Bethanidine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Gallamine triethiodide.,increase,risk
Bethanidine,Glycol salicylate,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Bethanidine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Glycopyrronium.,increase,risk
Bethanidine,Guanabenz,Bethanidine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Bethanidine,Guanadrel,Bethanidine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Bethanidine,Guanethidine,Bethanidine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Bethanidine,Guanfacine,Bethanidine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Bethanidine,Guanoxan,Bethanidine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Bethanidine,Halothane,Halothane may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Hexocyclium,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Hexocyclium.,increase,risk
Bethanidine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Homatropine methylbromide.,increase,risk
Bethanidine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Bethanidine.,increase,risk
Bethanidine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Bethanidine.,increase,risk
Bethanidine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Bethanidine.,increase,risk
Bethanidine,Hydralazine,Bethanidine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Bethanidine,Hydrochlorothiazide,The therapeutic efficacy of Bethanidine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Bethanidine,Hydroflumethiazide,The therapeutic efficacy of Bethanidine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Bethanidine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Hyoscyamine.,increase,risk
Bethanidine,Ketamine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Ketamine.,increase,risk
Bethanidine,Ketoprofen,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Bethanidine,Ketorolac,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Ketorolac.,decrease,no risk
Bethanidine,Obinutuzumab,Bethanidine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Bethanidine,Olanzapine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Olanzapine.,decrease,no risk
Bethanidine,Olmesartan,Bethanidine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Bethanidine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Opicapone,Opicapone may increase the hypotensive activities of Bethanidine.,increase,no risk
Bethanidine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Orphenadrine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Orphenadrine.,increase,risk
Bethanidine,Oxaprozin,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bethanidine,Oxprenolol,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Bethanidine,Oxybutynin,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Oxybutynin.,increase,risk
Bethanidine,Oxymetazoline,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Bethanidine,Oxyphenbutazone,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Bethanidine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Oxyphencyclimine.,increase,risk
Bethanidine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Oxyphenonium.,increase,risk
Bethanidine,Quetiapine,Quetiapine may increase the hypotensive activities of Bethanidine.,increase,no risk
Bethanidine,Quinapril,Bethanidine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Bethanidine,Quinidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Quinidine.,decrease,no risk
Bethanidine,Quinine,Quinine may increase the hypotensive activities of Bethanidine.,increase,no risk
Bethanidine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Bethanidine.,increase,risk
Bethanidine,Udenafil,Udenafil may increase the antihypertensive activities of Bethanidine.,increase,no risk
Bethanidine,Umeclidinium,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Umeclidinium.,increase,risk
Bethanidine,Unoprostone,Bethanidine may increase the hypotensive activities of Unoprostone.,increase,no risk
Bethanidine,Valdecoxib,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Valdecoxib.,decrease,no risk
Bethanidine,Valsartan,Bethanidine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Bethanidine,Vardenafil,Vardenafil may increase the antihypertensive activities of Bethanidine.,increase,no risk
Bethanidine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Bethanidine.,increase,no risk
Bethanidine,Verapamil,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Verapamil.,decrease,no risk
Bethanidine,Vericiguat,Vericiguat may increase the hypotensive activities of Bethanidine.,increase,no risk
Bethanidine,Vilanterol,Vilanterol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Vilazodone,Vilazodone may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Xamoterol,Xamoterol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Yohimbine,Yohimbine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Bethanidine.,increase,no risk
Bethanidine,Zofenopril,Bethanidine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Bethanidine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Bethanidine,Zuclopenthixol,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Moxifloxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Gadobenic acid.,increase,risk
Moxifloxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Gemifloxacin.,increase,risk
Moxifloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Gilteritinib.,increase,risk
Moxifloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Glasdegib.,increase,risk
Moxifloxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Moxifloxacin.,increase,no risk
Moxifloxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Moxifloxacin.,increase,no risk
Moxifloxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Moxifloxacin.,increase,no risk
Moxifloxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Moxifloxacin.,increase,no risk
Moxifloxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Moxifloxacin.,increase,no risk
Moxifloxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Moxifloxacin.,increase,no risk
Moxifloxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Moxifloxacin.,increase,no risk
Moxifloxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Granisetron.,increase,risk
Moxifloxacin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Grepafloxacin.,increase,risk
Moxifloxacin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Moxifloxacin.,decrease,no risk
Moxifloxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Halofantrine.,increase,risk
Moxifloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Haloperidol.,increase,risk
Moxifloxacin,Hetacillin,The serum concentration of Moxifloxacin can be increased when it is combined with Hetacillin.,increase,no risk
Moxifloxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Moxifloxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Hydroxyzine.,increase,risk
Moxifloxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Moxifloxacin.,increase,no risk
Moxifloxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Moxifloxacin.,increase,no risk
Moxifloxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Ofloxacin.,increase,risk
Moxifloxacin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Moxifloxacin.,decrease,no risk
Moxifloxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Ondansetron,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Ondansetron.,increase,risk
Moxifloxacin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Oxacillin,The serum concentration of Moxifloxacin can be increased when it is combined with Oxacillin.,increase,no risk
Moxifloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Moxifloxacin.,increase,no risk
Moxifloxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Oxatomide.,increase,risk
Moxifloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Moxifloxacin is combined with Oxetacaine.,increase,risk
Moxifloxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Moxifloxacin.,decrease,no risk
Moxifloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Moxifloxacin is combined with Oxybuprocaine.,increase,risk
Moxifloxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Moxifloxacin.,increase,no risk
Moxifloxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Moxifloxacin.,increase,risk
Moxifloxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quetiapine.,increase,risk
Moxifloxacin,Quinapril,Quinapril can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Moxifloxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quinidine.,increase,risk
Moxifloxacin,Quinine,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quinine.,increase,risk
Moxifloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quizartinib.,increase,risk
Oxyphenonium,Galantamine,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Galantamine.,decrease,no risk
Oxyphenonium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Gallamine triethiodide.,increase,risk
Oxyphenonium,Ginkgo biloba,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Oxyphenonium,Glucagon,Oxyphenonium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Oxyphenonium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Oxyphenonium,Glycopyrronium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Glycopyrronium.,increase,risk
Oxyphenonium,Guanabenz,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Guanabenz.,increase,risk
Oxyphenonium,Guanfacine,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Guanfacine.,increase,risk
Oxyphenonium,Hexafluronium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexafluronium.,increase,risk
Oxyphenonium,Hexocyclium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexocyclium.,increase,risk
Oxyphenonium,Homatropine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Homatropine.,increase,risk
Oxyphenonium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Homatropine methylbromide.,increase,risk
Oxyphenonium,Huperzine A,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Huperzine A.,decrease,no risk
Oxyphenonium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphenonium.,increase,no risk
Oxyphenonium,Hydrocodone,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hydrocodone.,increase,risk
Oxyphenonium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Oxyphenonium.,increase,no risk
Oxyphenonium,Hydromorphone,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hydromorphone.,increase,risk
Oxyphenonium,Hyoscyamine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hyoscyamine.,increase,risk
Oxyphenonium,Ketamine,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Ketamine.,decrease,no risk
Oxyphenonium,Olanzapine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Olanzapine.,increase,risk
Oxyphenonium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Oxyphenonium is combined with Oliceridine.",increase,risk
Oxyphenonium,Olodaterol,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Olodaterol.,increase,risk
Oxyphenonium,Opium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Opium.,increase,risk
Oxyphenonium,Orciprenaline,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Orciprenaline.,increase,risk
Oxyphenonium,Orphenadrine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Orphenadrine.,increase,risk
Oxyphenonium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxybutynin.,increase,risk
Oxyphenonium,Oxycodone,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxycodone.,increase,risk
Oxyphenonium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Oxymetazoline.,increase,risk
Oxyphenonium,Oxymorphone,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxymorphone.,increase,risk
Oxyphenonium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxyphencyclimine.,increase,risk
Oxyphenonium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Oxyphenonium,Quetiapine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quetiapine.,increase,risk
Oxyphenonium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Oxyphenonium.,increase,no risk
Oxyphenonium,Quinidine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quinidine.,increase,risk
Oxyphenonium,Quinupramine,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quinupramine.,increase,risk
Oxyphenonium,Umeclidinium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Umeclidinium.,increase,risk
Oxyphenonium,Vecuronium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Vecuronium.,increase,risk
Oxyphenonium,Venlafaxine,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Venlafaxine.,increase,risk
Oxyphenonium,Vilanterol,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Vilanterol.,increase,risk
Oxyphenonium,Xamoterol,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Xamoterol.,increase,risk
Oxyphenonium,Xylometazoline,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Xylometazoline.,increase,risk
Oxyphenonium,Ziprasidone,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Ziprasidone.,increase,risk
Nelfinavir,Bepridil,The metabolism of Bepridil can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bexagliflozin,The metabolism of Bexagliflozin can be increased when combined with Nelfinavir.,increase,no risk
Nelfinavir,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bilastine,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Bilastine.,increase,risk
Nelfinavir,Bimekizumab,The metabolism of Nelfinavir can be increased when combined with Bimekizumab.,increase,no risk
Nelfinavir,Binimetinib,The metabolism of Binimetinib can be increased when combined with Nelfinavir.,increase,no risk
Nelfinavir,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nelfinavir,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bretylium,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Bretylium.,increase,risk
Nelfinavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Brompheniramine,The metabolism of Brompheniramine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Buclizine,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Buclizine.,increase,risk
Nelfinavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Buserelin,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Buserelin.,increase,risk
Nelfinavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Busulfan,The metabolism of Busulfan can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Butriptyline,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Butriptyline.,increase,risk
Nelfinavir,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Gadobenic acid.,increase,risk
Nelfinavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Ganciclovir,The risk or severity of adverse effects can be increased when Nelfinavir is combined with Ganciclovir.,increase,risk
Nelfinavir,Garlic,Garlic can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nelfinavir,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Gatifloxacin.,increase,risk
Nelfinavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Gemifloxacin.,increase,risk
Nelfinavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Glecaprevir,Nelfinavir may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Nelfinavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Nelfinavir.,decrease,no risk
Nelfinavir,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Nelfinavir.,decrease,no risk
Nelfinavir,Glipizide,The metabolism of Glipizide can be increased when combined with Nelfinavir.,increase,no risk
Nelfinavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nelfinavir.,decrease,no risk
Nelfinavir,Glofitamab,The serum concentration of Nelfinavir can be increased when it is combined with Glofitamab.,increase,no risk
Nelfinavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Glycyrrhizic acid,Nelfinavir may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Nelfinavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Nelfinavir.,decrease,no risk
Nelfinavir,Golimumab,The metabolism of Nelfinavir can be increased when combined with Golimumab.,increase,no risk
Nelfinavir,Goserelin,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Goserelin.,increase,risk
Nelfinavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Haloperidol,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Haloperidol.,increase,risk
Nelfinavir,Halothane,The metabolism of Halothane can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Histamine,The risk or severity of adverse effects can be increased when Nelfinavir is combined with Histamine.,increase,risk
Nelfinavir,Histrelin,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Histrelin.,increase,risk
Nelfinavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Hydrochlorothiazide.,increase,risk
Nelfinavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nelfinavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Hydroxyzine.,increase,risk
Nelfinavir,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Hyoscyamine.,increase,risk
Nelfinavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Ketoprofen,The metabolism of Ketoprofen can be increased when combined with Nelfinavir.,increase,no risk
Nelfinavir,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Nelfinavir.,increase,risk
Nelfinavir,Ofloxacin,Nelfinavir may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Nelfinavir,Olanzapine,Olanzapine can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nelfinavir,Olaparib,The metabolism of Olaparib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Olmesartan,Olmesartan may decrease the excretion rate of Nelfinavir which could result in a higher serum level.,decrease,no risk
Nelfinavir,Olodaterol,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Olodaterol.,increase,risk
Nelfinavir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Ombitasvir,Nelfinavir may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Nelfinavir,Omeprazole,The serum concentration of Nelfinavir can be decreased when it is combined with Omeprazole.,decrease,no risk
Nelfinavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Opium,The metabolism of Opium can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Ouabain,The excretion of Ouabain can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Nelfinavir.,increase,risk
Nelfinavir,Oxatomide,The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Oxatomide.,increase,risk
Nelfinavir,Oxcarbazepine,The metabolism of Nelfinavir can be increased when combined with Oxcarbazepine.,increase,no risk
Nelfinavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Nelfinavir.,increase,risk
Nelfinavir,Ozanimod,Nelfinavir may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Nelfinavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Nelfinavir.,increase,no risk
Nelfinavir,Quinidine,The metabolism of Quinidine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Quinine,The metabolism of Quinine can be decreased when combined with Nelfinavir.,decrease,no risk
Nelfinavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Nelfinavir.,increase,no risk
Isoetharine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Gallamine triethiodide.,increase,risk
Isoetharine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Glycopyrronium.,increase,risk
Isoetharine,Guanabenz,Isoetharine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Isoetharine,Guanadrel,Isoetharine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Isoetharine,Guanethidine,Isoetharine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Isoetharine,Guanfacine,Isoetharine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Isoetharine,Guanoxan,Isoetharine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Isoetharine,Halothane,The risk or severity of hypertension can be increased when Isoetharine is combined with Halothane.,increase,risk
Isoetharine,Hexocyclium,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Hexocyclium.,increase,risk
Isoetharine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Homatropine methylbromide.,increase,risk
Isoetharine,Hydralazine,Isoetharine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Isoetharine,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Isoetharine is combined with Hydrochlorothiazide.,increase,risk
Isoetharine,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Isoetharine.,increase,risk
Isoetharine,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Isoetharine.,increase,risk
Isoetharine,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Isoetharine.,increase,risk
Isoetharine,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Isoetharine.,increase,risk
Isoetharine,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Isoetharine.,increase,risk
Isoetharine,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Isoetharine is combined with Hydroflumethiazide.,increase,risk
Isoetharine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Hyoscyamine.,increase,risk
Isoetharine,Ketamine,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Ketamine.,increase,risk
Isoetharine,Ketoprofen,The risk or severity of hypertension can be increased when Isoetharine is combined with Ketoprofen.,increase,risk
Isoetharine,Ketorolac,The risk or severity of hypertension can be increased when Isoetharine is combined with Ketorolac.,increase,risk
Isoetharine,Olanzapine,The therapeutic efficacy of Isoetharine can be decreased when used in combination with Olanzapine.,decrease,no risk
Isoetharine,Olmesartan,Isoetharine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Isoetharine,Olodaterol,The risk or severity of adverse effects can be increased when Isoetharine is combined with Olodaterol.,increase,risk
Isoetharine,Orciprenaline,The risk or severity of adverse effects can be increased when Isoetharine is combined with Orciprenaline.,increase,risk
Isoetharine,Orphenadrine,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Orphenadrine.,increase,risk
Isoetharine,Oxaprozin,The risk or severity of hypertension can be increased when Isoetharine is combined with Oxaprozin.,increase,risk
Isoetharine,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Isoetharine.,decrease,no risk
Isoetharine,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Isoetharine.,increase,risk
Isoetharine,Oxybutynin,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Oxybutynin.,increase,risk
Isoetharine,Oxymetazoline,The risk or severity of hypertension can be increased when Isoetharine is combined with Oxymetazoline.,increase,risk
Isoetharine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Isoetharine is combined with Oxyphenbutazone.,increase,risk
Isoetharine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Oxyphencyclimine.,increase,risk
Isoetharine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isoetharine.,increase,risk
Isoetharine,Quetiapine,The therapeutic efficacy of Isoetharine can be decreased when used in combination with Quetiapine.,decrease,no risk
Isoetharine,Quinapril,Isoetharine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Isoetharine,Quinethazone,Isoetharine may increase the hypokalemic activities of Quinethazone.,increase,no risk
Isoetharine,Quinidine,The therapeutic efficacy of Isoetharine can be decreased when used in combination with Quinidine.,decrease,no risk
Isoetharine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Isoetharine.,increase,risk
Isoetharine,Umeclidinium,The risk or severity of Tachycardia can be increased when Isoetharine is combined with Umeclidinium.,increase,risk
Isoetharine,Valdecoxib,The risk or severity of hypertension can be increased when Isoetharine is combined with Valdecoxib.,increase,risk
Isoetharine,Valsartan,Isoetharine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Isoetharine,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Isoetharine.,increase,risk
Isoetharine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Isoetharine.,increase,no risk
Isoetharine,Verapamil,The therapeutic efficacy of Isoetharine can be decreased when used in combination with Verapamil.,decrease,no risk
Isoetharine,Vilanterol,The risk or severity of adverse effects can be increased when Isoetharine is combined with Vilanterol.,increase,risk
Isoetharine,Vilazodone,The risk or severity of hypertension can be increased when Isoetharine is combined with Vilazodone.,increase,risk
Isoetharine,Vortioxetine,The risk or severity of hypertension can be increased when Isoetharine is combined with Vortioxetine.,increase,risk
Isoetharine,Xamoterol,The risk or severity of hypertension can be increased when Isoetharine is combined with Xamoterol.,increase,risk
Isoetharine,Xylometazoline,The risk or severity of hypertension can be increased when Isoetharine is combined with Xylometazoline.,increase,risk
Isoetharine,Yohimbine,The risk or severity of hypertension can be increased when Isoetharine is combined with Yohimbine.,increase,risk
Isoetharine,Ziprasidone,The therapeutic efficacy of Isoetharine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Isoetharine,Zofenopril,Isoetharine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Isoetharine,Zolmitriptan,The risk or severity of hypertension can be increased when Isoetharine is combined with Zolmitriptan.,increase,risk
Isoetharine,Zuclopenthixol,The therapeutic efficacy of Isoetharine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Glimepiride,Gatifloxacin,The therapeutic efficacy of Glimepiride can be increased when used in combination with Gatifloxacin.,increase,no risk
Glimepiride,Gefapixant,The therapeutic efficacy of Glimepiride can be increased when used in combination with Gefapixant.,increase,no risk
Glimepiride,Gemfibrozil,The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.,decrease,no risk
Glimepiride,Gemifloxacin,The therapeutic efficacy of Glimepiride can be increased when used in combination with Gemifloxacin.,increase,no risk
Glimepiride,Gestrinone,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Gestrinone.,decrease,no risk
Glimepiride,Ginkgo biloba,The metabolism of Glimepiride can be decreased when combined with Ginkgo biloba.,decrease,no risk
Glimepiride,Gliclazide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Gliclazide.,increase,risk
Glimepiride,Glipizide,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glipizide.,increase,risk
Glimepiride,Gliquidone,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Gliquidone.,increase,risk
Glimepiride,Glofitamab,The serum concentration of Glimepiride can be increased when it is combined with Glofitamab.,increase,no risk
Glimepiride,Glyburide,Glyburide may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Glimepiride,Glycol salicylate,The protein binding of Glimepiride can be decreased when combined with Glycol salicylate.,decrease,no risk
Glimepiride,Glycyrrhizic acid,Glimepiride may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Glimepiride,Glymidine,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glymidine.,increase,risk
Glimepiride,Golimumab,The metabolism of Glimepiride can be increased when combined with Golimumab.,increase,no risk
Glimepiride,Goserelin,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Goserelin.,decrease,no risk
Glimepiride,Grepafloxacin,The therapeutic efficacy of Glimepiride can be increased when used in combination with Grepafloxacin.,increase,no risk
Glimepiride,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glimepiride.,increase,risk
Glimepiride,Haloperidol,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Haloperidol.,decrease,no risk
Glimepiride,Halothane,The metabolism of Halothane can be decreased when combined with Glimepiride.,decrease,no risk
Glimepiride,Histrelin,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Histrelin.,decrease,no risk
Glimepiride,Hydrochlorothiazide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Glimepiride,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glimepiride.,increase,risk
Glimepiride,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glimepiride.,increase,risk
Glimepiride,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glimepiride.,increase,risk
Glimepiride,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glimepiride.,increase,risk
Glimepiride,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glimepiride.,increase,risk
Glimepiride,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glimepiride.,increase,risk
Glimepiride,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glimepiride.,increase,risk
Glimepiride,Hydroflumethiazide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Glimepiride,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Glimepiride.,decrease,no risk
Glimepiride,Hydroxychloroquine,The therapeutic efficacy of Glimepiride can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Glimepiride,Hydroxyprogesterone caproate,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Glimepiride,Ketamine,The metabolism of Ketamine can be decreased when combined with Glimepiride.,decrease,no risk
Glimepiride,Ketoconazole,Ketoconazole may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Glimepiride,Ketoprofen,The protein binding of Glimepiride can be decreased when combined with Ketoprofen.,decrease,no risk
Glimepiride,Ketorolac,The protein binding of Glimepiride can be decreased when combined with Ketorolac.,decrease,no risk
Glimepiride,Ketotifen,The risk or severity of thrombocytopenia can be increased when Glimepiride is combined with Ketotifen.,increase,risk
Glimepiride,Octreotide,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Octreotide.,decrease,no risk
Glimepiride,Ofloxacin,The therapeutic efficacy of Glimepiride can be increased when used in combination with Ofloxacin.,increase,no risk
Glimepiride,Olanzapine,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Olanzapine.,decrease,no risk
Glimepiride,Olmesartan,Olmesartan may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Glimepiride,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Glimepiride.,decrease,no risk
Glimepiride,Olsalazine,Olsalazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Glimepiride,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Glimepiride.,decrease,no risk
Glimepiride,Oritavancin,The metabolism of Glimepiride can be decreased when combined with Oritavancin.,decrease,no risk
Glimepiride,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Glimepiride.,decrease,no risk
Glimepiride,Oxandrolone,The metabolism of Glimepiride can be decreased when combined with Oxandrolone.,decrease,no risk
Glimepiride,Oxaprozin,The protein binding of Glimepiride can be decreased when combined with Oxaprozin.,decrease,no risk
Glimepiride,Oxprenolol,The therapeutic efficacy of Glimepiride can be increased when used in combination with Oxprenolol.,increase,no risk
Glimepiride,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Glimepiride,Oxyphenbutazone,The protein binding of Glimepiride can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Diflorasone,Bendroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Diflorasone is combined with Bendroflumethiazide.,increase,risk
Diflorasone,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Diflorasone is combined with Benzthiazide.,increase,risk
Diflorasone,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Bexagliflozin.,increase,risk
Diflorasone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Bromocriptine.,increase,risk
Diflorasone,Gliclazide,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Gliclazide.,increase,risk
Diflorasone,Glimepiride,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Glimepiride.,increase,risk
Diflorasone,Glipizide,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Glipizide.,increase,risk
Diflorasone,Gliquidone,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Gliquidone.,increase,risk
Diflorasone,Glyburide,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Glyburide.,increase,risk
Diflorasone,Glymidine,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Glymidine.,increase,risk
Diflorasone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Diflorasone is combined with Hydrochlorothiazide.,increase,risk
Diflorasone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Diflorasone is combined with Hydroflumethiazide.,increase,risk
Diflorasone,Quinine,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Quinine.,increase,risk
Diflorasone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Diflorasone.,increase,risk
Diflorasone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Diflorasone.,decrease,no risk
Diflorasone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Vildagliptin.,increase,risk
Diflorasone,Voriconazole,The serum concentration of Diflorasone can be increased when it is combined with Voriconazole.,increase,no risk
Indinavir,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Bumetanide.",increase,risk
Indinavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Busulfan,The metabolism of Busulfan can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ganciclovir.",increase,risk
Indinavir,Garlic,Garlic can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Indinavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Glofitamab,The serum concentration of Indinavir can be increased when it is combined with Glofitamab.,increase,no risk
Indinavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Glycyrrhizic acid,Indinavir may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Indinavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Golimumab,The metabolism of Indinavir can be increased when combined with Golimumab.,increase,no risk
Indinavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Histamine,The risk or severity of adverse effects can be increased when Indinavir is combined with Histamine.,increase,risk
Indinavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Indinavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ofloxacin,Indinavir may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Indinavir,Olanzapine,Olanzapine can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Indinavir,Olaparib,The metabolism of Olaparib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Olmesartan,Olmesartan may decrease the excretion rate of Indinavir which could result in a higher serum level.,decrease,no risk
Indinavir,Olutasidenib,The therapeutic efficacy of Indinavir can be decreased when used in combination with Olutasidenib.,decrease,no risk
Indinavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Omeprazole,Omeprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Indinavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Opium,The metabolism of Opium can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ouabain,The excretion of Ouabain can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Oxcarbazepine,The metabolism of Indinavir can be increased when combined with Oxcarbazepine.,increase,no risk
Indinavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Quinidine,The metabolism of Quinidine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Quinine,The metabolism of Quinine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ubidecarenone.",increase,risk
Indinavir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Udenafil,The metabolism of Udenafil can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Indinavir which could result in a higher serum level.,decrease,no risk
Indinavir,Vadadustat,The serum concentration of Indinavir can be increased when it is combined with Vadadustat.,increase,no risk
Indinavir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Valsartan,The excretion of Valsartan can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Venlafaxine,The serum concentration of Indinavir can be decreased when it is combined with Venlafaxine.,decrease,no risk
Indinavir,Verapamil,The metabolism of Verapamil can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Viloxazine,The metabolism of Indinavir can be decreased when combined with Viloxazine.,decrease,no risk
Indinavir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vincristine,The metabolism of Vincristine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vindesine,The metabolism of Vindesine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Voriconazole,The serum concentration of Voriconazole can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Indinavir.,increase,no risk
Indinavir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Warfarin,The metabolism of Warfarin can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Indinavir.,decrease,no risk
Indinavir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zileuton,The metabolism of Zileuton can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zimelidine,The metabolism of Indinavir can be decreased when combined with Zimelidine.,decrease,no risk
Indinavir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zotepine,The metabolism of Zotepine can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Indinavir.,decrease,no risk
Indinavir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Indinavir.,increase,no risk
Gadodiamide,Gabapentin enacarbil,Gadodiamide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gadobenic acid,Gadodiamide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gadofosveset trisodium,Gadodiamide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gadopentetic acid,Gadodiamide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gadoteric acid,Gadodiamide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gadoteridol,Gadodiamide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Gadodiamide,Ganciclovir,Gadodiamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gemcitabine,Gadodiamide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gemfibrozil,Gadodiamide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gentamicin,Gadodiamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Gadodiamide,Gimeracil,Gadodiamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Gadodiamide,Givosiran,Givosiran may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Glipizide,Gadodiamide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Glycerol phenylbutyrate,Gadodiamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Gadodiamide,Golodirsen,Gadodiamide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Gadodiamide,Goserelin,Goserelin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Guanethidine,Gadodiamide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Guanfacine,Gadodiamide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Haloperidol,Gadodiamide may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Gadodiamide,Hydralazine,Gadodiamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gadodiamide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gadodiamide,Hydromorphone,Gadodiamide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Gadodiamide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Hydroxyethyl Starch,Gadodiamide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Gadodiamide,Kanamycin,Gadodiamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Gadodiamide,Ketamine,Gadodiamide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Ketazolam,Gadodiamide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Gadodiamide,Ketoprofen,Ketoprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Ketorolac,Ketorolac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Octinoxate,Gadodiamide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Gadodiamide,Olsalazine,Olsalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Opium,Gadodiamide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oseltamivir,Oseltamivir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oxacillin,Gadodiamide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oxaprozin,Oxaprozin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oxazepam,Gadodiamide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oxybenzone,Gadodiamide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Oxyquinoline,Gadodiamide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Gadodiamide,Quetiapine,Gadodiamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Quinethazone,Quinethazone may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gadodiamide,Quinidine,Gadodiamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Vaborbactam,Gadodiamide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Gadodiamide,Valaciclovir,Valaciclovir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Valbenazine,Gadodiamide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Valdecoxib,Valdecoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Gadodiamide,Valganciclovir,Gadodiamide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Gadodiamide,Vancomycin,Gadodiamide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Gadodiamide,Varenicline,Gadodiamide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Gadodiamide,Venlafaxine,Gadodiamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Verapamil,Gadodiamide may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Gadodiamide,Vilanterol,Gadodiamide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Gadodiamide,Viloxazine,Gadodiamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Vortioxetine,Gadodiamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Gadodiamide,Warfarin,Gadodiamide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Gadodiamide,Zaleplon,Gadodiamide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Gadodiamide,Zanamivir,Gadodiamide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Gadodiamide,Zonisamide,Zonisamide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanadrel,Glycol salicylate,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Guanadrel,Guanabenz,Guanabenz may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Guanethidine,Guanadrel may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanadrel,Guanfacine,Guanfacine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Guanoxan,Guanadrel may increase the hypotensive activities of Guanoxan.,increase,no risk
Guanadrel,Halothane,Halothane may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Hydralazine,Guanadrel may increase the hypotensive activities of Hydralazine.,increase,no risk
Guanadrel,Hydrochlorothiazide,The therapeutic efficacy of Guanadrel can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Guanadrel,Hydroflumethiazide,The therapeutic efficacy of Guanadrel can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Guanadrel,Ketoprofen,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ketoprofen.,decrease,no risk
Guanadrel,Ketorolac,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ketorolac.,decrease,no risk
Guanadrel,Obinutuzumab,Guanadrel may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Guanadrel,Olanzapine,Olanzapine may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Olmesartan,Guanadrel may increase the hypotensive activities of Olmesartan.,increase,no risk
Guanadrel,Olodaterol,Olodaterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Opicapone,Opicapone may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Oxaprozin,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxaprozin.,decrease,no risk
Guanadrel,Oxprenolol,Guanadrel may increase the hypotensive activities of Oxprenolol.,increase,no risk
Guanadrel,Oxymetazoline,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Guanadrel,Oxyphenbutazone,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Guanadrel,Quetiapine,Quetiapine may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Quinapril,Guanadrel may increase the hypotensive activities of Quinapril.,increase,no risk
Guanadrel,Quinidine,Quinidine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Quinine,Quinine may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Quinupramine,Quinupramine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Udenafil,Udenafil may increase the antihypertensive activities of Guanadrel.,increase,no risk
Guanadrel,Unoprostone,Guanadrel may increase the hypotensive activities of Unoprostone.,increase,no risk
Guanadrel,Valdecoxib,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Valdecoxib.,decrease,no risk
Guanadrel,Valsartan,Valsartan may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Vardenafil,Vardenafil may increase the antihypertensive activities of Guanadrel.,increase,no risk
Guanadrel,Verapamil,Verapamil may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Vericiguat,Vericiguat may increase the hypotensive activities of Guanadrel.,increase,no risk
Guanadrel,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Guanadrel.,decrease,no risk
Guanadrel,Vilanterol,Vilanterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Vilazodone,Vilazodone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Xamoterol,Xamoterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Yohimbine,Yohimbine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Guanadrel.,increase,no risk
Guanadrel,Zofenopril,Guanadrel may increase the hypotensive activities of Zofenopril.,increase,no risk
Guanadrel,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanadrel,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Lovastatin,Bosentan,The serum concentration of Lovastatin can be decreased when it is combined with Bosentan.,decrease,no risk
Lovastatin,Bosutinib,The metabolism of Lovastatin can be decreased when combined with Bosutinib.,decrease,no risk
Lovastatin,Brentuximab vedotin,The metabolism of Lovastatin can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Lovastatin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Bromocriptine,The metabolism of Lovastatin can be decreased when combined with Bromocriptine.,decrease,no risk
Lovastatin,Budesonide,The metabolism of Budesonide can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Bumetanide.",increase,risk
Lovastatin,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Buprenorphine,The metabolism of Lovastatin can be decreased when combined with Buprenorphine.,decrease,no risk
Lovastatin,Bupropion,The metabolism of Bupropion can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Buspirone,The metabolism of Buspirone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Busulfan,The metabolism of Busulfan can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Galantamine,The metabolism of Galantamine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Ganciclovir.",increase,risk
Lovastatin,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Gemfibrozil,"The risk or severity of rhabdomyolysis, myoglobinuria, and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.",increase,risk
Lovastatin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Glecaprevir,The metabolism of Lovastatin can be decreased when combined with Glecaprevir.,decrease,no risk
Lovastatin,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Glimepiride,Glimepiride may decrease the excretion rate of Lovastatin which could result in a higher serum level.,decrease,no risk
Lovastatin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Glofitamab,The serum concentration of Lovastatin can be increased when it is combined with Glofitamab.,increase,no risk
Lovastatin,Glyburide,The metabolism of Lovastatin can be decreased when combined with Glyburide.,decrease,no risk
Lovastatin,Glycyrrhizic acid,Lovastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Lovastatin,Golimumab,The metabolism of Lovastatin can be increased when combined with Golimumab.,increase,no risk
Lovastatin,Granisetron,The metabolism of Granisetron can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Haloperidol,The metabolism of Lovastatin can be decreased when combined with Haloperidol.,decrease,no risk
Lovastatin,Halothane,The metabolism of Halothane can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydralazine,The metabolism of Lovastatin can be decreased when combined with Hydralazine.,decrease,no risk
Lovastatin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ketamine,The metabolism of Ketamine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ketazolam,The metabolism of Lovastatin can be decreased when combined with Ketazolam.,decrease,no risk
Lovastatin,Ketoconazole,The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.,increase,no risk
Lovastatin,Ketoprofen,The metabolism of Lovastatin can be decreased when combined with Ketoprofen.,decrease,no risk
Lovastatin,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Octreotide,The metabolism of Lovastatin can be decreased when combined with Octreotide.,decrease,no risk
Lovastatin,Ofloxacin,Lovastatin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Lovastatin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Olaparib,The metabolism of Olaparib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Olmesartan,Olmesartan may decrease the excretion rate of Lovastatin which could result in a higher serum level.,decrease,no risk
Lovastatin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Olutasidenib,The therapeutic efficacy of Lovastatin can be decreased when used in combination with Olutasidenib.,decrease,no risk
Lovastatin,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Opium,The metabolism of Opium can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Orphenadrine,The metabolism of Lovastatin can be decreased when combined with Orphenadrine.,decrease,no risk
Lovastatin,Osilodrostat,The metabolism of Lovastatin can be decreased when combined with Osilodrostat.,decrease,no risk
Lovastatin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ouabain,The excretion of Ouabain can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Oxcarbazepine,The metabolism of Lovastatin can be increased when combined with Oxcarbazepine.,increase,no risk
Lovastatin,Oxetacaine,The metabolism of Lovastatin can be decreased when combined with Oxetacaine.,decrease,no risk
Lovastatin,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Oxybutynin,The metabolism of Lovastatin can be decreased when combined with Oxybutynin.,decrease,no risk
Lovastatin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Oxymetholone,The metabolism of Lovastatin can be decreased when combined with Oxymetholone.,decrease,no risk
Lovastatin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Quazepam,The metabolism of Quazepam can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Quinidine,The metabolism of Lovastatin can be decreased when combined with Quinidine.,decrease,no risk
Lovastatin,Quinine,The metabolism of Lovastatin can be decreased when combined with Quinine.,decrease,no risk
Lovastatin,Quinupristin,The metabolism of Lovastatin can be decreased when combined with Quinupristin.,decrease,no risk
Lovastatin,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ubidecarenone,The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Lovastatin.,decrease,risk
Lovastatin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Udenafil,The metabolism of Udenafil can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Lovastatin which could result in a higher serum level.,decrease,no risk
Lovastatin,Vadadustat,The serum concentration of Lovastatin can be increased when it is combined with Vadadustat.,increase,no risk
Lovastatin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Valproic acid,The metabolism of Lovastatin can be decreased when combined with Valproic acid.,decrease,no risk
Lovastatin,Valsartan,The metabolism of Valsartan can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Venetoclax,The metabolism of Lovastatin can be decreased when combined with Venetoclax.,decrease,no risk
Lovastatin,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Verapamil,The risk or severity of myopathy and rhabdomyolysis can be increased when Verapamil is combined with Lovastatin.,increase,risk
Lovastatin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Viloxazine,The metabolism of Lovastatin can be decreased when combined with Viloxazine.,decrease,no risk
Lovastatin,Vinblastine,The metabolism of Lovastatin can be decreased when combined with Vinblastine.,decrease,no risk
Lovastatin,Vincristine,The metabolism of Vincristine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vindesine,The metabolism of Vindesine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Voriconazole,The serum concentration of Lovastatin can be increased when it is combined with Voriconazole.,increase,no risk
Lovastatin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Lovastatin.,increase,no risk
Lovastatin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zafirlukast,The metabolism of Lovastatin can be decreased when combined with Zafirlukast.,decrease,no risk
Lovastatin,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zidovudine,The metabolism of Lovastatin can be increased when combined with Zidovudine.,increase,no risk
Lovastatin,Zileuton,The metabolism of Zileuton can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zimelidine,The metabolism of Lovastatin can be decreased when combined with Zimelidine.,decrease,no risk
Lovastatin,Ziprasidone,The metabolism of Lovastatin can be decreased when combined with Ziprasidone.,decrease,no risk
Lovastatin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zotepine,The metabolism of Zotepine can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Lovastatin.,decrease,no risk
Lovastatin,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Lovastatin.,decrease,no risk
Enflurane,Gabapentin,The risk or severity of CNS depression can be increased when Enflurane is combined with Gabapentin.,increase,risk
Enflurane,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Enflurane is combined with Gabapentin enacarbil.,increase,risk
Enflurane,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Enflurane is combined with Gallamine triethiodide.,increase,risk
Enflurane,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Enflurane is combined with Ganaxolone.",increase,risk
Enflurane,Gepirone,The risk or severity of CNS depression can be increased when Enflurane is combined with Gepirone.,increase,risk
Enflurane,Glutethimide,The risk or severity of CNS depression can be increased when Enflurane is combined with Glutethimide.,increase,risk
Enflurane,Glycerin,The metabolism of Enflurane can be increased when combined with Glycerin.,increase,no risk
Enflurane,Golimumab,The metabolism of Enflurane can be increased when combined with Golimumab.,increase,no risk
Enflurane,Granisetron,The risk or severity of CNS depression can be increased when Enflurane is combined with Granisetron.,increase,risk
Enflurane,Guanfacine,The risk or severity of CNS depression can be increased when Enflurane is combined with Guanfacine.,increase,risk
Enflurane,Halazepam,The risk or severity of CNS depression can be increased when Enflurane is combined with Halazepam.,increase,risk
Enflurane,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Enflurane.,increase,risk
Enflurane,Halothane,The risk or severity of CNS depression can be increased when Enflurane is combined with Halothane.,increase,risk
Enflurane,Hexafluronium,The risk or severity of CNS depression can be increased when Enflurane is combined with Hexafluronium.,increase,risk
Enflurane,Hydrocodone,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Enflurane,Hydromorphone,The risk or severity of CNS depression can be increased when Enflurane is combined with Hydromorphone.,increase,risk
Enflurane,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Enflurane.,increase,risk
Enflurane,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Enflurane.,increase,no risk
Enflurane,Ketamine,The risk or severity of CNS depression can be increased when Enflurane is combined with Ketamine.,increase,risk
Enflurane,Ketazolam,The risk or severity of CNS depression can be increased when Enflurane is combined with Ketazolam.,increase,risk
Enflurane,Olanzapine,The risk or severity of CNS depression can be increased when Enflurane is combined with Olanzapine.,increase,risk
Enflurane,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Enflurane is combined with Oliceridine.",increase,risk
Enflurane,Ondansetron,The risk or severity of CNS depression can be increased when Enflurane is combined with Ondansetron.,increase,risk
Enflurane,Opium,The risk or severity of CNS depression can be increased when Enflurane is combined with Opium.,increase,risk
Enflurane,Orphenadrine,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Enflurane,Oxazepam,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxazepam.,increase,risk
Enflurane,Oxcarbazepine,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxcarbazepine.,increase,risk
Enflurane,Oxitriptan,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxitriptan.,increase,risk
Enflurane,Oxprenolol,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxprenolol.,increase,risk
Enflurane,Oxybuprocaine,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxybuprocaine.,increase,risk
Enflurane,Oxycodone,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxycodone.,increase,risk
Enflurane,Oxymorphone,The risk or severity of CNS depression can be increased when Enflurane is combined with Oxymorphone.,increase,risk
Enflurane,Quazepam,The risk or severity of CNS depression can be increased when Enflurane is combined with Quazepam.,increase,risk
Enflurane,Quetiapine,The risk or severity of CNS depression can be increased when Enflurane is combined with Quetiapine.,increase,risk
Enflurane,Quinine,The risk or severity of CNS depression can be increased when Enflurane is combined with Quinine.,increase,risk
Enflurane,Quinupramine,The risk or severity of CNS depression can be increased when Enflurane is combined with Quinupramine.,increase,risk
Enflurane,Urethane,The risk or severity of CNS depression can be increased when Enflurane is combined with Urethane.,increase,risk
Enflurane,Valproic acid,The risk or severity of CNS depression can be increased when Enflurane is combined with Valproic acid.,increase,risk
Enflurane,Vayarin,The metabolism of Enflurane can be decreased when combined with Vayarin.,decrease,no risk
Enflurane,Vecuronium,The risk or severity of adverse effects can be increased when Enflurane is combined with Vecuronium.,increase,risk
Enflurane,Venlafaxine,The risk or severity of CNS depression can be increased when Enflurane is combined with Venlafaxine.,increase,risk
Enflurane,Verapamil,The risk or severity of myocardial depression can be increased when Verapamil is combined with Enflurane.,increase,risk
Enflurane,Vigabatrin,The risk or severity of CNS depression can be increased when Enflurane is combined with Vigabatrin.,increase,risk
Enflurane,Vilazodone,The risk or severity of CNS depression can be increased when Enflurane is combined with Vilazodone.,increase,risk
Enflurane,Viloxazine,The risk or severity of CNS depression can be increased when Enflurane is combined with Viloxazine.,increase,risk
Enflurane,Vortioxetine,The risk or severity of CNS depression can be increased when Enflurane is combined with Vortioxetine.,increase,risk
Enflurane,Yohimbine,The risk or severity of CNS depression can be increased when Enflurane is combined with Yohimbine.,increase,risk
Enflurane,Zaleplon,The risk or severity of CNS depression can be increased when Enflurane is combined with Zaleplon.,increase,risk
Enflurane,Ziconotide,The risk or severity of CNS depression can be increased when Enflurane is combined with Ziconotide.,increase,risk
Enflurane,Zimelidine,The risk or severity of adverse effects can be increased when Enflurane is combined with Zimelidine.,increase,risk
Enflurane,Ziprasidone,The risk or severity of adverse effects can be increased when Enflurane is combined with Ziprasidone.,increase,risk
Enflurane,Zolmitriptan,The risk or severity of CNS depression can be increased when Enflurane is combined with Zolmitriptan.,increase,risk
Enflurane,Zolpidem,Enflurane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Enflurane,Zonisamide,The risk or severity of CNS depression can be increased when Enflurane is combined with Zonisamide.,increase,risk
Enflurane,Zopiclone,The risk or severity of adverse effects can be increased when Enflurane is combined with Zopiclone.,increase,risk
Enflurane,Zotepine,The risk or severity of CNS depression can be increased when Enflurane is combined with Zotepine.,increase,risk
Enflurane,Zuclopenthixol,The risk or severity of CNS depression can be increased when Enflurane is combined with Zuclopenthixol.,increase,risk
Enflurane,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Enflurane.,increase,risk
Cefotiam,Gabapentin enacarbil,Cefotiam may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefotiam,Gadobenic acid,Cefotiam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefotiam,Gadodiamide,Cefotiam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefotiam,Gadofosveset trisodium,Cefotiam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefotiam,Gadopentetic acid,Cefotiam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefotiam,Gadoteric acid,Cefotiam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefotiam,Gadoteridol,Cefotiam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefotiam,Ganciclovir,The excretion of Cefotiam can be decreased when combined with Ganciclovir.,decrease,no risk
Cefotiam,Gemcitabine,Cefotiam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefotiam,Gemfibrozil,The excretion of Cefotiam can be decreased when combined with Gemfibrozil.,decrease,no risk
Cefotiam,Gentamicin,Cefotiam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefotiam,Gimeracil,Cefotiam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefotiam,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Givosiran.,increase,risk
Cefotiam,Glipizide,Cefotiam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefotiam,Glyburide,The excretion of Cefotiam can be decreased when combined with Glyburide.,decrease,no risk
Cefotiam,Glycerol phenylbutyrate,Cefotiam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefotiam,Golodirsen,Cefotiam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefotiam,Goserelin,Cefotiam may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefotiam,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cefotiam.,decrease,no risk
Cefotiam,Guanethidine,Cefotiam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefotiam,Guanfacine,Cefotiam may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefotiam,Guanidine,The excretion of Cefotiam can be decreased when combined with Guanidine.,decrease,no risk
Cefotiam,Haloperidol,Cefotiam may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefotiam,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefotiam.,decrease,no risk
Cefotiam,Hydralazine,Cefotiam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefotiam,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cefotiam.,decrease,no risk
Cefotiam,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cefotiam.,decrease,no risk
Cefotiam,Hydromorphone,Cefotiam may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefotiam,Hydroxocobalamin,Cefotiam may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefotiam,Hydroxyethyl Starch,Cefotiam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefotiam,Kanamycin,Cefotiam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefotiam,Ketamine,Cefotiam may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefotiam,Ketazolam,Cefotiam may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefotiam,Ketoprofen,The excretion of Cefotiam can be decreased when combined with Ketoprofen.,decrease,no risk
Cefotiam,Ketorolac,The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Ketorolac.,increase,risk
Cefotiam,Octinoxate,Cefotiam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefotiam,Ofloxacin,The excretion of Cefotiam can be decreased when combined with Ofloxacin.,decrease,no risk
Cefotiam,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Olsalazine.,increase,risk
Cefotiam,Opium,Cefotiam may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefotiam,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cefotiam.,decrease,no risk
Cefotiam,Ouabain,The excretion of Cefotiam can be decreased when combined with Ouabain.,decrease,no risk
Cefotiam,Oxacillin,Cefotiam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefotiam,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefotiam.,increase,risk
Cefotiam,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Oxaprozin.,increase,risk
Cefotiam,Oxazepam,Cefotiam may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefotiam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefotiam is combined with Oxetacaine.,increase,risk
Cefotiam,Oxybenzone,Cefotiam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefotiam,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefotiam is combined with Oxybuprocaine.,increase,risk
Cefotiam,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Oxyphenbutazone.,increase,risk
Cefotiam,Oxyquinoline,Cefotiam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefotiam,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Cefotiam.,decrease,no risk
Cefotiam,Quetiapine,Cefotiam may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefotiam,Quinapril,The excretion of Quinapril can be decreased when combined with Cefotiam.,decrease,no risk
Cefotiam,Quinidine,Cefotiam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pregabalin,Benperidol,The therapeutic efficacy of Benperidol can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Benserazide,Pregabalin may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Pregabalin,Benzatropine,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Benzatropine.,increase,risk
Pregabalin,Benzhydrocodone,The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Pregabalin.,increase,risk
Pregabalin,Benznidazole,Pregabalin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Pregabalin,Benzocaine,The therapeutic efficacy of Benzocaine can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Benzphetamine,The therapeutic efficacy of Benzphetamine can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Benzthiazide,Benzthiazide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pregabalin,Benzydamine,Benzydamine may decrease the excretion rate of Pregabalin which could result in a higher serum level.,decrease,no risk
Pregabalin,Benzyl alcohol,The therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Bepotastine,Pregabalin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Pregabalin,Bepridil,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Bepridil.,increase,risk
Pregabalin,Beractant,Pregabalin may increase the bradycardic activities of Beractant.,increase,no risk
Pregabalin,Berotralstat,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Berotralstat.,increase,risk
Pregabalin,Betaxolol,Betaxolol may increase the bradycardic activities of Pregabalin.,increase,no risk
Pregabalin,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Bexagliflozin.,increase,risk
Pregabalin,Bicisate,Pregabalin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Pregabalin,Bilastine,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Bilastine.,increase,risk
Pregabalin,Bismuth subgallate,Pregabalin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Pregabalin,Bisoprolol,Pregabalin may increase the bradycardic activities of Bisoprolol.,increase,no risk
Pregabalin,Bisoxatin,Pregabalin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Pregabalin,Bleomycin,Pregabalin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Pregabalin,Borage oil,The therapeutic efficacy of Pregabalin can be decreased when used in combination with Borage oil.,decrease,no risk
Pregabalin,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Pregabalin.,increase,risk
Pregabalin,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Botulinum toxin type B,The therapeutic efficacy of Botulinum toxin type B can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Bretylium,Pregabalin may increase the bradycardic activities of Bretylium.,increase,no risk
Pregabalin,Brexanolone,The therapeutic efficacy of Brexanolone can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Brexpiprazole,The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.,increase,no risk
Pregabalin,Brivaracetam,The therapeutic efficacy of Brivaracetam can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Bromazepam,The therapeutic efficacy of Bromazepam can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Bromotheophylline,Pregabalin may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pregabalin,Bromperidol,The therapeutic efficacy of Bromperidol can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Brompheniramine,The therapeutic efficacy of Brompheniramine can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Buclizine,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Buclizine.,increase,risk
Pregabalin,Budesonide,Pregabalin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Pregabalin,Bumadizone,Bumadizone may decrease the excretion rate of Pregabalin which could result in a higher serum level.,decrease,no risk
Pregabalin,Bumetanide,Bumetanide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pregabalin,Bupivacaine,The therapeutic efficacy of Bupivacaine can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Buprenorphine,Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Pregabalin,Bupropion,The therapeutic efficacy of Bupropion can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Buserelin,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Buserelin.,increase,risk
Pregabalin,Buspirone,The therapeutic efficacy of Buspirone can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Butabarbital,The therapeutic efficacy of Butabarbital can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Butacaine,The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Butacaine.,increase,risk
Pregabalin,Butalbital,The therapeutic efficacy of Butalbital can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Butamben,The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Butamben.,increase,risk
Pregabalin,Butaperazine,The therapeutic efficacy of Butaperazine can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Butobarbital,The therapeutic efficacy of Butobarbital can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Butorphanol,The therapeutic efficacy of Butorphanol can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Butriptyline,The therapeutic efficacy of Butriptyline can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Gabapentin,The therapeutic efficacy of Gabapentin can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Gabapentin enacarbil,The therapeutic efficacy of Gabapentin enacarbil can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Gadobenic acid.,increase,risk
Pregabalin,Gadodiamide,Gadodiamide may decrease the excretion rate of Pregabalin which could result in a higher serum level.,decrease,no risk
Pregabalin,Gadofosveset trisodium,Pregabalin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pregabalin,Gadopentetic acid,Pregabalin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Pregabalin,Gadoteric acid,Pregabalin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pregabalin,Gadoteridol,Pregabalin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Pregabalin,Galantamine,Pregabalin may increase the bradycardic activities of Galantamine.,increase,no risk
Pregabalin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Gamolenic acid,The therapeutic efficacy of Pregabalin can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Pregabalin,Ganaxolone,The therapeutic efficacy of Ganaxolone can be increased when used in combination with Pregabalin.,increase,no risk
Pregabalin,Ganciclovir,The therapeutic efficacy of Pregabalin can be decreased when used in combination with Ganciclovir.,decrease,no risk
Pregabalin,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Gatifloxacin.,increase,risk
Pregabalin,Gemcitabine,Pregabalin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Pregabalin,Gemfibrozil,Pregabalin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Pregabalin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Gemifloxacin.,increase,risk
Pregabalin,Gentamicin,Pregabalin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pregabalin,Gepirone,The therapeutic efficacy of Gepirone can be increased when used in combination with Pregabalin.,increase,no risk
Temazepam,Brompheniramine,The risk or severity of CNS depression can be increased when Temazepam is combined with Brompheniramine.,increase,risk
Temazepam,Budesonide,Temazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Temazepam,Bumadizone,Bumadizone may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Bumetanide,Bumetanide may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temazepam,Bupivacaine,The risk or severity of CNS depression can be increased when Temazepam is combined with Bupivacaine.,increase,risk
Temazepam,Buprenorphine,Temazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Temazepam,Bupropion,The risk or severity of CNS depression can be increased when Temazepam is combined with Bupropion.,increase,risk
Temazepam,Buspirone,The risk or severity of CNS depression can be increased when Temazepam is combined with Buspirone.,increase,risk
Temazepam,Butabarbital,The risk or severity of CNS depression can be increased when Temazepam is combined with Butabarbital.,increase,risk
Temazepam,Butalbital,The risk or severity of CNS depression can be increased when Temazepam is combined with Butalbital.,increase,risk
Temazepam,Butaperazine,The risk or severity of CNS depression can be increased when Temazepam is combined with Butaperazine.,increase,risk
Temazepam,Butobarbital,The risk or severity of CNS depression can be increased when Temazepam is combined with Butobarbital.,increase,risk
Temazepam,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Temazepam.,increase,risk
Temazepam,Butriptyline,The risk or severity of CNS depression can be increased when Temazepam is combined with Butriptyline.,increase,risk
Temazepam,Gabapentin,The risk or severity of CNS depression can be increased when Temazepam is combined with Gabapentin.,increase,risk
Temazepam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Temazepam is combined with Gabapentin enacarbil.,increase,risk
Temazepam,Gadobenic acid,Temazepam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Temazepam,Gadodiamide,Gadodiamide may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Gadofosveset trisodium,Temazepam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Temazepam,Gadopentetic acid,Temazepam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Temazepam,Gadoteric acid,Temazepam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Temazepam,Gadoteridol,Temazepam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Temazepam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Temazepam is combined with Gallamine triethiodide.,increase,risk
Temazepam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Temazepam is combined with Ganaxolone.",increase,risk
Temazepam,Ganciclovir,Temazepam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Temazepam,Gemcitabine,Temazepam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Temazepam,Gemfibrozil,Temazepam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Temazepam,Gentamicin,Temazepam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Temazepam,Gepirone,The risk or severity of CNS depression can be increased when Temazepam is combined with Gepirone.,increase,risk
Temazepam,Gimeracil,Temazepam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Temazepam,Givosiran,Givosiran may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Glipizide,Temazepam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Temazepam,Glutethimide,The risk or severity of CNS depression can be increased when Temazepam is combined with Glutethimide.,increase,risk
Temazepam,Glycerol phenylbutyrate,Temazepam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Temazepam,Golodirsen,Temazepam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Temazepam,Goserelin,Goserelin may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Granisetron,The risk or severity of CNS depression can be increased when Temazepam is combined with Granisetron.,increase,risk
Temazepam,Guanethidine,Temazepam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Temazepam,Guanfacine,The risk or severity of CNS depression can be increased when Temazepam is combined with Guanfacine.,increase,risk
Temazepam,Halazepam,The risk or severity of CNS depression can be increased when Temazepam is combined with Halazepam.,increase,risk
Temazepam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Temazepam.,increase,risk
Temazepam,Halothane,The risk or severity of CNS depression can be increased when Temazepam is combined with Halothane.,increase,risk
Temazepam,Hexafluronium,The risk or severity of CNS depression can be increased when Temazepam is combined with Hexafluronium.,increase,risk
Temazepam,Hydralazine,Temazepam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Temazepam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temazepam,Hydrocodone,Temazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Temazepam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temazepam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Temazepam.,increase,risk
Temazepam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Hydroxyethyl Starch,Temazepam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Temazepam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Temazepam.,increase,no risk
Temazepam,Kanamycin,Temazepam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Temazepam,Ketamine,The risk or severity of CNS depression can be increased when Temazepam is combined with Ketamine.,increase,risk
Temazepam,Ketazolam,The risk or severity of CNS depression can be increased when Temazepam is combined with Ketazolam.,increase,risk
Temazepam,Ketoprofen,Ketoprofen may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Ketorolac,Ketorolac may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Octinoxate,Temazepam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Temazepam,Olanzapine,The risk or severity of CNS depression can be increased when Temazepam is combined with Olanzapine.,increase,risk
Temazepam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Temazepam is combined with Oliceridine.",increase,risk
Temazepam,Olsalazine,Olsalazine may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Ondansetron,The risk or severity of CNS depression can be increased when Temazepam is combined with Ondansetron.,increase,risk
Temazepam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Temazepam.,increase,risk
Temazepam,Orphenadrine,Temazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Temazepam,Oseltamivir,Oseltamivir may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Oxacillin,Temazepam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Temazepam,Oxaprozin,Oxaprozin may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Oxazepam,The risk or severity of CNS depression can be increased when Temazepam is combined with Oxazepam.,increase,risk
Temazepam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Temazepam is combined with Oxcarbazepine.,increase,risk
Temazepam,Oxitriptan,The risk or severity of CNS depression can be increased when Temazepam is combined with Oxitriptan.,increase,risk
Temazepam,Oxprenolol,The risk or severity of CNS depression can be increased when Temazepam is combined with Oxprenolol.,increase,risk
Temazepam,Oxtriphylline,The therapeutic efficacy of Temazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Temazepam,Oxybenzone,Temazepam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Temazepam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Temazepam is combined with Oxybuprocaine.,increase,risk
Temazepam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Temazepam.,increase,risk
Temazepam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Temazepam.,increase,risk
Temazepam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Oxyquinoline,Temazepam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Temazepam,Quazepam,The risk or severity of CNS depression can be increased when Temazepam is combined with Quazepam.,increase,risk
Temazepam,Quetiapine,The risk or severity of CNS depression can be increased when Temazepam is combined with Quetiapine.,increase,risk
Temazepam,Quinethazone,Quinethazone may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Temazepam,Quinidine,Temazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Temazepam,Quinine,The risk or severity of CNS depression can be increased when Temazepam is combined with Quinine.,increase,risk
Temazepam,Quinupramine,The risk or severity of CNS depression can be increased when Temazepam is combined with Quinupramine.,increase,risk
Temazepam,Urethane,The risk or severity of CNS depression can be increased when Temazepam is combined with Urethane.,increase,risk
Temazepam,Vaborbactam,Temazepam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Temazepam,Valaciclovir,Valaciclovir may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Valbenazine,Temazepam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Temazepam,Valdecoxib,Valdecoxib may decrease the excretion rate of Temazepam which could result in a higher serum level.,decrease,no risk
Temazepam,Valganciclovir,Temazepam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Temazepam,Valproic acid,The risk or severity of CNS depression can be increased when Temazepam is combined with Valproic acid.,increase,risk
Temazepam,Vancomycin,Temazepam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Temazepam,Varenicline,Temazepam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Temazepam,Vecuronium,The risk or severity of CNS depression can be increased when Temazepam is combined with Vecuronium.,increase,risk
Temazepam,Venlafaxine,The risk or severity of CNS depression can be increased when Temazepam is combined with Venlafaxine.,increase,risk
Temazepam,Verapamil,Temazepam may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Temazepam,Vigabatrin,The risk or severity of CNS depression can be increased when Temazepam is combined with Vigabatrin.,increase,risk
Temazepam,Vilanterol,Temazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Temazepam,Vilazodone,The risk or severity of CNS depression can be increased when Temazepam is combined with Vilazodone.,increase,risk
Temazepam,Viloxazine,The risk or severity of CNS depression can be increased when Temazepam is combined with Viloxazine.,increase,risk
Temazepam,Voriconazole,The serum concentration of Temazepam can be increased when it is combined with Voriconazole.,increase,no risk
Temazepam,Vortioxetine,The risk or severity of CNS depression can be increased when Temazepam is combined with Vortioxetine.,increase,risk
Temazepam,Warfarin,Temazepam may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Temazepam,Yohimbine,The therapeutic efficacy of Temazepam can be increased when used in combination with Yohimbine.,increase,no risk
Temazepam,Zaleplon,The risk or severity of CNS depression can be increased when Temazepam is combined with Zaleplon.,increase,risk
Temazepam,Zanamivir,Temazepam may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Temazepam,Ziconotide,The risk or severity of CNS depression can be increased when Temazepam is combined with Ziconotide.,increase,risk
Temazepam,Zimelidine,The risk or severity of adverse effects can be increased when Temazepam is combined with Zimelidine.,increase,risk
Temazepam,Ziprasidone,The risk or severity of adverse effects can be increased when Temazepam is combined with Ziprasidone.,increase,risk
Temazepam,Zolmitriptan,The risk or severity of CNS depression can be increased when Temazepam is combined with Zolmitriptan.,increase,risk
Temazepam,Zolpidem,Temazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Temazepam,Zonisamide,The risk or severity of CNS depression can be increased when Temazepam is combined with Zonisamide.,increase,risk
Temazepam,Zopiclone,The risk or severity of adverse effects can be increased when Temazepam is combined with Zopiclone.,increase,risk
Temazepam,Zotepine,The risk or severity of CNS depression can be increased when Temazepam is combined with Zotepine.,increase,risk
Temazepam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Temazepam is combined with Zuclopenthixol.,increase,risk
Temazepam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Temazepam.,increase,risk
Methyclothiazide,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Benznidazole,Methyclothiazide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Benzydamine,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Benzydamine.,decrease,no risk
Methyclothiazide,Benzylpenicillin,Methyclothiazide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Methyclothiazide,Bepotastine,Methyclothiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Bepridil,The therapeutic efficacy of Bepridil can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Betamethasone,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Betamethasone phosphate,The risk or severity of electrolyte imbalance can be increased when Betamethasone phosphate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Betaxolol,The therapeutic efficacy of Betaxolol can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Bethanidine,The therapeutic efficacy of Bethanidine can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Betrixaban,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Bexarotene,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Bexarotene.,increase,risk
Methyclothiazide,Bicisate,Methyclothiazide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Biperiden,The serum concentration of Methyclothiazide can be increased when it is combined with Biperiden.,increase,no risk
Methyclothiazide,Bisacodyl,The risk or severity of dehydration can be increased when Methyclothiazide is combined with Bisacodyl.,increase,risk
Methyclothiazide,Bismuth subgallate,Methyclothiazide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Bisoprolol,The therapeutic efficacy of Bisoprolol can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Bisoxatin,The risk or severity of dehydration can be increased when Methyclothiazide is combined with Bisoxatin.,increase,risk
Methyclothiazide,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Bleomycin,Methyclothiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Blinatumomab,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Blinatumomab.,increase,risk
Methyclothiazide,Bortezomib,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Bortezomib.,increase,risk
Methyclothiazide,Bosentan,The therapeutic efficacy of Bosentan can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Bosutinib,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Bosutinib.,increase,risk
Methyclothiazide,Bretylium,The therapeutic efficacy of Bretylium can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Brivaracetam,Methyclothiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Bromazepam,Methyclothiazide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Brompheniramine,The serum concentration of Methyclothiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Methyclothiazide,Buclizine,The serum concentration of Methyclothiazide can be increased when it is combined with Buclizine.,increase,no risk
Methyclothiazide,Budesonide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Bumadizone,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Bumadizone.,decrease,no risk
Methyclothiazide,Bumetanide,Methyclothiazide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Bupivacaine,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Bupivacaine.,increase,risk
Methyclothiazide,Buprenorphine,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Methyclothiazide,Bupropion,Methyclothiazide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Buspirone,Methyclothiazide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Busulfan,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Busulfan.,increase,risk
Methyclothiazide,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Butobarbital,The serum concentration of Methyclothiazide can be increased when it is combined with Butobarbital.,increase,no risk
Methyclothiazide,Butorphanol,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Butorphanol.,decrease,no risk
Methyclothiazide,Butylscopolamine,The serum concentration of Methyclothiazide can be increased when it is combined with Butylscopolamine.,increase,no risk
Methyclothiazide,Gabapentin enacarbil,Methyclothiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gadobenic acid,Methyclothiazide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gadodiamide,Methyclothiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gadofosveset trisodium,Methyclothiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gadopentetic acid,Methyclothiazide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gadoteric acid,Methyclothiazide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gadoteridol,Methyclothiazide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gallamine triethiodide,The serum concentration of Methyclothiazide can be increased when it is combined with Gallamine triethiodide.,increase,no risk
Methyclothiazide,Ganciclovir,Methyclothiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gemcitabine,Methyclothiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gemfibrozil,Methyclothiazide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gemtuzumab ozogamicin,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Gemtuzumab ozogamicin.,increase,risk
Methyclothiazide,Gimeracil,Methyclothiazide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Gluconic Acid,The risk or severity of dehydration can be increased when Methyclothiazide is combined with Gluconic Acid.,increase,risk
Methyclothiazide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Glycerin,The risk or severity of dehydration can be increased when Methyclothiazide is combined with Glycerin.,increase,risk
Methyclothiazide,Glycerol phenylbutyrate,Methyclothiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Glycol salicylate,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Methyclothiazide,Glycopyrronium,The serum concentration of Methyclothiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Methyclothiazide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Golodirsen,Methyclothiazide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Goserelin,Methyclothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Guanabenz,The therapeutic efficacy of Guanabenz can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Guanadrel,The therapeutic efficacy of Guanadrel can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Guanethidine,The therapeutic efficacy of Guanethidine can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Guanfacine,The therapeutic efficacy of Guanfacine can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Guanoxan,The therapeutic efficacy of Guanoxan can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Halcinonide,The risk or severity of electrolyte imbalance can be increased when Halcinonide is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Haloperidol,Methyclothiazide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Halothane,The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Halothane.,increase,risk
Methyclothiazide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Methyclothiazide.,decrease,no risk
Methyclothiazide,Hexafluronium,The serum concentration of Methyclothiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Methyclothiazide,Hexocyclium,The serum concentration of Methyclothiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Methyclothiazide,Homatropine methylbromide,The serum concentration of Methyclothiazide can be increased when it is combined with Homatropine methylbromide.,increase,no risk
Methyclothiazide,Hydralazine,The therapeutic efficacy of Hydralazine can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Hydrocodone,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Methyclothiazide,Hydrocortisone,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydrocortisone acetate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone acetate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydrocortisone butyrate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydrocortisone cypionate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone cypionate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydrocortisone probutate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydrocortisone succinate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone succinate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydrocortisone valerate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone valerate is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be increased when used in combination with Methyclothiazide.,increase,no risk
Methyclothiazide,Hydromorphone,Methyclothiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Hydroxocobalamin,Methyclothiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Hydroxyethyl Starch,Methyclothiazide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Hydroxyurea,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Hydroxyurea.,increase,risk
Methyclothiazide,Hyoscyamine,The serum concentration of Methyclothiazide can be increased when it is combined with Hyoscyamine.,increase,no risk
Methyclothiazide,Ketamine,Methyclothiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Ketazolam,Methyclothiazide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyclothiazide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Methyclothiazide.,increase,risk
Methyclothiazide,Ketorolac,The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Ketorolac.,decrease,no risk
Aminosalicylic acid,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Aminosalicylic acid.,increase,risk
Aminosalicylic acid,Gliclazide,Aminosalicylic acid may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Aminosalicylic acid,Glimepiride,Aminosalicylic acid may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Aminosalicylic acid,Glipizide,Aminosalicylic acid may increase the hypoglycemic activities of Glipizide.,increase,no risk
Aminosalicylic acid,Gliquidone,Aminosalicylic acid may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Aminosalicylic acid,Glyburide,Aminosalicylic acid may increase the hypoglycemic activities of Glyburide.,increase,no risk
Aminosalicylic acid,Glymidine,Aminosalicylic acid may increase the hypoglycemic activities of Glymidine.,increase,no risk
Aminosalicylic acid,Heparin,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Heparin.,increase,risk
Aminosalicylic acid,Hydrocortisone,The serum concentration of Aminosalicylic acid can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Aminosalicylic acid,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Hydroxyurea.,increase,risk
Aminosalicylic acid,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Ketoprofen.,increase,risk
Aminosalicylic acid,Ketorolac,The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Ketorolac.,decrease,no risk
Aminosalicylic acid,Olsalazine,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Olsalazine.",increase,risk
Aminosalicylic acid,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Aminosalicylic acid.,decrease,no risk
Aminosalicylic acid,Oxaprozin,The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Oxaprozin.,decrease,no risk
Aminosalicylic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Oxetacaine.,increase,risk
Aminosalicylic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Oxybuprocaine.,increase,risk
Aminosalicylic acid,Quinapril,The risk or severity of renal failure can be increased when Aminosalicylic acid is combined with Quinapril.,increase,risk
Aminosalicylic acid,Quinine,Aminosalicylic acid may increase the hypoglycemic activities of Quinine.,increase,no risk
Aminosalicylic acid,Urokinase,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Urokinase.,increase,risk
Aminosalicylic acid,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Aminosalicylic acid.,increase,no risk
Aminosalicylic acid,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Aminosalicylic acid,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Aminosalicylic acid.,increase,risk
Aminosalicylic acid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Aminosalicylic acid.,decrease,no risk
Aminosalicylic acid,Vildagliptin,Aminosalicylic acid may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Aminosalicylic acid,Vorapaxar,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Vorapaxar.,increase,risk
Aminosalicylic acid,Warfarin,Aminosalicylic acid may increase the anticoagulant activities of Warfarin.,increase,no risk
Aminosalicylic acid,Ximelagatran,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Ximelagatran.,increase,risk
Aminosalicylic acid,Zofenopril,The risk or severity of renal failure can be increased when Aminosalicylic acid is combined with Zofenopril.,increase,risk
Aminosalicylic acid,Zonisamide,The risk or severity of adverse effects can be increased when Aminosalicylic acid is combined with Zonisamide.,increase,risk
Aminosalicylic acid,Zopiclone,The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Zopiclone.,increase,risk
Reboxetine,Gabapentin,The risk or severity of CNS depression can be increased when Reboxetine is combined with Gabapentin.,increase,risk
Reboxetine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Reboxetine is combined with Gabapentin enacarbil.,increase,risk
Reboxetine,Galantamine,The metabolism of Galantamine can be decreased when combined with Reboxetine.,decrease,no risk
Reboxetine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Reboxetine is combined with Gallamine triethiodide.,increase,risk
Reboxetine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Reboxetine is combined with Ganaxolone.",increase,risk
Reboxetine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Reboxetine.,decrease,no risk
Reboxetine,Gepirone,The risk or severity of CNS depression can be increased when Reboxetine is combined with Gepirone.,increase,risk
Reboxetine,Glofitamab,The serum concentration of Reboxetine can be increased when it is combined with Glofitamab.,increase,no risk
Reboxetine,Glutethimide,The risk or severity of CNS depression can be increased when Reboxetine is combined with Glutethimide.,increase,risk
Reboxetine,Granisetron,The risk or severity of CNS depression can be increased when Reboxetine is combined with Granisetron.,increase,risk
Reboxetine,Guanfacine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Guanfacine.,increase,risk
Reboxetine,Halazepam,The risk or severity of CNS depression can be increased when Reboxetine is combined with Halazepam.,increase,risk
Reboxetine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Reboxetine.,increase,risk
Reboxetine,Halothane,The risk or severity of CNS depression can be increased when Reboxetine is combined with Halothane.,increase,risk
Reboxetine,Hexafluronium,The risk or severity of CNS depression can be increased when Reboxetine is combined with Hexafluronium.,increase,risk
Reboxetine,Hydrocodone,Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Reboxetine,Hydromorphone,The risk or severity of CNS depression can be increased when Reboxetine is combined with Hydromorphone.,increase,risk
Reboxetine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Reboxetine.,decrease,no risk
Reboxetine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Reboxetine.,increase,no risk
Reboxetine,Ketamine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Ketamine.,increase,risk
Reboxetine,Ketazolam,The risk or severity of CNS depression can be increased when Reboxetine is combined with Ketazolam.,increase,risk
Reboxetine,Ketoconazole,The metabolism of Reboxetine can be decreased when combined with Ketoconazole.,decrease,no risk
Reboxetine,Olanzapine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Olanzapine.,increase,risk
Reboxetine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Reboxetine is combined with Oliceridine.",increase,risk
Reboxetine,Omaveloxolone,The serum concentration of Reboxetine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Reboxetine,Ondansetron,The risk or severity of CNS depression can be increased when Reboxetine is combined with Ondansetron.,increase,risk
Reboxetine,Opium,The risk or severity of CNS depression can be increased when Reboxetine is combined with Opium.,increase,risk
Reboxetine,Orphenadrine,Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Reboxetine,Oxazepam,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxazepam.,increase,risk
Reboxetine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxcarbazepine.,increase,risk
Reboxetine,Oxitriptan,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxitriptan.,increase,risk
Reboxetine,Oxprenolol,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxprenolol.,increase,risk
Reboxetine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxybuprocaine.,increase,risk
Reboxetine,Oxycodone,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxycodone.,increase,risk
Reboxetine,Oxymorphone,The risk or severity of CNS depression can be increased when Reboxetine is combined with Oxymorphone.,increase,risk
Reboxetine,Quazepam,The risk or severity of CNS depression can be increased when Reboxetine is combined with Quazepam.,increase,risk
Reboxetine,Quetiapine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Quetiapine.,increase,risk
Reboxetine,Quinine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Quinine.,increase,risk
Reboxetine,Quinupramine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Quinupramine.,increase,risk
Reboxetine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Reboxetine.,decrease,no risk
Reboxetine,Urethane,The risk or severity of CNS depression can be increased when Reboxetine is combined with Urethane.,increase,risk
Reboxetine,Vadadustat,The serum concentration of Reboxetine can be increased when it is combined with Vadadustat.,increase,no risk
Reboxetine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Reboxetine.,decrease,no risk
Reboxetine,Valproic acid,The risk or severity of CNS depression can be increased when Reboxetine is combined with Valproic acid.,increase,risk
Reboxetine,Vecuronium,The risk or severity of CNS depression can be increased when Reboxetine is combined with Vecuronium.,increase,risk
Reboxetine,Venetoclax,The metabolism of Reboxetine can be decreased when combined with Venetoclax.,decrease,no risk
Reboxetine,Venlafaxine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Venlafaxine.,increase,risk
Reboxetine,Verapamil,The metabolism of Reboxetine can be decreased when combined with Verapamil.,decrease,no risk
Reboxetine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Reboxetine.,decrease,no risk
Reboxetine,Vigabatrin,The risk or severity of CNS depression can be increased when Reboxetine is combined with Vigabatrin.,increase,risk
Reboxetine,Vilazodone,The risk or severity of CNS depression can be increased when Reboxetine is combined with Vilazodone.,increase,risk
Reboxetine,Viloxazine,The metabolism of Reboxetine can be decreased when combined with Viloxazine.,decrease,no risk
Reboxetine,Voriconazole,The metabolism of Reboxetine can be decreased when combined with Voriconazole.,decrease,no risk
Reboxetine,Vortioxetine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Vortioxetine.,increase,risk
Reboxetine,Warfarin,The risk or severity of adverse effects can be increased when Reboxetine is combined with Warfarin.,increase,risk
Reboxetine,Yohimbine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Yohimbine.,increase,risk
Reboxetine,Zaleplon,The risk or severity of CNS depression can be increased when Reboxetine is combined with Zaleplon.,increase,risk
Reboxetine,Ziconotide,The risk or severity of CNS depression can be increased when Reboxetine is combined with Ziconotide.,increase,risk
Reboxetine,Zimelidine,The risk or severity of adverse effects can be increased when Reboxetine is combined with Zimelidine.,increase,risk
Reboxetine,Ziprasidone,The risk or severity of adverse effects can be increased when Reboxetine is combined with Ziprasidone.,increase,risk
Reboxetine,Zolmitriptan,The risk or severity of CNS depression can be increased when Reboxetine is combined with Zolmitriptan.,increase,risk
Reboxetine,Zolpidem,Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Reboxetine,Zonisamide,The risk or severity of CNS depression can be increased when Reboxetine is combined with Zonisamide.,increase,risk
Reboxetine,Zopiclone,The risk or severity of adverse effects can be increased when Reboxetine is combined with Zopiclone.,increase,risk
Reboxetine,Zotepine,The risk or severity of CNS depression can be increased when Reboxetine is combined with Zotepine.,increase,risk
Reboxetine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Reboxetine is combined with Zuclopenthixol.,increase,risk
Reboxetine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Reboxetine.,increase,risk
Milrinone,Gabapentin enacarbil,Milrinone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Milrinone,Gadobenic acid,Milrinone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Milrinone,Gadodiamide,Gadodiamide may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Gadofosveset trisodium,Milrinone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Milrinone,Gadopentetic acid,Milrinone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Milrinone,Gadoteric acid,Milrinone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Milrinone,Gadoteridol,Milrinone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Milrinone,Ganciclovir,Milrinone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Milrinone,Gemcitabine,Milrinone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Milrinone,Gemfibrozil,Milrinone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Milrinone,Gentamicin,Milrinone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Milrinone,Gimeracil,Milrinone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Milrinone,Givosiran,Givosiran may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Glipizide,Milrinone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Milrinone,Glycerol phenylbutyrate,Milrinone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Milrinone,Golodirsen,Milrinone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Milrinone,Goserelin,Goserelin may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Guanethidine,Milrinone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Milrinone,Guanfacine,Milrinone may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Milrinone,Haloperidol,Milrinone may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Milrinone,Hydralazine,Milrinone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Milrinone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Milrinone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Milrinone,Hydromorphone,Milrinone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Milrinone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Hydroxyethyl Starch,Milrinone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Milrinone,Kanamycin,Milrinone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Milrinone,Ketamine,Milrinone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Milrinone,Ketazolam,Milrinone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Milrinone,Ketoprofen,Ketoprofen may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Ketorolac,Ketorolac may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Octinoxate,Milrinone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Milrinone,Olsalazine,Olsalazine may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Opium,Milrinone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Milrinone,Oseltamivir,Oseltamivir may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Oxacillin,Milrinone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Milrinone,Oxaprozin,Oxaprozin may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Oxazepam,Milrinone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Milrinone,Oxybenzone,Milrinone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Milrinone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Oxyquinoline,Milrinone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Milrinone,Quetiapine,Milrinone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Milrinone,Quinethazone,Quinethazone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Milrinone,Quinidine,Milrinone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Milrinone,Vaborbactam,Milrinone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Milrinone,Valaciclovir,Valaciclovir may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Valbenazine,Milrinone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Milrinone,Valdecoxib,Valdecoxib may decrease the excretion rate of Milrinone which could result in a higher serum level.,decrease,no risk
Milrinone,Valganciclovir,Milrinone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Milrinone,Vancomycin,Milrinone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Milrinone,Varenicline,Milrinone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Milrinone,Venlafaxine,Milrinone may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Milrinone,Verapamil,Milrinone may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Milrinone,Vilanterol,Milrinone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Milrinone,Viloxazine,Milrinone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Milrinone,Vortioxetine,Milrinone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Milrinone,Warfarin,Milrinone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Milrinone,Zaleplon,Milrinone may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Milrinone,Zanamivir,Milrinone may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Milrinone,Zonisamide,Zonisamide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pipobroman,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Benzocaine.,increase,risk
Pipobroman,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Benzyl alcohol.,increase,risk
Pipobroman,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Bupivacaine.,increase,risk
Pipobroman,Butacaine,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Butacaine.,increase,risk
Pipobroman,Butamben,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Butamben.,increase,risk
Pipobroman,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Oxetacaine.,increase,risk
Pipobroman,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Oxybuprocaine.,increase,risk
Butabarbital,Benzydamine,Benzydamine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Benzyl alcohol,The risk or severity of CNS depression can be increased when Butabarbital is combined with Benzyl alcohol.,increase,risk
Butabarbital,Bepotastine,Butabarbital may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Butabarbital,Bepridil,Butabarbital may increase the hypotensive activities of Bepridil.,increase,no risk
Butabarbital,Betaine,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Betaine.,decrease,no risk
Butabarbital,Betaxolol,Butabarbital may increase the hypotensive activities of Betaxolol.,increase,no risk
Butabarbital,Bicisate,Butabarbital may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Butabarbital,Biperiden,The risk or severity of adverse effects can be increased when Butabarbital is combined with Biperiden.,increase,risk
Butabarbital,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Butabarbital.,decrease,no risk
Butabarbital,Bismuth subgallate,Butabarbital may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Butabarbital,Bisoprolol,Butabarbital may increase the hypotensive activities of Bisoprolol.,increase,no risk
Butabarbital,Bisoxatin,Butabarbital may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Butabarbital,Bleomycin,Butabarbital may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Butabarbital,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum toxin type A.,increase,risk
Butabarbital,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum toxin type B.,increase,risk
Butabarbital,Bretylium,Butabarbital may increase the hypotensive activities of Bretylium.,increase,no risk
Butabarbital,Brexanolone,The risk or severity of CNS depression can be increased when Butabarbital is combined with Brexanolone.,increase,risk
Butabarbital,Brexpiprazole,The risk or severity of CNS depression can be increased when Butabarbital is combined with Brexpiprazole.,increase,risk
Butabarbital,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Butabarbital,Brivaracetam,The risk or severity of CNS depression can be increased when Butabarbital is combined with Brivaracetam.,increase,risk
Butabarbital,Bromazepam,The risk or severity of CNS depression can be increased when Butabarbital is combined with Bromazepam.,increase,risk
Butabarbital,Bromocriptine,Butabarbital may increase the hypotensive activities of Bromocriptine.,increase,no risk
Butabarbital,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Butabarbital.,decrease,no risk
Butabarbital,Bromperidol,The risk or severity of CNS depression can be increased when Butabarbital is combined with Bromperidol.,increase,risk
Butabarbital,Brompheniramine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Brompheniramine.,increase,risk
Butabarbital,Buclizine,The risk or severity of adverse effects can be increased when Butabarbital is combined with Buclizine.,increase,risk
Butabarbital,Budesonide,Butabarbital may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Butabarbital,Bumadizone,Bumadizone may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Bumetanide,Butabarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Butabarbital,Bupivacaine,Butabarbital may increase the hypotensive activities of Bupivacaine.,increase,no risk
Butabarbital,Buprenorphine,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Butabarbital,Bupropion,The risk or severity of CNS depression can be increased when Butabarbital is combined with Bupropion.,increase,risk
Butabarbital,Buspirone,The risk or severity of CNS depression can be increased when Butabarbital is combined with Buspirone.,increase,risk
Butabarbital,Butalbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Butalbital.,increase,risk
Butabarbital,Butaperazine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Butaperazine.,increase,risk
Butabarbital,Butobarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Butobarbital.,increase,risk
Butabarbital,Butorphanol,The risk or severity of adverse effects can be increased when Butabarbital is combined with Butorphanol.,increase,risk
Butabarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Butabarbital.,increase,no risk
Butabarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Butabarbital is combined with Butylscopolamine.,increase,risk
Butabarbital,Gabapentin,The risk or severity of CNS depression can be increased when Butabarbital is combined with Gabapentin.,increase,risk
Butabarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Butabarbital is combined with Gabapentin enacarbil.,increase,risk
Butabarbital,Gadobenic acid,Butabarbital may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Butabarbital,Gadodiamide,Gadodiamide may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Gadofosveset trisodium,Butabarbital may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Butabarbital,Gadopentetic acid,Butabarbital may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Butabarbital,Gadoteric acid,Butabarbital may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Butabarbital,Gadoteridol,Butabarbital may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Butabarbital,Galantamine,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Galantamine.,decrease,no risk
Butabarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Butabarbital is combined with Gallamine triethiodide.,increase,risk
Butabarbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Butabarbital is combined with Ganaxolone.",increase,risk
Butabarbital,Ganciclovir,Butabarbital may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Butabarbital,Gemcitabine,Butabarbital may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Butabarbital,Gemfibrozil,Butabarbital may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Butabarbital,Gentamicin,Butabarbital may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Butabarbital,Gepirone,The risk or severity of CNS depression can be increased when Butabarbital is combined with Gepirone.,increase,risk
Butabarbital,Gimeracil,Butabarbital may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Butabarbital,Ginkgo biloba,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Butabarbital,Givosiran,Givosiran may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Glipizide,Butabarbital may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Butabarbital,Glutethimide,The risk or severity of CNS depression can be increased when Butabarbital is combined with Glutethimide.,increase,risk
Butabarbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Butabarbital.,decrease,no risk
Butabarbital,Glycerol phenylbutyrate,Butabarbital may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Butabarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Butabarbital is combined with Glycopyrronium.,increase,risk
Butabarbital,Golodirsen,Butabarbital may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Butabarbital,Goserelin,Goserelin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Granisetron,The risk or severity of CNS depression can be increased when Butabarbital is combined with Granisetron.,increase,risk
Butabarbital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Butabarbital.,decrease,no risk
Butabarbital,Guanethidine,Butabarbital may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Butabarbital,Guanfacine,Butabarbital may increase the hypotensive activities of Guanfacine.,increase,no risk
Butabarbital,Halazepam,The risk or severity of CNS depression can be increased when Butabarbital is combined with Halazepam.,increase,risk
Butabarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Butabarbital.,increase,risk
Butabarbital,Halothane,Butabarbital may increase the hypotensive activities of Halothane.,increase,no risk
Butabarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Butabarbital is combined with Hexafluronium.,increase,risk
Butabarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Butabarbital is combined with Hexocyclium.,increase,risk
Butabarbital,Homatropine,The risk or severity of adverse effects can be increased when Butabarbital is combined with Homatropine.,increase,risk
Butabarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Butabarbital is combined with Homatropine methylbromide.,increase,risk
Butabarbital,Huperzine A,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Butabarbital,Hydralazine,Butabarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Butabarbital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Hydrochlorothiazide.,increase,risk
Butabarbital,Hydrocodone,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Butabarbital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Hydroflumethiazide.,increase,risk
Butabarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Butabarbital is combined with Hydromorphone.,increase,risk
Butabarbital,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Hydroxyethyl Starch,Butabarbital may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Butabarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Butabarbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Butabarbital is combined with Hyoscyamine.,increase,risk
Butabarbital,Kanamycin,Butabarbital may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Butabarbital,Ketamine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ketamine.,increase,risk
Butabarbital,Ketazolam,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ketazolam.,increase,risk
Butabarbital,Ketoprofen,Ketoprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Ketorolac,Ketorolac may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Obinutuzumab,Butabarbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Butabarbital,Octinoxate,Butabarbital may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Butabarbital,Olanzapine,Butabarbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Butabarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Butabarbital is combined with Oliceridine.",increase,risk
Butabarbital,Olmesartan,Butabarbital may increase the hypotensive activities of Olmesartan.,increase,no risk
Butabarbital,Olsalazine,Olsalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Ondansetron,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ondansetron.,increase,risk
Butabarbital,Opicapone,Butabarbital may increase the hypotensive activities of Opicapone.,increase,no risk
Butabarbital,Opium,The risk or severity of adverse effects can be increased when Butabarbital is combined with Opium.,increase,risk
Butabarbital,Orphenadrine,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Butabarbital,Oseltamivir,Oseltamivir may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Oxacillin,Butabarbital may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Butabarbital,Oxaprozin,Oxaprozin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Oxazepam,The risk or severity of CNS depression can be increased when Butabarbital is combined with Oxazepam.,increase,risk
Butabarbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Oxcarbazepine.,increase,risk
Butabarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Butabarbital is combined with Oxitriptan.,increase,risk
Butabarbital,Oxprenolol,Butabarbital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Butabarbital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Butabarbital.,decrease,no risk
Butabarbital,Oxybenzone,Butabarbital may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Butabarbital,Oxybuprocaine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Oxybuprocaine.,increase,risk
Butabarbital,Oxybutynin,The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxybutynin.,increase,risk
Butabarbital,Oxycodone,The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxycodone.,increase,risk
Butabarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxymorphone.,increase,risk
Butabarbital,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxyphencyclimine.,increase,risk
Butabarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Butabarbital.,decrease,no risk
Butabarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Butabarbital.,increase,risk
Butabarbital,Oxyquinoline,Butabarbital may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Butabarbital,Quazepam,The risk or severity of CNS depression can be increased when Butabarbital is combined with Quazepam.,increase,risk
Butabarbital,Quetiapine,Butabarbital may increase the hypotensive activities of Quetiapine.,increase,no risk
Butabarbital,Quinapril,Butabarbital may increase the hypotensive activities of Quinapril.,increase,no risk
Butabarbital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Quinethazone.,increase,risk
Butabarbital,Quinidine,Butabarbital may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Butabarbital,Quinine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Quinine.,increase,risk
Butabarbital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Butabarbital.,increase,no risk
Butabarbital,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Butabarbital.,decrease,no risk
Butabarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Butabarbital is combined with Umeclidinium.,increase,risk
Butabarbital,Urethane,The risk or severity of CNS depression can be increased when Butabarbital is combined with Urethane.,increase,risk
Butabarbital,Vaborbactam,Butabarbital may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Butabarbital,Valaciclovir,Valaciclovir may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Valbenazine,Butabarbital may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Butabarbital,Valdecoxib,Valdecoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Butabarbital,Valganciclovir,Butabarbital may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Butabarbital,Valproic acid,The serum concentration of Butabarbital can be increased when it is combined with Valproic acid.,increase,no risk
Butabarbital,Valsartan,Butabarbital may increase the hypotensive activities of Valsartan.,increase,no risk
Butabarbital,Vancomycin,Butabarbital may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Butabarbital,Varenicline,Butabarbital may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Butabarbital,Vecuronium,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vecuronium.,increase,risk
Butabarbital,Venlafaxine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Venlafaxine.,increase,risk
Butabarbital,Verapamil,Butabarbital may increase the hypotensive activities of Verapamil.,increase,no risk
Butabarbital,Vericiguat,Butabarbital may increase the hypotensive activities of Vericiguat.,increase,no risk
Butabarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vigabatrin.,increase,risk
Butabarbital,Vilanterol,Butabarbital may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Butabarbital,Vilazodone,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vilazodone.,increase,risk
Butabarbital,Viloxazine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Viloxazine.,increase,risk
Butabarbital,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Butabarbital.,decrease,no risk
Butabarbital,Vortioxetine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vortioxetine.,increase,risk
Butabarbital,Warfarin,Butabarbital may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Butabarbital,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Butabarbital.,increase,no risk
Butabarbital,Yohimbine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Yohimbine.,increase,risk
Butabarbital,Zaleplon,The risk or severity of CNS depression can be increased when Butabarbital is combined with Zaleplon.,increase,risk
Butabarbital,Zanamivir,Butabarbital may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Butabarbital,Ziconotide,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ziconotide.,increase,risk
Butabarbital,Zimelidine,The risk or severity of adverse effects can be increased when Butabarbital is combined with Zimelidine.,increase,risk
Butabarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Butabarbital is combined with Ziprasidone.,increase,risk
Butabarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Butabarbital is combined with Zolmitriptan.,increase,risk
Butabarbital,Zolpidem,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Butabarbital,Zonisamide,The metabolism of Zonisamide can be increased when combined with Butabarbital.,increase,no risk
Butabarbital,Zopiclone,The risk or severity of adverse effects can be increased when Butabarbital is combined with Zopiclone.,increase,risk
Butabarbital,Zotepine,The risk or severity of CNS depression can be increased when Butabarbital is combined with Zotepine.,increase,risk
Butabarbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Butabarbital is combined with Zuclopenthixol.,increase,risk
Butabarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Butabarbital.,increase,risk
Nevirapine,Galantamine,The metabolism of Galantamine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Ganciclovir,The risk or severity of adverse effects can be increased when Nevirapine is combined with Ganciclovir.,increase,risk
Nevirapine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Gemfibrozil,The metabolism of Nevirapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Nevirapine,Ginkgo biloba,The metabolism of Nevirapine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Nevirapine,Givosiran,The serum concentration of Nevirapine can be increased when it is combined with Givosiran.,increase,no risk
Nevirapine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Glimepiride,The metabolism of Nevirapine can be decreased when combined with Glimepiride.,decrease,no risk
Nevirapine,Glipizide,The metabolism of Glipizide can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Glofitamab,The serum concentration of Nevirapine can be increased when it is combined with Glofitamab.,increase,no risk
Nevirapine,Glyburide,The metabolism of Nevirapine can be decreased when combined with Glyburide.,decrease,no risk
Nevirapine,Glycerol phenylbutyrate,The metabolism of Nevirapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Nevirapine,Golimumab,The metabolism of Nevirapine can be increased when combined with Golimumab.,increase,no risk
Nevirapine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Guanfacine,The risk or severity of adverse effects can be increased when Nevirapine is combined with Guanfacine.,increase,risk
Nevirapine,Halofantrine,The metabolism of Nevirapine can be decreased when combined with Halofantrine.,decrease,no risk
Nevirapine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nevirapine.,increase,no risk
Nevirapine,Halothane,The metabolism of Halothane can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Histamine,The risk or severity of adverse effects can be increased when Nevirapine is combined with Histamine.,increase,risk
Nevirapine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Nevirapine.,decrease,no risk
Nevirapine,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Hydrocortisone,The metabolism of Nevirapine can be increased when combined with Hydrocortisone.,increase,no risk
Nevirapine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Hydroxychloroquine,The metabolism of Nevirapine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Nevirapine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Hydroxyzine,The metabolism of Nevirapine can be decreased when combined with Hydroxyzine.,decrease,no risk
Nevirapine,Ketamine,The metabolism of Ketamine can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Ketoconazole,The metabolism of Nevirapine can be decreased when combined with Ketoconazole.,decrease,no risk
Nevirapine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Olaparib,The metabolism of Olaparib can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Omaveloxolone,The serum concentration of Nevirapine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nevirapine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Opium,The metabolism of Opium can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Oritavancin,The metabolism of Nevirapine can be decreased when combined with Oritavancin.,decrease,no risk
Nevirapine,Orphenadrine,The metabolism of Nevirapine can be decreased when combined with Orphenadrine.,decrease,no risk
Nevirapine,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Nevirapine.,decrease,no risk
Nevirapine,Ospemifene,The metabolism of Ospemifene can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Oxamniquine,The metabolism of Nevirapine can be decreased when combined with Oxamniquine.,decrease,no risk
Nevirapine,Oxandrolone,The metabolism of Nevirapine can be decreased when combined with Oxandrolone.,decrease,no risk
Nevirapine,Oxcarbazepine,The metabolism of Nevirapine can be increased when combined with Oxcarbazepine.,increase,no risk
Nevirapine,Oxprenolol,The metabolism of Nevirapine can be decreased when combined with Oxprenolol.,decrease,no risk
Nevirapine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Oxybutynin,The metabolism of Nevirapine can be decreased when combined with Oxybutynin.,decrease,no risk
Nevirapine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Quinidine,The metabolism of Quinidine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Quinine,The metabolism of Nevirapine can be decreased when combined with Quinine.,decrease,no risk
Nevirapine,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Udenafil,The metabolism of Udenafil can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Vadadustat,The serum concentration of Nevirapine can be decreased when it is combined with Vadadustat.,decrease,no risk
Nevirapine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Valdecoxib,The metabolism of Nevirapine can be decreased when combined with Valdecoxib.,decrease,no risk
Nevirapine,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Nevirapine.,decrease,no risk
Nevirapine,Valproic acid,The metabolism of Valproic acid can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Valsartan,The metabolism of Nevirapine can be decreased when combined with Valsartan.,decrease,no risk
Nevirapine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Nevirapine.,decrease,no risk
Nevirapine,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Vemurafenib,The metabolism of Nevirapine can be decreased when combined with Vemurafenib.,decrease,no risk
Nevirapine,Venetoclax,The metabolism of Nevirapine can be decreased when combined with Venetoclax.,decrease,no risk
Nevirapine,Venlafaxine,The metabolism of Nevirapine can be decreased when combined with Venlafaxine.,decrease,no risk
Nevirapine,Verapamil,The metabolism of Nevirapine can be decreased when combined with Verapamil.,decrease,no risk
Nevirapine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Nevirapine.,decrease,no risk
Nevirapine,Vilazodone,The metabolism of Nevirapine can be decreased when combined with Vilazodone.,decrease,no risk
Nevirapine,Viloxazine,The metabolism of Nevirapine can be decreased when combined with Viloxazine.,decrease,no risk
Nevirapine,Vinblastine,The metabolism of Nevirapine can be decreased when combined with Vinblastine.,decrease,no risk
Nevirapine,Vincristine,The metabolism of Vincristine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Vinorelbine,The metabolism of Nevirapine can be decreased when combined with Vinorelbine.,decrease,no risk
Nevirapine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Voriconazole,The metabolism of Nevirapine can be decreased when combined with Voriconazole.,decrease,no risk
Nevirapine,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Voxelotor,The metabolism of Voxelotor can be increased when combined with Nevirapine.,increase,no risk
Nevirapine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Warfarin,The metabolism of Warfarin can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Nevirapine.,decrease,no risk
Nevirapine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zafirlukast,The metabolism of Nevirapine can be decreased when combined with Zafirlukast.,decrease,no risk
Nevirapine,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zileuton,The metabolism of Zileuton can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zimelidine,The metabolism of Nevirapine can be decreased when combined with Zimelidine.,decrease,no risk
Nevirapine,Ziprasidone,The metabolism of Nevirapine can be decreased when combined with Ziprasidone.,decrease,no risk
Nevirapine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zotepine,The metabolism of Zotepine can be decreased when combined with Nevirapine.,decrease,no risk
Nevirapine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Nevirapine.,decrease,no risk
Oxiconazole,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Oxiconazole.,decrease,no risk
Oxiconazole,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Oxiconazole.,decrease,no risk
Alclometasone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Alclometasone.,increase,risk
Alclometasone,Vadadustat,The serum concentration of Alclometasone can be increased when it is combined with Vadadustat.,increase,no risk
Alclometasone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Alclometasone.,decrease,no risk
Alclometasone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Vildagliptin.,increase,risk
Alclometasone,Viloxazine,The metabolism of Alclometasone can be decreased when combined with Viloxazine.,decrease,no risk
Alclometasone,Voriconazole,The serum concentration of Alclometasone can be increased when it is combined with Voriconazole.,increase,no risk
Butalbital,Buprenorphine,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Butalbital,Bupropion,The risk or severity of CNS depression can be increased when Butalbital is combined with Bupropion.,increase,risk
Butalbital,Buspirone,The risk or severity of CNS depression can be increased when Butalbital is combined with Buspirone.,increase,risk
Butalbital,Busulfan,The metabolism of Busulfan can be increased when combined with Butalbital.,increase,no risk
Butalbital,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Butalbital.,increase,risk
Butalbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Butacaine.,increase,risk
Butalbital,Butamben,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Butamben.,increase,risk
Butalbital,Butaperazine,The risk or severity of CNS depression can be increased when Butalbital is combined with Butaperazine.,increase,risk
Butalbital,Butobarbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Butobarbital.,increase,risk
Butalbital,Butorphanol,The risk or severity of adverse effects can be increased when Butalbital is combined with Butorphanol.,increase,risk
Butalbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Butalbital.,increase,no risk
Butalbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Butalbital is combined with Butylscopolamine.,increase,risk
Butalbital,Gabapentin,The risk or severity of CNS depression can be increased when Butalbital is combined with Gabapentin.,increase,risk
Butalbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Butalbital is combined with Gabapentin enacarbil.,increase,risk
Butalbital,Galantamine,The therapeutic efficacy of Butalbital can be decreased when used in combination with Galantamine.,decrease,no risk
Butalbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Butalbital is combined with Gallamine triethiodide.,increase,risk
Butalbital,Gamolenic acid,The therapeutic efficacy of Butalbital can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Butalbital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Butalbital is combined with Ganaxolone.",increase,risk
Butalbital,Ganciclovir,The therapeutic efficacy of Butalbital can be decreased when used in combination with Ganciclovir.,decrease,no risk
Butalbital,Gepirone,The risk or severity of CNS depression can be increased when Butalbital is combined with Gepirone.,increase,risk
Butalbital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Butalbital.,increase,no risk
Butalbital,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Butalbital.,increase,no risk
Butalbital,Ginkgo biloba,The therapeutic efficacy of Butalbital can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Butalbital,Glutethimide,The risk or severity of CNS depression can be increased when Butalbital is combined with Glutethimide.,increase,risk
Butalbital,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Butalbital.,decrease,no risk
Butalbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Butalbital is combined with Glycopyrronium.,increase,risk
Butalbital,Granisetron,The risk or severity of CNS depression can be increased when Butalbital is combined with Granisetron.,increase,risk
Butalbital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Butalbital.,decrease,no risk
Butalbital,Guanfacine,Butalbital may increase the hypotensive activities of Guanfacine.,increase,no risk
Butalbital,Halazepam,The risk or severity of CNS depression can be increased when Butalbital is combined with Halazepam.,increase,risk
Butalbital,Halofantrine,The therapeutic efficacy of Butalbital can be decreased when used in combination with Halofantrine.,decrease,no risk
Butalbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Butalbital.,increase,risk
Butalbital,Halothane,Butalbital may increase the hypotensive activities of Halothane.,increase,no risk
Butalbital,Hexafluronium,The risk or severity of CNS depression can be increased when Butalbital is combined with Hexafluronium.,increase,risk
Butalbital,Hexocyclium,The risk or severity of adverse effects can be increased when Butalbital is combined with Hexocyclium.,increase,risk
Butalbital,Homatropine,The risk or severity of adverse effects can be increased when Butalbital is combined with Homatropine.,increase,risk
Butalbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Butalbital is combined with Homatropine methylbromide.,increase,risk
Butalbital,Huperzine A,The therapeutic efficacy of Butalbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Butalbital,Hydralazine,Butalbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Butalbital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Hydrochlorothiazide.,increase,risk
Butalbital,Hydrocodone,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Butalbital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Hydroflumethiazide.,increase,risk
Butalbital,Hydromorphone,The risk or severity of adverse effects can be increased when Butalbital is combined with Hydromorphone.,increase,risk
Butalbital,Hydroxychloroquine,The therapeutic efficacy of Butalbital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Butalbital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Butalbital.,increase,no risk
Butalbital,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Hydroxyurea.,increase,risk
Butalbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butalbital.,increase,no risk
Butalbital,Hyoscyamine,The risk or severity of adverse effects can be increased when Butalbital is combined with Hyoscyamine.,increase,risk
Butalbital,Ketamine,The risk or severity of CNS depression can be increased when Butalbital is combined with Ketamine.,increase,risk
Butalbital,Ketazolam,The risk or severity of CNS depression can be increased when Butalbital is combined with Ketazolam.,increase,risk
Butalbital,Obinutuzumab,Butalbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Butalbital,Olanzapine,Butalbital may increase the hypotensive activities of Olanzapine.,increase,no risk
Butalbital,Olaparib,The metabolism of Olaparib can be increased when combined with Butalbital.,increase,no risk
Butalbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Butalbital is combined with Oliceridine.",increase,risk
Butalbital,Olmesartan,Butalbital may increase the hypotensive activities of Olmesartan.,increase,no risk
Butalbital,Ondansetron,The risk or severity of CNS depression can be increased when Butalbital is combined with Ondansetron.,increase,risk
Butalbital,Opicapone,Butalbital may increase the hypotensive activities of Opicapone.,increase,no risk
Butalbital,Opium,The risk or severity of adverse effects can be increased when Butalbital is combined with Opium.,increase,risk
Butalbital,Orlistat,Orlistat can cause a decrease in the absorption of Butalbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Butalbital,Orphenadrine,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Butalbital,Osimertinib,The metabolism of Osimertinib can be increased when combined with Butalbital.,increase,no risk
Butalbital,Oxazepam,The risk or severity of CNS depression can be increased when Butalbital is combined with Oxazepam.,increase,risk
Butalbital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Butalbital is combined with Oxcarbazepine.,increase,risk
Butalbital,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Oxetacaine.,increase,risk
Butalbital,Oxitriptan,The risk or severity of CNS depression can be increased when Butalbital is combined with Oxitriptan.,increase,risk
Butalbital,Oxprenolol,Butalbital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Butalbital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Butalbital.,decrease,no risk
Butalbital,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Oxybuprocaine.,increase,risk
Butalbital,Oxybutynin,The risk or severity of adverse effects can be increased when Butalbital is combined with Oxybutynin.,increase,risk
Butalbital,Oxycodone,The risk or severity of adverse effects can be increased when Butalbital is combined with Oxycodone.,increase,risk
Butalbital,Oxymorphone,The risk or severity of adverse effects can be increased when Butalbital is combined with Oxymorphone.,increase,risk
Butalbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Butalbital is combined with Oxyphencyclimine.,increase,risk
Butalbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Butalbital.,decrease,no risk
Butalbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Butalbital.,increase,risk
Butalbital,Quazepam,The risk or severity of CNS depression can be increased when Butalbital is combined with Quazepam.,increase,risk
Butalbital,Quetiapine,Butalbital may increase the hypotensive activities of Quetiapine.,increase,no risk
Butalbital,Quinapril,Butalbital may increase the hypotensive activities of Quinapril.,increase,no risk
Butalbital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Quinethazone.,increase,risk
Butalbital,Quinidine,The metabolism of Quinidine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Quinine,The risk or severity of CNS depression can be increased when Butalbital is combined with Quinine.,increase,risk
Butalbital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Butalbital.,decrease,no risk
Butalbital,Umeclidinium,The risk or severity of adverse effects can be increased when Butalbital is combined with Umeclidinium.,increase,risk
Butalbital,Urethane,The risk or severity of CNS depression can be increased when Butalbital is combined with Urethane.,increase,risk
Butalbital,Valganciclovir,The therapeutic efficacy of Butalbital can be decreased when used in combination with Valganciclovir.,decrease,no risk
Butalbital,Valproic acid,The serum concentration of Butalbital can be increased when it is combined with Valproic acid.,increase,no risk
Butalbital,Valsartan,Butalbital may increase the hypotensive activities of Valsartan.,increase,no risk
Butalbital,Vandetanib,The metabolism of Vandetanib can be increased when combined with Butalbital.,increase,no risk
Butalbital,Vecuronium,The risk or severity of CNS depression can be increased when Butalbital is combined with Vecuronium.,increase,risk
Butalbital,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Butalbital.,increase,no risk
Butalbital,Venetoclax,The metabolism of Venetoclax can be increased when combined with Butalbital.,increase,no risk
Butalbital,Venlafaxine,The risk or severity of CNS depression can be increased when Butalbital is combined with Venlafaxine.,increase,risk
Butalbital,Verapamil,Butalbital may increase the hypotensive activities of Verapamil.,increase,no risk
Butalbital,Vericiguat,Butalbital may increase the hypotensive activities of Vericiguat.,increase,no risk
Butalbital,Vigabatrin,The risk or severity of CNS depression can be increased when Butalbital is combined with Vigabatrin.,increase,risk
Butalbital,Vilazodone,The risk or severity of CNS depression can be increased when Butalbital is combined with Vilazodone.,increase,risk
Butalbital,Viloxazine,The risk or severity of CNS depression can be increased when Butalbital is combined with Viloxazine.,increase,risk
Butalbital,Vinblastine,The metabolism of Vinblastine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Vincristine,The metabolism of Vincristine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Vindesine,The metabolism of Vindesine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Vinflunine,The metabolism of Vinflunine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Butalbital.,increase,no risk
Butalbital,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Butalbital.,increase,no risk
Butalbital,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Butalbital.,decrease,no risk
Butalbital,Vortioxetine,The risk or severity of CNS depression can be increased when Butalbital is combined with Vortioxetine.,increase,risk
Butalbital,Warfarin,The metabolism of Warfarin can be increased when combined with Butalbital.,increase,no risk
Butalbital,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Butalbital.,increase,no risk
Butalbital,Yohimbine,The risk or severity of CNS depression can be increased when Butalbital is combined with Yohimbine.,increase,risk
Butalbital,Zaleplon,The risk or severity of CNS depression can be increased when Butalbital is combined with Zaleplon.,increase,risk
Butalbital,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Butalbital.,increase,no risk
Butalbital,Ziconotide,The risk or severity of CNS depression can be increased when Butalbital is combined with Ziconotide.,increase,risk
Butalbital,Zimelidine,The risk or severity of adverse effects can be increased when Butalbital is combined with Zimelidine.,increase,risk
Butalbital,Ziprasidone,The risk or severity of adverse effects can be increased when Butalbital is combined with Ziprasidone.,increase,risk
Butalbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Butalbital is combined with Zolmitriptan.,increase,risk
Butalbital,Zolpidem,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Butalbital,Zonisamide,The metabolism of Zonisamide can be increased when combined with Butalbital.,increase,no risk
Butalbital,Zopiclone,The risk or severity of adverse effects can be increased when Butalbital is combined with Zopiclone.,increase,risk
Butalbital,Zotepine,The risk or severity of CNS depression can be increased when Butalbital is combined with Zotepine.,increase,risk
Butalbital,Zuclopenthixol,The risk or severity of CNS depression can be increased when Butalbital is combined with Zuclopenthixol.,increase,risk
Butalbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Butalbital.,increase,risk
Cladribine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ganciclovir.",increase,risk
Cladribine,Gefitinib,Gefitinib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Gemcitabine,The risk or severity of adverse effects can be increased when Cladribine is combined with Gemcitabine.,increase,risk
Cladribine,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Gemfibrozil.",increase,risk
Cladribine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cladribine.,increase,risk
Cladribine,Gilteritinib,Gilteritinib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Glasdegib,Glasdegib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Glatiramer,The risk or severity of adverse effects can be increased when Cladribine is combined with Glatiramer.,increase,risk
Cladribine,Glecaprevir,Glecaprevir may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Golimumab,The risk or severity of adverse effects can be increased when Cladribine is combined with Golimumab.,increase,risk
Cladribine,Grazoprevir,Grazoprevir may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Guselkumab,The risk or severity of adverse effects can be increased when Cladribine is combined with Guselkumab.,increase,risk
Cladribine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Cladribine.,increase,risk
Cladribine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Cladribine.,increase,risk
Cladribine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Cladribine.,increase,risk
Cladribine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Cladribine is combined with Hydrocortisone acetate.,increase,risk
Cladribine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Cladribine is combined with Hydrocortisone butyrate.,increase,risk
Cladribine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Cladribine is combined with Hydrocortisone succinate.,increase,risk
Cladribine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Cladribine.,increase,risk
Cladribine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Cladribine is combined with Hydroxychloroquine.,increase,risk
Cladribine,Hydroxyurea,The risk or severity of adverse effects can be increased when Cladribine is combined with Hydroxyurea.,increase,risk
Cladribine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Obinutuzumab,The risk or severity of adverse effects can be increased when Cladribine is combined with Obinutuzumab.,increase,risk
Cladribine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Cladribine.,increase,no risk
Cladribine,Ofatumumab,The risk or severity of adverse effects can be increased when Cladribine is combined with Ofatumumab.,increase,risk
Cladribine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ofloxacin.",increase,risk
Cladribine,Olaparib,The risk or severity of adverse effects can be increased when Cladribine is combined with Olaparib.,increase,risk
Cladribine,Osimertinib,Osimertinib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Oteseconazole,The serum concentration of Cladribine can be increased when it is combined with Oteseconazole.,increase,no risk
Cladribine,Ouabain,Ouabain may decrease the cardiotoxic activities of Cladribine.,decrease,no risk
Cladribine,Oxaliplatin,The risk or severity of adverse effects can be increased when Cladribine is combined with Oxaliplatin.,increase,risk
Cladribine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cladribine is combined with Oxetacaine.,increase,risk
Cladribine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cladribine is combined with Oxybuprocaine.,increase,risk
Cladribine,Ozanimod,The risk or severity of adverse effects can be increased when Cladribine is combined with Ozanimod.,increase,risk
Cladribine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ubidecarenone.",increase,risk
Cladribine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Cladribine.,increase,risk
Cladribine,Upadacitinib,The risk or severity of adverse effects can be increased when Cladribine is combined with Upadacitinib.,increase,risk
Cladribine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Cladribine.,increase,risk
Cladribine,Vadadustat,Vadadustat may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Vandetanib,Vandetanib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Cladribine.,increase,risk
Cladribine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Vedolizumab,The risk or severity of adverse effects can be increased when Cladribine is combined with Vedolizumab.,increase,risk
Cladribine,Velpatasvir,Velpatasvir may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Vemurafenib,Vemurafenib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Venetoclax,Venetoclax may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Venlafaxine,Venlafaxine may increase the excretion rate of Cladribine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cladribine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cladribine.,decrease,no risk
Cladribine,Vilanterol,The risk or severity of adverse effects can be increased when Cladribine is combined with Vilanterol.,increase,risk
Cladribine,Vinblastine,The risk or severity of adverse effects can be increased when Cladribine is combined with Vinblastine.,increase,risk
Cladribine,Vincristine,The risk or severity of adverse effects can be increased when Cladribine is combined with Vincristine.,increase,risk
Cladribine,Vindesine,The risk or severity of adverse effects can be increased when Cladribine is combined with Vindesine.,increase,risk
Cladribine,Vinorelbine,The risk or severity of adverse effects can be increased when Cladribine is combined with Vinorelbine.,increase,risk
Cladribine,Vismodegib,Vismodegib may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Voclosporin,The risk or severity of adverse effects can be increased when Cladribine is combined with Voclosporin.,increase,risk
Cladribine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Cladribine.,increase,risk
Cladribine,Vorinostat,The risk or severity of adverse effects can be increased when Cladribine is combined with Vorinostat.,increase,risk
Cladribine,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Cladribine which could result in a higher serum level.,decrease,no risk
Cladribine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Cladribine.,increase,risk
Cladribine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Cladribine.,increase,risk
Cladribine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Cladribine.,increase,risk
Cladribine,Zidovudine,The risk or severity of adverse effects can be increased when Cladribine is combined with Zidovudine.,increase,risk
Ranolazine,Balsalazide,Balsalazide may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Baricitinib,The excretion of Baricitinib can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Beclomethasone dipropionate,The metabolism of Ranolazine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Ranolazine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Bedaquiline.,increase,risk
Ranolazine,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Belumosudil,The serum concentration of Ranolazine can be increased when it is combined with Belumosudil.,increase,no risk
Ranolazine,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Benorilate,Benorilate may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Benserazide,Ranolazine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ranolazine,Benzatropine,The serum concentration of Benzatropine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Benznidazole,Ranolazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ranolazine,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Benzthiazide,Benzthiazide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Benzydamine,Benzydamine may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bepotastine,Ranolazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Ranolazine,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Betamethasone,The metabolism of Ranolazine can be increased when combined with Betamethasone.,increase,no risk
Ranolazine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bexarotene,The metabolism of Ranolazine can be increased when combined with Bexarotene.,increase,no risk
Ranolazine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Bicisate,Ranolazine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ranolazine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ranolazine.,increase,risk
Ranolazine,Bimekizumab,The metabolism of Ranolazine can be increased when combined with Bimekizumab.,increase,no risk
Ranolazine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Biperiden,The metabolism of Ranolazine can be decreased when combined with Biperiden.,decrease,no risk
Ranolazine,Bismuth subgallate,Ranolazine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ranolazine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bisoxatin,Ranolazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ranolazine,Bleomycin,Ranolazine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Ranolazine,Boceprevir,The metabolism of Ranolazine can be decreased when combined with Boceprevir.,decrease,no risk
Ranolazine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bosentan,The metabolism of Ranolazine can be increased when combined with Bosentan.,increase,no risk
Ranolazine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ranolazine.,increase,risk
Ranolazine,Brexpiprazole,The serum concentration of Brexpiprazole can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Brigatinib,The metabolism of Ranolazine can be increased when combined with Brigatinib.,increase,no risk
Ranolazine,Brivaracetam,Ranolazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Ranolazine,Bromazepam,Ranolazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Ranolazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ranolazine.,increase,risk
Ranolazine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ranolazine.,increase,risk
Ranolazine,Budesonide,The metabolism of Ranolazine can be increased when combined with Budesonide.,increase,no risk
Ranolazine,Bumadizone,Bumadizone may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Bumetanide,Bumetanide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Bupropion,The metabolism of Ranolazine can be decreased when combined with Bupropion.,decrease,no risk
Ranolazine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ranolazine.,increase,risk
Ranolazine,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Busulfan,The metabolism of Busulfan can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Butabarbital,Butabarbital may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Butalbital,The metabolism of Ranolazine can be increased when combined with Butalbital.,increase,no risk
Ranolazine,Butriptyline,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Butriptyline.,increase,risk
Ranolazine,Gabapentin enacarbil,Ranolazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ranolazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Gadobenic acid.,increase,risk
Ranolazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Gadofosveset trisodium,Ranolazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ranolazine,Gadopentetic acid,Ranolazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ranolazine,Gadoteric acid,Ranolazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ranolazine,Gadoteridol,Ranolazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ranolazine,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ranolazine.,increase,risk
Ranolazine,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Gemfibrozil,Ranolazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ranolazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Gemifloxacin.,increase,risk
Ranolazine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Gimeracil,Ranolazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ranolazine,Givosiran,The serum concentration of Ranolazine can be increased when it is combined with Givosiran.,increase,no risk
Ranolazine,Glasdegib,The serum concentration of Ranolazine can be increased when it is combined with Glasdegib.,increase,no risk
Ranolazine,Glecaprevir,The serum concentration of Ranolazine can be increased when it is combined with Glecaprevir.,increase,no risk
Ranolazine,Glimepiride,Glimepiride may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Glipizide,Ranolazine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ranolazine,Glofitamab,The serum concentration of Ranolazine can be increased when it is combined with Glofitamab.,increase,no risk
Ranolazine,Glyburide,Glyburide may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Glycerol phenylbutyrate,The metabolism of Ranolazine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ranolazine,Glycyrrhizic acid,Ranolazine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Ranolazine,Golimumab,The metabolism of Ranolazine can be increased when combined with Golimumab.,increase,no risk
Ranolazine,Golodirsen,Ranolazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ranolazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ranolazine.,increase,risk
Ranolazine,Granisetron,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Granisetron.,increase,risk
Ranolazine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Grepafloxacin.,increase,risk
Ranolazine,Griseofulvin,The metabolism of Ranolazine can be increased when combined with Griseofulvin.,increase,no risk
Ranolazine,Guanethidine,Ranolazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ranolazine,Guanfacine,Ranolazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ranolazine,Guanidine,The excretion of Guanidine can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Halofantrine.,increase,risk
Ranolazine,Haloperidol,The metabolism of Ranolazine can be decreased when combined with Haloperidol.,decrease,no risk
Ranolazine,Histamine,The serum concentration of Histamine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ranolazine.,increase,risk
Ranolazine,Hydralazine,Ranolazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Hydrocodone,The serum concentration of Hydrocodone can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Hydrocortamate,The metabolism of Ranolazine can be increased when combined with Hydrocortamate.,increase,no risk
Ranolazine,Hydrocortisone,The metabolism of Ranolazine can be increased when combined with Hydrocortisone.,increase,no risk
Ranolazine,Hydrocortisone acetate,The metabolism of Ranolazine can be increased when combined with Hydrocortisone acetate.,increase,no risk
Ranolazine,Hydrocortisone butyrate,The metabolism of Ranolazine can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Ranolazine,Hydrocortisone probutate,The metabolism of Ranolazine can be increased when combined with Hydrocortisone probutate.,increase,no risk
Ranolazine,Hydrocortisone succinate,The metabolism of Ranolazine can be increased when combined with Hydrocortisone succinate.,increase,no risk
Ranolazine,Hydrocortisone valerate,The metabolism of Ranolazine can be increased when combined with Hydrocortisone valerate.,increase,no risk
Ranolazine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Hydromorphone,Ranolazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ranolazine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Hydroxyethyl Starch,Ranolazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ranolazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Hydroxyzine.,increase,risk
Ranolazine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ranolazine.,increase,risk
Ranolazine,Kanamycin,Ranolazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ranolazine,Ketamine,The metabolism of Ranolazine can be increased when combined with Ketamine.,increase,no risk
Ranolazine,Ketazolam,Ranolazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ranolazine,Ketoconazole,The metabolism of Ranolazine can be decreased when combined with Ketoconazole.,decrease,no risk
Ranolazine,Ketoprofen,Ketoprofen may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Ketorolac,Ketorolac may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Octinoxate,Ranolazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ranolazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ranolazine.,increase,risk
Ranolazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Ofloxacin.,increase,risk
Ranolazine,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Olaparib,The metabolism of Olaparib can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Olmesartan,Olmesartan may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ranolazine.,increase,risk
Ranolazine,Olsalazine,Olsalazine may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Olutasidenib,The metabolism of Ranolazine can be increased when combined with Olutasidenib.,increase,no risk
Ranolazine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Omaveloxolone,The metabolism of Ranolazine can be increased when combined with Omaveloxolone.,increase,no risk
Ranolazine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Opium,The serum concentration of Opium can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Oritavancin,The metabolism of Ranolazine can be increased when combined with Oritavancin.,increase,no risk
Ranolazine,Orphenadrine,The metabolism of Ranolazine can be decreased when combined with Orphenadrine.,decrease,no risk
Ranolazine,Oseltamivir,Oseltamivir may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Osilodrostat,The metabolism of Ranolazine can be decreased when combined with Osilodrostat.,decrease,no risk
Ranolazine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Ospemifene,The metabolism of Ranolazine can be decreased when combined with Ospemifene.,decrease,no risk
Ranolazine,Oxacillin,Ranolazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ranolazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ranolazine.,increase,risk
Ranolazine,Oxamniquine,The metabolism of Ranolazine can be decreased when combined with Oxamniquine.,decrease,no risk
Ranolazine,Oxaprozin,Oxaprozin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Oxatomide.,increase,risk
Ranolazine,Oxazepam,Ranolazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ranolazine,Oxcarbazepine,The metabolism of Ranolazine can be increased when combined with Oxcarbazepine.,increase,no risk
Ranolazine,Oxiconazole,The metabolism of Ranolazine can be increased when combined with Oxiconazole.,increase,no risk
Ranolazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Oxybenzone,Ranolazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ranolazine,Oxybutynin,The metabolism of Ranolazine can be decreased when combined with Oxybutynin.,decrease,no risk
Ranolazine,Oxycodone,The serum concentration of Oxycodone can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Oxymorphone,The serum concentration of Oxymorphone can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Oxyquinoline,Ranolazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ranolazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ranolazine.,increase,risk
Ranolazine,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Quinethazone,Quinethazone may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ranolazine,Quinidine,The serum concentration of Ranolazine can be increased when it is combined with Quinidine.,increase,no risk
Ranolazine,Quinine,The metabolism of Ranolazine can be increased when combined with Quinine.,increase,no risk
Ranolazine,Quizartinib,The serum concentration of Ranolazine can be increased when it is combined with Quizartinib.,increase,no risk
Ranolazine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Umbralisib,The serum concentration of Ranolazine can be increased when it is combined with Umbralisib.,increase,no risk
Ranolazine,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Vaborbactam,Ranolazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ranolazine,Vadadustat,The serum concentration of Ranolazine can be increased when it is combined with Vadadustat.,increase,no risk
Ranolazine,Valaciclovir,Valaciclovir may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Valdecoxib,Valdecoxib may decrease the excretion rate of Ranolazine which could result in a higher serum level.,decrease,no risk
Ranolazine,Valganciclovir,Ranolazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ranolazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Valproic acid.,increase,risk
Ranolazine,Vancomycin,Ranolazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ranolazine,Vandetanib,The serum concentration of Ranolazine can be increased when it is combined with Vandetanib.,increase,no risk
Ranolazine,Vardenafil,The serum concentration of Ranolazine can be increased when it is combined with Vardenafil.,increase,no risk
Ranolazine,Varenicline,The excretion of Varenicline can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Velpatasvir,The serum concentration of Ranolazine can be increased when it is combined with Velpatasvir.,increase,no risk
Ranolazine,Vemurafenib,The metabolism of Ranolazine can be increased when combined with Vemurafenib.,increase,no risk
Ranolazine,Venetoclax,The serum concentration of Ranolazine can be increased when it is combined with Venetoclax.,increase,no risk
Ranolazine,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Verapamil,The serum concentration of Ranolazine can be increased when it is combined with Verapamil.,increase,no risk
Ranolazine,Vernakalant,The serum concentration of Vernakalant can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ranolazine.,increase,risk
Ranolazine,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Viloxazine,The metabolism of Ranolazine can be decreased when combined with Viloxazine.,decrease,no risk
Ranolazine,Vinblastine,The metabolism of Ranolazine can be increased when combined with Vinblastine.,increase,no risk
Ranolazine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Vindesine,The metabolism of Vindesine can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Vitamin E,The metabolism of Ranolazine can be increased when combined with Vitamin E.,increase,no risk
Ranolazine,Voclosporin,The serum concentration of Ranolazine can be increased when it is combined with Voclosporin.,increase,no risk
Ranolazine,Vorapaxar,The serum concentration of Ranolazine can be increased when it is combined with Vorapaxar.,increase,no risk
Ranolazine,Voriconazole,The metabolism of Ranolazine can be decreased when combined with Voriconazole.,decrease,no risk
Ranolazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ranolazine.,increase,risk
Ranolazine,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Voxilaprevir,The serum concentration of Ranolazine can be increased when it is combined with Voxilaprevir.,increase,no risk
Ranolazine,Warfarin,The metabolism of Ranolazine can be increased when combined with Warfarin.,increase,no risk
Ranolazine,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Zaleplon,Ranolazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ranolazine,Zanamivir,Ranolazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ranolazine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Zimelidine,The metabolism of Ranolazine can be decreased when combined with Zimelidine.,decrease,no risk
Ranolazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Ziprasidone.,increase,risk
Ranolazine,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Ranolazine.,increase,no risk
Ranolazine,Zonisamide,The serum concentration of Ranolazine can be increased when it is combined with Zonisamide.,increase,no risk
Ranolazine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ranolazine.,decrease,no risk
Ranolazine,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Ranolazine.,increase,no risk
Mesalazine,Benzatropine,Mesalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Mesalazine,Benznidazole,Mesalazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Mesalazine,Benzphetamine,The risk or severity of hypertension can be increased when Mesalazine is combined with Benzphetamine.,increase,risk
Mesalazine,Benzydamine,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Benzydamine.,increase,risk
Mesalazine,Bepotastine,Mesalazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Mesalazine,Bepridil,Mesalazine may decrease the antihypertensive activities of Bepridil.,decrease,no risk
Mesalazine,Betamethasone,The serum concentration of Mesalazine can be decreased when it is combined with Betamethasone.,decrease,no risk
Mesalazine,Betaxolol,Mesalazine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Mesalazine,Bethanidine,Mesalazine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Mesalazine,Betrixaban,The risk or severity of bleeding can be increased when Mesalazine is combined with Betrixaban.,increase,risk
Mesalazine,Betulinic Acid,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Betulinic Acid.,increase,risk
Mesalazine,Bexagliflozin,Mesalazine may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Mesalazine,Bezafibrate,The excretion of Mesalazine can be decreased when combined with Bezafibrate.,decrease,no risk
Mesalazine,Bicisate,Mesalazine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Mesalazine,Bismuth subgallate,Mesalazine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Mesalazine,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mesalazine,Bismuth subsalicylate,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Mesalazine is combined with Bismuth subsalicylate.",increase,risk
Mesalazine,Bisoprolol,Mesalazine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Mesalazine,Bisoxatin,Mesalazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Mesalazine,Bivalirudin,The risk or severity of bleeding can be increased when Mesalazine is combined with Bivalirudin.,increase,risk
Mesalazine,Bleomycin,Mesalazine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Mesalazine,Bosentan,Mesalazine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Mesalazine,Bretylium,Mesalazine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Mesalazine,Brexpiprazole,The risk or severity of hypertension can be increased when Mesalazine is combined with Brexpiprazole.,increase,risk
Mesalazine,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Mesalazine.,increase,risk
Mesalazine,Brivaracetam,Mesalazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Mesalazine,Bromazepam,Mesalazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Mesalazine,Bromfenac,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Bromfenac.,increase,risk
Mesalazine,Bromocriptine,Mesalazine may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Mesalazine,Budesonide,The serum concentration of Mesalazine can be decreased when it is combined with Budesonide.,decrease,no risk
Mesalazine,Bufexamac,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Bufexamac.,increase,risk
Mesalazine,Bumadizone,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Bumadizone.,increase,risk
Mesalazine,Bumetanide,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Bumetanide.,increase,risk
Mesalazine,Bupropion,Mesalazine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Mesalazine,Buspirone,The risk or severity of hypertension can be increased when Mesalazine is combined with Buspirone.,increase,risk
Mesalazine,Butabarbital,Mesalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Mesalazine,Butriptyline,The risk or severity of hypertension can be increased when Mesalazine is combined with Butriptyline.,increase,risk
Mesalazine,Gabapentin enacarbil,Mesalazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Mesalazine,Gadobenic acid,Mesalazine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Mesalazine,Gadodiamide,Mesalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Mesalazine,Gadofosveset trisodium,Mesalazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Mesalazine,Gadopentetic acid,Mesalazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Mesalazine,Gadoteric acid,Mesalazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Mesalazine,Gadoteridol,Mesalazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Mesalazine,Ganciclovir,Mesalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Mesalazine,Gemcitabine,Mesalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Mesalazine,Gemfibrozil,The excretion of Mesalazine can be decreased when combined with Gemfibrozil.,decrease,no risk
Mesalazine,Gentamicin,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Gentamicin.,increase,risk
Mesalazine,Gimeracil,Mesalazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Mesalazine,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Mesalazine.,increase,risk
Mesalazine,Givosiran,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Givosiran.,increase,risk
Mesalazine,Glecaprevir,The excretion of Mesalazine can be decreased when combined with Glecaprevir.,decrease,no risk
Mesalazine,Gliclazide,Mesalazine may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Mesalazine,Glimepiride,Mesalazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Mesalazine,Glipizide,Mesalazine may increase the hypoglycemic activities of Glipizide.,increase,no risk
Mesalazine,Gliquidone,Mesalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Mesalazine,Glyburide,Mesalazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Mesalazine,Glycerol phenylbutyrate,Mesalazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Mesalazine,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Glycol salicylate.,increase,risk
Mesalazine,Glymidine,Mesalazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Mesalazine,Golodirsen,Mesalazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Mesalazine,Goserelin,Mesalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Mesalazine,Guanabenz,Mesalazine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Mesalazine,Guanadrel,Mesalazine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Mesalazine,Guanethidine,Mesalazine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Mesalazine,Guanfacine,Mesalazine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Mesalazine,Guanoxan,Mesalazine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Mesalazine,Haloperidol,Mesalazine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Mesalazine,Halothane,The risk or severity of hypertension can be increased when Mesalazine is combined with Halothane.,increase,risk
Mesalazine,Heparin,The risk or severity of bleeding can be increased when Mesalazine is combined with Heparin.,increase,risk
Mesalazine,Hydralazine,Mesalazine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Mesalazine,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Hydrochlorothiazide.,increase,risk
Mesalazine,Hydrocortisone,The serum concentration of Mesalazine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Mesalazine,Hydroflumethiazide,Mesalazine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Mesalazine,Hydromorphone,Mesalazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Mesalazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mesalazine,Hydroxocobalamin,Mesalazine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Mesalazine,Hydroxyethyl Starch,Mesalazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Mesalazine,Kanamycin,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Kanamycin.,increase,risk
Mesalazine,Ketamine,Mesalazine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Mesalazine,Ketazolam,Mesalazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Mesalazine,Ketoconazole,The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Ketoconazole.,increase,risk
Mesalazine,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ketoprofen.,increase,risk
Mesalazine,Ketorolac,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Ketorolac.,increase,risk
Mesalazine,Octinoxate,Mesalazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Mesalazine,Olanzapine,The therapeutic efficacy of Mesalazine can be decreased when used in combination with Olanzapine.,decrease,no risk
Mesalazine,Olmesartan,Mesalazine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Mesalazine,Olodaterol,The risk or severity of hypertension can be increased when Mesalazine is combined with Olodaterol.,increase,risk
Mesalazine,Olsalazine,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Olsalazine.,increase,risk
Mesalazine,Omeprazole,Omeprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mesalazine,Opium,Mesalazine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Mesalazine,Orciprenaline,The risk or severity of hypertension can be increased when Mesalazine is combined with Orciprenaline.,increase,risk
Mesalazine,Oseltamivir,Mesalazine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Mesalazine,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Mesalazine.,decrease,no risk
Mesalazine,Oxacillin,Mesalazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Mesalazine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Mesalazine.,increase,risk
Mesalazine,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Oxaprozin.,increase,risk
Mesalazine,Oxazepam,Mesalazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Mesalazine,Oxprenolol,Mesalazine may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Mesalazine,Oxybenzone,Mesalazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Mesalazine,Oxymetazoline,The risk or severity of hypertension can be increased when Mesalazine is combined with Oxymetazoline.,increase,risk
Mesalazine,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Oxyphenbutazone.,increase,risk
Mesalazine,Oxyquinoline,Mesalazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Mesalazine,Quetiapine,The risk or severity of hypertension can be increased when Mesalazine is combined with Quetiapine.,increase,risk
Mesalazine,Quinapril,The risk or severity of renal failure can be increased when Mesalazine is combined with Quinapril.,increase,risk
Mesalazine,Quinidine,Mesalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Mesalazine,Quinine,Mesalazine may increase the hypoglycemic activities of Quinine.,increase,no risk
Mesalazine,Quinupramine,The risk or severity of hypertension can be increased when Mesalazine is combined with Quinupramine.,increase,risk
Mesalazine,Urokinase,The risk or severity of bleeding can be increased when Mesalazine is combined with Urokinase.,increase,risk
Mesalazine,Vaborbactam,Mesalazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Mesalazine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Valaciclovir.,increase,risk
Mesalazine,Valbenazine,Mesalazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Mesalazine,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Valdecoxib.,increase,risk
Mesalazine,Valganciclovir,Mesalazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Mesalazine,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Mesalazine.,increase,no risk
Mesalazine,Valsartan,Mesalazine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Mesalazine,Vancomycin,The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Vancomycin.,increase,risk
Mesalazine,Varenicline,Mesalazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Mesalazine,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Mesalazine is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Mesalazine,Velpatasvir,The excretion of Mesalazine can be decreased when combined with Velpatasvir.,decrease,no risk
Mesalazine,Venetoclax,The excretion of Mesalazine can be decreased when combined with Venetoclax.,decrease,no risk
Mesalazine,Venlafaxine,Mesalazine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Mesalazine,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Mesalazine.,increase,risk
Mesalazine,Vilanterol,The risk or severity of hypertension can be increased when Mesalazine is combined with Vilanterol.,increase,risk
Mesalazine,Vilazodone,The risk or severity of hypertension can be increased when Mesalazine is combined with Vilazodone.,increase,risk
Mesalazine,Vildagliptin,Mesalazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Mesalazine,Viloxazine,Mesalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Mesalazine,Vinblastine,The excretion of Mesalazine can be decreased when combined with Vinblastine.,decrease,no risk
Mesalazine,Vincristine,The excretion of Mesalazine can be decreased when combined with Vincristine.,decrease,no risk
Mesalazine,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mesalazine,Vorapaxar,The risk or severity of bleeding can be increased when Mesalazine is combined with Vorapaxar.,increase,risk
Mesalazine,Vortioxetine,The risk or severity of hypertension can be increased when Mesalazine is combined with Vortioxetine.,increase,risk
Mesalazine,Voxilaprevir,The excretion of Mesalazine can be decreased when combined with Voxilaprevir.,decrease,no risk
Mesalazine,Warfarin,Mesalazine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Mesalazine,Xamoterol,The risk or severity of hypertension can be increased when Mesalazine is combined with Xamoterol.,increase,risk
Mesalazine,Ximelagatran,The risk or severity of bleeding can be increased when Mesalazine is combined with Ximelagatran.,increase,risk
Mesalazine,Xylometazoline,The risk or severity of hypertension can be increased when Mesalazine is combined with Xylometazoline.,increase,risk
Mesalazine,Yohimbine,The risk or severity of hypertension can be increased when Mesalazine is combined with Yohimbine.,increase,risk
Mesalazine,Zaleplon,Mesalazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Mesalazine,Zanamivir,Mesalazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Mesalazine,Ziprasidone,The risk or severity of hypertension can be increased when Mesalazine is combined with Ziprasidone.,increase,risk
Mesalazine,Zofenopril,The risk or severity of renal failure can be increased when Mesalazine is combined with Zofenopril.,increase,risk
Mesalazine,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Mesalazine is combined with Zoledronic acid.,increase,risk
Mesalazine,Zolmitriptan,The risk or severity of hypertension can be increased when Mesalazine is combined with Zolmitriptan.,increase,risk
Mesalazine,Zonisamide,The risk or severity of adverse effects can be increased when Mesalazine is combined with Zonisamide.,increase,risk
Mesalazine,Zuclopenthixol,The risk or severity of hypertension can be increased when Mesalazine is combined with Zuclopenthixol.,increase,risk
Benzatropine,Benznidazole,Benzatropine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Benzatropine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Benzatropine.,decrease,no risk
Benzatropine,Benzphetamine,Benzphetamine may decrease the sedative activities of Benzatropine.,decrease,no risk
Benzatropine,Benzthiazide,Benzthiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Benzatropine,Benzydamine,Benzydamine may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Benzatropine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Benzatropine.,decrease,no risk
Benzatropine,Benzylpenicilloyl polylysine,Benzatropine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Benzatropine,Bepotastine,Benzatropine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Benzatropine,Bepridil,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bepridil.,increase,risk
Benzatropine,Berotralstat,The metabolism of Benzatropine can be decreased when combined with Berotralstat.,decrease,no risk
Benzatropine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzatropine.,decrease,no risk
Benzatropine,Betaine,The therapeutic efficacy of Benzatropine can be decreased when used in combination with Betaine.,decrease,no risk
Benzatropine,Betaxolol,The metabolism of Benzatropine can be decreased when combined with Betaxolol.,decrease,no risk
Benzatropine,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Benzatropine.,increase,risk
Benzatropine,Bicisate,Benzatropine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Benzatropine,Bilastine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bilastine.,increase,risk
Benzatropine,Bimekizumab,The metabolism of Benzatropine can be increased when combined with Bimekizumab.,increase,no risk
Benzatropine,Biperiden,The metabolism of Benzatropine can be decreased when combined with Biperiden.,decrease,no risk
Benzatropine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Benzatropine.,decrease,no risk
Benzatropine,Bismuth subgallate,Benzatropine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Benzatropine,Bisoprolol,Benzatropine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Benzatropine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Benzatropine.,decrease,no risk
Benzatropine,Bleomycin,Benzatropine may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Benzatropine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Benzatropine.,increase,risk
Benzatropine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum toxin type A.,increase,risk
Benzatropine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum toxin type B.,increase,risk
Benzatropine,Bretylium,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Bretylium.,increase,risk
Benzatropine,Brexpiprazole,The therapeutic efficacy of Benzatropine can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Benzatropine,Brivaracetam,Benzatropine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Benzatropine,Bromazepam,Benzatropine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Benzatropine,Bromocriptine,The risk or severity of Tachycardia can be increased when Benzatropine is combined with Bromocriptine.,increase,risk
Benzatropine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Benzatropine,Brompheniramine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Brompheniramine.,increase,risk
Benzatropine,Buclizine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Buclizine.,increase,risk
